1	Effect	NN	O	effect	_	0	SENT_1	[p1l58t158r295b228],
2	of	IN	O	of	_	0	SENT_1	[p1l327t158r415b228],
3	Polymorphic	JJ	MISC	polymorphic	amod	5	SENT_1	[p1l434t158r979b250],
4	CYP3A5	NN	MISC	cyp3a5	nn	5	SENT_1	[p1l1019t161r1372b228],
5	Genotype	NN	MISC	genotype	prep_of	1	SENT_1	[p1l1405t161r1805b250],
6	on	IN	O	on	_	0	SENT_1	[p1l1840t182r1942b228],
7	the	DT	O	the	prep_on	1	SENT_1	[p1l1972t158r2101b228],

1	Single-Dose	JJ	O	single-dose	amod	3	SENT_2	[p1l168t266r660b358],
2	Simvastatin	NNP	O	Simvastatin	nn	3	SENT_2	[p1l695t269r1198b336],
3	Pharmacokinetics	NNPS	O	Pharmacokinetics	_	0	SENT_2	[p1l1228t266r1994b336],
4	in	IN	O	in	_	0	SENT_2	[p1l668t377r750b443],
5	Healthy	JJ	O	healthy	amod	6	SENT_2	[p1l781t374r1115b466],
6	Subjects	NNS	O	subject	prep_in	3	SENT_2	[p1l1148t374r1492b466],

1	Kyoung-Ah	NNP	O	Kyoung-Ah	nn	2	SENT_3	[p1l89t541r345b592],
2	Kim	NNP	PERSON	Kim	_	0	SENT_3	[p1l363t543r467b586],
3	,	,	O	,	_	0	SENT_3	[p1l363t543r467b586],
4	PhD	NNP	O	PhD	appos	2	SENT_3	[p1l486t541r593b586],
5	,	,	O	,	_	0	SENT_3	[p1l486t541r593b586],
6	Pil-Whan	NNP	O	Pil-Whan	nn	13	SENT_3	[p1l612t541r824b579],
7	Park	NNP	O	Park	nn	13	SENT_3	[p1l842t541r958b586],
8	,	,	O	,	_	0	SENT_3	[p1l842t541r958b586],
9	MD	NNP	O	MD	appos	13	SENT_3	[p1l977t544r1068b586],
10	,	,	O	,	_	0	SENT_3	[p1l977t544r1068b586],
11	PhD	NNP	O	PhD	appos	13	SENT_3	[p1l1086t541r1194b586],
12	,	,	O	,	_	0	SENT_3	[p1l1086t541r1194b586],
13	Ocl	NNP	O	Ocl	appos	2	SENT_3	[p1l1216t541r1362b589],
14	<	JJR	O	<	rcmod	13	SENT_3	[p1l1216t541r1362b589],
15	-	:	O	-	_	0	SENT_3	[p1l1216t541r1362b589],
16	]	NN	O	]	dep	14	SENT_3	[p1l1216t541r1362b589],
17	e	SYM	O	e	dep	18	SENT_3	[p1l1216t541r1362b589],
18	Lee	NNP	PERSON	Lee	dep	14	SENT_3	[p1l1378t544r1466b586],
19	,	,	O	,	_	0	SENT_3	[p1l1378t544r1466b586],
20	BS	NNP	O	BS	appos	18	SENT_3	[p1l1485t543r1558b586],
21	,	,	O	,	_	0	SENT_3	[p1l1485t543r1558b586],
22	Dong-Kyun	NNP	PERSON	Dong-Kyun	nn	23	SENT_3	[p1l1577t544r1831b592],
23	Kong	NNP	PERSON	Kong	appos	18	SENT_3	[p1l1849t544r1976b592],
24	,	,	O	,	_	0	SENT_3	[p1l1849t544r1976b592],
25	BS	NNP	O	BS	appos	18	SENT_3	[p1l1995t543r2068b586],
26	,	,	O	,	_	0	SENT_3	[p1l1995t543r2068b586],

1	and	CC	O	and	dep	4	SENT_4	[p1l755t599r842b637],
2	]	JJ	O	]	amod	4	SENT_4	[p1l854t601r1053b649],
3	i-Young	JJ	O	i-young	amod	4	SENT_4	[p1l854t601r1053b649],
4	Park	NN	O	park	_	0	SENT_4	[p1l1067t599r1182b643],
5	,	,	O	,	_	0	SENT_4	[p1l1067t599r1182b643],
6	MD	NN	O	md	appos	4	SENT_4	[p1l1201t601r1292b643],
7	,	,	O	,	_	0	SENT_4	[p1l1201t601r1292b643],
8	PhD	NN	O	phd	appos	4	SENT_4	[p1l1311t599r1409b637],

1	Simvastatin	NNP	MISC	Simvastatin	nsubjpass	9	SENT_5	[p1l17t785r487b853],
2	,	,	O	,	_	0	SENT_5	[p1l17t785r487b853],
3	a	DT	O	a	det	5	SENT_5	[p1l552t804r589b843],
4	cholesterol-lowering	JJ	O	cholesterol-lowering	amod	5	SENT_5	[p1l651t782r1427b862],
5	agent	NN	O	agent	appos	1	SENT_5	[p1l1482t791r1704b862],
6	,	,	O	,	_	0	SENT_5	[p1l1482t791r1704b862],
7	is	VBZ	O	be	auxpass	9	SENT_5	[p1l1765t786r1826b843],
8	mainly	RB	O	mainly	advmod	9	SENT_5	[p1l1882t782r2152b863],
9	metabolized	VBN	O	metabolize	_	0	SENT_5	[p1l14t880r465b941],
10	by	IN	O	by	_	0	SENT_5	[p1l489t880r577b960],
11	C	NN	O	c	nn	12	SENT_5	[p1l599t883r651b941],
12	YPSA4/5	NN	O	ypsa4/5	agent	9	SENT_5	[p1l656t880r977b941],
13	.	.	O	.	_	0	SENT_5	[p1l985t930r994b941],

1	The	DT	O	the	det	2	SENT_6	[p1l1030t880r1163b941],
2	objective	NN	O	objective	nsubj	6	SENT_6	[p1l1191t880r1509b960],
3	of	IN	O	of	_	0	SENT_6	[p1l1536t880r1614b960],
4	this	DT	O	this	det	5	SENT_6	[p1l1629t880r1760b941],
5	study	NN	O	study	prep_of	2	SENT_6	[p1l1786t880r1990b960],
6	was	VBD	O	be	_	0	SENT_6	[p1l2011t901r2146b941],
7	to	TO	O	to	aux	8	SENT_6	[p1l18t985r82b1038],
8	investigate	VB	O	investigate	xcomp	6	SENT_6	[p1l127t980r520b1057],
9	the	DT	O	the	det	10	SENT_6	[p1l569t977r678b1038],
10	effect	NN	O	effect	dobj	8	SENT_6	[p1l726t977r924b1057],
11	of	IN	O	of	_	0	SENT_6	[p1l969t977r1047b1057],
12	CYP3A5	NN	O	cyp3a5	prep_of	10	SENT_6	[p1l1080t980r1472b1038],
13	*	CD	NUMBER	*	number	14	SENT_6	[p1l1080t980r1472b1038],
14	3	CD	NUMBER	3	num	15	SENT_6	[p1l1080t980r1472b1038],
15	genotype	NN	O	genotype	xcomp	8	SENT_6	[p1l1521t985r1851b1057],
16	on	IN	O	on	_	0	SENT_6	[p1l1899t998r1984b1038],
17	the	DT	O	the	det	18	SENT_6	[p1l2036t977r2145b1038],
18	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	15	SENT_6	[p1l11t1073r672b1153],
19	of	IN	O	of	_	0	SENT_6	[p1l710t1073r787b1153],
20	simvastatin	NN	O	simvastatin	prep_of	18	SENT_6	[p1l812t1077r1230b1134],
21	in	IN	O	in	_	0	SENT_6	[p1l1267t1077r1336b1134],
22	humans	NNS	O	human	prep_in	8	SENT_6	[p1l1373t1073r1687b1134],
23	.	.	O	.	_	0	SENT_6	[p1l1373t1073r1687b1134],

1	Twenty-two	CD	NUMBER	twenty-two	num	2	SENT_7	[p1l1734t1077r2145b1154],
2	men	NNS	O	man	_	0	SENT_7	[p1l13t1193r169b1233],
3	with	IN	O	with	_	0	SENT_7	[p1l205t1172r356b1233],
4	CYP3A5	NN	O	cyp3a5	nn	5	SENT_7	[p1l389t1172r899b1233],
5	*	NN	O	*	prep_with	2	SENT_7	[p1l389t1172r899b1233],
6	1	CD	NUMBER	1	num	5	SENT_7	[p1l389t1172r899b1233],
7	/	:	O	/	punct	2	SENT_7	[p1l389t1172r899b1233],
8	*	CD	NUMBER	*	number	9	SENT_7	[p1l389t1172r899b1233],
9	1	CD	NUMBER	1	num	14	SENT_7	[p1l389t1172r899b1233],
10	(	NN	O	(	nn	14	SENT_7	[p1l937t1172r1005b1245],
11	n	NN	O	n	nn	14	SENT_7	[p1l937t1172r1005b1245],
12	=	JJ	O	=	amod	14	SENT_7	[p1l1038t1201r1079b1223],
13	4	CD	NUMBER	4	num	14	SENT_7	[p1l1113t1172r1197b1245],
14	]	NN	O	]	nsubjpass	42	SENT_7	[p1l1113t1172r1197b1245],
15	,	,	O	,	_	0	SENT_7	[p1l1113t1172r1197b1245],
16	CYP3A5	NN	O	cyp3a5	nn	17	SENT_7	[p1l1230t1172r1742b1233],
17	*	NN	O	*	appos	14	SENT_7	[p1l1230t1172r1742b1233],
18	1	CD	NUMBER	1	dep	17	SENT_7	[p1l1230t1172r1742b1233],
19	/	:	O	/	punct	26	SENT_7	[p1l1230t1172r1742b1233],
20	*	CD	NUMBER	*	number	21	SENT_7	[p1l1230t1172r1742b1233],
21	3	CD	NUMBER	3	num	26	SENT_7	[p1l1230t1172r1742b1233],
22	(	NN	O	(	nn	26	SENT_7	[p1l1780t1172r1847b1245],
23	n	NN	O	n	nn	26	SENT_7	[p1l1780t1172r1847b1245],
24	=	JJ	O	=	amod	26	SENT_7	[p1l1880t1201r1921b1223],
25	8	CD	NUMBER	8	num	26	SENT_7	[p1l1956t1172r2039b1245],
26	]	NN	O	]	dep	18	SENT_7	[p1l1956t1172r2039b1245],
27	,	,	O	,	_	0	SENT_7	[p1l1956t1172r2039b1245],
28	or	CC	O	or	_	0	SENT_7	[p1l2075t1193r2150b1233],
29	CYP3A5	NN	O	cyp3a5	conj_or	26	SENT_7	[p1l15t1269r426b1330],
30	*	CD	NUMBER	*	num	31	SENT_7	[p1l15t1269r426b1330],
31	3	CD	NUMBER	3	dep	26	SENT_7	[p1l15t1269r426b1330],
32	/	:	O	/	punct	26	SENT_7	[p1l15t1269r426b1330],
33	*	CD	NUMBER	*	number	34	SENT_7	[p1l435t1273r508b1330],
34	3	CD	NUMBER	3	num	40	SENT_7	[p1l435t1273r508b1330],
35	(	NN	O	(	nn	40	SENT_7	[p1l538t1269r603b1341],
36	n	NN	O	n	nn	40	SENT_7	[p1l538t1269r603b1341],
37	=	JJ	O	=	amod	40	SENT_7	[p1l628t1298r669b1319],
38	10	CD	NUMBER	10	number	39	SENT_7	[p1l699t1269r803b1341],
39	)	CD	NUMBER	)	num	40	SENT_7	[p1l699t1269r803b1341],
40	genotypes	NNS	O	genotype	dep	17	SENT_7	[p1l821t1277r1172b1349],
41	were	VBD	O	be	auxpass	42	SENT_7	[p1l1196t1290r1356b1330],
42	enrolled	VBN	O	enrol	dep	2	SENT_7	[p1l1379t1269r1681b1330],
43	.	.	O	.	_	0	SENT_7	[p1l1379t1269r1681b1330],

1	Each	DT	O	each	nsubj	3	SENT_8	[p1l1705t1269r1877b1330],
2	subject	JJ	O	subject	advmod	3	SENT_8	[p1l1902t1269r2149b1349],
3	ingested	VBN	O	ingest	_	0	SENT_8	[p1l14t1365r304b1445],
4	a	DT	O	a	det	6	SENT_8	[p1l323t1387r360b1426],
5	20-mg	JJ	O	20-mg	amod	6	SENT_8	[p1l382t1374r600b1445],
6	dose	NN	O	dose	dobj	3	SENT_8	[p1l618t1365r774b1426],
7	of	IN	O	of	_	0	SENT_8	[p1l796t1365r871b1445],
8	simvastatin	NN	O	simvastatin	prep_of	6	SENT_8	[p1l879t1369r1293b1436],
9	,	,	O	,	_	0	SENT_8	[p1l879t1369r1293b1436],
10	and	CC	O	and	_	0	SENT_8	[p1l1319t1365r1454b1426],
11	plasma	NN	O	plasma	nn	13	SENT_8	[p1l1467t1365r1724b1445],
12	simvastatin	NN	O	simvastatin	nn	13	SENT_8	[p1l1746t1369r2143b1426],
13	concentrations	NNS	O	concentration	nsubjpass	15	SENT_8	[p1l17t1467r563b1524],
14	were	VBD	O	be	auxpass	15	SENT_8	[p1l599t1484r765b1524],
15	measured	VBN	O	measure	conj_and	3	SENT_8	[p1l796t1463r1160b1524],
16	for	IN	O	for	_	0	SENT_8	[p1l1182t1463r1295b1543],
17	12	CD	DURATION	12	num	18	SENT_8	[p1l1328t1471r1408b1523],
18	hours	NNS	NUMBER	hour	prep_for	15	SENT_8	[p1l1440t1463r1649b1524],
19	after	IN	O	after	_	0	SENT_8	[p1l1683t1463r1853b1543],
20	dosing	NN	O	dosing	prep_after	15	SENT_8	[p1l1884t1463r2140b1543],
21	.	.	O	.	_	0	SENT_8	[p1l1884t1463r2140b1543],

1	The	DT	O	the	det	4	SENT_9	[p1l21t1560r154b1621],
2	mean	JJ	O	mean	amod	4	SENT_9	[p1l179t1581r378b1621],
3	(	NN	O	(	nn	4	SENT_9	[p1l409t1560r608b1632],
4	i-SD	NN	O	i-sd	dep	13	SENT_9	[p1l409t1560r608b1632],
5	}	CD	NUMBER	}	num	6	SENT_9	[p1l409t1560r608b1632],
6	area	NN	O	area	dep	4	SENT_9	[p1l635t1581r789b1621],
7	under	IN	O	under	_	0	SENT_9	[p1l821t1560r1036b1621],
8	the	DT	O	the	det	9	SENT_9	[p1l1060t1560r1169b1621],
9	plasma	NN	O	plasma	prep_under	6	SENT_9	[p1l1191t1560r1460b1640],
10	concentration	NN	O	concentration	dep	13	SENT_9	[p1l1489t1563r2146b1621],
11	—	CD	NUMBER	—	num	10	SENT_9	[p1l1489t1563r2146b1621],
12	time	NN	O	time	nn	13	SENT_9	[p1l1489t1563r2146b1621],
13	curve	NN	O	curve	dep	19	SENT_9	[p1l17t1678r205b1717],
14	for	IN	O	for	_	0	SENT_9	[p1l230t1656r338b1736],
15	simvastatin	NN	O	simvastatin	prep_for	13	SENT_9	[p1l368t1660r764b1717],
16	in	IN	O	in	_	0	SENT_9	[p1l799t1660r866b1717],
17	the	DT	O	the	det	18	SENT_9	[p1l906t1656r1011b1717],
18	CYP3A5	NN	O	cyp3a5	prep_in	15	SENT_9	[p1l1045t1656r1533b1717],
19	*	NN	O	*	dep	24	SENT_9	[p1l1045t1656r1533b1717],
20	1	CD	NUMBER	1	num	19	SENT_9	[p1l1045t1656r1533b1717],
21	/	:	O	/	punct	24	SENT_9	[p1l1045t1656r1533b1717],
22	*	CD	NUMBER	*	num	24	SENT_9	[p1l1045t1656r1533b1717],
23	1	CD	NUMBER	1	num	24	SENT_9	[p1l1045t1656r1533b1717],
24	carriers	NNS	O	carrier	_	0	SENT_9	[p1l1576t1660r1849b1717],
25	(	VBP	O	(	rcmod	24	SENT_9	[p1l1889t1656r2064b1729],
26	4.94	CD	NUMBER	4.94	number	27	SENT_9	[p1l1889t1656r2064b1729],
27	_	CD	NUMBER	_	dobj	25	SENT_9	[p1l2103t1664r2152b1717, p1l16t1762r166b1815],
28	l2	NN	O	l2	nn	31	SENT_9	[p1l2103t1664r2152b1717, p1l16t1762r166b1815],
29	.25	CD	NUMBER	.25	num	31	SENT_9	[p1l2103t1664r2152b1717, p1l16t1762r166b1815],
30	ng	NN	O	ng	nn	31	SENT_9	[p1l188t1775r278b1834],
31	o	NN	O	o	dep	27	SENT_9	[p1l306t1771r335b1800],
32	h/mL	NN	O	h/ml	nn	33	SENT_9	[p1l358t1754r578b1826],
33	)	NN	O	)	nsubj	36	SENT_9	[p1l358t1754r578b1826],
34	was	VBD	O	be	cop	36	SENT_9	[p1l603t1775r737b1815],
35	significantly	RB	O	significantly	advmod	36	SENT_9	[p1l760t1754r1210b1834],
36	lower	JJR	O	lower	rcmod	31	SENT_9	[p1l1225t1754r1428b1815],
37	than	IN	O	than	_	0	SENT_9	[p1l1449t1754r1607b1815],
38	CYP3A5	CD	NUMBER	cyp3a5	number	39	SENT_9	[p1l1632t1754r2139b1815],
39	*	CD	NUMBER	*	num	40	SENT_9	[p1l1632t1754r2139b1815],
40	3	CD	NUMBER	3	prep_than	36	SENT_9	[p1l1632t1754r2139b1815],
41	/	:	O	/	punct	31	SENT_9	[p1l1632t1754r2139b1815],
42	*	CD	NUMBER	*	number	43	SENT_9	[p1l1632t1754r2139b1815],
43	3	CD	NUMBER	3	num	44	SENT_9	[p1l1632t1754r2139b1815],
44	carriers	NNS	O	carrier	nsubj	45	SENT_9	[p1l17t1854r291b1912],
45	(	VBP	O	(	dep	31	SENT_9	[p1l317t1851r538b1923],
46	16.35	CD	NUMBER	16.35	dobj	45	SENT_9	[p1l317t1851r538b1923],
47	i	LS	O	i	dep	31	SENT_9	[p1l561t1858r611b1911],
48	-	:	O	-	_	0	SENT_9	[p1l561t1858r611b1911],
49	6.37	CD	NUMBER	6.37	num	50	SENT_9	[p1l632t1859r784b1912],
50	ng	NN	O	ng	dep	27	SENT_9	[p1l804t1872r895b1931],
51	o	NN	O	o	nn	52	SENT_9	[p1l923t1868r952b1897],
52	h/mL	NN	O	h/ml	dep	50	SENT_9	[p1l977t1851r1194b1922],
53	;	:	O	;	_	0	SENT_9	[p1l977t1851r1194b1922],
54	P	NN	O	p	nn	59	SENT_9	[p1l1216t1855r1260b1911],
55	=	JJ	O	=	amod	59	SENT_9	[p1l1289t1880r1330b1901],
56	.013	CD	NUMBER	.013	tmod	55	SENT_9	[p1l1362t1859r1528b1922],
57	,	,	O	,	_	0	SENT_9	[p1l1362t1859r1528b1922],
58	Bonferroni	NNP	PERSON	Bonferroni	nn	59	SENT_9	[p1l1555t1851r1948b1931],
59	test	NN	O	test	dep	27	SENT_9	[p1l1974t1851r2140b1923],
60	)	NN	O	)	dep	27	SENT_9	[p1l1974t1851r2140b1923],
61	.	.	O	.	_	0	SENT_9	[p1l1974t1851r2140b1923],

1	The	DT	O	the	det	2	SENT_10	[p1l21t1947r154b2008],
2	mean	NN	O	mean	dep	38	SENT_10	[p1l179t1969r378b2008],
3	(	SYM	O	(	dep	38	SENT_10	[p1l410t1947r609b2020],
4	-	:	O	-	_	0	SENT_10	[p1l410t1947r609b2020],
5	_	NN	O	_	dep	15	SENT_10	[p1l410t1947r609b2020],
6	/	:	O	/	punct	5	SENT_10	[p1l410t1947r609b2020],
7	-	:	O	-	_	0	SENT_10	[p1l410t1947r609b2020],
8	SD	NN	O	sd	nsubj	15	SENT_10	[p1l410t1947r609b2020],
9	)	CD	NUMBER	)	num	11	SENT_10	[p1l410t1947r609b2020],
10	oral	JJ	O	oral	amod	11	SENT_10	[p1l636t1947r778b2008],
11	clearance	NN	O	clearance	dep	8	SENT_10	[p1l804t1947r1153b2008],
12	was	VBD	O	be	cop	15	SENT_10	[p1l1182t1969r1317b2008],
13	also	RB	O	also	advmod	15	SENT_10	[p1l1344t1947r1488b2008],
14	significantly	RB	O	significantly	advmod	15	SENT_10	[p1l1516t1947r1993b2028],
15	different	JJ	O	different	dep	38	SENT_10	[p1l2019t1947r2144b2027, p1l7t2045r237b2125],
16	between	IN	O	between	_	0	SENT_10	[p1l273t2045r577b2106],
17	CYP3A5	NN	O	cyp3a5	nn	18	SENT_10	[p1l618t2045r1146b2106],
18	*	NN	O	*	prep_between	15	SENT_10	[p1l618t2045r1146b2106],
19	1	CD	NUMBER	1	num	18	SENT_10	[p1l618t2045r1146b2106],
20	/	:	O	/	punct	24	SENT_10	[p1l618t2045r1146b2106],
21	*	CD	NUMBER	*	number	22	SENT_10	[p1l618t2045r1146b2106],
22	1	CD	NUMBER	1	num	23	SENT_10	[p1l618t2045r1146b2106],
23	carriers	NNS	O	carrier	nsubj	24	SENT_10	[p1l1193t2049r1479b2106],
24	(	VBP	O	(	parataxis	38	SENT_10	[p1l1519t2045r1697b2117],
25	4.80	CD	NUMBER	4.80	dobj	24	SENT_10	[p1l1519t2045r1697b2117],
26	1	CD	NUMBER	1	number	27	SENT_10	[p1l1732t2064r1772b2105],
27	2.35	CD	NUMBER	2.35	num	29	SENT_10	[p1l1811t2053r1963b2106],
28	L/h	NN	O	l/h	nn	29	SENT_10	[p1l1995t2045r2146b2118],
29	}	NN	O	}	dep	25	SENT_10	[p1l1995t2045r2146b2118],
30	and	CC	O	and	_	0	SENT_10	[p1l17t2142r157b2203],
31	CYP3A5	NN	O	cyp3a5	conj_and	25	SENT_10	[p1l206t2142r717b2204],
32	*	CD	NUMBER	*	number	33	SENT_10	[p1l206t2142r717b2204],
33	3	CD	NUMBER	3	dep	31	SENT_10	[p1l206t2142r717b2204],
34	/	:	O	/	punct	24	SENT_10	[p1l206t2142r717b2204],
35	*	CD	NUMBER	*	num	37	SENT_10	[p1l206t2142r717b2204],
36	3	CD	NUMBER	3	num	37	SENT_10	[p1l206t2142r717b2204],
37	carriers	NNS	O	carrier	nsubj	38	SENT_10	[p1l777t2146r1051b2204],
38	(	VBP	O	(	_	0	SENT_10	[p1l1104t2142r1281b2215],
39	1.35	CD	NUMBER	1.35	dobj	38	SENT_10	[p1l1104t2142r1281b2215],
40	i	FW	O	i	dep	39	SENT_10	[p1l1331t2150r1381b2203],
41	0.61	CD	NUMBER	0.61	num	42	SENT_10	[p1l1428t2151r1569b2203],
42	L/h	NN	O	l/h	dep	39	SENT_10	[p1l1627t2142r1774b2214],
43	;	:	O	;	_	0	SENT_10	[p1l1627t2142r1774b2214],
44	P	NN	O	p	dep	45	SENT_10	[p1l1823t2146r1867b2203],
45	<	JJR	O	<	dep	39	SENT_10	[p1l1922t2161r1963b2203],
46	.05	CD	NUMBER	.05	dep	45	SENT_10	[p1l2023t2151r2144b2214],
47	,	,	O	,	_	0	SENT_10	[p1l2023t2151r2144b2214],
48	Dunn	NNP	PERSON	Dunn	poss	51	SENT_10	[p1l13t2244r214b2301],
49	’s	POS	O	’s	_	0	SENT_10	[p1l228t2244r270b2301],
50	test	NN	O	test	nn	51	SENT_10	[p1l303t2240r469b2313],
51	)	NN	O	)	appos	39	SENT_10	[p1l303t2240r469b2313],
52	.	.	O	.	_	0	SENT_10	[p1l303t2240r469b2313],

1	However	RB	O	however	advmod	16	SENT_11	[p1l502t2244r834b2311],
2	,	,	O	,	_	0	SENT_11	[p1l502t2244r834b2311],
3	other	JJ	O	other	amod	5	SENT_11	[p1l871t2240r1062b2301],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_11	[p1l1083t2240r1710b2320],
5	parameters	NNS	O	parameter	nsubj	16	SENT_11	[p1l1734t2248r2149b2320],
6	including	VBG	O	include	_	0	SENT_11	[p1l14t2337r367b2417],
7	peak	JJ	O	peak	amod	9	SENT_11	[p1l402t2337r585b2417],
8	plasma	NN	O	plasma	nn	9	SENT_11	[p1l620t2337r888b2417],
9	concentrations	NNS	O	concentration	prep_including	5	SENT_11	[p1l935t2340r1476b2398],
10	and	CC	O	and	_	0	SENT_11	[p1l1520t2337r1660b2398],
11	half	JJ	O	half	amod	13	SENT_11	[p1l1698t2337r1986b2417],
12	—	JJ	O	—	amod	13	SENT_11	[p1l1698t2337r1986b2417],
13	life	NN	O	life	prep_including	5	SENT_11	[p1l1698t2337r1986b2417],
14	did	VBD	O	do	aux	16	SENT_11	[p1l2032t2337r2151b2398],
15	not	RB	O	not	neg	16	SENT_11	[p1l14t2442r135b2494],
16	show	VB	O	show	_	0	SENT_11	[p1l163t2433r355b2494],
17	any	DT	O	any	det	18	SENT_11	[p1l380t2455r517b2514],
18	difference	NN	O	difference	dobj	16	SENT_11	[p1l543t2433r905b2513],
19	between	IN	O	between	_	0	SENT_11	[p1l936t2433r1229b2494],
20	genotype	NN	O	genotype	nn	21	SENT_11	[p1l1259t2442r1590b2514],
21	groups	NNS	O	group	prep_between	18	SENT_11	[p1l1617t2455r1891b2514],
22	.	.	O	.	_	0	SENT_11	[p1l1617t2455r1891b2514],

1	These	DT	O	these	det	2	SENT_12	[p1l1934t2433r2149b2494],
2	findings	NNS	O	finding	nsubj	3	SENT_12	[p1l7t2531r321b2611],
3	suggest	VBP	O	suggest	_	0	SENT_12	[p1l379t2539r652b2611],
4	that	IN	O	that	complm	9	SENT_12	[p1l709t2531r857b2592],
5	the	DT	O	the	det	8	SENT_12	[p1l914t2531r1026b2592],
6	polymorphic	JJ	O	polymorphic	amod	8	SENT_12	[p1l1079t2531r1565b2611],
7	CYP3A5	NN	O	cyp3a5	nn	8	SENT_12	[p1l1620t2534r1922b2592],
8	gene	NN	O	gene	nsubj	9	SENT_12	[p1l1980t2552r2149b2611],
9	affects	VBZ	O	affect	ccomp	3	SENT_12	[p1l17t2628r253b2708],
10	the	DT	O	the	det	11	SENT_12	[p1l280t2628r390b2689],
11	disposition	NN	O	disposition	dobj	9	SENT_12	[p1l419t2628r819b2708],
12	of	IN	O	of	_	0	SENT_12	[p1l849t2628r927b2708],
13	simvastatin	NN	O	simvastatin	prep_of	11	SENT_12	[p1l941t2631r1360b2689],
14	and	CC	O	and	_	0	SENT_12	[p1l1390t2628r1530b2689],
15	provides	VBZ	O	provide	ccomp	3	SENT_12	[p1l1549t2628r1866b2708],
16	a	DT	O	a	det	18	SENT_12	[p1l1892t2649r1930b2689],
17	plausible	JJ	O	plausible	amod	18	SENT_12	[p1l1953t2628r2148b2708, p1l16t2724r182b2785],
18	explanation	NN	O	explanation	dobj	15	SENT_12	[p1l211t2724r645b2805],
19	for	IN	O	for	_	0	SENT_12	[p1l666t2724r778b2804],
20	interindividual	JJ	O	interindividual	amod	21	SENT_12	[p1l799t2724r1354b2785],
21	variability	NN	O	variability	prep_for	15	SENT_12	[p1l1380t2724r1757b2805],
22	of	IN	O	of	_	0	SENT_12	[p1l1779t2724r1857b2804],
23	simvastatin	NN	O	simvastatin	nn	24	SENT_12	[p1l1872t2728r2148b2785, p1l18t2826r181b2883],
24	disposition	NN	O	disposition	prep_of	21	SENT_12	[p1l215t2822r635b2902],
25	.	.	O	.	_	0	SENT_12	[p1l215t2822r635b2902],

1	Keywords	NNS	O	keyword	_	0	SENT_13	[p1l11t3000r413b3080],
2	:	:	O	:	_	0	SENT_13	[p1l11t3000r413b3080],
3	Cytochrome	NN	O	cytochrome	nn	8	SENT_13	[p1l512t3000r947b3080],
4	P450	NN	O	p450	nn	8	SENT_13	[p1l999t3004r1181b3061],
5	3A5	NN	O	3a5	nn	8	SENT_13	[p1l1236t3004r1381b3061],
6	(	CD	NUMBER	(	num	8	SENT_13	[p1l1437t3000r1819b3072],
7	CYP3A5	NN	O	cyp3a5	nn	8	SENT_13	[p1l1437t3000r1819b3072],
8	)	NN	O	)	dep	1	SENT_13	[p1l1437t3000r1819b3072],
9	;	:	O	;	_	0	SENT_13	[p1l1437t3000r1819b3072],
10	simvastatin	NN	O	simvastatin	dep	8	SENT_13	[p1l1872t3003r2148b3061, p1l511t3110r700b3178],
11	;	:	O	;	_	0	SENT_13	[p1l1872t3003r2148b3061, p1l511t3110r700b3178],
12	pharmacokinetics	NNS	O	pharmacokinetic	dep	8	SENT_13	[p1l735t3107r1420b3187],
13	;	:	O	;	_	0	SENT_13	[p1l735t3107r1420b3187],
14	pharmacogenetics	NNS	O	pharmacogenetic	dep	12	SENT_13	[p1l1455t3107r2150b3187],
15	;	:	O	;	_	0	SENT_13	[p1l1455t3107r2150b3187],
16	CYP3A5	NN	O	cyp3a5	dep	8	SENT_13	[p1l508t3217r900b3275],
17	*	CD	NUMBER	*	number	18	SENT_13	[p1l508t3217r900b3275],
18	3	CD	NUMBER	3	dep	16	SENT_13	[p1l508t3217r900b3275],

1	Iournal	NNP	O	Iournal	nsubjpass	36	SENT_14	[p1l291t3315r581b3393],
2	of	IN	O	of	_	0	SENT_14	[p1l608t3315r689b3395],
3	Clinical	JJ	O	clinical	amod	4	SENT_14	[p1l710t3315r1007b3376],
4	Pharmacology	NN	O	pharmacology	prep_of	1	SENT_14	[p1l1030t3315r1592b3395],
5	,	,	O	,	_	0	SENT_14	[p1l1030t3315r1592b3395],
6	2007	CD	DATE	2007	appos	4	SENT_14	[p1l1626t3324r2147b3387],
7	;	:	O	;	_	0	SENT_14	[p1l1626t3324r2147b3387],
8	47:87	CD	NUMBER	47:87	number	9	SENT_14	[p1l1626t3324r2147b3387],
9	-93	CD	NUMBER	-93	dep	6	SENT_14	[p1l1626t3324r2147b3387],
10	©	CD	NUMBER	©	num	11	SENT_14	[p1l51t3422r287b3479],
11	2007	CD	DATE	2007	dep	20	SENT_14	[p1l51t3422r287b3479],
12	the	DT	O	the	det	14	SENT_14	[p1l313t3418r427b3479],
13	American	NNP	ORGANIZATION	American	nn	14	SENT_14	[p1l452t3420r829b3479],
14	College	NNP	ORGANIZATION	College	dep	11	SENT_14	[p1l863t3418r1144b3498],
15	of	IN	ORGANIZATION	of	_	0	SENT_14	[p1l1174t3418r1255b3498],
16	Clinical	JJ	ORGANIZATION	clinical	amod	17	SENT_14	[p1l1276t3418r1574b3479],
17	Pharmacology	NN	ORGANIZATION	pharmacology	prep_of	14	SENT_14	[p1l1597t3418r2152b3498],
18	he	PRP	O	he	dep	20	SENT_14	[p2l185t106r278b174],
19	cytochrome	NN	O	cytochrome	nn	20	SENT_14	[p2l307t106r773b195],
20	P450	NN	O	p450	dep	6	SENT_14	[p2l799t111r993b174],
21	(	CD	NUMBER	(	num	22	SENT_14	[p2l1026t106r1247b187],
22	CYP	NN	O	cyp	dep	20	SENT_14	[p2l1026t106r1247b187],
23	)	CD	NUMBER	)	num	25	SENT_14	[p2l1026t106r1247b187],
24	3A	NN	O	3a	nn	25	SENT_14	[p2l1281t111r1391b174],
25	subfamily	NN	O	subfamily	dep	6	SENT_14	[p2l1419t106r1825b195],
26	,	,	O	,	_	0	SENT_14	[p2l1419t106r1825b195],
27	including	VBG	O	include	_	0	SENT_14	[p2l1856t106r2148b174, p2l186t212r310b298],
28	CYPBA4	NN	O	cypba4	prep_including	1	SENT_14	[p2l348t212r712b287],
29	,	,	O	,	_	0	SENT_14	[p2l348t212r712b287],
30	CYP3A5	NN	O	cyp3a5	prep_including	1	SENT_14	[p2l753t212r1117b288],
31	,	,	O	,	_	0	SENT_14	[p2l753t212r1117b288],
32	and	CC	O	and	_	0	SENT_14	[p2l1158t209r1307b277],
33	CYP3A7	NN	O	cyp3a7	prep_including	1	SENT_14	[p2l1345t212r1708b287],
34	,	,	O	,	_	0	SENT_14	[p2l1345t212r1708b287],
35	is	VBZ	O	be	auxpass	36	SENT_14	[p2l1749t212r1811b277],
36	considered	VBN	O	consider	_	0	SENT_14	[p2l1852t209r2148b277, p2l11t311r184b380],
37	the	DT	O	the	det	41	SENT_14	[p2l237t312r362b380],
38	most	RBS	O	most	advmod	39	SENT_14	[p2l417t322r613b380],
39	important	JJ	O	important	amod	41	SENT_14	[p2l667t315r1070b401],
40	CYP	NN	O	cyp	nn	41	SENT_14	[p2l1125t315r1296b380],
41	group	NN	O	group	dobj	36	SENT_14	[p2l1352t336r1584b401],
42	of	IN	O	of	_	0	SENT_14	[p2l1644t312r1724b380],
43	oxidative	JJ	O	oxidative	amod	44	SENT_14	[p2l1773t311r2148b380],
44	enzymes	NNS	O	enzyme	prep_of	41	SENT_14	[p2l11t437r360b503],
45	in	IN	O	in	_	0	SENT_14	[p2l404t417r484b481],
46	human	JJ	O	human	amod	48	SENT_14	[p2l524t413r808b481],
47	Xenobiotic	JJ	MISC	xenobiotic	amod	48	SENT_14	[p2l847t413r1274b481],
48	metabolism	NN	O	metabolism	prep_in	36	SENT_14	[p2l1317t413r1790b481],
49	because	IN	O	because	_	0	SENT_14	[p2l1827t413r2148b481],
50	of	IN	O	of	_	0	SENT_14	[p2l11t515r92b583],
51	its	PRP$	O	its	poss	53	SENT_14	[p2l123t519r214b583],
52	high	JJ	O	high	amod	53	SENT_14	[p2l254t515r434b605],
53	expression	NN	O	expression	prep_because_of	36	SENT_14	[p2l472t519r908b605],
54	in	IN	O	in	_	0	SENT_14	[p2l946t519r1026b583],
55	the	DT	O	the	det	56	SENT_14	[p2l1062t515r1186b583],
56	liver	NN	O	liver	prep_in	53	SENT_14	[p2l1226t515r1410b583],
57	and	CC	O	and	_	0	SENT_14	[p2l1448t515r1597b583],
58	the	DT	O	the	det	59	SENT_14	[p2l1633t515r1757b583],
59	intestine	NN	O	intestine	prep_because_of	36	SENT_14	[p2l1797t519r2147b583],
60	and	CC	O	and	_	0	SENT_14	[p2l10t617r159b685],
61	its	PRP$	O	its	poss	64	SENT_14	[p2l206t621r298b685],
62	wide	JJ	O	wide	amod	64	SENT_14	[p2l346t617r544b685],
63	substrate	NN	O	substrate	nn	64	SENT_14	[p2l594t617r954b685],
64	spectrum	NN	O	spectrum	conj_and	59	SENT_14	[p2l1004t627r1399b707],
65	.	.	O	.	_	0	SENT_14	[p2l1004t627r1399b707],

1	CYP3A	NN	O	cyp3a	nn	2	SENT_15	[p2l1452t621r1745b685],
2	accounts	NNS	O	account	_	0	SENT_15	[p2l1793t627r2147b685],
3	for	IN	O	for	prep	2	SENT_15	[p2l10t719r120b787],
4	up	RB	O	up	pcomp	3	SENT_15	[p2l145t743r248b808],
5	to	TO	O	to	_	0	SENT_15	[p2l277t729r351b787],
6	50	CD	PERCENT	50	num	7	SENT_15	[p2l384t719r557b792],
7	%	NN	PERCENT	%	prep_to	4	SENT_15	[p2l384t719r557b792],
8	of	IN	O	of	_	0	SENT_15	[p2l594t719r675b787],
9	the	DT	O	the	det	11	SENT_15	[p2l694t719r818b787],
10	hepatic	JJ	O	hepatic	amod	11	SENT_15	[p2l846t719r1142b808],
11	CYPs	NNS	O	cyp	prep_of	7	SENT_15	[p2l1172t722r1383b787],
12	and	CC	O	and	_	0	SENT_15	[p2l1414t719r1563b787],
13	contributes	VBZ	O	contribute	conj_and	4	SENT_15	[p2l1591t719r2044b787],
14	to	TO	O	to	_	0	SENT_15	[p2l2073t729r2147b787],
15	the	DT	O	the	det	16	SENT_15	[p2l8t822r133b890],
16	metabolism	NN	O	metabolism	prep_to	2	SENT_15	[p2l170t822r643b890],
17	of	IN	O	of	prep	2	SENT_15	[p2l681t822r762b890],
18	about	IN	O	about	pcomp	17	SENT_15	[p2l792t822r1016b890],
19	half	NN	O	half	pobj	18	SENT_15	[p2l1051t822r1213b890],
20	of	IN	O	of	_	0	SENT_15	[p2l1245t822r1325b890],
21	all	DT	O	all	det	24	SENT_15	[p2l1355t822r1453b890],
22	commonly	RB	O	commonly	advmod	23	SENT_15	[p2l1492t822r1924b911],
23	used	VBN	O	use	amod	24	SENT_15	[p2l1959t822r2149b890],
24	drugs	NNS	O	drug	prep_of	2	SENT_15	[p2l12t923r285b1013],
25	?	.	O	?	_	0	SENT_15	[p2l12t923r285b1013],

1	Because	IN	O	because	_	0	SENT_16	[p2l334t928r661b992],
2	of	IN	O	of	pcomp	1	SENT_16	[p2l710t924r791b992],
3	its	PRP$	O	its	poss	4	SENT_16	[p2l830t927r922b992],
4	involvement	NN	O	involvement	pobj	2	SENT_16	[p2l972t923r1483b992],
5	in	IN	O	in	_	0	SENT_16	[p2l1529t927r1609b991],
6	the	DT	O	the	det	7	SENT_16	[p2l1654t923r1778b992],
7	metabolism	NN	O	metabolism	prep_in	4	SENT_16	[p2l1825t923r2148b992, p2l10t1025r184b1093],
8	of	IN	O	of	_	0	SENT_16	[p2l222t1025r302b1093],
9	a	DT	O	a	det	11	SENT_16	[p2l333t1049r373b1093],
10	large	JJ	O	large	amod	11	SENT_16	[p2l409t1025r601b1115],
11	number	NN	O	number	prep_of	7	SENT_16	[p2l638t1025r953b1093],
12	of	IN	O	of	_	0	SENT_16	[p2l990t1025r1071b1093],
13	drugs	NNS	O	drug	prep_of	11	SENT_16	[p2l1102t1025r1376b1115],
14	?	.	O	?	_	0	SENT_16	[p2l1102t1025r1376b1115],

1	elucidation	NN	O	elucidation	_	0	SENT_17	[p2l1416t1025r1877b1093],
2	of	IN	O	of	_	0	SENT_17	[p2l1915t1025r1995b1093],
3	the	DT	O	the	prep_of	1	SENT_17	[p2l2023t1025r2148b1093],

1	From	IN	O	from	dep	10	SENT_18	[p2l16t1344r155b1397],
2	the	DT	O	the	det	3	SENT_18	[p2l190t1341r277b1397],
3	Department	NNP	ORGANIZATION	Department	pobj	1	SENT_18	[p2l315t1344r658b1412],
4	of	IN	ORGANIZATION	of	_	0	SENT_18	[p2l691t1341r747b1397],
5	Clinical	JJ	ORGANIZATION	clinical	amod	6	SENT_18	[p2l779t1341r995b1398],
6	Pharmacology	NN	ORGANIZATION	pharmacology	prep_of	3	SENT_18	[p2l1036t1341r1454b1412],
7	and	CC	ORGANIZATION	and	_	0	SENT_18	[p2l1487t1341r1594b1397],
8	Toxicology	NN	ORGANIZATION	toxicology	prep_of	3	SENT_18	[p2l1629t1341r1945b1412],
9	,	,	O	,	_	0	SENT_18	[p2l1629t1341r1945b1412],
10	Anam	NNP	ORGANIZATION	Anam	_	0	SENT_18	[p2l1978t1343r2149b1397],
11	Hospital	NNP	ORGANIZATION	Hospital	dep	10	SENT_18	[p2l16t1430r271b1500],
12	,	,	O	,	_	0	SENT_18	[p2l16t1430r271b1500],
13	Korea	NNP	ORGANIZATION	Korea	nn	15	SENT_18	[p2l306t1432r470b1486],
14	University	NNP	ORGANIZATION	University	nn	15	SENT_18	[p2l506t1432r781b1500],
15	College	NNP	ORGANIZATION	College	dep	10	SENT_18	[p2l810t1430r1037b1500],
16	of	IN	ORGANIZATION	of	_	0	SENT_18	[p2l1067t1429r1123b1486],
17	Medicine	NNP	ORGANIZATION	Medicine	prep_of	15	SENT_18	[p2l1149t1430r1435b1495],
18	,	,	O	,	_	0	SENT_18	[p2l1149t1430r1435b1495],
19	Seoul	NNP	LOCATION	Seoul	nn	22	SENT_18	[p2l1466t1429r1623b1486],
20	(	CD	NUMBER	(	num	22	SENT_18	[p2l1659t1430r1746b1500],
21	Dr	NNP	O	Dr	nn	22	SENT_18	[p2l1659t1430r1746b1500],
22	Kim	NNP	PERSON	Kim	prep_of	15	SENT_18	[p2l1775t1432r1899b1495],
23	,	,	O	,	_	0	SENT_18	[p2l1775t1432r1899b1495],
24	Mr	NNP	PERSON	Mr	nn	25	SENT_18	[p2l1930t1431r2011b1486],
25	Lee	NNP	PERSON	Lee	conj_and	17	SENT_18	[p2l2040t1432r2149b1496],
26	,	,	O	,	_	0	SENT_18	[p2l2040t1432r2149b1496],
27	Mr	NNP	PERSON	Mr	nn	28	SENT_18	[p2l13t1519r93b1573],
28	Kang	NNP	PERSON	Kang	conj_and	17	SENT_18	[p2l133t1520r296b1587],
29	,	,	O	,	_	0	SENT_18	[p2l133t1520r296b1587],
30	Dr	NNP	O	Dr	nn	33	SENT_18	[p2l341t1520r408b1572],
31	J-Y	NNP	O	J-Y	nn	33	SENT_18	[p2l442t1520r525b1573],
32	Park	NNP	O	Park	nn	33	SENT_18	[p2l565t1517r721b1587],
33	)	NN	O	)	conj_and	17	SENT_18	[p2l565t1517r721b1587],
34	,	,	O	,	_	0	SENT_18	[p2l565t1517r721b1587],
35	and	CC	O	and	_	0	SENT_18	[p2l763t1517r869b1573],
36	the	DT	O	the	det	54	SENT_18	[p2l909t1517r997b1573],
37	Department	NNP	ORGANIZATION	Department	dep	54	SENT_18	[p2l1040t1520r1383b1587],
38	of	IN	ORGANIZATION	of	_	0	SENT_18	[p2l1421t1516r1477b1573],
39	Laboratory	NNP	ORGANIZATION	Laboratory	nn	40	SENT_18	[p2l1517t1517r1825b1587],
40	Medicine	NNP	ORGANIZATION	Medicine	prep_of	37	SENT_18	[p2l1864t1517r2149b1583],
41	,	,	O	,	_	0	SENT_18	[p2l1864t1517r2149b1583],
42	Gachon	NNP	ORGANIZATION	Gachon	nn	47	SENT_18	[p2l13t1605r249b1662],
43	Medical	NNP	ORGANIZATION	Medical	nn	47	SENT_18	[p2l288t1605r517b1662],
44	School	NNP	ORGANIZATION	School	nn	47	SENT_18	[p2l556t1605r749b1662],
45	Gil	NNP	ORGANIZATION	Gil	nn	47	SENT_18	[p2l789t1605r871b1661],
46	Medical	NNP	ORGANIZATION	Medical	nn	47	SENT_18	[p2l911t1605r1140b1662],
47	Center	NNP	ORGANIZATION	Center	appos	40	SENT_18	[p2l1181t1607r1385b1671],
48	,	,	O	,	_	0	SENT_18	[p2l1181t1607r1385b1671],
49	Incheon	NNP	LOCATION	Incheon	dep	54	SENT_18	[p2l1426t1605r1674b1671],
50	,	,	O	,	_	0	SENT_18	[p2l1426t1605r1674b1671],
51	Korea	NNP	LOCATION	Korea	appos	54	SENT_18	[p2l1715t1608r1880b1661],
52	(	CD	NUMBER	(	num	54	SENT_18	[p2l1922t1606r2009b1676],
53	Dr	NN	O	dr	nn	54	SENT_18	[p2l1922t1606r2009b1676],
54	P	NN	O	p	conj_and	17	SENT_18	[p2l2045t1607r2153b1661],
55	.	.	O	.	_	0	SENT_18	[p2l2045t1607r2153b1661],

1	—	NN	O	—	_	0	SENT_19	[p2l2045t1607r2153b1661],
2	.	.	O	.	_	0	SENT_19	[p2l2045t1607r2153b1661],

1	W	NNP	O	W	nn	2	SENT_20	[p2l2045t1607r2153b1661],
2	Park	NNP	O	Park	_	0	SENT_20	[p2l16t1694r169b1764],
3	)	NN	O	)	dep	2	SENT_20	[p2l16t1694r169b1764],
4	.	.	O	.	_	0	SENT_20	[p2l16t1694r169b1764],

1	Drs	NNP	O	Drs	nn	2	SENT_21	[p2l204t1696r295b1750],
2	Kim	NNP	PERSON	Kim	_	0	SENT_21	[p2l326t1696r429b1748],
3	and	CC	O	and	_	0	SENT_21	[p2l459t1694r566b1750],
4	P	NN	O	p	conj_and	2	SENT_21	[p2l600t1695r708b1749],
5	.	.	O	.	_	0	SENT_21	[p2l600t1695r708b1749],

1	—	NN	O	—	_	0	SENT_22	[p2l600t1695r708b1749],
2	.	.	O	.	_	0	SENT_22	[p2l600t1695r708b1749],

1	W	NNP	O	W	nn	2	SENT_23	[p2l600t1695r708b1749],
2	Park	NNP	O	Park	nsubj	3	SENT_23	[p2l737t1694r856b1750],
3	contributed	VBD	O	contribute	_	0	SENT_23	[p2l882t1693r1208b1750],
4	equally	RB	O	equally	advmod	3	SENT_23	[p2l1239t1693r1447b1764],
5	to	TO	O	to	_	0	SENT_23	[p2l1471t1704r1526b1750],
6	this	DT	O	this	det	7	SENT_23	[p2l1552t1694r1647b1750],
7	study	NN	O	study	prep_to	3	SENT_23	[p2l1675t1694r1830b1764],
8	.	.	O	.	_	0	SENT_23	[p2l1675t1694r1830b1764],

1	Submitted	VBN	O	submit	_	0	SENT_24	[p2l1861t1694r2148b1750],
2	for	IN	O	for	_	0	SENT_24	[p2l10t1780r92b1837],
3	publication	NN	O	publication	prep_for	1	SENT_24	[p2l126t1781r446b1851],
4	July	NNP	DATE	July	tmod	1	SENT_24	[p2l482t1781r589b1851],
5	3	CD	DATE	3	num	4	SENT_24	[p2l624t1783r678b1847],
6	,	,	DATE	,	_	0	SENT_24	[p2l624t1783r678b1847],
7	2006	CD	DATE	2006	num	4	SENT_24	[p2l715t1783r895b1847],
8	;	:	O	;	_	0	SENT_24	[p2l715t1783r895b1847],
9	revised	VBN	O	revise	amod	10	SENT_24	[p2l934t1781r1130b1837],
10	version	NN	O	version	nsubj	11	SENT_24	[p2l1167t1789r1370b1837],
11	accepted	VBD	O	accept	parataxis	1	SENT_24	[p2l1408t1781r1670b1851],
12	September	NNP	DATE	September	nn	13	SENT_24	[p2l1707t1781r2022b1851],
13	ll	NN	O	ll	dobj	11	SENT_24	[p2l2061t1784r2150b1847],
14	,	,	O	,	_	0	SENT_24	[p2l2061t1784r2150b1847],
15	2006	CD	DATE	2006	appos	13	SENT_24	[p2l12t1871r187b1925],
16	.	.	O	.	_	0	SENT_24	[p2l12t1871r187b1925],

1	Address	NN	O	address	_	0	SENT_25	[p2l213t1869r441b1925],
2	for	IN	O	for	_	0	SENT_25	[p2l464t1869r545b1925],
3	correspondence	NN	O	correspondence	prep_for	1	SENT_25	[p2l567t1869r1048b1940],
4	:	:	O	:	_	0	SENT_25	[p2l567t1869r1048b1940],
5	Ji	NNP	O	Ji	dep	1	SENT_25	[p2l1076t1872r1314b1940],
6	.	.	O	.	_	0	SENT_25	[p2l1076t1872r1314b1940],

1	—	NN	O	—	_	0	SENT_26	[p2l1076t1872r1314b1940],
2	.	.	O	.	_	0	SENT_26	[p2l1076t1872r1314b1940],

1	Young	NNP	O	Young	nn	2	SENT_27	[p2l1076t1872r1314b1940],
2	Park	NNP	O	Park	_	0	SENT_27	[p2l1346t1869r1480b1935],
3	,	,	O	,	_	0	SENT_27	[p2l1346t1869r1480b1935],
4	MD	NNP	O	MD	appos	2	SENT_27	[p2l1507t1871r1625b1935],
5	,	,	O	,	_	0	SENT_27	[p2l1507t1871r1625b1935],
6	PhD	NNP	O	PhD	appos	2	SENT_27	[p2l1656t1869r1783b1935],
7	,	,	O	,	_	0	SENT_27	[p2l1656t1869r1783b1935],
8	Department	NNP	ORGANIZATION	Department	appos	2	SENT_27	[p2l1814t1872r2153b1940],
9	of	IN	ORGANIZATION	of	_	0	SENT_27	[p2l13t1957r68b2014],
10	Clinical	JJ	ORGANIZATION	clinical	amod	11	SENT_27	[p2l89t1958r299b2014],
11	Pharmacology	NN	ORGANIZATION	pharmacology	prep_of	8	SENT_27	[p2l329t1957r738b2028],
12	and	CC	ORGANIZATION	and	_	0	SENT_27	[p2l760t1958r865b2014],
13	Toxicology	NN	ORGANIZATION	toxicology	conj_and	11	SENT_27	[p2l890t1957r1198b2028],
14	,	,	O	,	_	0	SENT_27	[p2l890t1957r1198b2028],
15	Anam	NNP	ORGANIZATION	Anam	nn	16	SENT_27	[p2l1220t1959r1388b2014],
16	Hospital	NNP	ORGANIZATION	Hospital	appos	2	SENT_27	[p2l1417t1958r1665b2028],
17	,	,	O	,	_	0	SENT_27	[p2l1417t1958r1665b2028],
18	Korea	NNP	ORGANIZATION	Korea	nn	20	SENT_27	[p2l1694t1960r1855b2014],
19	University	NNP	ORGANIZATION	University	nn	20	SENT_27	[p2l1885t1960r2152b2028],
20	College	NNP	ORGANIZATION	College	appos	2	SENT_27	[p2l13t2045r240b2115],
21	of	IN	ORGANIZATION	of	_	0	SENT_27	[p2l264t2044r320b2101],
22	Medicine	NNP	ORGANIZATION	Medicine	prep_of	20	SENT_27	[p2l340t2045r625b2111],
23	,	,	O	,	_	0	SENT_27	[p2l340t2045r625b2111],
24	l26-l	NN	O	l26-l	appos	2	SENT_27	[p2l657t2047r819b2101],
25	,	,	O	,	_	0	SENT_27	[p2l841t2091r853b2111],
26	Anam-dong	JJ	O	anam-dong	amod	32	SENT_27	[p2l873t2045r1224b2115],
27	5-ga	NN	O	5-ga	nn	32	SENT_27	[p2l1250t2048r1407b2115],
28	,	,	O	,	_	0	SENT_27	[p2l1250t2048r1407b2115],
29	Sungbuk-gu	NN	O	sungbuk-gu	dep	32	SENT_27	[p2l1431t2045r1801b2115],
30	,	,	O	,	_	0	SENT_27	[p2l1431t2045r1801b2115],
31	Seoul	NNP	LOCATION	Seoul	dep	32	SENT_27	[p2l1825t2045r1983b2101],
32	l	NN	O	l	appos	2	SENT_27	[p2l2016t2048r2029b2100],
33	36705	CD	NUMBER	36705	num	32	SENT_27	[p2l2050t2047r2149b2101, p2l16t2137r150b2199],
34	,	,	O	,	_	0	SENT_27	[p2l2050t2047r2149b2101, p2l16t2137r150b2199],
35	Korea	NNP	LOCATION	Korea	appos	2	SENT_27	[p2l183t2137r367b2190],
36	.	.	O	.	_	0	SENT_27	[p2l183t2137r367b2190],

1	DOI	NNP	O	DOI	_	0	SENT_28	[p2l16t2224r154b2278],
2	:	:	O	:	_	0	SENT_28	[p2l16t2224r154b2278],
3	lo	FW	O	lo	dep	1	SENT_28	[p2l194t2225r311b2278],
4	.	.	O	.	_	0	SENT_28	[p2l194t2225r311b2278],

1	l	NN	O	l	_	0	SENT_29	[p2l194t2225r311b2278],
2	1 77/0091	CD	NUMBER	1 77/0091	num	3	SENT_29	[p2l376t2224r628b2284],[p2l338t2226r352b2277],
3	270006295063	CD	NUMBER	270006295063	dep	1	SENT_29	[p2l648t2224r1134b2279],

1	I	PRP	O	I	nsubj	2	SENT_30	[p2l8t2449r37b2521],
2	Clin	VBP	O	clin	_	0	SENT_30	[p2l65t2445r218b2506],
3	Pharmacol	NNP	O	Pharmacol	dobj	2	SENT_30	[p2l244t2445r648b2506],
4	2007	CD	DATE	2007	num	3	SENT_30	[p2l678t2453r1188b2517],
5	;	:	O	;	_	0	SENT_30	[p2l678t2453r1188b2517],
6	47:87	CD	NUMBER	47:87	num	8	SENT_30	[p2l678t2453r1188b2517],
7	-93	CD	NUMBER	-93	num	8	SENT_30	[p2l678t2453r1188b2517],
8	determinants	NNS	O	determinant	nsubj	13	SENT_30	[p2l13t2540r543b2608],
9	of	IN	O	of	_	0	SENT_30	[p2l635t2540r716b2608],
10	CYP3A	NN	O	cyp3a	nn	11	SENT_30	[p2l796t2543r1089b2608],
11	activity	NN	O	activity	prep_of	8	SENT_30	[p2l1177t2543r1479b2629],
12	is	VBZ	O	be	cop	13	SENT_30	[p2l1567t2543r1629b2608],
13	important	JJ	O	important	parataxis	2	SENT_30	[p2l1720t2543r2140b2629],
14	.	.	O	.	_	0	SENT_30	[p2l1720t2543r2140b2629],

1	Considerable	JJ	O	considerable	amod	3	SENT_31	[p2l11t2643r540b2711],
2	interindividual	JJ	O	interindividual	amod	3	SENT_31	[p2l593t2643r1211b2711],
3	variability	NN	O	variability	nsubj	5	SENT_31	[p2l1262t2643r1680b2732],
4	is	VBZ	O	be	cop	5	SENT_31	[p2l1732t2646r1794b2711],
5	present	JJ	DATE	present	dep	52	SENT_31	[p2l1848t2653r2147b2732],
6	in	IN	O	in	_	0	SENT_31	[p2l11t2748r91b2812],
7	the	DT	O	the	det	8	SENT_31	[p2l121t2744r245b2813],
8	activity	NN	O	activity	prep_in	5	SENT_31	[p2l280t2748r582b2834],
9	of	IN	O	of	_	0	SENT_31	[p2l616t2745r696b2813],
10	this	DT	O	this	det	11	SENT_31	[p2l720t2744r868b2813],
11	isoform	NN	O	isoform	prep_of	8	SENT_31	[p2l903t2745r1231b2823],
12	,	,	O	,	_	0	SENT_31	[p2l903t2745r1231b2823],
13	manifested	VBN	O	manifest	partmod	11	SENT_31	[p2l1266t2744r1713b2813],
14	by	IN	O	by	_	0	SENT_31	[p2l1742t2744r1841b2834],
15	greater	JJR	O	greater	quantmod	16	SENT_31	[p2l1872t2755r2146b2834],
16	than	IN	O	than	num	18	SENT_31	[p2l9t2845r190b2913],
17	10-fold	RB	O	10-fold	quantmod	16	SENT_31	[p2l221t2845r505b2913],
18	differences	NNS	O	difference	agent	13	SENT_31	[p2l534t2845r975b2913],
19	in	IN	O	in	_	0	SENT_31	[p2l1006t2849r1085b2912],
20	the	DT	O	the	prep_in	13	SENT_31	[p2l1112t2845r1235b2913],
21	in	FW	O	in	nn	22	SENT_31	[p2l1265t2849r1344b2912],
22	vivo	FW	O	vivo	advmod	23	SENT_31	[p2l1370t2849r1543b2913],
23	metabolism	NN	O	metabolism	dep	20	SENT_31	[p2l1572t2845r2044b2913],
24	of	IN	O	of	_	0	SENT_31	[p2l2073t2845r2153b2913],
25	drugs	NNS	O	drug	prep_of	23	SENT_31	[p2l13t2947r232b3036],
26	that	WDT	O	that	nsubj	28	SENT_31	[p2l280t2947r435b3015],
27	are	VBP	O	be	cop	28	SENT_31	[p2l482t2971r599b3015],
28	substrates	NNS	O	substrate	rcmod	20	SENT_31	[p2l649t2947r1046b3015],
29	of	IN	O	of	_	0	SENT_31	[p2l1097t2947r1177b3015],
30	CYP3A	NN	O	cyp3a	nn	31	SENT_31	[p2l1217t2947r1609b3015],
31	.3	NN	NUMBER	.3	prep_of	28	SENT_31	[p2l1217t2947r1609b3015],
32	'	''	O	'	_	0	SENT_31	[p2l1217t2947r1609b3015],
33	5	CD	NUMBER	5	dep	40	SENT_31	[p2l1217t2947r1609b3015],
34	Most	JJS	O	most	dep	33	SENT_31	[p2l1657t2952r1857b3015],
35	(	CD	PERCENT	(	number	36	SENT_31	[p2l1907t2947r2144b3028, p2l13t3049r220b3130],
36	60	CD	PERCENT	60	num	37	SENT_31	[p2l1907t2947r2144b3028, p2l13t3049r220b3130],
37	%	NN	PERCENT	%	dep	34	SENT_31	[p2l1907t2947r2144b3028, p2l13t3049r220b3130],
38	90	CD	PERCENT	90	num	39	SENT_31	[p2l1907t2947r2144b3028, p2l13t3049r220b3130],
39	%	NN	PERCENT	%	dep	40	SENT_31	[p2l1907t2947r2144b3028, p2l13t3049r220b3130],
40	)	CD	NUMBER	)	dep	5	SENT_31	[p2l1907t2947r2144b3028, p2l13t3049r220b3130],
41	of	IN	O	of	_	0	SENT_31	[p2l268t3049r348b3117],
42	the	DT	O	the	det	44	SENT_31	[p2l381t3049r505b3117],
43	interindividual	JJ	O	interindividual	amod	44	SENT_31	[p2l549t3049r1167b3117],
44	variability	NN	O	variability	prep_of	40	SENT_31	[p2l1207t3049r1626b3138],
45	in	IN	O	in	_	0	SENT_31	[p2l1667t3052r1747b3116],
46	constitutive	JJ	O	constitutive	amod	47	SENT_31	[p2l1790t3052r2144b3117, p2l9t3154r158b3219],
47	expression	NN	O	expression	prep_in	5	SENT_31	[p2l199t3154r634b3240],
48	of	IN	O	of	_	0	SENT_31	[p2l673t3151r754b3219],
49	CYP3A	NN	O	cyp3a	prep_of	47	SENT_31	[p2l785t3154r1077b3219],
50	has	VBZ	O	have	aux	52	SENT_31	[p2l1114t3151r1247b3219],
51	been	VBN	O	be	auxpass	52	SENT_31	[p2l1284t3151r1476b3219],
52	suggested	VBN	O	suggest	_	0	SENT_31	[p2l1515t3151r1906b3240],
53	to	TO	O	to	aux	55	SENT_31	[p2l1942t3161r2016b3219],
54	be	VB	O	be	cop	55	SENT_31	[p2l2053t3151r2144b3219],
55	due	JJ	O	due	xcomp	52	SENT_31	[p2l13t3254r158b3322],
56	to	TO	O	to	_	0	SENT_31	[p2l190t3264r264b3322],
57	as	RB	O	as	advmod	59	SENT_31	[p2l299t3278r375b3322],
58	yet	RB	O	yet	advmod	59	SENT_31	[p2l408t3264r529b3343],
59	unknown	JJ	O	unknown	amod	61	SENT_31	[p2l559t3254r947b3322],
60	genetic	JJ	O	genetic	amod	61	SENT_31	[p2l978t3257r1264b3343],
61	factors	NNS	O	factor	prep_to	55	SENT_31	[p2l1298t3253r1619b3322],
62	.6	CD	NUMBER	.6	nsubjpass	52	SENT_31	[p2l1298t3253r1619b3322],

1	Simvastatin	NNP	O	Simvastatin	nsubj	6	SENT_32	[p2l120t3359r618b3424],
2	is	VBZ	O	be	cop	6	SENT_32	[p2l697t3359r760b3424],
3	a	DT	O	a	det	6	SENT_32	[p2l842t3380r882b3424],
4	widely	RB	O	widely	advmod	5	SENT_32	[p2l958t3355r1248b3445],
5	used	VBN	O	use	amod	6	SENT_32	[p2l1325t3355r1520b3424],
6	3hydroXy3methylglutaryl	NN	O	3hydroxy3methylglutaryl	_	0	SENT_32	[p2l1602t3355r2144b3445, p2l10t3457r609b3547],
7	coenzyme	NN	O	coenzyme	nn	8	SENT_32	[p2l661t3481r1064b3547],
8	A	NN	O	a	dep	13	SENT_32	[p2l1114t3462r1180b3525],
9	(	CD	NUMBER	(	dep	8	SENT_32	[p2l1234t3457r1706b3538],
10	HMG-CoA	NN	O	hmg-coa	dep	13	SENT_32	[p2l1234t3457r1706b3538],
11	)	CD	NUMBER	)	num	10	SENT_32	[p2l1234t3457r1706b3538],
12	reductase	NN	O	reductase	nn	13	SENT_32	[p2l1758t3457r2144b3525],
13	inhibitor	NN	O	inhibitor	dep	6	SENT_32	[p2l11t3559r384b3638],
14	,	,	O	,	_	0	SENT_32	[p2l11t3559r384b3638],
15	with	IN	O	with	_	0	SENT_32	[p2l414t3559r600b3627],
16	beneficial	JJ	O	beneficial	amod	17	SENT_32	[p2l625t3559r1024b3627],
17	effects	NNS	O	effect	prep_with	13	SENT_32	[p2l1054t3559r1309b3627],
18	on	IN	O	on	_	0	SENT_32	[p2l1341t3583r1439b3627],
19	coronary	JJ	O	coronary	amod	20	SENT_32	[p2l1469t3583r1826b3648],
20	disease	NN	O	disease	prep_on	6	SENT_32	[p2l1856t3559r2145b3627],
21	and	CC	O	and	_	0	SENT_32	[p2l11t3661r160b3729],
22	mortality	NN	O	mortality	nn	23	SENT_32	[p2l211t3661r585b3750],
23	rates	NNS	O	rate	conj_and	20	SENT_32	[p2l635t3671r822b3729],
24	in	IN	O	in	_	0	SENT_32	[p2l878t3664r957b3728],
25	patients	NNS	O	patient	prep_in	20	SENT_32	[p2l1009t3664r1329b3750],
26	with	IN	O	with	_	0	SENT_32	[p2l1383t3661r1568b3729],
27	hypercholes	NNS	O	hyperchole	prep_with	25	SENT_32	[p2l1619t3661r2144b3750],
28	—	IN	O	—	prep	6	SENT_32	[p2l1619t3661r2144b3750],

1	terolemia	NN	O	terolemia	nn	3	SENT_33	[p3l9t12r491b81],
2	.7	CD	NUMBER	.7	num	3	SENT_33	[p3l9t12r491b81],
3	’	NN	O	’	nsubj	9	SENT_33	[p3l9t12r491b81],
4	8	CD	NUMBER	8	num	7	SENT_33	[p3l9t12r491b81],
5	Many	JJ	O	many	amod	7	SENT_33	[p3l542t17r772b102],
6	clinical	JJ	O	clinical	amod	7	SENT_33	[p3l824t13r1125b81],
7	trials	NNS	O	trial	dep	3	SENT_33	[p3l1176t13r1378b81],
8	have	VBP	O	have	aux	9	SENT_33	[p3l1431t13r1619b81],
9	shown	VBN	O	show	_	0	SENT_33	[p3l1674t13r1940b81],
10	that	IN	O	that	complm	12	SENT_33	[p3l1991t13r2147b81],
11	simvastatin	NN	O	simvastatin	nsubj	12	SENT_33	[p3l12t119r477b183],
12	reduces	VBZ	O	reduce	ccomp	9	SENT_33	[p3l508t116r819b183],
13	the	DT	O	the	det	14	SENT_33	[p3l854t116r978b183],
14	risk	NN	O	risk	dobj	12	SENT_33	[p3l1011t116r1163b183],
15	of	IN	O	of	_	0	SENT_33	[p3l1196t116r1276b183],
16	death	NN	O	death	prep_of	14	SENT_33	[p3l1305t116r1526b183],
17	and	CC	O	and	_	0	SENT_33	[p3l1559t116r1708b183],
18	disease	NN	O	disease	prep_of	14	SENT_33	[p3l1743t116r2032b183],
19	in	IN	O	in	_	0	SENT_33	[p3l2066t119r2146b182],
20	patients	NNS	O	patient	prep_in	12	SENT_33	[p3l10t221r330b307],
21	with	IN	O	with	_	0	SENT_33	[p3l380t217r566b286],
22	chronic	JJ	O	chronic	amod	24	SENT_33	[p3l616t218r920b286],
23	heart	NN	O	heart	nn	24	SENT_33	[p3l971t218r1176b286],
24	disease	NN	O	disease	prep_with	20	SENT_33	[p3l1227t217r1615b286],
25	.	.	O	.	_	0	SENT_33	[p3l1227t217r1615b286],

1	”	NN	O	”	nn	2	SENT_34	[p3l1227t217r1615b286],
2	Simvastatin	NN	O	simvastatin	nsubj	3	SENT_34	[p3l1668t221r2146b286],
3	undergoes	VBZ	O	undergo	_	0	SENT_34	[p3l9t319r440b409],
4	extensive	JJ	O	extensive	amod	6	SENT_34	[p3l488t323r883b387],
5	first-pass	JJ	O	first-pass	amod	6	SENT_34	[p3l930t319r1311b409],
6	metabolism	NN	O	metabolism	dobj	3	SENT_34	[p3l1357t319r1847b387],
7	in	IN	O	in	_	0	SENT_34	[p3l1892t323r1973b387],
8	the	DT	O	the	det	10	SENT_34	[p3l2016t319r2144b387],
9	intestinal	JJ	O	intestinal	amod	10	SENT_34	[p3l11t421r391b489],
10	wall	NN	O	wall	prep_in	6	SENT_34	[p3l433t421r607b489],
11	and	CC	O	and	_	0	SENT_34	[p3l651t421r799b489],
12	liver	NN	O	liver	conj_and	10	SENT_34	[p3l841t421r1041b500],
13	,	,	O	,	_	0	SENT_34	[p3l841t421r1041b500],
14	which	WDT	O	which	nsubjpass	17	SENT_34	[p3l1085t421r1340b489],
15	is	VBZ	O	be	auxpass	17	SENT_34	[p3l1382t425r1444b489],
16	primarily	RB	O	primarily	advmod	17	SENT_34	[p3l1489t421r1871b511],
17	mediated	VBN	O	mediate	rcmod	10	SENT_34	[p3l1911t421r2144b489, p3l11t522r179b590],
18	by	IN	O	by	_	0	SENT_34	[p3l212t522r311b611],
19	CYP3A4/5	NN	O	cyp3a4/5	nn	21	SENT_34	[p3l347t521r929b601],
20	,10	CD	NUMBER	,10	num	21	SENT_34	[p3l347t521r929b601],
21	“	NN	O	“	agent	17	SENT_34	[p3l347t521r929b601],
22	with	IN	O	with	_	0	SENT_34	[p3l967t522r1152b590],
23	the	DT	O	the	det	24	SENT_34	[p3l1187t522r1311b590],
24	production	NN	O	production	prep_with	17	SENT_34	[p3l1348t522r1800b611],
25	of	IN	O	of	_	0	SENT_34	[p3l1838t522r1918b590],
26	inactive	JJ	O	inactive	amod	27	SENT_34	[p3l1948t525r2144b590, p3l9t627r158b691],
27	metabolites	NNS	O	metabolite	prep_of	24	SENT_34	[p3l191t624r676b691],
28	.	.	O	.	_	0	SENT_34	[p3l191t624r676b691],

1	In	IN	O	in	_	0	SENT_35	[p3l117t731r198b794],
2	the	DT	O	the	det	4	SENT_35	[p3l235t727r359b795],
3	CYP3A	NN	O	cyp3a	nn	4	SENT_35	[p3l400t730r692b795],
4	family	NN	O	family	prep_in	9	SENT_35	[p3l732t727r1004b816],
5	,	,	O	,	_	0	SENT_35	[p3l732t727r1004b816],
6	CYP3A4	NN	O	cyp3a4	nsubjpass	9	SENT_35	[p3l1047t730r1386b795],
7	is	VBZ	O	be	auxpass	9	SENT_35	[p3l1428t730r1490b795],
8	widely	RB	O	widely	advmod	9	SENT_35	[p3l1530t727r1810b816],
9	considered	VBN	O	consider	_	0	SENT_35	[p3l1850t727r2144b795, p3l12t827r185b895],
10	the	DT	O	the	det	12	SENT_35	[p3l237t827r360b895],
11	dominant	JJ	O	dominant	amod	12	SENT_35	[p3l418t828r808b895],
12	form	NN	O	form	dobj	9	SENT_35	[p3l861t828r1068b895],
13	.	.	O	.	_	0	SENT_35	[p3l861t828r1068b895],

1	However	RB	O	however	advmod	8	SENT_36	[p3l1127t832r1506b906],
2	,	,	O	,	_	0	SENT_36	[p3l1127t832r1506b906],
3	this	DT	O	this	det	4	SENT_36	[p3l1561t827r1709b895],
4	view	NN	O	view	nsubjpass	8	SENT_36	[p3l1763t831r1959b895],
5	has	VBZ	O	have	aux	8	SENT_36	[p3l2011t827r2143b895],
6	been	VBN	O	be	auxpass	8	SENT_36	[p3l7t929r200b997],
7	recently	RB	DATE	recently	advmod	8	SENT_36	[p3l230t929r559b1019],
8	challenged	VBN	O	challenge	_	0	SENT_36	[p3l592t929r1032b1019],
9	by	IN	O	by	_	0	SENT_36	[p3l1061t929r1159b1019],
10	data	NNS	O	datum	agent	8	SENT_36	[p3l1193t929r1361b997],
11	indicating	VBG	O	indicate	partmod	10	SENT_36	[p3l1392t929r1803b1019],
12	that	IN	O	that	dep	11	SENT_36	[p3l1834t929r1991b997],
13	the	DT	O	the	dep	12	SENT_36	[p3l2020t929r2145b997],

1	KIM	NNP	O	KIM	nn	3	SENT_37	[p3l974t1321r1056b1350],
2	ET	NNP	O	ET	nn	3	SENT_37	[p3l1065t1321r1122b1350],
3	AL	NNP	O	AL	_	0	SENT_37	[p3l1131t1321r1186b1350],

1	relative	JJ	O	relative	amod	2	SENT_38	[p3l15t1529r317b1596],
2	contribution	NN	O	contribution	nsubj	13	SENT_38	[p3l354t1529r857b1596],
3	of	IN	O	of	_	0	SENT_38	[p3l893t1529r973b1596],
4	CYP3A5	NN	O	cyp3a5	prep_of	2	SENT_38	[p3l1000t1532r1336b1596],
5	to	TO	O	to	_	0	SENT_38	[p3l1374t1539r1447b1596],
6	the	DT	O	the	det	9	SENT_38	[p3l1483t1529r1606b1596],
7	total	JJ	O	total	amod	9	SENT_38	[p3l1641t1529r1819b1596],
8	CYP3A	NN	O	cyp3a	nn	9	SENT_38	[p3l1854t1533r2146b1596],
9	pool	NN	O	pool	prep_to	4	SENT_38	[p3l17t1631r195b1720],
10	may	MD	O	may	aux	13	SENT_38	[p3l234t1655r404b1720],
11	be	VB	O	be	cop	13	SENT_38	[p3l440t1631r531b1699],
12	much	RB	O	much	advmod	13	SENT_38	[p3l572t1631r801b1699],
13	larger	JJR	O	larger	_	0	SENT_38	[p3l840t1631r1068b1720],
14	than	IN	O	than	mark	16	SENT_38	[p3l1106t1631r1286b1699],
15	previously	RB	DATE	previously	advmod	16	SENT_38	[p3l1325t1631r1756b1720],
16	assumed	VBN	O	assume	ccomp	13	SENT_38	[p3l1796t1631r2146b1699],
17	in	IN	O	in	_	0	SENT_38	[p3l17t1737r96b1801],
18	individuals	NNS	O	individual	prep_in	16	SENT_38	[p3l119t1734r566b1802],
19	with	IN	O	with	_	0	SENT_38	[p3l590t1734r771b1802],
20	increased	VBN	O	increase	amod	21	SENT_38	[p3l794t1734r1167b1802],
21	expression	NN	O	expression	prep_with	18	SENT_38	[p3l1192t1737r1612b1823],
22	of	IN	O	of	_	0	SENT_38	[p3l1638t1734r1716b1802],
23	CYP3A5	NN	O	cyp3a5	prep_of	21	SENT_38	[p3l1733t1733r2144b1802],
24	.	.	O	.	_	0	SENT_38	[p3l1733t1733r2144b1802],

1	”	NN	O	”	nsubjpass	6	SENT_39	[p3l1733t1733r2144b1802],
2	The	DT	O	the	det	4	SENT_39	[p3l17t1835r169b1904],
3	CYP3A5	NN	O	cyp3a5	nn	4	SENT_39	[p3l207t1839r543b1904],
4	protein	NN	O	protein	dep	1	SENT_39	[p3l585t1839r877b1925],
5	is	VBZ	O	be	auxpass	6	SENT_39	[p3l913t1839r975b1904],
6	expressed	VBN	O	express	_	0	SENT_39	[p3l1016t1835r1415b1925],
7	polymorphically	RB	O	polymorphically	advmod	6	SENT_39	[p3l1451t1835r2143b1925],
8	,	,	O	,	_	0	SENT_39	[p3l1451t1835r2143b1925],
9	and	CC	O	and	_	0	SENT_39	[p3l18t1937r166b2005],
10	several	JJ	O	several	amod	12	SENT_39	[p3l202t1937r481b2005],
11	genetic	JJ	O	genetic	amod	12	SENT_39	[p3l515t1941r801b2027],
12	variants	NNS	O	variant	nsubj	30	SENT_39	[p3l835t1941r1179b2016],
13	,	,	O	,	_	0	SENT_39	[p3l835t1941r1179b2016],
14	of	IN	O	of	_	0	SENT_39	[p3l1219t1937r1299b2005],
15	which	WDT	O	which	rel	23	SENT_39	[p3l1324t1937r1578b2005],
16	CYP3A5	NN	O	cyp3a5	nsubj	23	SENT_39	[p3l1617t1941r2047b2005],
17	*	CD	NUMBER	*	num	18	SENT_39	[p3l1617t1941r2047b2005],
18	3	CD	NUMBER	3	dep	16	SENT_39	[p3l1617t1941r2047b2005],
19	is	VBZ	O	be	cop	23	SENT_39	[p3l2082t1941r2144b2005],
20	the	DT	O	the	det	23	SENT_39	[p3l16t2039r139b2107],
21	single	JJ	O	single	amod	23	SENT_39	[p3l187t2039r422b2128],
22	common	JJ	O	common	amod	23	SENT_39	[p3l469t2063r819b2107],
23	allele	NN	O	allele	rcmod	12	SENT_39	[p3l865t2039r1080b2107],
24	for	IN	O	for	_	0	SENT_39	[p3l1127t2039r1236b2107],
25	major	JJ	O	major	amod	27	SENT_39	[p3l1279t2043r1508b2128],
26	ethnic	JJ	O	ethnic	amod	27	SENT_39	[p3l1554t2039r1802b2107],
27	groups	NNS	O	group	prep_for	23	SENT_39	[p3l1849t2063r2143b2129],
28	,	,	O	,	_	0	SENT_39	[p3l1849t2063r2143b2129],
29	can	MD	O	can	aux	30	SENT_39	[p3l19t2165r156b2209],
30	reduce	VB	O	reduce	conj_and	6	SENT_39	[p3l203t2141r475b2209],
31	the	DT	O	the	det	32	SENT_39	[p3l524t2141r648b2209],
32	expression	NN	O	expression	dobj	30	SENT_39	[p3l700t2145r1134b2231],
33	of	IN	O	of	_	0	SENT_39	[p3l1184t2141r1264b2209],
34	CYP3A5	NN	O	cyp3a5	prep_of	32	SENT_39	[p3l1306t2140r1803b2209],
35	.	.	O	.	_	0	SENT_39	[p3l1306t2140r1803b2209],

1	”’	RB	O	”’	dep	2	SENT_40	[p3l1306t2140r1803b2209],
2	13	CD	NUMBER	13	dep	4	SENT_40	[p3l1306t2140r1803b2209],
3	This	DT	O	this	nsubj	4	SENT_40	[p3l1854t2141r2030b2209],
4	is	VBZ	O	be	dep	42	SENT_40	[p3l2081t2145r2144b2209],
5	because	RB	O	because	prep	4	SENT_40	[p3l14t2243r355b2322],
6	,	,	O	,	_	0	SENT_40	[p3l14t2243r355b2322],
7	in	IN	O	in	dep	5	SENT_40	[p3l387t2246r467b2310],
8	general	JJ	O	general	pobj	7	SENT_40	[p3l494t2243r808b2332],
9	,	,	O	,	_	0	SENT_40	[p3l494t2243r808b2332],
10	CYP3A4	NN	O	cyp3a4	nsubj	13	SENT_40	[p3l840t2246r1178b2311],
11	and	CC	O	and	_	0	SENT_40	[p3l1210t2243r1358b2311],
12	CYP3A5	NN	O	cyp3a5	conj_and	10	SENT_40	[p3l1387t2246r1722b2311],
13	have	VBP	O	have	dep	4	SENT_40	[p3l1755t2243r1943b2311],
14	similar	JJ	O	similar	amod	16	SENT_40	[p3l1975t2246r2145b2311, p3l17t2346r152b2414],
15	catalytic	JJ	O	catalytic	amod	16	SENT_40	[p3l188t2346r526b2435],
16	specificities	NNS	O	specificity	dobj	13	SENT_40	[p3l565t2346r1069b2435],
17	,	,	O	,	_	0	SENT_40	[p3l565t2346r1069b2435],
18	and	CC	O	and	_	0	SENT_40	[p3l1110t2346r1257b2414],
19	although	IN	O	although	mark	26	SENT_40	[p3l1294t2346r1649b2435],
20	the	DT	O	the	det	21	SENT_40	[p3l1684t2346r1807b2414],
21	activity	NN	O	activity	nsubj	26	SENT_40	[p3l1846t2349r2147b2435],
22	of	IN	O	of	_	0	SENT_40	[p3l19t2447r99b2514],
23	CYP3A5	NN	O	cyp3a5	prep_of	21	SENT_40	[p3l137t2450r472b2514],
24	is	VBZ	O	be	cop	26	SENT_40	[p3l522t2450r584b2514],
25	often	RB	O	often	advmod	26	SENT_40	[p3l633t2447r834b2514],
26	less	RBR	O	less	conj_and	13	SENT_40	[p3l879t2446r1025b2514],
27	than	IN	O	than	_	0	SENT_40	[p3l1071t2446r1250b2514],
28	that	DT	O	that	prep_than	26	SENT_40	[p3l1293t2446r1449b2514],
29	of	IN	O	of	_	0	SENT_40	[p3l1494t2447r1574b2514],
30	CYP3A4	NN	O	cyp3a4	prep_of	28	SENT_40	[p3l1612t2450r1974b2525],
31	,	,	O	,	_	0	SENT_40	[p3l1612t2450r1974b2525],
32	the	DT	O	the	det	36	SENT_40	[p3l2021t2446r2145b2514],
33	amount	NN	O	amount	nn	36	SENT_40	[p3l18t2558r325b2616],
34	and	CC	O	and	_	0	SENT_40	[p3l380t2548r528b2616],
35	relative	JJ	O	relative	nn	36	SENT_40	[p3l582t2548r884b2616],
36	contribution	NN	O	contribution	nsubj	42	SENT_40	[p3l942t2548r1445b2616],
37	of	IN	O	of	_	0	SENT_40	[p3l1502t2548r1582b2616],
38	this	DT	O	this	det	39	SENT_40	[p3l1629t2548r1777b2616],
39	enzyme	NN	O	enzyme	prep_of	36	SENT_40	[p3l1836t2572r2145b2638],
40	may	MD	O	may	aux	42	SENT_40	[p3l16t2674r186b2739],
41	be	VB	O	be	cop	42	SENT_40	[p3l214t2650r305b2718],
42	greater	JJR	O	greater	_	0	SENT_40	[p3l337t2660r611b2739],
43	than	IN	O	than	mark	45	SENT_40	[p3l640t2650r820b2718],
44	previously	RB	DATE	previously	advmod	45	SENT_40	[p3l852t2650r1282b2740],
45	thought	VBN	O	think	ccomp	42	SENT_40	[p3l1312t2650r1781b2739],
46	.	.	O	.	_	0	SENT_40	[p3l1312t2650r1781b2739],

1	”’	RB	O	”’	dep	2	SENT_41	[p3l1312t2650r1781b2739],
2	15	CD	NUMBER	15	_	0	SENT_41	[p3l1312t2650r1781b2739],

1	However	RB	O	however	advmod	13	SENT_42	[p3l123t2756r501b2830],
2	,	,	O	,	_	0	SENT_42	[p3l123t2756r501b2830],
3	recent	JJ	O	recent	amod	4	SENT_42	[p3l532t2761r782b2819],
4	research	NN	O	research	nsubj	13	SENT_42	[p3l808t2751r1146b2819],
5	on	IN	O	on	_	0	SENT_42	[p3l1176t2775r1274b2819],
6	CYP3A5	NN	O	cyp3a5	prep_on	4	SENT_42	[p3l1303t2754r1638b2819],
7	in	FW	O	in	nn	8	SENT_42	[p3l1673t2755r1752b2818],
8	vitro	FW	O	vitro	dep	6	SENT_42	[p3l1779t2755r1966b2819],
9	and	CC	O	and	_	0	SENT_42	[p3l1998t2751r2146b2819],
10	in	IN	O	in	dep	6	SENT_42	[p3l17t2856r97b2920],
11	humans	NNS	O	human	pobj	10	SENT_42	[p3l132t2853r452b2921],
12	has	VBZ	O	have	aux	13	SENT_42	[p3l490t2853r623b2921],
13	provided	VBN	O	provide	_	0	SENT_42	[p3l662t2853r1028b2942],
14	discordant	JJ	O	discordant	amod	15	SENT_42	[p3l1067t2853r1495b2921],
15	information	NN	O	information	dobj	13	SENT_42	[p3l1531t2853r2010b2921],
16	on	IN	O	on	_	0	SENT_42	[p3l2048t2877r2146b2921],
17	the	DT	O	the	det	18	SENT_42	[p3l16t2956r139b3024],
18	role	NN	O	role	prep_on	13	SENT_42	[p3l189t2956r342b3024],
19	played	VBN	O	play	partmod	18	SENT_42	[p3l393t2956r666b3045],
20	by	IN	O	by	_	0	SENT_42	[p3l712t2956r810b3045],
21	CYP3A5	NN	O	cyp3a5	agent	19	SENT_42	[p3l859t2959r1195b3024],
22	in	IN	O	in	_	0	SENT_42	[p3l1250t2959r1330b3023],
23	the	DT	O	the	det	24	SENT_42	[p3l1378t2956r1501b3024],
24	metabolism	NN	O	metabolism	prep_in	19	SENT_42	[p3l1551t2956r2022b3024],
25	of	IN	O	of	_	0	SENT_42	[p3l2073t2956r2153b3024],
26	CYP3A	NN	O	cyp3a	nn	27	SENT_42	[p3l17t3061r309b3126],
27	substrates	NNS	O	substrate	prep_of	24	SENT_42	[p3l337t3058r733b3126],
28	in	FW	O	in	prep	27	SENT_42	[p3l762t3061r841b3125],
29	vivo	FW	O	vivo	pobj	28	SENT_42	[p3l865t3057r1123b3126],
30	.	.	O	.	_	0	SENT_42	[p3l865t3057r1123b3126],

1	”	NN	O	”	dep	7	SENT_43	[p3l865t3057r1123b3126],
2	Even	RB	O	even	advmod	7	SENT_43	[p3l1148t3062r1348b3126],
3	though	IN	O	though	dep	7	SENT_43	[p3l1373t3057r1656b3147],
4	simvastatin	NN	O	simvastatin	nsubjpass	7	SENT_43	[p3l1683t3061r2146b3126],
5	is	VBZ	O	be	auxpass	7	SENT_43	[p3l17t3163r80b3227],
6	mainly	RB	O	mainly	advmod	7	SENT_43	[p3l127t3159r410b3249],
7	metabolized	VBN	O	metabolize	ccomp	12	SENT_43	[p3l455t3159r950b3227],
8	by	IN	O	by	_	0	SENT_43	[p3l993t3159r1091b3249],
9	CYP3A4/5	NN	O	cyp3a4/5	agent	7	SENT_43	[p3l1137t3159r1583b3238],
10	,	,	O	,	_	0	SENT_43	[p3l1137t3159r1583b3238],
11	there	EX	O	there	expl	12	SENT_43	[p3l1631t3159r1834b3227],
12	are	VBP	O	be	_	0	SENT_43	[p3l1883t3183r1999b3227],
13	no	DT	O	no	det	15	SENT_43	[p3l2046t3183r2144b3227],
14	available	JJ	O	available	amod	15	SENT_43	[p3l18t3261r376b3329],
15	data	NNS	O	datum	nsubj	12	SENT_43	[p3l409t3261r576b3329],
16	to	TO	O	to	aux	17	SENT_43	[p3l602t3271r676b3329],
17	show	VB	O	show	infmod	15	SENT_43	[p3l709t3261r920b3329],
18	whether	IN	O	whether	complm	20	SENT_43	[p3l947t3261r1280b3329],
19	CYP3A5	NN	O	cyp3a5	nsubj	20	SENT_43	[p3l1308t3265r1644b3329],
20	plays	VBZ	O	play	ccomp	17	SENT_43	[p3l1677t3261r1888b3351],
21	a	DT	O	a	det	23	SENT_43	[p3l1920t3285r1960b3329],
22	crucial	JJ	O	crucial	amod	23	SENT_43	[p3l1989t3285r2145b3329, p3l19t3363r160b3431],
23	role	NN	O	role	dobj	20	SENT_43	[p3l207t3363r361b3431],
24	in	IN	O	in	_	0	SENT_43	[p3l411t3367r490b3431],
25	the	DT	O	the	det	27	SENT_43	[p3l537t3363r661b3431],
26	pharmacokinetic	JJ	O	pharmacokinetic	amod	27	SENT_43	[p3l710t3363r1390b3453],
27	characteristics	NNS	O	characteristic	prep_in	23	SENT_43	[p3l1442t3363r2021b3431],
28	of	IN	O	of	_	0	SENT_43	[p3l2073t3363r2153b3431],
29	simvastatin	NN	O	simvastatin	prep_of	27	SENT_43	[p3l19t3467r482b3531],
30	in	IN	O	in	_	0	SENT_43	[p3l513t3467r593b3531],
31	humans	NNS	O	human	prep_in	29	SENT_43	[p3l623t3464r965b3531],
32	.	.	O	.	_	0	SENT_43	[p3l623t3464r965b3531],

1	Therefore	RB	O	therefore	advmod	4	SENT_44	[p4l124t25r553b103],
2	,	,	O	,	_	0	SENT_44	[p4l124t25r553b103],
3	We	PRP	O	we	nsubj	4	SENT_44	[p4l622t49r739b93],
4	investigated	VBD	O	investigate	_	0	SENT_44	[p4l808t25r1318b114],
5	the	DT	O	the	det	6	SENT_44	[p4l1384t25r1511b93],
6	effect	NN	O	effect	dobj	4	SENT_44	[p4l1581t25r1808b93],
7	of	IN	O	of	_	0	SENT_44	[p4l1876t25r1958b93],
8	the	DT	O	the	det	13	SENT_44	[p4l2017t25r2145b93],
9	CYP3A5	NN	O	cyp3a5	nn	13	SENT_44	[p4l22t130r358b195],
10	*	NN	O	*	nn	13	SENT_44	[p4l374t130r452b195],
11	3	CD	NUMBER	3	num	13	SENT_44	[p4l374t130r452b195],
12	genetic	JJ	O	genetic	amod	13	SENT_44	[p4l483t130r768b216],
13	polymorphism	NN	O	polymorphism	prep_of	6	SENT_44	[p4l801t126r1399b216],
14	on	IN	O	on	_	0	SENT_44	[p4l1432t151r1530b195],
15	the	DT	O	the	det	16	SENT_44	[p4l1560t126r1683b195],
16	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	13	SENT_44	[p4l1716t126r2145b216, p4l16t228r331b296],
17	of	IN	O	of	_	0	SENT_44	[p4l367t228r447b296],
18	simvastatin	NN	O	simvastatin	prep_of	16	SENT_44	[p4l473t232r936b296],
19	in	IN	O	in	_	0	SENT_44	[p4l968t232r1047b296],
20	healthy	JJ	O	healthy	amod	21	SENT_44	[p4l1078t228r1381b318],
21	subjects	NNS	O	subject	prep_in	4	SENT_44	[p4l1413t228r1752b317],
22	.	.	O	.	_	0	SENT_44	[p4l1413t228r1752b317],

1	METHODS	NNS	O	method	_	0	SENT_45	[p4l16t446r465b510],

1	Subjects	NNS	O	subject	_	0	SENT_46	[p4l19t655r353b744],
2	and	CC	O	and	_	0	SENT_46	[p4l387t655r538b723],
3	Study	NN	O	study	nn	4	SENT_46	[p4l572t655r809b745],
4	Design	NN	O	design	conj_and	1	SENT_46	[p4l838t658r1112b745],

1	The	DT	O	the	det	3	SENT_47	[p4l17t864r165b932],
2	study	NN	O	study	nn	3	SENT_47	[p4l202t864r416b953],
3	protocol	NN	O	protocol	nsubjpass	5	SENT_47	[p4l449t864r771b954],
4	was	VBD	O	be	auxpass	5	SENT_47	[p4l805t888r953b932],
5	approved	VBN	O	approve	_	0	SENT_47	[p4l990t864r1356b954],
6	by	IN	O	by	_	0	SENT_47	[p4l1387t864r1483b953],
7	the	DT	O	the	det	10	SENT_47	[p4l1516t864r1635b932],
8	Institutional	JJ	ORGANIZATION	institutional	amod	10	SENT_47	[p4l1670t864r2145b932],
9	Review	NNP	ORGANIZATION	Review	nn	10	SENT_47	[p4l16t969r305b1033],
10	Board	NNP	ORGANIZATION	Board	agent	5	SENT_47	[p4l341t965r570b1033],
11	of	IN	ORGANIZATION	of	_	0	SENT_47	[p4l608t965r687b1033],
12	Gil	NNP	ORGANIZATION	Gil	nn	14	SENT_47	[p4l716t965r830b1033],
13	Medical	NNP	ORGANIZATION	Medical	nn	14	SENT_47	[p4l866t965r1181b1033],
14	Center	NNP	ORGANIZATION	Center	prep_of	10	SENT_47	[p4l1218t969r1485b1043],
15	,	,	O	,	_	0	SENT_47	[p4l1218t969r1485b1043],
16	Incheon	NNP	LOCATION	Incheon	nn	18	SENT_47	[p4l1524t965r1859b1043],
17	,	,	O	,	_	0	SENT_47	[p4l1524t965r1859b1043],
18	Korea	NNP	LOCATION	Korea	appos	14	SENT_47	[p4l1898t970r2142b1043],
19	,	,	O	,	_	0	SENT_47	[p4l1898t970r2142b1043],
20	and	CC	O	and	_	0	SENT_47	[p4l18t1067r162b1135],
21	all	DT	O	all	det	22	SENT_47	[p4l198t1067r291b1135],
22	subjects	NNS	O	subject	nsubj	23	SENT_47	[p4l329t1067r632b1156],
23	provided	VBD	O	provide	conj_and	5	SENT_47	[p4l669t1067r1022b1156],
24	their	PRP$	O	they	dep	23	SENT_47	[p4l1055t1067r1238b1135],
25	written	VBN	O	write	amod	27	SENT_47	[p4l1270t1070r1552b1135],
26	informed	VBN	O	inform	amod	27	SENT_47	[p4l1587t1067r1943b1135],
27	consent	NN	O	consent	dobj	23	SENT_47	[p4l1980t1091r2144b1135, p4l19t1180r192b1238],
28	.	.	O	.	_	0	SENT_47	[p4l1980t1091r2144b1135, p4l19t1180r192b1238],

1	Among	IN	O	among	prep	13	SENT_48	[p4l221t1174r506b1259],
2	the	DT	O	the	det	3	SENT_48	[p4l530t1170r650b1238],
3	previously	RB	DATE	previously	pobj	1	SENT_48	[p4l676t1170r1089b1259],
4	genotyped	VBN	O	genotype	dep	3	SENT_48	[p4l1113t1170r1518b1259],
5	130	CD	NUMBER	130	num	6	SENT_48	[p4l1547t1179r1681b1238],
6	subjects	NNS	O	subject	dobj	4	SENT_48	[p4l1710t1170r2013b1259],
7	for	IN	O	for	_	0	SENT_48	[p4l2041t1170r2147b1238],
8	CYP3/l5	NN	O	cyp3/l5	prep_for	6	SENT_48	[p4l22t1274r477b1349],
9	*	CD	NUMBER	*	number	10	SENT_48	[p4l22t1274r477b1349],
10	3	CD	NUMBER	3	num	3	SENT_48	[p4l22t1274r477b1349],
11	,	,	O	,	_	0	SENT_48	[p4l22t1274r477b1349],
12	we	PRP	O	we	nsubj	13	SENT_48	[p4l517t1294r631b1338],
13	advertised	VBD	O	advertise	_	0	SENT_48	[p4l671t1270r1095b1338],
14	the	DT	O	the	det	16	SENT_48	[p4l1131t1270r1255b1338],
15	clinical	JJ	O	clinical	amod	16	SENT_48	[p4l1295t1270r1598b1338],
16	trial	NN	O	trial	dobj	13	SENT_48	[p4l1635t1270r1823b1349],
17	,	,	O	,	_	0	SENT_48	[p4l1635t1270r1823b1349],
18	and	CC	O	and	_	0	SENT_48	[p4l1865t1270r2014b1338],
19	22	CD	NUMBER	22	num	20	SENT_48	[p4l2054t1280r2140b1337],
20	subjects	NNS	O	subject	nsubjpass	22	SENT_48	[p4l19t1372r322b1462],
21	were	VBD	O	be	auxpass	22	SENT_48	[p4l361t1396r548b1440],
22	enrolled	VBN	O	enrol	conj_and	13	SENT_48	[p4l588t1372r909b1440],
23	and	CC	O	and	_	0	SENT_48	[p4l947t1372r1091b1440],
24	grouped	VBN	O	group	conj_and	13	SENT_48	[p4l1128t1372r1448b1462],
25	as	IN	O	as	_	0	SENT_48	[p4l1486t1396r1560b1440],
26	CYP3A5	NN	O	cyp3a5	nn	27	SENT_48	[p4l1606t1376r1932b1440],
27	*	NN	O	*	prep_as	24	SENT_48	[p4l1945t1372r2063b1440],
28	1	CD	NUMBER	1	num	27	SENT_48	[p4l1945t1372r2063b1440],
29	/	:	O	/	punct	40	SENT_48	[p4l1945t1372r2063b1440],
30	*	CD	NUMBER	*	number	31	SENT_48	[p4l2069t1376r2137b1440],
31	1	CD	NUMBER	1	num	36	SENT_48	[p4l2069t1376r2137b1440],
32	(	NN	O	(	nn	36	SENT_48	[p4l22t1473r95b1553],
33	n	NN	O	n	nn	36	SENT_48	[p4l22t1473r95b1553],
34	=	JJ	O	=	amod	36	SENT_48	[p4l121t1505r166b1529],
35	4	CD	NUMBER	4	num	36	SENT_48	[p4l192t1473r285b1553],
36	)	NN	O	)	dep	40	SENT_48	[p4l192t1473r285b1553],
37	,	,	O	,	_	0	SENT_48	[p4l192t1473r285b1553],
38	CYP3A5	NN	O	cyp3a5	nn	39	SENT_48	[p4l318t1473r858b1541],
39	*	NN	O	*	appos	36	SENT_48	[p4l318t1473r858b1541],
40	1	CD	NUMBER	1	parataxis	24	SENT_48	[p4l318t1473r858b1541],
41	/	:	O	/	punct	40	SENT_48	[p4l318t1473r858b1541],
42	*	CD	NUMBER	*	number	43	SENT_48	[p4l318t1473r858b1541],
43	3	CD	NUMBER	3	num	48	SENT_48	[p4l318t1473r858b1541],
44	(	NN	O	(	nn	48	SENT_48	[p4l887t1473r961b1553],
45	n	NN	O	n	nn	48	SENT_48	[p4l887t1473r961b1553],
46	=	JJ	O	=	amod	48	SENT_48	[p4l986t1505r1032b1529],
47	8	CD	NUMBER	8	num	48	SENT_48	[p4l1061t1473r1150b1553],
48	)	NN	O	)	dobj	22	SENT_48	[p4l1061t1473r1150b1553],
49	,	,	O	,	_	0	SENT_48	[p4l1061t1473r1150b1553],
50	or	CC	O	or	_	0	SENT_48	[p4l1180t1497r1256b1541],
51	CYP3/l5	NN	O	cyp3/l5	conj_or	48	SENT_48	[p4l1285t1473r1826b1541],
52	*	CD	NUMBER	*	number	53	SENT_48	[p4l1285t1473r1826b1541],
53	3	CD	NUMBER	3	num	62	SENT_48	[p4l1285t1473r1826b1541],
54	/	:	O	/	punct	56	SENT_48	[p4l1285t1473r1826b1541],
55	*	CD	NUMBER	*	num	56	SENT_48	[p4l1285t1473r1826b1541],
56	3	CD	NUMBER	3	dep	62	SENT_48	[p4l1285t1473r1826b1541],
57	(	NN	O	(	dep	56	SENT_48	[p4l1854t1473r1928b1553],
58	n	NN	O	n	nn	62	SENT_48	[p4l1854t1473r1928b1553],
59	=	JJ	O	=	amod	62	SENT_48	[p4l1954t1505r1999b1529],
60	10	CD	NUMBER	10	number	61	SENT_48	[p4l2030t1473r2141b1553],
61	)	CD	NUMBER	)	num	62	SENT_48	[p4l2030t1473r2141b1553],
62	carriers	NNS	O	carrier	dep	51	SENT_48	[p4l19t1579r322b1643],
63	.	.	O	.	_	0	SENT_48	[p4l19t1579r322b1643],

1	Their	PRP$	O	they	poss	2	SENT_49	[p4l362t1575r572b1643],
2	ages	NNS	O	age	nsubjpass	20	SENT_49	[p4l607t1599r788b1664],
3	,	,	O	,	_	0	SENT_49	[p4l607t1599r788b1664],
4	heights	NNS	O	height	conj_and	2	SENT_49	[p4l825t1575r1124b1664],
5	,	,	O	,	_	0	SENT_49	[p4l825t1575r1124b1664],
6	and	CC	O	and	_	0	SENT_49	[p4l1163t1575r1307b1643],
7	weights	NNS	O	weight	conj_and	2	SENT_49	[p4l1340t1575r1638b1664],
8	are	VBP	O	be	auxpass	9	SENT_49	[p4l1676t1599r1788b1643],
9	given	VBN	O	give	_	0	SENT_49	[p4l1823t1579r2034b1664],
10	in	IN	O	in	_	0	SENT_49	[p4l2069t1579r2146b1643],
11	Table	NNP	O	Table	nn	13	SENT_49	[p4l17t1677r222b1745],
12	I.	NNP	O	I.	nn	13	SENT_49	[p4l254t1681r297b1745],
13	The	NNP	O	The	prep_in	9	SENT_49	[p4l334t1677r482b1745],
14	subjects	NNS	O	subject	nsubjpass	16	SENT_49	[p4l516t1677r820b1766],
15	were	VBD	O	be	auxpass	16	SENT_49	[p4l852t1701r1039b1745],
16	assessed	VBN	O	assess	rcmod	13	SENT_49	[p4l1072t1677r1399b1745],
17	by	IN	O	by	_	0	SENT_49	[p4l1426t1677r1523b1766],
18	physicians	NNS	O	physician	agent	16	SENT_49	[p4l1553t1677r1968b1766],
19	and	CC	O	and	_	0	SENT_49	[p4l2002t1677r2146b1745],
20	deemed	VBD	O	deem	conj_and	9	SENT_49	[p4l20t1780r324b1848],
21	healthy	JJ	O	healthy	acomp	20	SENT_49	[p4l345t1780r636b1869],
22	based	VBN	O	base	_	0	SENT_49	[p4l655t1780r878b1848],
23	on	IN	O	on	prepc_based_on	21	SENT_49	[p4l902t1804r998b1848],
24	the	DT	O	the	det	25	SENT_49	[p4l1019t1780r1138b1848],
25	results	NNS	O	result	pobj	21	SENT_49	[p4l1160t1780r1415b1848],
26	of	IN	O	of	_	0	SENT_49	[p4l1441t1780r1519b1848],
27	a	DT	O	a	det	30	SENT_49	[p4l1535t1804r1575b1848],
28	detailed	JJ	O	detailed	amod	30	SENT_49	[p4l1599t1780r1909b1848],
29	physical	JJ	O	physical	amod	30	SENT_49	[p4l1931t1780r2144b1869, p4l17t1881r154b1950],
30	examination	NN	O	examination	prep_of	25	SENT_49	[p4l199t1885r700b1960],
31	,	,	O	,	_	0	SENT_49	[p4l199t1885r700b1960],
32	12-lead	JJ	O	12-lead	amod	33	SENT_49	[p4l751t1881r1031b1950],
33	electrocardiography	NN	O	electrocardiography	prep_of	25	SENT_49	[p4l1075t1881r1861b1971],
34	,	,	O	,	_	0	SENT_49	[p4l1075t1881r1861b1971],
35	serum	NN	O	serum	nn	36	SENT_49	[p4l1908t1906r2146b1950],
36	biochemistry	NN	O	biochemistry	prep_of	25	SENT_49	[p4l14t1983r584b2073],
37	,	,	O	,	_	0	SENT_49	[p4l14t1983r584b2073],
38	hematology	NN	O	hematology	conj_and	30	SENT_49	[p4l624t1983r1129b2073],
39	,	,	O	,	_	0	SENT_49	[p4l624t1983r1129b2073],
40	and	CC	O	and	_	0	SENT_49	[p4l1171t1983r1322b2051],
41	routine	JJ	O	routine	amod	42	SENT_49	[p4l1359t1987r1662b2051],
42	urinalysis	NN	O	urinalysis	conj_and	30	SENT_49	[p4l1700t1983r2140b2073],
43	.	.	O	.	_	0	SENT_49	[p4l1700t1983r2140b2073],

1	Subjects	NNS	O	subject	nsubjpass	3	SENT_50	[p4l20t2085r337b2174],
2	were	VBD	O	be	auxpass	3	SENT_50	[p4l379t2109r566b2153],
3	excluded	VBN	O	exclude	_	0	SENT_50	[p4l610t2085r965b2153],
4	if	IN	O	if	mark	6	SENT_50	[p4l1006t2085r1066b2153],
5	they	PRP	O	they	nsubj	6	SENT_50	[p4l1098t2085r1268b2174],
6	had	VBD	O	have	advcl	3	SENT_50	[p4l1307t2085r1452b2153],
7	a	DT	O	a	det	8	SENT_50	[p4l1494t2109r1534b2153],
8	history	NN	O	history	dobj	6	SENT_50	[p4l1573t2085r1845b2174],
9	or	CC	O	or	_	0	SENT_50	[p4l1886t2109r1963b2153],
10	evidence	NN	O	evidence	dobj	6	SENT_50	[p4l2005t2089r2144b2153, p4l20t2187r245b2255],
11	of	IN	O	of	_	0	SENT_50	[p4l278t2187r356b2255],
12	hepatic	JJ	O	hepatic	amod	20	SENT_50	[p4l377t2187r682b2277],
13	,	,	O	,	_	0	SENT_50	[p4l377t2187r682b2277],
14	renal	JJ	O	renal	amod	20	SENT_50	[p4l714t2187r929b2266],
15	,	,	O	,	_	0	SENT_50	[p4l714t2187r929b2266],
16	gastrointestinal	JJ	O	gastrointestinal	amod	20	SENT_50	[p4l961t2187r1574b2276],
17	,	,	O	,	_	0	SENT_50	[p4l961t2187r1574b2276],
18	or	CC	O	or	_	0	SENT_50	[p4l1609t2211r1685b2255],
19	hematological	JJ	O	hematological	amod	20	SENT_50	[p4l1713t2187r2144b2276, p4l17t2289r154b2357],
20	abnormalities	NNS	O	abnormality	prep_of	10	SENT_50	[p4l183t2289r730b2367],
21	;	:	O	;	_	0	SENT_50	[p4l183t2289r730b2367],
22	hepatitis	NN	O	hepatitis	nn	23	SENT_50	[p4l760t2289r1094b2378],
23	B	NN	O	b	conj_or	8	SENT_50	[p4l1123t2293r1173b2356],
24	or	CC	O	or	_	0	SENT_50	[p4l1207t2313r1283b2357],
25	C	NN	O	c	nn	28	SENT_50	[p4l1309t2292r1363b2357],
26	or	CC	O	or	_	0	SENT_50	[p4l1392t2313r1469b2357],
27	HIV	NN	MISC	hiv	nn	28	SENT_50	[p4l1495t2293r1651b2356],
28	infection	NN	O	infection	conj_or	23	SENT_50	[p4l1677t2289r2022b2357],
29	on	IN	O	on	_	0	SENT_50	[p4l2050t2313r2146b2357],
30	screening	NN	O	screening	prep_on	28	SENT_50	[p4l19t2395r406b2481],
31	;	:	O	;	_	0	SENT_50	[p4l19t2395r406b2481],
32	any	DT	O	any	det	34	SENT_50	[p4l454t2416r593b2481],
33	other	JJ	O	other	amod	34	SENT_50	[p4l638t2392r837b2460],
34	acute	JJ	O	acute	conj_or	8	SENT_50	[p4l880t2402r1083b2460],
35	or	CC	O	or	_	0	SENT_50	[p4l1129t2416r1206b2460],
36	chronic	JJ	O	chronic	amod	37	SENT_50	[p4l1250t2392r1541b2460],
37	disease	NN	O	disease	conj_or	10	SENT_50	[p4l1589t2392r1885b2470],
38	;	:	O	;	_	0	SENT_50	[p4l1589t2392r1885b2470],
39	or	CC	O	or	_	0	SENT_50	[p4l1934t2416r2011b2460],
40	an	DT	O	a	det	41	SENT_50	[p4l2054t2416r2146b2460],
41	allergy	NN	O	allergy	conj_or	8	SENT_50	[p4l18t2493r278b2583],
42	to	TO	O	to	_	0	SENT_50	[p4l303t2504r374b2562],
43	any	DT	O	any	det	44	SENT_50	[p4l404t2518r543b2583],
44	drug	NN	O	drug	prep_to	41	SENT_50	[p4l572t2493r763b2583],
45	.	.	O	.	_	0	SENT_50	[p4l572t2493r763b2583],

1	None	NN	O	none	nsubj	10	SENT_51	[p4l795t2498r1001b2562],
2	of	IN	O	of	_	0	SENT_51	[p4l1031t2494r1109b2562],
3	the	DT	O	the	det	4	SENT_51	[p4l1127t2493r1246b2562],
4	subjects	NNS	O	subject	prep_of	1	SENT_51	[p4l1276t2493r1579b2583],
5	was	VBD	O	be	cop	8	SENT_51	[p4l1607t2518r1755b2562],
6	a	DT	O	a	det	8	SENT_51	[p4l1786t2518r1826b2562],
7	tobacco	NN	O	tobacco	nn	8	SENT_51	[p4l1850t2494r2143b2562],
8	smoker	NN	O	smoker	_	0	SENT_51	[p4l19t2595r300b2663],
9	or	CC	O	or	_	0	SENT_51	[p4l335t2619r412b2663],
10	used	VBN	O	use	conj_or	8	SENT_51	[p4l444t2595r628b2663],
11	any	DT	O	any	det	13	SENT_51	[p4l664t2619r803b2685],
12	continuous	JJ	O	continuous	amod	13	SENT_51	[p4l838t2599r1271b2663],
13	medication	NN	O	medication	dobj	10	SENT_51	[p4l1307t2595r1762b2663],
14	.	.	O	.	_	0	SENT_51	[p4l1307t2595r1762b2663],

1	No	DT	O	no	det	2	SENT_52	[p4l1801t2600r1912b2663],
2	medications	NNS	O	medication	nsubjpass	17	SENT_52	[p4l1948t2595r2144b2663, p4l17t2701r339b2776],
3	,	,	O	,	_	0	SENT_52	[p4l1948t2595r2144b2663, p4l17t2701r339b2776],
4	herbal	JJ	O	herbal	amod	5	SENT_52	[p4l376t2697r618b2765],
5	medicine	NN	O	medicine	nsubjpass	17	SENT_52	[p4l652t2697r1034b2776],
6	,	,	O	,	_	0	SENT_52	[p4l652t2697r1034b2776],
7	alcohol	NN	O	alcohol	nsubjpass	17	SENT_52	[p4l1073t2697r1376b2776],
8	,	,	O	,	_	0	SENT_52	[p4l1073t2697r1376b2776],
9	grapefruit	NN	O	grapefruit	nn	10	SENT_52	[p4l1413t2697r1793b2787],
10	juice	NN	O	juice	nsubjpass	17	SENT_52	[p4l1823t2701r2030b2786],
11	,	,	O	,	_	0	SENT_52	[p4l1823t2701r2030b2786],
12	or	CC	O	or	_	0	SENT_52	[p4l2070t2721r2147b2765],
13	beverage	NN	O	beverage	nsubjpass	17	SENT_52	[p4l14t2799r353b2888],
14	containing	VBG	O	contain	partmod	2	SENT_52	[p4l387t2803r798b2888],
15	caffeine	NN	O	caffeine	dobj	14	SENT_52	[p4l831t2799r1130b2867],
16	was	VBD	O	be	auxpass	17	SENT_52	[p4l1162t2823r1310b2867],
17	permitted	VBN	O	permit	_	0	SENT_52	[p4l1344t2799r1724b2889],
18	for	IN	O	for	_	0	SENT_52	[p4l1756t2799r1861b2867],
19	7	CD	DURATION	7	num	20	SENT_52	[p4l1898t2810r1934b2866],
20	days	NNS	NUMBER	day	prep_for	17	SENT_52	[p4l1971t2799r2143b2888],
21	before	IN	O	before	_	0	SENT_52	[p4l14t2901r253b2969],
22	the	DT	O	the	det	23	SENT_52	[p4l281t2901r401b2969],
23	study	NN	O	study	prep_before	20	SENT_52	[p4l431t2901r645b2990],
24	and	CC	O	and	_	0	SENT_52	[p4l673t2901r817b2969],
25	for	IN	O	for	_	0	SENT_52	[p4l845t2901r950b2969],
26	the	DT	O	the	det	27	SENT_52	[p4l976t2901r1096b2969],
27	duration	NN	O	duration	prep_for	20	SENT_52	[p4l1128t2901r1457b2969],
28	of	IN	O	of	_	0	SENT_52	[p4l1486t2901r1564b2969],
29	the	DT	O	the	det	30	SENT_52	[p4l1584t2901r1703b2969],
30	study	NN	O	study	prep_of	27	SENT_52	[p4l1734t2901r1958b2990],
31	.	.	O	.	_	0	SENT_52	[p4l1734t2901r1958b2990],

1	Study	NNP	O	Study	nn	2	SENT_53	[p4l19t3114r256b3203],
2	Procedures	NNS	O	procedure	_	0	SENT_53	[p4l284t3114r745b3182],

1	All	DT	O	all	det	2	SENT_54	[p4l16t3323r140b3390],
2	subjects	NNS	O	subject	nsubjpass	4	SENT_54	[p4l170t3323r487b3412],
3	were	VBD	O	be	auxpass	4	SENT_54	[p4l516t3347r709b3391],
4	admitted	VBN	O	admit	_	0	SENT_54	[p4l739t3323r1098b3391],
5	to	TO	O	to	_	0	SENT_54	[p4l1125t3333r1198b3391],
6	the	DT	O	the	det	9	SENT_54	[p4l1227t3323r1350b3391],
7	clinical	JJ	O	clinical	amod	9	SENT_54	[p4l1381t3323r1680b3391],
8	trial	NN	O	trial	nn	9	SENT_54	[p4l1707t3323r1870b3391],
9	center	NN	O	center	prep_to	4	SENT_54	[p4l1900t3333r2147b3391],
10	the	DT	DATE	the	det	11	SENT_54	[p4l16t3424r139b3493],
11	evening	NN	DATE	evening	tmod	4	SENT_54	[p4l184t3428r499b3514],
12	before	IN	DATE	before	_	0	SENT_54	[p4l538t3424r787b3493],
13	the	DT	DATE	the	det	14	SENT_54	[p4l829t3424r953b3493],
14	day	NN	DATE	day	prep_before	4	SENT_54	[p4l999t3424r1141b3514],
15	of	IN	O	of	_	0	SENT_54	[p4l1184t3425r1264b3493],
16	drug	NN	O	drug	nn	17	SENT_54	[p4l1301t3424r1481b3514],
17	administration	NN	O	administration	prep_of	14	SENT_54	[p4l1525t3424r2140b3493],
18	.	.	O	.	_	0	SENT_54	[p4l1525t3424r2140b3493],

1	88	CD	NUMBER	88	num	2	SENT_55	[p5l7t65r100b130],
2	o	NN	O	o	tmod	16	SENT_55	[p5l158t90r188b120],
3	I	PRP	O	I	nsubj	4	SENT_55	[p5l244t72r274b144],
4	Clin	VBP	O	clin	rcmod	2	SENT_55	[p5l301t68r454b129],
5	Pharmacol	NNP	O	Pharmacol	dobj	4	SENT_55	[p5l479t68r882b129],
6	2007	CD	DATE	2007	num	5	SENT_55	[p5l911t77r1418b140],
7	;	:	O	;	_	0	SENT_55	[p5l911t77r1418b140],
8	47:87	CD	NUMBER	47:87	number	9	SENT_55	[p5l911t77r1418b140],
9	-93	CD	NUMBER	-93	num	10	SENT_55	[p5l911t77r1418b140],
10	The	DT	DATE	the	dep	5	SENT_55	[p5l11t164r163b232],
11	following	VBG	DATE	follow	_	0	SENT_55	[p5l192t164r577b253],
12	morning	NN	DATE	morning	prep_following	10	SENT_55	[p5l603t168r967b253],
13	,	,	O	,	_	0	SENT_55	[p5l603t168r967b253],
14	they	PRP	O	they	nsubjpass	16	SENT_55	[p5l996t164r1171b253],
15	were	VBD	O	be	auxpass	16	SENT_55	[p5l1195t188r1389b232],
16	given	VBN	O	give	_	0	SENT_55	[p5l1416t168r1635b253],
17	a	DT	O	a	det	20	SENT_55	[p5l1663t188r1703b232],
18	single	JJ	O	single	amod	20	SENT_55	[p5l1729t164r1964b253],
19	oral	JJ	O	oral	amod	20	SENT_55	[p5l1994t164r2145b232],
20	dose	NN	O	dose	iobj	16	SENT_55	[p5l13t266r193b334],
21	of	IN	O	of	_	0	SENT_55	[p5l242t266r322b334],
22	20	CD	NUMBER	20	num	23	SENT_55	[p5l363t276r452b334],
23	mg	NN	O	mg	prep_of	20	SENT_55	[p5l500t290r620b355],
24	simvastatin	NN	O	simvastatin	nn	26	SENT_55	[p5l667t269r1131b334],
25	(	CD	NUMBER	(	num	26	SENT_55	[p5l1181t266r1461b347],
26	Zocor	NNP	O	Zocor	dobj	16	SENT_55	[p5l1181t266r1461b347],
27	;	:	O	;	_	0	SENT_55	[p5l1181t266r1461b347],
28	Merck	NNP	ORGANIZATION	Merck	nn	34	SENT_55	[p5l1509t266r1765b334],
29	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	34	SENT_55	[p5l1808t266r2145b334, p5l12t369r327b437],
30	Co	NNP	ORGANIZATION	Co	nn	34	SENT_55	[p5l365t372r491b448],
31	,	,	O	,	_	0	SENT_55	[p5l365t372r491b448],
32	Seoul	NNP	LOCATION	Seoul	appos	34	SENT_55	[p5l534t369r781b447],
33	,	,	O	,	_	0	SENT_55	[p5l534t369r781b447],
34	Korea	NNP	LOCATION	Korea	dep	26	SENT_55	[p5l822t369r1104b450],
35	)	CD	NUMBER	)	num	34	SENT_55	[p5l822t369r1104b450],
36	.	.	O	.	_	0	SENT_55	[p5l822t369r1104b450],

1	An	DT	O	a	det	2	SENT_56	[p5l1145t373r1266b436],
2	angiocatheter	NN	O	angiocatheter	nsubjpass	9	SENT_56	[p5l1304t369r1849b458],
3	with	IN	O	with	_	0	SENT_56	[p5l1884t369r2069b437],
4	a	DT	O	a	det	7	SENT_56	[p5l2107t393r2147b437],
5	normal	JJ	O	normal	amod	7	SENT_56	[p5l10t469r298b537],
6	saline	NN	O	saline	nn	7	SENT_56	[p5l343t469r577b537],
7	lock	NN	O	lock	prep_with	2	SENT_56	[p5l622t469r793b537],
8	was	VBD	O	be	auxpass	9	SENT_56	[p5l832t493r984b537],
9	inserted	VBN	O	insert	_	0	SENT_56	[p5l1030t469r1357b537],
10	into	IN	O	into	_	0	SENT_56	[p5l1400t473r1556b537],
11	a	DT	O	a	det	12	SENT_56	[p5l1602t493r1642b537],
12	vein	NN	O	vein	prep_into	9	SENT_56	[p5l1682t473r1857b537],
13	in	IN	O	in	_	0	SENT_56	[p5l1900t473r1980b536],
14	the	DT	O	the	det	16	SENT_56	[p5l2020t470r2145b537],
15	antecubital	JJ	O	antecubital	amod	16	SENT_56	[p5l12t571r451b639],
16	area	NN	O	area	prep_in	12	SENT_56	[p5l478t595r656b639],
17	.	.	O	.	_	0	SENT_56	[p5l478t595r656b639],

1	Blood	NN	O	blood	nn	2	SENT_57	[p5l686t571r921b639],
2	samples	NNS	O	sample	nsubjpass	4	SENT_57	[p5l947t571r1265b661],
3	were	VBD	O	be	auxpass	4	SENT_57	[p5l1291t595r1481b639],
4	collected	VBN	O	collect	_	0	SENT_57	[p5l1509t571r1867b639],
5	immediately	RB	O	immediately	advmod	4	SENT_57	[p5l1893t575r2145b639, p5l13t673r283b762],
6	before	IN	O	before	_	0	SENT_57	[p5l304t673r549b741],
7	drug	NN	O	drug	nn	8	SENT_57	[p5l578t673r755b762],
8	administration	NN	O	administration	prep_before	4	SENT_57	[p5l781t673r1367b741],
9	(	CD	NUMBER	(	num	11	SENT_57	[p5l1396t673r1770b754],
10	baseline	NN	O	baseline	nn	11	SENT_57	[p5l1396t673r1770b754],
11	)	NN	O	)	dep	8	SENT_57	[p5l1396t673r1770b754],
12	and	CC	O	and	_	0	SENT_57	[p5l1800t673r1946b741],
13	then	RB	O	then	prep_before	4	SENT_57	[p5l1969t673r2146b741],
14	at	IN	O	at	_	0	SENT_57	[p5l12t790r82b848],
15	0.33	CD	NUMBER	0.33	prep_at	13	SENT_57	[p5l123t790r311b859],
16	,	,	O	,	_	0	SENT_57	[p5l123t790r311b859],
17	0.67	CD	NUMBER	0.67	prep_at	13	SENT_57	[p5l357t790r545b858],
18	,	,	O	,	_	0	SENT_57	[p5l357t790r545b858],
19	1	CD	NUMBER	1	prep_at	13	SENT_57	[p5l593t791r655b858],
20	,	,	O	,	_	0	SENT_57	[p5l593t791r655b858],
21	1.5	CD	NUMBER	1.5	prep_at	13	SENT_57	[p5l703t791r839b858],
22	,	,	O	,	_	0	SENT_57	[p5l703t791r839b858],
23	2	CD	NUMBER	2	prep_at	13	SENT_57	[p5l886t790r950b859],
24	,	,	O	,	_	0	SENT_57	[p5l886t790r950b859],
25	3	CD	NUMBER	3	prep_at	13	SENT_57	[p5l997t790r1060b859],
26	,	,	O	,	_	0	SENT_57	[p5l997t790r1060b859],
27	4	CD	NUMBER	4	prep_at	13	SENT_57	[p5l1103t791r1170b858],
28	,	,	O	,	_	0	SENT_57	[p5l1103t791r1170b858],
29	6	CD	NUMBER	6	prep_at	13	SENT_57	[p5l1216t790r1280b858],
30	,	,	O	,	_	0	SENT_57	[p5l1216t790r1280b858],
31	8	CD	NUMBER	8	prep_at	13	SENT_57	[p5l1326t790r1390b858],
32	,	,	O	,	_	0	SENT_57	[p5l1326t790r1390b858],
33	10	CD	NUMBER	10	prep_at	13	SENT_57	[p5l1438t790r1550b859],
34	,	,	O	,	_	0	SENT_57	[p5l1438t790r1550b859],
35	and	CC	DURATION	and	_	0	SENT_57	[p5l1594t780r1743b848],
36	12	CD	DURATION	12	num	37	SENT_57	[p5l1787t790r1872b847],
37	hours	NNS	NUMBER	hour	prep_at	13	SENT_57	[p5l1917t780r2144b848],
38	after	IN	O	after	_	0	SENT_57	[p5l12t882r184b950],
39	drug	NN	O	drug	nn	40	SENT_57	[p5l209t882r386b971],
40	administration	NN	O	administration	prep_after	4	SENT_57	[p5l410t882r1007b950],
41	.	.	O	.	_	0	SENT_57	[p5l410t882r1007b950],

1	Blood	NN	O	blood	nn	2	SENT_58	[p5l1036t882r1268b950],
2	samples	NNS	O	sample	nsubj	3	SENT_58	[p5l1293t882r1607b971],
3	(	VBP	O	(	_	0	SENT_58	[p5l1637t882r1752b963],
4	10	CD	NUMBER	10	num	6	SENT_58	[p5l1637t882r1752b963],
5	mL	NN	O	ml	nn	6	SENT_58	[p5l1777t882r1929b963],
6	)	NN	O	)	nsubjpass	8	SENT_58	[p5l1777t882r1929b963],
7	were	VBD	O	be	auxpass	8	SENT_58	[p5l1956t906r2145b950],
8	collected	VBN	O	collect	ccomp	3	SENT_58	[p5l12t985r377b1053],
9	in	IN	O	in	_	0	SENT_58	[p5l423t988r502b1052],
10	heparinized	JJ	O	heparinized	amod	11	SENT_58	[p5l546t985r1032b1074],
11	tubes	NNS	O	tube	prep_in	8	SENT_58	[p5l1076t985r1288b1053],
12	(	VBP	O	(	rcmod	11	SENT_58	[p5l1339t985r1820b1066],
13	Vacutainer	NN	O	vacutainer	dobj	12	SENT_58	[p5l1339t985r1820b1066],
14	;	:	O	;	_	0	SENT_58	[p5l1339t985r1820b1066],
15	Becton	NNP	PERSON	Becton	nn	16	SENT_58	[p5l1868t989r2146b1053],
16	Dickinson	NNP	PERSON	Dickinson	dep	13	SENT_58	[p5l9t1086r444b1165],
17	,	,	O	,	_	0	SENT_58	[p5l9t1086r444b1165],
18	Franklin	NNP	PERSON	Franklin	nn	19	SENT_58	[p5l475t1086r822b1155],
19	Lakes	NNP	PERSON	Lakes	appos	16	SENT_58	[p5l850t1086r1099b1165],
20	,	,	O	,	_	0	SENT_58	[p5l850t1086r1099b1165],
21	NJ	NNP	O	NJ	appos	16	SENT_58	[p5l1130t1087r1250b1172],
22	)	CD	NUMBER	)	num	21	SENT_58	[p5l1130t1087r1250b1172],
23	after	IN	O	after	_	0	SENT_58	[p5l1284t1087r1462b1155],
24	discarding	VBG	O	discard	prepc_after	21	SENT_58	[p5l1492t1086r1916b1176],
25	1	CD	NUMBER	1	num	26	SENT_58	[p5l1948t1097r1983b1154],
26	mL	NN	O	ml	dobj	24	SENT_58	[p5l2016t1091r2145b1154],
27	of	IN	O	of	_	0	SENT_58	[p5l12t1188r92b1256],
28	blood	NN	O	blood	prep_of	26	SENT_58	[p5l107t1188r335b1256],
29	from	IN	O	from	_	0	SENT_58	[p5l362t1188r547b1256],
30	the	DT	O	the	det	31	SENT_58	[p5l572t1188r694b1256],
31	angiocatheter	NN	O	angiocatheter	prep_from	24	SENT_58	[p5l722t1188r1268b1278],
32	.	.	O	.	_	0	SENT_58	[p5l722t1188r1268b1278],

1	Plasma	NN	O	plasma	nn	2	SENT_59	[p5l1298t1188r1583b1256],
2	samples	NNS	O	sample	nsubjpass	4	SENT_59	[p5l1610t1188r1927b1278],
3	were	VBD	O	be	auxpass	4	SENT_59	[p5l1954t1212r2145b1256],
4	centrifuged	VBN	O	centrifuge	_	0	SENT_59	[p5l12t1290r493b1379],
5	,	,	O	,	_	0	SENT_59	[p5l12t1290r493b1379],
6	and	CC	O	and	_	0	SENT_59	[p5l543t1290r691b1358],
7	separated	JJ	O	separated	amod	8	SENT_59	[p5l739t1290r1124b1380],
8	samples	NNS	O	sample	nsubjpass	10	SENT_59	[p5l1172t1290r1494b1380],
9	were	VBD	O	be	auxpass	10	SENT_59	[p5l1541t1314r1735b1358],
10	stored	VBN	O	store	conj_and	4	SENT_59	[p5l1784t1290r2030b1358],
11	at	IN	O	at	_	0	SENT_59	[p5l2077t1300r2147b1358],
12	—	CD	NUMBER	—	number	13	SENT_59	[p5l8t1396r249b1460],
13	20	CD	NUMBER	20	num	15	SENT_59	[p5l8t1396r249b1460],
14	°	NN	O	°	nn	15	SENT_59	[p5l8t1396r249b1460],
15	C	NN	O	c	prep_at	10	SENT_59	[p5l8t1396r249b1460],
16	until	IN	O	until	_	0	SENT_59	[p5l281t1392r475b1460],
17	assay	NN	O	assay	prep_until	10	SENT_59	[p5l508t1416r733b1481],
18	.	.	O	.	_	0	SENT_59	[p5l508t1416r733b1481],

1	Genotyping	NN	O	genotyping	_	0	SENT_60	[p5l12t1608r487b1696],
2	of	IN	O	of	_	0	SENT_60	[p5l519t1606r605b1674],
3	CYP3A5	NN	O	cyp3a5	prep_of	1	SENT_60	[p5l629t1610r973b1674],
4	*	CD	NUMBER	*	number	5	SENT_60	[p5l985t1609r1071b1674],
5	3	CD	NUMBER	3	num	3	SENT_60	[p5l985t1609r1071b1674],

1	DNA	NN	O	dna	nsubjpass	3	SENT_61	[p5l9t1819r214b1882],
2	was	VBD	O	be	auxpass	3	SENT_61	[p5l273t1839r430b1883],
3	extracted	VBN	O	extract	_	0	SENT_61	[p5l496t1815r882b1883],
4	from	IN	O	from	_	0	SENT_61	[p5l944t1815r1138b1883],
5	the	DT	O	the	det	8	SENT_61	[p5l1198t1815r1326b1883],
6	peripheral	JJ	O	peripheral	amod	8	SENT_61	[p5l1389t1815r1828b1904],
7	whole	JJ	O	whole	amod	8	SENT_61	[p5l1889t1815r2145b1883],
8	blood	NN	O	blood	prep_from	3	SENT_61	[p5l7t1918r242b1986],
9	of	IN	O	of	_	0	SENT_61	[p5l286t1918r367b1986],
10	each	DT	O	each	det	11	SENT_61	[p5l404t1918r588b1986],
11	subject	NN	O	subject	prep_of	8	SENT_61	[p5l632t1918r917b2007],
12	using	VBG	O	use	xcomp	3	SENT_61	[p5l957t1921r1178b2007],
13	a	DT	O	a	det	17	SENT_61	[p5l1221t1942r1261b1986],
14	Qiagen	NNP	O	Qiagen	nn	17	SENT_61	[p5l1302t1921r1587b2007],
15	DNA	NN	O	dna	nn	17	SENT_61	[p5l1627t1922r1828b1985],
16	extraction	NN	O	extraction	nn	17	SENT_61	[p5l1871t1928r2144b1986, p5l10t2023r171b2088],
17	kit	NN	O	kit	nsubj	18	SENT_61	[p5l208t2019r314b2088],
18	(	CD	NUMBER	(	xcomp	12	SENT_61	[p5l355t2020r698b2109],
19	Qiagen	NNP	ORGANIZATION	Qiagen	nn	23	SENT_61	[p5l355t2020r698b2109],
20	,	,	O	,	_	0	SENT_61	[p5l355t2020r698b2109],
21	Hilden	NNP	PERSON	Hilden	appos	23	SENT_61	[p5l742t2019r1053b2098],
22	,	,	O	,	_	0	SENT_61	[p5l742t2019r1053b2098],
23	Germany	NNP	LOCATION	Germany	dep	18	SENT_61	[p5l1098t2020r1530b2109],
24	)	CD	NUMBER	)	num	23	SENT_61	[p5l1098t2020r1530b2109],
25	.	.	O	.	_	0	SENT_61	[p5l1098t2020r1530b2109],

1	The	DT	O	the	det	2	SENT_62	[p5l1576t2019r1733b2088],
2	presence	NN	O	presence	nsubjpass	10	SENT_62	[p5l1775t2044r2145b2109],
3	of	IN	O	of	_	0	SENT_62	[p5l12t2121r92b2189],
4	the	DT	O	the	det	8	SENT_62	[p5l111t2121r234b2189],
5	CYP3A5	NN	O	cyp3a5	nn	8	SENT_62	[p5l267t2125r602b2189],
6	*	NN	O	*	nn	8	SENT_62	[p5l616t2125r695b2189],
7	3	CD	NUMBER	3	num	8	SENT_62	[p5l616t2125r695b2189],
8	allele	NN	O	allele	prep_of	2	SENT_62	[p5l723t2121r936b2189],
9	was	VBD	O	be	auxpass	10	SENT_62	[p5l962t2145r1114b2189],
10	determined	VBN	O	determine	_	0	SENT_62	[p5l1146t2121r1605b2189],
11	by	IN	O	by	_	0	SENT_62	[p5l1629t2121r1726b2211],
12	mismatch	NN	O	mismatch	nn	14	SENT_62	[p5l1752t2121r2146b2189],
13	polymerase	NN	O	polymerase	nn	14	SENT_62	[p5l11t2223r484b2313],
14	chain	NN	O	chain	agent	10	SENT_62	[p5l537t2223r764b2291],
15	reaction	NN	O	reaction	nn	18	SENT_62	[p5l812t2227r1148b2291],
16	(	CD	NUMBER	(	num	18	SENT_62	[p5l1203t2223r1913b2304],
17	PCR	NN	O	pcr	nn	18	SENT_62	[p5l1203t2223r1913b2304],
18	)	NN	O	)	dep	14	SENT_62	[p5l1203t2223r1913b2304],
19	.	.	O	.	_	0	SENT_62	[p5l1203t2223r1913b2304],

1	—	NN	O	—	_	0	SENT_63	[p5l1203t2223r1913b2304],
2	.	.	O	.	_	0	SENT_63	[p5l1203t2223r1913b2304],

1	restriction	NN	O	restriction	nn	5	SENT_64	[p5l1203t2223r1913b2304],
2	fragment	NN	O	fragment	nn	5	SENT_64	[p5l1964t2223r2145b2312, p5l10t2335r215b2393],
3	length	NN	O	length	nn	5	SENT_64	[p5l258t2325r511b2414],
4	polymorphism	NN	O	polymorphism	nn	5	SENT_64	[p5l554t2325r1154b2415],
5	analysis	NN	O	analysis	nsubj	9	SENT_64	[p5l1197t2325r1545b2414],
6	,	,	O	,	_	0	SENT_64	[p5l1197t2325r1545b2414],
7	as	IN	O	as	mark	8	SENT_64	[p5l1593t2349r1669b2393],
8	previously	RB	DATE	previously	dep	5	SENT_64	[p5l1714t2325r2147b2415],
9	reported	VBN	O	report	_	0	SENT_64	[p5l9t2427r436b2516],
10	.	.	O	.	_	0	SENT_64	[p5l9t2427r436b2516],

1	”	NN	O	”	npadvmod	8	SENT_65	[p5l9t2427r436b2516],
2	In	IN	O	in	_	0	SENT_65	[p5l471t2431r552b2494],
3	brief	NN	O	brief	prep_in	8	SENT_65	[p5l582t2427r790b2506],
4	,	,	O	,	_	0	SENT_65	[p5l582t2427r790b2506],
5	genomic	JJ	O	genomic	amod	6	SENT_65	[p5l827t2430r1168b2516],
6	DNA	NN	O	dna	nsubjpass	8	SENT_65	[p5l1203t2431r1403b2494],
7	was	VBD	O	be	auxpass	8	SENT_65	[p5l1436t2451r1589b2495],
8	amplified	VBN	O	amplify	_	0	SENT_65	[p5l1626t2427r2017b2516],
9	by	IN	O	by	_	0	SENT_65	[p5l2048t2427r2147b2516],
10	the	DT	O	the	det	11	SENT_65	[p5l10t2529r133b2596],
11	use	NN	O	use	agent	8	SENT_65	[p5l167t2552r301b2596],
12	of	IN	O	of	_	0	SENT_65	[p5l337t2529r417b2596],
13	CYP3A5	NN	O	cyp3a5	nn	14	SENT_65	[p5l448t2532r785b2596],
14	6956Fm	NN	O	6956fm	prep_of	11	SENT_65	[p5l819t2533r1144b2596],
15	(	CD	NUMBER	(	number	16	SENT_65	[p5l1182t2529r1481b2609],
16	5	CD	NUMBER	5	num	14	SENT_65	[p5l1182t2529r1481b2609],
17	’	SYM	O	’	dep	11	SENT_65	[p5l1182t2529r1481b2609],
18	-	:	O	-	_	0	SENT_65	[p5l1182t2529r1481b2609],
19	CTT	NNP	O	CTT	nn	26	SENT_65	[p5l1182t2529r1481b2609],
20	TAA	NNP	O	TAA	nn	26	SENT_65	[p5l1515t2533r1703b2596],
21	AGA	NNP	O	AGA	nn	26	SENT_65	[p5l1734t2532r1934b2596],
22	GCT	NN	O	gct	nn	26	SENT_65	[p5l1968t2532r2145b2596],
23	CTT	NNP	O	CTT	nn	26	SENT_65	[p5l11t2634r184b2699],
24	TTG	NNP	O	TTG	nn	26	SENT_65	[p5l218t2634r398b2699],
25	TCT	NNP	O	TCT	nn	26	SENT_65	[p5l429t2634r602b2699],
26	CTC	NNP	O	CTC	dep	11	SENT_65	[p5l636t2634r808b2699],
27	A-3	NN	O	a-3	nn	29	SENT_65	[p5l841t2631r1034b2711],
28	’	CD	NUMBER	’	num	29	SENT_65	[p5l841t2631r1034b2711],
29	)	NN	O	)	dep	26	SENT_65	[p5l841t2631r1034b2711],
30	as	IN	O	as	_	0	SENT_65	[p5l1072t2655r1149b2699],
31	the	DT	O	the	det	33	SENT_65	[p5l1183t2630r1307b2699],
32	forward	JJ	O	forward	amod	33	SENT_65	[p5l1342t2630r1658b2699],
33	primer	NN	O	primer	prep_as	29	SENT_65	[p5l1691t2634r1965b2720],
34	and	CC	O	and	_	0	SENT_65	[p5l1998t2630r2146b2699],
35	CYP3A5	NN	O	cyp3a5	nn	36	SENT_65	[p5l16t2735r353b2799],
36	7155R	NN	O	7155r	prep_as	29	SENT_65	[p5l399t2736r648b2799],
37	(	CD	NUMBER	(	number	38	SENT_65	[p5l693t2731r1003b2812],
38	5	CD	NUMBER	5	num	33	SENT_65	[p5l693t2731r1003b2812],
39	’	SYM	O	’	dep	29	SENT_65	[p5l693t2731r1003b2812],
40	-	:	O	-	_	0	SENT_65	[p5l693t2731r1003b2812],
41	CCA	NNP	ORGANIZATION	CCA	nn	47	SENT_65	[p5l693t2731r1003b2812],
42	GGA	NNP	O	GGA	nn	47	SENT_65	[p5l1045t2735r1239b2799],
43	AGC	NNP	O	AGC	nn	47	SENT_65	[p5l1279t2735r1468b2799],
44	GAG	NN	O	gag	nn	47	SENT_65	[p5l1511t2735r1701b2799],
45	ACT	NN	O	act	nn	47	SENT_65	[p5l1740t2735r1924b2799],
46	TTG	NN	O	ttg	nn	47	SENT_65	[p5l1967t2735r2147b2799],
47	AT-3	NN	O	at-3	dep	26	SENT_65	[p5l10t2833r245b2914],
48	’	CD	NUMBER	’	num	49	SENT_65	[p5l10t2833r245b2914],
49	)	NN	O	)	dep	47	SENT_65	[p5l10t2833r245b2914],
50	as	IN	O	as	_	0	SENT_65	[p5l281t2857r358b2901],
51	the	DT	O	the	det	53	SENT_65	[p5l390t2833r513b2901],
52	reverse	JJ	O	reverse	amod	53	SENT_65	[p5l544t2857r832b2901],
53	primer	NN	O	primer	prep_as	8	SENT_65	[p5l864t2837r1151b2923],
54	.	.	O	.	_	0	SENT_65	[p5l864t2837r1151b2923],

1	After	IN	O	after	_	0	SENT_66	[p5l1186t2833r1391b2901],
2	amplification	NN	O	amplification	prep_after	14	SENT_66	[p5l1422t2833r1987b2923],
3	,	,	O	,	_	0	SENT_66	[p5l1422t2833r1987b2923],
4	the	DT	O	the	det	7	SENT_66	[p5l2020t2833r2145b2901],
5	200	CD	NUMBER	200	num	7	SENT_66	[p5l14t2945r153b3003],
6	base	NN	O	base	nn	7	SENT_66	[p5l194t2935r370b3003],
7	pair	NN	O	pair	nsubjpass	14	SENT_66	[p5l413t2939r573b3025],
8	(	CD	NUMBER	(	num	9	SENT_66	[p5l619t2935r769b3025],
9	bp	NN	O	bp	amod	7	SENT_66	[p5l619t2935r769b3025],
10	)	CD	NUMBER	)	num	12	SENT_66	[p5l619t2935r769b3025],
11	PCR	NN	O	pcr	nn	12	SENT_66	[p5l815t2939r987b3003],
12	product	NN	O	product	dep	9	SENT_66	[p5l1027t2935r1346b3025],
13	was	VBD	O	be	auxpass	14	SENT_66	[p5l1385t2959r1538b3003],
14	digested	VBN	O	digest	_	0	SENT_66	[p5l1586t2935r1920b3024],
15	with	IN	O	with	_	0	SENT_66	[p5l1961t2935r2147b3003],
16	Ddel	NN	PERSON	ddel	prep_with	14	SENT_66	[p5l9t3037r217b3105],
17	.	.	O	.	_	0	SENT_66	[p5l9t3037r217b3105],

1	For	IN	O	for	_	0	SENT_67	[p5l248t3042r382b3105],
2	the	DT	O	the	det	6	SENT_67	[p5l406t3037r528b3105],
3	CYP3A5	NN	O	cyp3a5	nn	6	SENT_67	[p5l561t3040r895b3105],
4	*	NN	O	*	nn	6	SENT_67	[p5l910t3040r988b3105],
5	3	CD	NUMBER	3	num	6	SENT_67	[p5l910t3040r988b3105],
6	allele	NN	O	allele	prep_for	10	SENT_67	[p5l1015t3037r1251b3116],
7	,	,	O	,	_	0	SENT_67	[p5l1015t3037r1251b3116],
8	this	DT	O	this	det	9	SENT_67	[p5l1279t3037r1425b3105],
9	digestion	NN	O	digestion	nsubj	10	SENT_67	[p5l1456t3037r1821b3126],
10	yielded	VBD	O	yield	_	0	SENT_67	[p5l1845t3037r2146b3126],
11	fragments	NNS	O	fragment	dobj	10	SENT_67	[p5l11t3140r405b3229],
12	of	IN	O	of	_	0	SENT_67	[p5l458t3140r538b3208],
13	22	CD	NUMBER	22	prep_of	11	SENT_67	[p5l583t3149r696b3218],
14	,	,	O	,	_	0	SENT_67	[p5l583t3149r696b3218],
15	71	CD	NUMBER	71	prep_of	11	SENT_67	[p5l754t3150r864b3218],
16	,	,	O	,	_	0	SENT_67	[p5l754t3150r864b3218],
17	and	CC	NUMBER	and	_	0	SENT_67	[p5l918t3140r1066b3208],
18	107	CD	NUMBER	107	num	19	SENT_67	[p5l1119t3149r1257b3208],
19	bp	NN	O	bp	prep_of	11	SENT_67	[p5l1305t3140r1429b3229],
20	,	,	O	,	_	0	SENT_67	[p5l1305t3140r1429b3229],
21	whereas	IN	O	whereas	mark	30	SENT_67	[p5l1481t3140r1812b3208],
22	for	IN	O	for	_	0	SENT_67	[p5l1864t3140r1973b3208],
23	the	DT	O	the	det	27	SENT_67	[p5l2020t3140r2145b3208],
24	CYP3A5	NN	O	cyp3a5	nn	27	SENT_67	[p5l16t3245r439b3310],
25	*	NN	O	*	nn	27	SENT_67	[p5l16t3245r439b3310],
26	1	CD	NUMBER	1	num	27	SENT_67	[p5l16t3245r439b3310],
27	allele	NN	O	allele	prep_for	30	SENT_67	[p5l478t3241r716b3320],
28	,	,	O	,	_	0	SENT_67	[p5l478t3241r716b3320],
29	it	PRP	O	it	nsubj	30	SENT_67	[p5l750t3245r806b3310],
30	yielded	VBD	O	yield	advcl	10	SENT_67	[p5l833t3241r1137b3331],
31	fragments	NNS	O	fragment	dobj	30	SENT_67	[p5l1168t3242r1561b3331],
32	of	IN	O	of	_	0	SENT_67	[p5l1595t3242r1676b3310],
33	71	CD	NUMBER	71	prep_of	31	SENT_67	[p5l1704t3252r1787b3309],
34	and	CC	O	and	_	0	SENT_67	[p5l1824t3241r1972b3310],
35	129	CD	NUMBER	129	num	36	SENT_67	[p5l2006t3251r2143b3310],
36	bp	NN	O	bp	prep_of	31	SENT_67	[p5l7t3343r129b3433],
37	.	.	O	.	_	0	SENT_67	[p5l7t3343r129b3433],

1	The	DT	O	the	det	2	SENT_68	[p5l165t3343r317b3411],
2	results	NNS	O	result	nsubjpass	7	SENT_68	[p5l347t3343r614b3411],
3	for	IN	O	for	_	0	SENT_68	[p5l647t3343r757b3411],
4	each	DT	O	each	det	5	SENT_68	[p5l787t3343r970b3411],
5	genotype	NN	O	genotype	prep_for	2	SENT_68	[p5l999t3353r1365b3433],
6	were	VBD	O	be	auxpass	7	SENT_68	[p5l1395t3367r1588b3411],
7	confirmed	VBN	O	confirm	_	0	SENT_68	[p5l1621t3343r2037b3411],
8	in	IN	O	in	_	0	SENT_68	[p5l2066t3347r2146b3411],
9	randomly	RB	O	randomly	advmod	11	SENT_68	[p5l9t3445r403b3534],
10	selected	VBN	O	select	amod	11	SENT_68	[p5l454t3445r780b3513],
11	individuals	NNS	O	individual	prep_in	7	SENT_68	[p5l831t3445r1293b3513],
12	by	IN	O	by	_	0	SENT_68	[p5l1343t3445r1441b3534],
13	direct	JJ	O	direct	amod	15	SENT_68	[p5l1493t3445r1725b3513],
14	sequence	NN	O	sequence	nn	15	SENT_68	[p5l1776t3469r2145b3535],
15	analysis	NN	O	analysis	prep_by	11	SENT_68	[p5l12t3547r357b3636],
16	.	.	O	.	_	0	SENT_68	[p5l12t3547r357b3636],

1	Determination	NN	O	determination	_	0	SENT_69	[p6l9t74r606b138],
2	of	IN	O	of	_	0	SENT_69	[p6l638t71r723b138],
3	Plasma	NN	O	plasma	nn	5	SENT_69	[p6l742t71r1042b138],
4	Simvastatin	NN	O	simvastatin	nn	5	SENT_69	[p6l1074t73r1564b138],
5	Concentrations	NNS	O	concentration	prep_of	1	SENT_69	[p6l11t179r634b244],

1	Plasma	NN	O	plasma	nn	3	SENT_70	[p6l10t386r307b454],
2	simvastatin	NN	O	simvastatin	nn	3	SENT_70	[p6l350t390r829b454],
3	concentrations	NNS	O	concentration	nsubjpass	5	SENT_70	[p6l873t390r1488b454],
4	were	VBD	O	be	auxpass	5	SENT_70	[p6l1531t410r1730b454],
5	analyzed	VBN	O	analyze	_	0	SENT_70	[p6l1775t386r2146b475],
6	using	VBG	O	use	xcomp	5	SENT_70	[p6l10t491r227b577],
7	a	DT	O	a	dobj	6	SENT_70	[p6l256t512r297b556],
8	Validated	VBN	O	validate	partmod	7	SENT_70	[p6l322t488r697b556],
9	high	JJ	O	high	amod	10	SENT_70	[p6l724t488r1440b577],
10	—	NN	O	—	dobj	8	SENT_70	[p6l724t488r1440b577],
11	performance	NN	O	performance	nn	19	SENT_70	[p6l724t488r1440b577],
12	liquid	JJ	O	liquid	amod	19	SENT_70	[p6l1470t488r1710b577],
13	chromatographic	JJ	O	chromatographic	amod	19	SENT_70	[p6l1740t488r2144b556, p6l10t591r309b680],
14	mass	NN	O	mass	nn	19	SENT_70	[p6l345t615r541b659],
15	spectrometry	NN	O	spectrometry	nn	19	SENT_70	[p6l580t601r1109b680],
16	(	CD	NUMBER	(	num	19	SENT_70	[p6l1148t591r1774b672],
17	HPLC-MS/MS	NN	O	hplc-ms/ms	nn	19	SENT_70	[p6l1148t591r1774b672],
18	)	NN	O	)	nn	19	SENT_70	[p6l1148t591r1774b672],
19	method	NN	O	method	dep	10	SENT_70	[p6l1813t591r2140b659],
20	.	.	O	.	_	0	SENT_70	[p6l1813t591r2140b659],

1	Brieﬂy	NNP	O	Brieﬂy	nsubjpass	7	SENT_71	[p6l11t692r298b782],
2	,	,	O	,	_	0	SENT_71	[p6l11t692r298b782],
3	0.2	CD	NUMBER	0.2	num	5	SENT_71	[p6l336t702r448b761],
4	mL	NN	O	ml	nn	5	SENT_71	[p6l485t697r614b760],
5	plasma	NN	O	plasma	nsubjpass	7	SENT_71	[p6l647t692r936b782],
6	was	VBD	O	be	auxpass	7	SENT_71	[p6l965t717r1119b761],
7	added	VBN	O	add	_	0	SENT_71	[p6l1154t692r1401b761],
8	to	TO	O	to	_	0	SENT_71	[p6l1432t703r1506b761],
9	a	DT	O	a	det	13	SENT_71	[p6l1542t717r1582b761],
10	2-mL	JJ	O	2-ml	amod	13	SENT_71	[p6l1616t697r1820b760],
11	disposable	JJ	O	disposable	amod	13	SENT_71	[p6l1856t692r2145b782, p6l12t794r173b862],
12	glass	NN	O	glass	nn	13	SENT_71	[p6l213t794r405b884],
13	tube	NN	O	tube	prep_to	7	SENT_71	[p6l445t794r619b862],
14	containing	VBG	O	contain	partmod	13	SENT_71	[p6l661t798r1091b884],
15	internal	JJ	O	internal	amod	18	SENT_71	[p6l1131t794r1447b862],
16	standard	JJ	O	standard	amod	18	SENT_71	[p6l1488t794r1839b862],
17	(	NN	O	(	nn	18	SENT_71	[p6l1882t794r2145b875, p6l10t900r216b975],
18	lovastatin	NN	O	lovastatin	dobj	14	SENT_71	[p6l1882t794r2145b875, p6l10t900r216b975],
19	,	,	O	,	_	0	SENT_71	[p6l1882t794r2145b875, p6l10t900r216b975],
20	20	CD	NUMBER	20	num	21	SENT_71	[p6l258t906r347b964],
21	uL	NN	O	ul	appos	18	SENT_71	[p6l386t901r486b983],
22	of	IN	O	of	_	0	SENT_71	[p6l524t896r605b964],
23	200	CD	NUMBER	200	num	25	SENT_71	[p6l636t906r775b964],
24	ng/mL	NN	O	ng/ml	nn	25	SENT_71	[p6l812t896r1125b985],
25	)	NN	O	)	prep_of	21	SENT_71	[p6l812t896r1125b985],
26	.	.	O	.	_	0	SENT_71	[p6l812t896r1125b985],

1	We	PRP	O	we	nsubj	3	SENT_72	[p6l1165t901r1290b964],
2	then	RB	O	then	advmod	3	SENT_72	[p6l1326t896r1506b964],
3	added	VBD	O	add	_	0	SENT_72	[p6l1542t896r1789b964],
4	1	CD	NUMBER	1	num	5	SENT_72	[p6l1830t907r1864b964],
5	mL	NN	O	ml	dobj	3	SENT_72	[p6l1905t901r2034b964],
6	of	IN	O	of	_	0	SENT_72	[p6l2073t896r2153b964],
7	extraction	NN	O	extraction	prep_of	5	SENT_72	[p6l12t1001r413b1065],
8	solvent	JJ	O	solvent	amod	10	SENT_72	[p6l439t997r729b1065],
9	(	NN	O	(	nn	10	SENT_72	[p6l757t997r1719b1077],
10	etherzdichloromethane	NN	O	etherzdichloromethane	tmod	3	SENT_72	[p6l757t997r1719b1077],
11	,	,	O	,	_	0	SENT_72	[p6l757t997r1719b1077],
12	6:4	CD	NUMBER	6:4	num	13	SENT_72	[p6l1750t997r1914b1077],
13	)	NN	O	)	appos	10	SENT_72	[p6l1750t997r1914b1077],
14	.	.	O	.	_	0	SENT_72	[p6l1750t997r1914b1077],

1	After	IN	O	after	_	0	SENT_73	[p6l1943t997r2147b1065],
2	Vigorous	JJ	O	vigorous	amod	3	SENT_73	[p6l9t1102r356b1188],
3	vortex	NN	O	vortex	prep_after	12	SENT_73	[p6l393t1109r649b1167],
4	mixing	VBG	O	mix	partmod	3	SENT_73	[p6l684t1102r968b1188],
5	for	IN	O	for	_	0	SENT_73	[p6l1006t1099r1115b1167],
6	30	CD	DURATION	30	num	7	SENT_73	[p6l1155t1109r1244b1167],
7	seconds	NNS	NUMBER	seconds	prep_for	4	SENT_73	[p6l1285t1099r1627b1178],
8	,	,	O	,	_	0	SENT_73	[p6l1285t1099r1627b1178],
9	the	DT	O	the	det	10	SENT_73	[p6l1666t1099r1790b1167],
10	mixture	NN	O	mixture	nsubjpass	12	SENT_73	[p6l1828t1102r2145b1167],
11	was	VBD	O	be	auxpass	12	SENT_73	[p6l9t1226r162b1270],
12	centrifuged	VBN	O	centrifuge	_	0	SENT_73	[p6l210t1202r691b1291],
13	,	,	O	,	_	0	SENT_73	[p6l210t1202r691b1291],
14	and	CC	O	and	_	0	SENT_73	[p6l740t1202r888b1270],
15	the	DT	O	the	det	17	SENT_73	[p6l931t1202r1055b1270],
16	organic	JJ	O	organic	amod	17	SENT_73	[p6l1102t1205r1396b1291],
17	phase	NN	O	phase	nsubjpass	26	SENT_73	[p6l1442t1202r1674b1291],
18	was	VBD	O	be	auxpass	19	SENT_73	[p6l1718t1226r1871b1270],
19	transferred	VBN	O	transfer	conj_and	12	SENT_73	[p6l1917t1212r2145b1270, p6l11t1303r249b1372],
20	to	TO	O	to	_	0	SENT_73	[p6l286t1313r360b1372],
21	a	DT	O	a	det	24	SENT_73	[p6l402t1328r442b1372],
22	clean	JJ	O	clean	amod	24	SENT_73	[p6l481t1303r693b1372],
23	glass	NN	O	glass	nn	24	SENT_73	[p6l731t1303r923b1393],
24	tube	NN	O	tube	prep_to	19	SENT_73	[p6l963t1303r1136b1372],
25	and	CC	O	and	_	0	SENT_73	[p6l1177t1304r1325b1372],
26	evaporated	VBN	O	evaporate	conj_and	12	SENT_73	[p6l1365t1303r1810b1393],
27	using	VBG	O	use	xcomp	26	SENT_73	[p6l1848t1307r2067b1393],
28	a	DT	O	a	det	30	SENT_73	[p6l2107t1328r2147b1372],
29	vacuum	NN	O	vacuum	nn	30	SENT_73	[p6l9t1428r333b1472],
30	drier	NN	O	drier	dobj	27	SENT_73	[p6l367t1404r573b1472],
31	.	.	O	.	_	0	SENT_73	[p6l367t1404r573b1472],

1	The	DT	O	the	det	3	SENT_74	[p6l118t1506r270b1574],
2	dry	JJ	O	dry	amod	3	SENT_74	[p6l320t1506r453b1595],
3	residue	NN	O	residue	nsubjpass	5	SENT_74	[p6l497t1506r795b1574],
4	was	VBD	O	be	auxpass	5	SENT_74	[p6l841t1530r994b1574],
5	reconstituted	VBN	O	reconstitute	_	0	SENT_74	[p6l1041t1506r1578b1574],
6	with	IN	O	with	_	0	SENT_74	[p6l1623t1506r1808b1574],
7	100	CD	NUMBER	100	num	8	SENT_74	[p6l1859t1516r1996b1574],
8	uL	NN	O	ul	prep_with	5	SENT_74	[p6l2045t1511r2145b1593],
9	mobile	JJ	O	mobile	amod	10	SENT_74	[p6l10t1608r287b1676],
10	phase	NN	O	phase	dep	8	SENT_74	[p6l331t1608r586b1698],
11	,	,	O	,	_	0	SENT_74	[p6l331t1608r586b1698],
12	and	CC	O	and	_	0	SENT_74	[p6l633t1608r781b1676],
13	a	DT	O	a	det	15	SENT_74	[p6l824t1632r865b1676],
14	20-uL	NN	O	20-ul	nn	15	SENT_74	[p6l910t1613r1136b1695],
15	aliquot	NN	O	aliquot	nsubjpass	20	SENT_74	[p6l1180t1608r1463b1698],
16	of	IN	O	of	_	0	SENT_74	[p6l1507t1608r1587b1676],
17	this	DT	O	this	det	18	SENT_74	[p6l1621t1608r1769b1676],
18	solution	NN	O	solution	prep_of	15	SENT_74	[p6l1816t1608r2146b1676],
19	was	VBD	O	be	auxpass	20	SENT_74	[p6l9t1734r159b1778],
20	injected	VBN	O	inject	conj_and	5	SENT_74	[p6l188t1710r499b1799],
21	onto	IN	O	onto	_	0	SENT_74	[p6l527t1720r697b1778],
22	the	DT	O	the	det	24	SENT_74	[p6l725t1710r846b1778],
23	HPLC-MS/MS	NN	O	hplc-ms/ms	nn	24	SENT_74	[p6l872t1710r1431b1778],
24	system	NN	O	system	prep_onto	20	SENT_74	[p6l1462t1720r1731b1799],
25	(	CD	NUMBER	(	num	28	SENT_74	[p6l1761t1710r1931b1791],
26	API	NNP	O	API	nn	28	SENT_74	[p6l1761t1710r1931b1791],
27	4000	CD	NUMBER	4000	num	28	SENT_74	[p6l1956t1720r2144b1778],
28	QTRAP	NNP	O	QTRAP	dobj	20	SENT_74	[p6l12t1816r329b1898],
29	;	:	O	;	_	0	SENT_74	[p6l12t1816r329b1898],
30	Applied	NNP	ORGANIZATION	Applied	nn	31	SENT_74	[p6l356t1813r678b1902],
31	Biosystems	NNP	ORGANIZATION	Biosystems	dep	28	SENT_74	[p6l701t1816r1158b1902],
32	,	,	O	,	_	0	SENT_74	[p6l701t1816r1158b1902],
33	Foster	NNP	LOCATION	Foster	nn	34	SENT_74	[p6l1186t1817r1425b1881],
34	City	NNP	LOCATION	City	appos	28	SENT_74	[p6l1448t1816r1618b1902],
35	,	,	O	,	_	0	SENT_74	[p6l1448t1816r1618b1902],
36	Calif	NNP	LOCATION	Calif	nn	37	SENT_74	[p6l1646t1813r1873b1894],
37	)	NNP	O	)	appos	28	SENT_74	[p6l1646t1813r1873b1894],
38	,	,	O	,	_	0	SENT_74	[p6l1646t1813r1873b1894],
39	which	WDT	O	which	nsubj	40	SENT_74	[p6l1899t1813r2146b1881],
40	included	VBD	O	include	rcmod	28	SENT_74	[p6l11t1913r369b1982],
41	a	DT	O	a	det	44	SENT_74	[p6l395t1938r435b1982],
42	Gemini	NNP	MISC	Gemini	nn	44	SENT_74	[p6l460t1917r754b1982],
43	C18	NN	MISC	c18	nn	44	SENT_74	[p6l780t1917r929b1982],
44	column	NN	O	column	dobj	40	SENT_74	[p6l959t1914r1263b1982],
45	(	CD	NUMBER	(	num	47	SENT_74	[p6l1292t1914r1433b1995],
46	5.0	CD	NUMBER	5.0	num	47	SENT_74	[p6l1292t1914r1433b1995],
47	um	NN	O	um	dep	44	SENT_74	[p6l1461t1935r1607b2000],
48	,	,	O	,	_	0	SENT_74	[p6l1461t1935r1607b2000],
49	2.0	CD	NUMBER	2.0	number	50	SENT_74	[p6l1639t1923r1752b1982],
50	X	NN	O	x	appos	44	SENT_74	[p6l1778t1933r1824b1980],
51	50	CD	NUMBER	50	num	52	SENT_74	[p6l1852t1923r1940b1982],
52	mm	NN	O	mm	dep	50	SENT_74	[p6l1967t1938r2142b1993],
53	;	:	O	;	_	0	SENT_74	[p6l1967t1938r2142b1993],

1	EFFECT	NN	O	effect	_	0	SENT_75	[p6l553t2075r712b2105],
2	OF	IN	O	of	_	0	SENT_75	[p6l725t2075r782b2105],
3	CYP3A5	NN	O	cyp3a5	prep_of	1	SENT_75	[p6l793t2075r997b2105],
4	*	CD	NUMBER	*	number	5	SENT_75	[p6l793t2075r997b2105],
5	3	CD	NUMBER	3	dep	1	SENT_75	[p6l793t2075r997b2105],
6	ON	IN	O	on	_	0	SENT_75	[p6l1016t2075r1082b2105],
7	THE	DT	O	the	det	8	SENT_75	[p6l1095t2075r1178b2105],
8	PK	NN	O	pk	prep_on	5	SENT_75	[p6l1189t2075r1246b2105],
9	OF	IN	O	of	_	0	SENT_75	[p6l1258t2075r1315b2105],
10	SIMVASTATIN	NNP	O	SIMVASTATIN	prep_of	8	SENT_75	[p6l1327t2075r1616b2105],

1	Table	NNP	O	Table	nn	4	SENT_76	[p6l323t2199r426b2231],
2	I	PRP	O	I	dep	4	SENT_76	[p6l441t2201r455b2231],
3	Demographic	NNP	O	Demographic	nn	4	SENT_76	[p6l503t2199r755b2241],
4	Data	NNP	O	Data	_	0	SENT_76	[p6l770t2201r855b2231],
5	of	IN	O	of	_	0	SENT_76	[p6l870t2199r908b2231],
6	Study	NNP	O	Study	nn	7	SENT_76	[p6l920t2199r1031b2241],
7	Subjects	NNP	O	Subjects	prep_of	4	SENT_76	[p6l1046t2199r1202b2241],
8	According	VBG	O	accord	_	0	SENT_76	[p6l1217t2199r1415b2241],
9	to	TO	O	to	prepc_according_to	4	SENT_76	[p6l1429t2204r1463b2231],
10	CYP3A5	NNP	O	CYP3A5	nn	11	SENT_76	[p6l1481t2201r1639b2231],
11	Genotype	NN	O	genotype	pobj	4	SENT_76	[p6l1653t2201r1833b2241],

1	CYP3A5	NN	O	cyp3a5	nn	2	SENT_77	[p6l742t2286r952b2312],
2	*	NN	O	*	_	0	SENT_77	[p6l742t2286r952b2312],
3	1	CD	NUMBER	1	dep	2	SENT_77	[p6l742t2286r952b2312],
4	/	:	O	/	punct	2	SENT_77	[p6l742t2286r952b2312],
5	*	CD	NUMBER	*	number	6	SENT_77	[p6l742t2286r952b2312],
6	1	CD	NUMBER	1	num	8	SENT_77	[p6l742t2286r952b2312],
7	CYP3A5	NN	O	cyp3a5	nn	8	SENT_77	[p6l1324t2286r1535b2312],
8	*	NN	O	*	dep	2	SENT_77	[p6l1324t2286r1535b2312],
9	1	CD	NUMBER	1	dep	8	SENT_77	[p6l1324t2286r1535b2312],
10	/	:	O	/	punct	2	SENT_77	[p6l1324t2286r1535b2312],
11	*	CD	NUMBER	*	num	13	SENT_77	[p6l1324t2286r1535b2312],
12	3	CD	NUMBER	3	num	13	SENT_77	[p6l1324t2286r1535b2312],
13	CYP3A5	NN	O	cyp3a5	dep	2	SENT_77	[p6l1906t2286r2117b2312],
14	*	CD	NUMBER	*	num	15	SENT_77	[p6l1906t2286r2117b2312],
15	3	CD	NUMBER	3	dep	13	SENT_77	[p6l1906t2286r2117b2312],
16	/	:	O	/	punct	13	SENT_77	[p6l1906t2286r2117b2312],
17	*	CD	NUMBER	*	dep	13	SENT_77	[p6l1906t2286r2117b2312],
18	3	CD	NUMBER	3	dep	17	SENT_77	[p6l1906t2286r2117b2312],

1	Number	NN	O	number	dep	23	SENT_78	[p6l40t2375r178b2404],
2	of	IN	O	of	_	0	SENT_78	[p6l192t2375r226b2404],
3	subjects	NNS	O	subject	prep_of	1	SENT_78	[p6l236t2375r370b2413],
4	4	CD	NUMBER	4	num	3	SENT_78	[p6l837t2379r855b2404],
5	8	CD	NUMBER	8	number	6	SENT_78	[p6l1420t2379r1437b2404],
6	10	CD	NUMBER	10	num	11	SENT_78	[p6l1993t2379r2030b2404],
7	Age	NNP	O	Age	nn	11	SENT_78	[p6l40t2420r114b2456],
8	,	,	O	,	_	0	SENT_78	[p6l40t2420r114b2456],
9	y	JJ	O	y	amod	11	SENT_78	[p6l128t2429r148b2456],
10	25.3	CD	NUMBER	25.3	tmod	9	SENT_78	[p6l775t2422r843b2447],
11	J_r	NN	O	j_r	dep	3	SENT_78	[p6l857t2422r878b2447],
12	2.8	CD	NUMBER	2.8	number	13	SENT_78	[p6l892t2422r939b2447],
13	25.4	CD	NUMBER	25.4	num	14	SENT_78	[p6l1357t2422r1426b2447],
14	J_r	NN	O	j_r	dep	3	SENT_78	[p6l1439t2422r1460b2447],
15	3.5	CD	NUMBER	3.5	number	16	SENT_78	[p6l1474t2422r1520b2447],
16	24.5	CD	NUMBER	24.5	amod	14	SENT_78	[p6l1939t2422r2008b2447],
17	:	:	O	:	_	0	SENT_78	[p6l2021t2422r2042b2447],
18	1.8	CD	NUMBER	1.8	dep	3	SENT_78	[p6l2056t2422r2103b2447],
19	Weight	NNP	O	Weight	dep	18	SENT_78	[p6l39t2462r168b2500],
20	,	,	O	,	_	0	SENT_78	[p6l39t2462r168b2500],
21	kg	NN	O	kg	dep	23	SENT_78	[p6l182t2462r220b2500],
22	68.8	CD	NUMBER	68.8	num	21	SENT_78	[p6l775t2466r844b2491],
23	i	FW	O	i	dep	28	SENT_78	[p6l857t2465r878b2491],
24	3.9	CD	NUMBER	3.9	number	25	SENT_78	[p6l892t2466r940b2491],
25	68.4	CD	NUMBER	68.4	dep	23	SENT_78	[p6l1357t2466r1426b2491],
26	i	FW	O	i	dep	25	SENT_78	[p6l1439t2465r1460b2491],
27	4.4	CD	NUMBER	4.4	num	28	SENT_78	[p6l1472t2466r1521b2491],
28	71.0	CD	NUMBER	71.0	dep	35	SENT_78	[p6l1940t2466r2008b2491],
29	i	FW	O	i	dep	28	SENT_78	[p6l2021t2465r2042b2491],
30	5.6	CD	NUMBER	5.6	num	31	SENT_78	[p6l2056t2466r2103b2491],
31	Height	NN	O	height	dep	29	SENT_78	[p6l40t2505r162b2543],
32	,	,	O	,	_	0	SENT_78	[p6l40t2505r162b2543],
33	cm	NN	O	cm	appos	31	SENT_78	[p6l177t2515r227b2534],
34	171.5	CD	NUMBER	171.5	num	33	SENT_78	[p6l755t2510r843b2534],
35	i	FW	O	i	dep	40	SENT_78	[p6l857t2509r878b2534],
36	2.6	CD	NUMBER	2.6	number	37	SENT_78	[p6l892t2509r939b2534],
37	171.8	CD	NUMBER	171.8	dep	35	SENT_78	[p6l1337t2509r1426b2534],
38	i	FW	O	i	dep	37	SENT_78	[p6l1439t2509r1460b2534],
39	5.4	CD	NUMBER	5.4	number	40	SENT_78	[p6l1474t2510r1521b2534],
40	172.6	CD	NUMBER	172.6	_	0	SENT_78	[p6l1919t2509r2008b2534],
41	i	LS	O	i	prep	40	SENT_78	[p6l2021t2509r2042b2534],
42	‘	CD	NUMBER	‘	number	43	SENT_78	[p6l2021t2509r2042b2534],
43	3.2	CD	NUMBER	3.2	dep	41	SENT_78	[p6l2056t2509r2102b2534],

1	Phenomenex	NNP	ORGANIZATION	Phenomenex	nn	2	SENT_79	[p6l8t2740r535b2809],
2	Inc	NNP	ORGANIZATION	Inc	_	0	SENT_79	[p6l563t2745r709b2819],
3	,	,	O	,	_	0	SENT_79	[p6l563t2745r709b2819],
4	Torrance	NNP	PERSON	Torrance	nn	6	SENT_79	[p6l742t2745r1117b2819],
5	,	,	O	,	_	0	SENT_79	[p6l742t2745r1117b2819],
6	Calif	NNP	LOCATION	Calif	appos	2	SENT_79	[p6l1149t2740r1386b2821],
7	)	CD	NUMBER	)	num	6	SENT_79	[p6l1149t2740r1386b2821],
8	.	.	O	.	_	0	SENT_79	[p6l1149t2740r1386b2821],

1	The	DT	O	the	det	3	SENT_80	[p6l1421t2740r1573b2809],
2	mobile	JJ	O	mobile	amod	3	SENT_80	[p6l1603t2740r1880b2809],
3	phase	NN	O	phase	nsubj	4	SENT_80	[p6l1911t2740r2143b2830],
4	consisted	VBD	O	consist	_	0	SENT_80	[p6l10t2842r391b2910],
5	of	IN	O	of	_	0	SENT_80	[p6l447t2842r527b2910],
6	80	CD	PERCENT	80	number	7	SENT_80	[p6l576t2842r749b2916],
7	%	NN	PERCENT	%	amod	8	SENT_80	[p6l576t2842r749b2916],
8	acetonitrile	NN	O	acetonitrile	prep_of	4	SENT_80	[p6l812t2842r1271b2910],
9	containing	VBG	O	contain	partmod	8	SENT_80	[p6l1328t2846r1757b2932],
10	0.1	CD	NUMBER	0.1	num	13	SENT_80	[p6l1814t2852r1925b2910],
11	mM	NN	O	mm	nn	13	SENT_80	[p6l1985t2847r2145b2910],
12	ammonium	NN	O	ammonium	nn	13	SENT_80	[p6l10t2948r475b3012],
13	acetate	NN	O	acetate	dobj	9	SENT_80	[p6l508t2954r783b3012],
14	buffer	NN	O	buffer	nn	16	SENT_80	[p6l813t2944r1055b3012],
15	(	CD	NUMBER	(	num	16	SENT_80	[p6l1090t2944r1235b3034],
16	pH	NN	O	ph	tmod	9	SENT_80	[p6l1090t2944r1235b3034],
17	4.5	CD	NUMBER	4.5	num	18	SENT_80	[p6l1266t2944r1435b3025],
18	)	NN	O	)	dep	16	SENT_80	[p6l1266t2944r1435b3025],
19	.	.	O	.	_	0	SENT_80	[p6l1266t2944r1435b3025],

1	The	DT	O	the	det	3	SENT_81	[p6l116t3046r267b3114],
2	mass	NN	O	mass	nn	3	SENT_81	[p6l292t3070r486b3114],
3	spectrometer	NN	O	spectrometer	nsubjpass	9	SENT_81	[p6l515t3056r1029b3136],
4	with	IN	O	with	_	0	SENT_81	[p6l1051t3046r1233b3114],
5	an	DT	O	a	det	7	SENT_81	[p6l1259t3070r1352b3114],
6	electrospray	NN	O	electrospray	nn	7	SENT_81	[p6l1378t3046r1862b3136],
7	source	NN	O	source	prep_with	3	SENT_81	[p6l1888t3070r2143b3114],
8	was	VBD	O	be	auxpass	9	SENT_81	[p6l8t3172r160b3216],
9	run	VBN	O	run	_	0	SENT_81	[p6l195t3172r336b3216],
10	in	IN	O	in	_	0	SENT_81	[p6l369t3151r449b3215],
11	the	DT	O	the	det	14	SENT_81	[p6l481t3148r605b3216],
12	positive	JJ	O	positive	amod	14	SENT_81	[p6l639t3151r960b3237],
13	ion	NN	O	ion	nn	14	SENT_81	[p6l995t3151r1125b3216],
14	mode	NN	O	mode	prep_in	9	SENT_81	[p6l1157t3148r1402b3227],
15	,	,	O	,	_	0	SENT_81	[p6l1157t3148r1402b3227],
16	and	CC	O	and	_	0	SENT_81	[p6l1440t3148r1588b3216],
17	m/z	NN	PERCENT	m/z	nsubjpass	26	SENT_81	[p6l1620t3148r1774b3216],
18	436.2	CD	PERCENT	436.2	num	19	SENT_81	[p6l1808t3158r2022b3216],
19	%	NN	PERCENT	%	dep	17	SENT_81	[p6l2062t3169r2144b3216],
20	199.2	CD	NUMBER	199.2	num	23	SENT_81	[p6l13t3259r222b3317],
21	and	CC	O	and	_	0	SENT_81	[p6l272t3250r420b3317],
22	405.2	CD	PERCENT	405.2	num	23	SENT_81	[p6l464t3259r677b3317],
23	%	NN	PERCENT	%	dep	17	SENT_81	[p6l728t3271r809b3317],
24	199.1	CD	NUMBER	199.1	dep	23	SENT_81	[p6l857t3259r1066b3317],
25	were	VBD	O	be	auxpass	26	SENT_81	[p6l1114t3273r1307b3317],
26	monitored	VBN	O	monitor	conj_and	9	SENT_81	[p6l1352t3250r1774b3317],
27	for	IN	O	for	_	0	SENT_81	[p6l1818t3250r1928b3317],
28	simvastatin	NN	O	simvastatin	prep_for	26	SENT_81	[p6l1972t3253r2143b3317, p7l8t28r326b93],

1	and	CC	O	and	dep	3	SENT_82	[p7l369t24r517b93],
2	internal	JJ	O	internal	amod	3	SENT_82	[p7l559t24r875b93],
3	standard	NN	O	standard	_	0	SENT_82	[p7l919t24r1291b103],
4	,	,	O	,	_	0	SENT_82	[p7l919t24r1291b103],
5	respectively	RB	O	respectively	amod	3	SENT_82	[p7l1334t24r1839b114],
6	.	.	O	.	_	0	SENT_82	[p7l1334t24r1839b114],

1	Linear	JJ	O	linear	amod	3	SENT_83	[p7l1886t28r2145b93],
2	calibration	NN	O	calibration	nn	3	SENT_83	[p7l10t126r446b194],
3	curves	NNS	O	curve	nsubjpass	5	SENT_83	[p7l482t150r741b194],
4	were	VBD	O	be	auxpass	5	SENT_83	[p7l778t150r972b194],
5	established	VBN	O	establish	_	0	SENT_83	[p7l1010t126r1465b194],
6	in	IN	O	in	_	0	SENT_83	[p7l1501t130r1580b194],
7	the	DT	O	the	det	8	SENT_83	[p7l1615t126r1738b194],
8	ranges	NNS	O	range	prep_in	5	SENT_83	[p7l1774t150r2031b216],
9	of	IN	O	of	_	0	SENT_83	[p7l2071t126r2152b194],
10	0.05	CD	NUMBER	0.05	prep_of	8	SENT_83	[p7l11t238r179b296],
11	to	TO	O	to	_	0	SENT_83	[p7l238t238r313b296],
12	10	CD	NUMBER	10	num	13	SENT_83	[p7l375t238r464b296],
13	ng/mL	NN	O	ng/ml	prep_to	5	SENT_83	[p7l521t228r791b317],
14	for	IN	O	for	_	0	SENT_83	[p7l848t228r961b296],
15	simvastatin	NN	O	simvastatin	nn	17	SENT_83	[p7l1017t232r1502b296],
16	(	CD	NUMBER	(	num	17	SENT_83	[p7l1560t228r1647b309],
17	r2	NN	O	r2	prep_for	13	SENT_83	[p7l1560t228r1647b309],
18	=	JJ	O	=	amod	17	SENT_83	[p7l1705t260r1751b284],
19	0.9994	CD	NUMBER	0.9994	num	20	SENT_83	[p7l1810t228r2138b309],
20	)	NN	O	)	dep	18	SENT_83	[p7l1810t228r2138b309],
21	.	.	O	.	_	0	SENT_83	[p7l1810t228r2138b309],

1	Intraday	NNP	O	Intraday	nn	2	SENT_84	[p7l9t330r347b419],
2	coefficients	NNS	O	coefficient	nsubj	14	SENT_84	[p7l383t330r845b398],
3	of	IN	O	of	_	0	SENT_84	[p7l884t330r964b398],
4	variation	NN	O	variation	nn	6	SENT_84	[p7l991t334r1354b398],
5	(	NN	O	(	nn	6	SENT_84	[p7l1393t330r1564b411],
6	CV	NN	O	cv	prep_of	2	SENT_84	[p7l1393t330r1564b411],
7	)	CD	NUMBER	)	dep	6	SENT_84	[p7l1393t330r1564b411],
8	and	CC	O	and	_	0	SENT_84	[p7l1604t330r1752b398],
9	accuracy	NN	O	accuracy	prep_of	2	SENT_84	[p7l1788t354r2145b419],
10	were	VBD	O	be	cop	14	SENT_84	[p7l8t456r201b500],
11	less	JJR	O	less	mwe	12	SENT_84	[p7l235t432r381b500],
12	than	IN	O	than	quantmod	13	SENT_84	[p7l414t432r594b500],
13	6.8	CD	PERCENT	6.8	num	14	SENT_84	[p7l627t432r826b505],
14	%	NN	PERCENT	%	_	0	SENT_84	[p7l627t432r826b505],
15	and	CC	O	and	_	0	SENT_84	[p7l867t432r1015b500],
16	94.1	CD	PERCENT	94.1	number	20	SENT_84	[p7l1049t432r1296b505],
17	%	NN	PERCENT	%	dep	20	SENT_84	[p7l1049t432r1296b505],
18	to	TO	O	to	dep	20	SENT_84	[p7l1335t442r1409b500],
19	100.5	CD	PERCENT	100.5	number	20	SENT_84	[p7l1447t432r1770b505],
20	%	NN	PERCENT	%	conj_and	14	SENT_84	[p7l1447t432r1770b505],
21	.	.	O	.	_	0	SENT_84	[p7l1447t432r1770b505],

1	Interday	NNP	O	Interday	nn	2	SENT_85	[p7l1806t432r2145b521],
2	CV	NNP	O	CV	nsubj	9	SENT_85	[p7l9t538r129b603],
3	and	CC	O	and	_	0	SENT_85	[p7l162t535r311b603],
4	accuracy	NN	O	accuracy	nsubj	9	SENT_85	[p7l345t559r701b624],
5	were	VBD	O	be	cop	9	SENT_85	[p7l732t559r926b603],
6	less	JJR	O	less	mwe	7	SENT_85	[p7l961t535r1107b603],
7	than	IN	O	than	quantmod	8	SENT_85	[p7l1142t535r1321b603],
8	5.1	CD	PERCENT	5.1	num	9	SENT_85	[p7l1357t535r1555b608],
9	%	NN	PERCENT	%	_	0	SENT_85	[p7l1357t535r1555b608],
10	and	CC	O	and	_	0	SENT_85	[p7l1597t535r1745b603],
11	98.8	CD	PERCENT	98.8	number	15	SENT_85	[p7l1781t535r2028b608],
12	%	NN	PERCENT	%	dep	15	SENT_85	[p7l1781t535r2028b608],
13	to	TO	O	to	dep	15	SENT_85	[p7l2068t545r2142b603],
14	106.8	CD	PERCENT	106.8	number	15	SENT_85	[p7l13t636r336b710],
15	%	NN	PERCENT	%	conj_and	9	SENT_85	[p7l13t636r336b710],
16	.	.	O	.	_	0	SENT_85	[p7l13t636r336b710],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	2	SENT_86	[p7l7t850r711b918],
2	Evaluations	NNS	O	evaluation	_	0	SENT_86	[p7l744t850r1230b918],

1	The	DT	O	the	det	3	SENT_87	[p7l9t1059r161b1127],
2	software	NN	O	software	nn	3	SENT_87	[p7l195t1059r534b1127],
3	WinNONLIN	NN	O	winnonlin	nsubjpass	18	SENT_87	[p7l564t1063r1093b1127],
4	professional	JJ	O	professional	amod	5	SENT_87	[p7l1122t1059r1617b1149],
5	version	NN	O	version	dep	3	SENT_87	[p7l1646t1063r1946b1127],
6	5.01	CD	NUMBER	5.01	number	7	SENT_87	[p7l1979t1069r2138b1127],
7	(	CD	NUMBER	(	dep	3	SENT_87	[p7l13t1161r421b1250],
8	Pharsight	NNP	ORGANIZATION	Pharsight	nn	10	SENT_87	[p7l13t1161r421b1250],
9	Corp	NNP	ORGANIZATION	Corp	nn	10	SENT_87	[p7l450t1165r640b1251],
10	Inc	NNP	ORGANIZATION	Inc	dep	7	SENT_87	[p7l671t1166r817b1240],
11	,	,	O	,	_	0	SENT_87	[p7l671t1166r817b1240],
12	Mountain	NNP	O	Mountain	nn	13	SENT_87	[p7l849t1165r1247b1229],
13	View	NNP	O	View	appos	7	SENT_87	[p7l1274t1165r1493b1240],
14	,	,	O	,	_	0	SENT_87	[p7l1274t1165r1493b1240],
15	Calif	NNP	LOCATION	Calif	nn	16	SENT_87	[p7l1526t1161r1739b1242],
16	)	NNP	O	)	appos	13	SENT_87	[p7l1526t1161r1739b1242],
17	was	VBD	O	be	auxpass	18	SENT_87	[p7l1772t1185r1924b1229],
18	used	VBN	O	use	_	0	SENT_87	[p7l1955t1161r2145b1229],
19	for	IN	O	for	_	0	SENT_87	[p7l10t1263r116b1331],
20	pharmacokinetic	JJ	O	pharmacokinetic	amod	21	SENT_87	[p7l140t1263r801b1353],
21	analysis	NN	O	analysis	prep_for	18	SENT_87	[p7l829t1263r1163b1352],
22	.	.	O	.	_	0	SENT_87	[p7l829t1263r1163b1352],

1	We	PRP	O	we	nsubj	2	SENT_88	[p7l1192t1268r1315b1331],
2	analyzed	VBD	O	analyze	_	0	SENT_88	[p7l1342t1263r1693b1352],
3	the	DT	O	the	det	5	SENT_88	[p7l1717t1263r1838b1331],
4	plasma	NN	O	plasma	nn	5	SENT_88	[p7l1864t1263r2145b1353],
5	concentrations	NNS	O	concentration	dobj	2	SENT_88	[p7l10t1368r606b1433],
6	of	IN	O	of	_	0	SENT_88	[p7l642t1365r723b1433],
7	simvastatin	NN	O	simvastatin	prep_of	5	SENT_88	[p7l749t1368r1213b1433],
8	by	IN	O	by	_	0	SENT_88	[p7l1241t1365r1340b1454],
9	noncompartmental	JJ	O	noncompartmental	amod	10	SENT_88	[p7l1371t1365r2144b1454],
10	analysis	NN	O	analysis	prep_by	2	SENT_88	[p7l10t1468r356b1557],
11	.	.	O	.	_	0	SENT_88	[p7l10t1468r356b1557],

1	The	DT	O	the	det	3	SENT_89	[p7l395t1468r548b1536],
2	Cmax	NN	MISC	cmax	nn	3	SENT_89	[p7l584t1471r744b1559],
3	values	NNS	O	value	nsubjpass	14	SENT_89	[p7l775t1468r1032b1536],
4	and	CC	O	and	_	0	SENT_89	[p7l1070t1468r1218b1536],
5	the	DT	O	the	det	6	SENT_89	[p7l1251t1468r1375b1536],
6	time	NN	O	time	conj_and	3	SENT_89	[p7l1409t1471r1588b1536],
7	to	TO	O	to	aux	8	SENT_89	[p7l1622t1478r1696b1536],
8	reach	VB	O	reach	infmod	6	SENT_89	[p7l1731t1468r1951b1536],
9	Cmax	NNP	O	Cmax	nsubj	12	SENT_89	[p7l1986t1471r2146b1559],
10	(	CD	NUMBER	(	num	12	SENT_89	[p7l13t1570r223b1661],
11	Tmax	NN	O	tmax	nn	12	SENT_89	[p7l13t1570r223b1661],
12	)	NN	O	)	xcomp	8	SENT_89	[p7l13t1570r223b1661],
13	were	VBD	O	be	auxpass	14	SENT_89	[p7l283t1593r477b1638],
14	estimated	VBN	O	estimate	_	0	SENT_89	[p7l537t1570r927b1638],
15	directly	RB	O	directly	advmod	14	SENT_89	[p7l987t1569r1297b1659],
16	from	IN	O	from	_	0	SENT_89	[p7l1355t1570r1543b1637],
17	the	DT	O	the	det	21	SENT_89	[p7l1600t1569r1723b1638],
18	observed	VBN	O	observe	amod	21	SENT_89	[p7l1784t1569r2145b1638],
19	plasma	NN	O	plasma	nn	21	SENT_89	[p7l9t1671r298b1761],
20	concentration-time	NN	O	concentration-time	nn	21	SENT_89	[p7l331t1675r1102b1739],
21	data	NNS	O	datum	prep_from	14	SENT_89	[p7l1139t1671r1324b1739],
22	.	.	O	.	_	0	SENT_89	[p7l1139t1671r1324b1739],

1	The	DT	O	the	det	2	SENT_90	[p7l1363t1671r1516b1739],
2	area	NN	O	area	nsubj	7	SENT_90	[p7l1552t1695r1716b1739],
3	under	IN	O	under	_	0	SENT_90	[p7l1747t1671r1987b1739],
4	the	DT	O	the	det	6	SENT_90	[p7l2019t1671r2143b1739],
5	plasma	NN	O	plasma	nn	6	SENT_90	[p7l9t1773r298b1863],
6	concentration-time	NN	O	concentration-time	prep_under	2	SENT_90	[p7l329t1777r1099b1841],
7	curve	NN	O	curve	_	0	SENT_90	[p7l1133t1797r1353b1841],
8	(	CD	NUMBER	(	num	9	SENT_90	[p7l1390t1773r1634b1854],
9	AUC	NN	O	auc	dobj	7	SENT_90	[p7l1390t1773r1634b1854],
10	)	CD	NUMBER	)	nsubj	17	SENT_90	[p7l1390t1773r1634b1854],
11	from	IN	O	from	_	0	SENT_90	[p7l1670t1773r1859b1841],
12	time	NN	O	time	nn	13	SENT_90	[p7l1889t1777r2067b1841],
13	o	NN	O	o	prep_from	10	SENT_90	[p7l2101t1783r2142b1841],
14	to	TO	O	to	_	0	SENT_90	[p7l8t1885r82b1943],
15	12	CD	DURATION	12	num	16	SENT_90	[p7l120t1885r205b1942],
16	hours	NNS	NUMBER	hour	prep_to	13	SENT_90	[p7l241t1875r467b1943],
17	(	VBP	O	(	rcmod	9	SENT_90	[p7l505t1875r836b1966],
18	AUCM	NN	O	aucm	nn	19	SENT_90	[p7l505t1875r836b1966],
19	)	NN	O	)	nsubjpass	21	SENT_90	[p7l505t1875r836b1966],
20	was	VBD	O	be	auxpass	21	SENT_90	[p7l870t1899r1024b1943],
21	calculated	VBN	O	calculate	ccomp	17	SENT_90	[p7l1059t1875r1474b1943],
22	using	VBG	O	use	xcomp	21	SENT_90	[p7l1505t1879r1723b1964],
23	the	DT	O	the	det	26	SENT_90	[p7l1754t1875r1878b1943],
24	linear	JJ	O	linear	amod	26	SENT_90	[p7l1912t1875r2145b1943],
25	trapezoidal	JJ	O	trapezoidal	amod	26	SENT_90	[p7l8t1977r464b2066],
26	rule	NN	O	rule	dobj	22	SENT_90	[p7l508t1977r688b2045],
27	.	.	O	.	_	0	SENT_90	[p7l508t1977r688b2045],

1	The	DT	O	the	det	2	SENT_91	[p7l738t1977r891b2045],
2	AUC	NN	O	auc	nsubjpass	12	SENT_91	[p7l936t1980r1129b2045],
3	from	IN	O	from	_	0	SENT_91	[p7l1176t1977r1365b2045],
4	time	NN	O	time	nn	5	SENT_91	[p7l1408t1980r1586b2045],
5	o	NN	O	o	prep_from	2	SENT_91	[p7l1634t1987r1675b2045],
6	to	TO	O	to	_	0	SENT_91	[p7l1721t1987r1795b2045],
7	infinity	NN	O	infinity	nn	10	SENT_91	[p7l1842t1977r2145b2066],
8	(	CD	NUMBER	(	num	10	SENT_91	[p7l13t2080r296b2164],
9	AUCW	NN	O	aucw	nn	10	SENT_91	[p7l13t2080r296b2164],
10	)	NN	O	)	prep_to	5	SENT_91	[p7l13t2080r296b2164],
11	was	VBD	O	be	auxpass	12	SENT_91	[p7l342t2104r495b2148],
12	calculated	VBN	O	calculate	_	0	SENT_91	[p7l542t2080r957b2148],
13	as	IN	O	as	_	0	SENT_91	[p7l1002t2104r1078b2148],
14	AUC	NN	O	auc	nn	18	SENT_91	[p7l1123t2083r1356b2164],
15	,	,	O	,	_	0	SENT_91	[p7l1123t2083r1356b2164],
16	»	NN	O	»	nn	18	SENT_91	[p7l1123t2083r1356b2164],
17	=	JJ	O	=	amod	18	SENT_91	[p7l1401t2112r1446b2136],
18	AUCMS	NNS	O	aucm	prep_as	12	SENT_91	[p7l1491t2083r1773b2171],
19	,	,	O	,	_	0	SENT_91	[p7l1491t2083r1773b2171],
20	+	CC	O	+	_	0	SENT_91	[p7l1817t2101r1862b2147],
21	Ct/Ke	NN	O	ct/ke	prep_as	12	SENT_91	[p7l1913t2080r2141b2171],
22	,	,	O	,	_	0	SENT_91	[p7l1913t2080r2141b2171],
23	where	WRB	O	where	advmod	30	SENT_91	[p7l8t2181r255b2250],
24	C	NN	O	c	ccomp	30	SENT_91	[p7l297t2185r369b2273],
25	,	,	O	,	_	0	SENT_91	[p7l297t2185r369b2273],
26	is	VBZ	O	be	cop	30	SENT_91	[p7l401t2185r463b2250],
27	the	DT	O	the	det	30	SENT_91	[p7l499t2181r623b2250],
28	last	JJ	O	last	amod	30	SENT_91	[p7l661t2181r800b2250],
29	plasma	NN	O	plasma	nn	30	SENT_91	[p7l834t2181r1123b2271],
30	concentration	NN	O	concentration	advcl	12	SENT_91	[p7l1158t2185r1718b2250],
31	measured	VBN	O	measure	partmod	30	SENT_91	[p7l1752t2181r2144b2250],
32	and	CC	O	and	_	0	SENT_91	[p7l10t2282r161b2350],
33	Ke	NNP	PERSON	Ke	nsubj	38	SENT_91	[p7l210t2287r315b2350],
34	is	VBZ	O	be	cop	38	SENT_91	[p7l366t2286r429b2350],
35	the	DT	O	the	det	37	SENT_91	[p7l482t2282r609b2350],
36	elimination	NN	O	elimination	nn	37	SENT_91	[p7l663t2282r1148b2350],
37	rate	NN	O	rate	npadvmod	38	SENT_91	[p7l1198t2292r1351b2350],
38	constant	JJ	O	constant	conj_and	12	SENT_91	[p7l1406t2292r1779b2361],
39	;	:	O	;	_	0	SENT_91	[p7l1406t2292r1779b2361],
40	Ke	NNP	O	Ke	nsubjpass	42	SENT_91	[p7l1833t2287r1937b2350],
41	was	VBD	O	be	auxpass	42	SENT_91	[p7l1986t2306r2142b2350],
42	determined	VBN	O	determine	parataxis	12	SENT_91	[p7l12t2384r475b2452],
43	by	IN	O	by	_	0	SENT_91	[p7l507t2384r606b2473],
44	linear	JJ	O	linear	amod	46	SENT_91	[p7l641t2384r875b2452],
45	regression	NN	O	regression	nn	46	SENT_91	[p7l909t2388r1321b2473],
46	analysis	NN	O	analysis	agent	42	SENT_91	[p7l1358t2384r1682b2473],
47	by	IN	O	by	_	0	SENT_91	[p7l1716t2384r1815b2473],
48	the	DT	O	the	det	49	SENT_91	[p7l1849t2384r1973b2452],
49	use	NN	O	use	agent	42	SENT_91	[p7l2009t2408r2143b2452],
50	of	IN	O	of	_	0	SENT_91	[p7l11t2486r91b2554],
51	at	IN	O	at	quantmod	53	SENT_91	[p7l120t2496r190b2554],
52	least	JJS	O	least	mwe	51	SENT_91	[p7l224t2486r408b2554],
53	3	CD	NUMBER	3	num	55	SENT_91	[p7l445t2496r482b2554],
54	sampling	NN	O	sampling	nn	55	SENT_91	[p7l524t2486r893b2576],
55	points	NNS	O	point	prep_of	49	SENT_91	[p7l928t2490r1179b2576],
56	of	IN	O	of	_	0	SENT_91	[p7l1218t2486r1298b2554],
57	the	DT	O	the	det	59	SENT_91	[p7l1325t2486r1449b2554],
58	logarithm-linear	JJ	O	logarithm-linear	amod	59	SENT_91	[p7l1486t2486r2145b2575],
59	part	NN	O	part	prep_of	55	SENT_91	[p7l9t2598r169b2677],
60	of	IN	O	of	_	0	SENT_91	[p7l204t2588r284b2656],
61	the	DT	O	the	det	63	SENT_91	[p7l310t2588r434b2656],
62	elimination	NN	O	elimination	nn	63	SENT_91	[p7l471t2588r941b2656],
63	phase	NN	O	phase	prep_of	59	SENT_91	[p7l975t2588r1207b2677],
64	to	TO	O	to	_	0	SENT_91	[p7l1241t2598r1315b2656],
65	the	DT	O	the	det	68	SENT_91	[p7l1350t2588r1474b2656],
66	last	JJ	O	last	amod	68	SENT_91	[p7l1510t2588r1650b2656],
67	measurable	JJ	O	measurable	amod	68	SENT_91	[p7l1682t2588r2143b2656],
68	concentrations	NNS	O	concentration	prep_to	42	SENT_91	[p7l10t2694r642b2759],
69	.	.	O	.	_	0	SENT_91	[p7l10t2694r642b2759],

1	The	DT	O	the	det	2	SENT_92	[p7l694t2691r848b2759],
2	tm	NN	O	tm	nsubjpass	6	SENT_92	[p7l895t2701r1001b2782],
3	of	IN	O	of	_	0	SENT_92	[p7l1051t2691r1133b2759],
4	simvastatin	NN	O	simvastatin	prep_of	2	SENT_92	[p7l1173t2694r1648b2759],
5	was	VBD	O	be	auxpass	6	SENT_92	[p7l1693t2715r1847b2759],
6	calculated	VBN	O	calculate	_	0	SENT_92	[p7l1897t2691r2143b2759, p7l9t2792r207b2861],
7	as	IN	O	as	_	0	SENT_92	[p7l252t2816r328b2861],
8	t1	NN	O	t1	nn	11	SENT_92	[p7l372t2803r476b2884],
9	,2	NN	O	,2	nn	11	SENT_92	[p7l372t2803r476b2884],
10	=	JJ	O	=	amod	11	SENT_92	[p7l523t2825r569b2849],
11	ln2/Ke	NN	O	ln2/ke	prep_as	6	SENT_92	[p7l615t2792r901b2861],
12	.	.	O	.	_	0	SENT_92	[p7l615t2792r901b2861],

1	The	DT	O	the	det	6	SENT_93	[p7l950t2792r1102b2861],
2	oral	JJ	O	oral	amod	6	SENT_93	[p7l1148t2792r1300b2861],
3	clearance	NN	O	clearance	nn	6	SENT_93	[p7l1345t2792r1724b2861],
4	(	CD	NUMBER	(	num	6	SENT_93	[p7l1773t2792r2022b2873],
5	CL/F	NN	O	cl/f	nn	6	SENT_93	[p7l1773t2792r2022b2873],
6	)	NN	O	)	nsubjpass	10	SENT_93	[p7l1773t2792r2022b2873],
7	of	IN	O	of	_	0	SENT_93	[p7l2071t2793r2151b2861],
8	simvastatin	NN	O	simvastatin	prep_of	6	SENT_93	[p7l11t2898r475b2962],
9	was	VBD	O	be	auxpass	10	SENT_93	[p7l505t2918r658b2962],
10	calculated	VBN	O	calculate	_	0	SENT_93	[p7l694t2894r1109b2962],
11	as	IN	O	as	_	0	SENT_93	[p7l1141t2918r1217b2962],
12	CL/F	NN	O	cl/f	nn	14	SENT_93	[p7l1252t2894r1449b2962],
13	=	JJ	O	=	amod	14	SENT_93	[p7l1484t2927r1529b2950],
14	dose/AUCOM	NN	O	dose/aucom	prep_as	10	SENT_93	[p7l1566t2894r2085b2986],
15	.	.	O	.	_	0	SENT_93	[p7l1566t2894r2085b2986],

1	Statistical	JJ	O	statistical	amod	2	SENT_94	[p7l11t3107r420b3175],
2	Analysis	NN	O	analysis	_	0	SENT_94	[p7l451t3107r808b3197],

1	The	DT	O	the	det	2	SENT_95	[p7l9t3316r161b3384],
2	data	NNS	O	datum	nsubjpass	4	SENT_95	[p7l204t3316r372b3384],
3	are	VBP	O	be	auxpass	4	SENT_95	[p7l410t3340r527b3384],
4	expressed	VBN	O	express	_	0	SENT_95	[p7l569t3316r969b3406],
5	as	IN	O	as	_	0	SENT_95	[p7l1008t3340r1085b3384],
6	means	NNS	O	means	prep_as	4	SENT_95	[p7l1125t3340r1381b3384],
7	i	FW	O	i	dep	6	SENT_95	[p7l1420t3325r1468b3383],
8	standard	JJ	O	standard	amod	9	SENT_95	[p7l1507t3316r1858b3384],
9	deviations	NNS	O	deviation	dep	7	SENT_95	[p7l1899t3316r2143b3384, p7l8t3422r229b3497],
10	,	,	O	,	_	0	SENT_95	[p7l1899t3316r2143b3384, p7l8t3422r229b3497],
11	and	CC	O	and	_	0	SENT_95	[p7l261t3418r409b3486],
12	differences	NNS	O	difference	nsubjpass	18	SENT_95	[p7l439t3418r880b3486],
13	at	IN	O	at	_	0	SENT_95	[p7l911t3428r981b3486],
14	P	NN	O	p	prep_at	12	SENT_95	[p7l1006t3423r1064b3486],
15	<	VBG	O	<	partmod	14	SENT_95	[p7l1087t3439r1133b3486],
16	.05	CD	NUMBER	.05	dobj	15	SENT_95	[p7l1167t3428r1277b3486],
17	were	VBD	O	be	auxpass	18	SENT_95	[p7l1309t3442r1502b3486],
18	considered	VBN	O	consider	conj_and	4	SENT_95	[p7l1533t3418r1978b3486],
19	significant	JJ	O	significant	acomp	18	SENT_95	[p7l2007t3422r2143b3507, p7l8t3520r341b3588],
20	.	.	O	.	_	0	SENT_95	[p7l2007t3422r2143b3507, p7l8t3520r341b3588],

1	After	IN	O	after	_	0	SENT_96	[p7l394t3520r600b3588],
2	normality	NN	O	normality	nn	5	SENT_96	[p7l647t3520r1045b3609],
3	and	CC	O	and	_	0	SENT_96	[p7l1095t3520r1243b3588],
4	equal	JJ	O	equal	conj_and	2	SENT_96	[p7l1293t3520r1509b3609],
5	variance	NN	O	variance	prep_after	7	SENT_96	[p7l1558t3523r1900b3588],
6	were	VBD	O	be	aux	7	SENT_96	[p7l1949t3544r2143b3588],
7	tested	VBN	O	test	_	0	SENT_96	[p7l8t3623r268b3701],
8	,	,	O	,	_	0	SENT_96	[p7l8t3623r268b3701],
9	data	NNS	O	datum	dobj	7	SENT_96	[p7l314t3623r482b3691],
10	with	IN	O	with	_	0	SENT_96	[p7l519t3623r705b3691],
11	homogeneity	NN	O	homogeneity	prep_with	9	SENT_96	[p7l743t3623r1271b3712],
12	of	IN	O	of	_	0	SENT_96	[p7l1312t3623r1392b3691],
13	variance	NN	O	variance	prep_of	11	SENT_96	[p7l1423t3626r1766b3691],
14	between	IN	O	between	_	0	SENT_96	[p7l1803t3623r2145b3691],
15	CYP3A5	NN	O	cyp3a5	nn	16	SENT_96	[p7l14t3727r351b3791],
16	*	NN	O	*	prep_between	13	SENT_96	[p7l366t3723r597b3802],
17	1	CD	NUMBER	1	nsubj	7	SENT_96	[p7l366t3723r597b3802],
18	/	:	O	/	punct	35	SENT_96	[p7l366t3723r597b3802],
19	*	CD	NUMBER	*	num	20	SENT_96	[p7l366t3723r597b3802],
20	1	CD	NUMBER	1	dep	35	SENT_96	[p7l366t3723r597b3802],
21	,	,	O	,	_	0	SENT_96	[p7l366t3723r597b3802],
22	CYP3A5	NN	O	cyp3a5	nn	23	SENT_96	[p7l684t3727r1021b3791],
23	*	NN	O	*	appos	20	SENT_96	[p7l1037t3727r1107b3790],
24	1	CD	NUMBER	1	dep	23	SENT_96	[p7l1037t3727r1107b3790],
25	/	:	O	/	punct	26	SENT_96	[p7l1122t3723r1267b3802],
26	*	CD	NUMBER	*	dep	24	SENT_96	[p7l1122t3723r1267b3802],
27	3	CD	NUMBER	3	dep	26	SENT_96	[p7l1122t3723r1267b3802],
28	,	,	O	,	_	0	SENT_96	[p7l1122t3723r1267b3802],
29	and	CC	O	and	_	0	SENT_96	[p7l1351t3723r1499b3791],
30	CYP3A5	NN	O	cyp3a5	dep	24	SENT_96	[p7l1582t3727r1919b3791],
31	*	CD	NUMBER	*	number	32	SENT_96	[p7l1935t3723r2144b3791],
32	3	CD	NUMBER	3	dep	30	SENT_96	[p7l1935t3723r2144b3791],
33	/	:	O	/	punct	26	SENT_96	[p7l1935t3723r2144b3791],
34	*	CD	NUMBER	*	num	35	SENT_96	[p7l1935t3723r2144b3791],
35	3	CD	NUMBER	3	dep	17	SENT_96	[p7l1935t3723r2144b3791],

1	were	VBD	O	be	auxpass	2	SENT_97	[p8l8t42r201b86],
2	analyzed	VBN	O	analyze	_	0	SENT_97	[p8l248t18r609b108],
3	using	VBG	O	use	dep	2	SENT_97	[p8l652t22r872b108],
4	1-way	JJ	O	1-way	amod	5	SENT_97	[p8l921t29r1160b108],
5	ANOVA	NNP	O	ANOVA	dobj	3	SENT_97	[p8l1203t22r1556b97],
6	,	,	O	,	_	0	SENT_97	[p8l1203t22r1556b97],
7	and	CC	O	and	_	0	SENT_97	[p8l1605t18r1753b86],
8	multiple	JJ	O	multiple	dep	2	SENT_97	[p8l1797t18r2143b108],

1	PHARMACOGENOMICS	NN	O	pharmacogenomic	_	0	SENT_98	[p8l13t269r850b330],

1	post	NN	O	post	amod	3	SENT_99	[p8l10t501r180b580],
2	hoc	FW	O	hoc	dep	1	SENT_99	[p8l236t490r379b559],
3	comparisons	NNS	O	comparison	nsubjpass	5	SENT_99	[p8l441t494r952b580],
4	were	VBD	O	be	auxpass	5	SENT_99	[p8l1012t514r1205b559],
5	performed	VBN	O	perform	_	0	SENT_99	[p8l1265t490r1686b580],
6	using	VBG	O	use	xcomp	5	SENT_99	[p8l1743t494r1963b580],
7	the	DT	O	the	det	9	SENT_99	[p8l2020t490r2144b559],
8	Bonferroni	NNP	LOCATION	Bonferroni	nn	9	SENT_99	[p8l10t592r446b660],
9	test	NN	O	test	dobj	6	SENT_99	[p8l488t602r647b660],
10	.	.	O	.	_	0	SENT_99	[p8l488t602r647b660],

1	Data	NNS	O	datum	nsubjpass	7	SENT_100	[p8l694t597r875b660],
2	without	IN	O	without	_	0	SENT_100	[p8l915t592r1235b660],
3	homogeneity	NN	O	homogeneity	prep_without	1	SENT_100	[p8l1275t592r1802b682],
4	of	IN	O	of	_	0	SENT_100	[p8l1846t592r1926b660],
5	Variance	NNP	O	Variance	prep_of	3	SENT_100	[p8l1960t596r2144b660, p8l11t718r192b762],
6	were	VBD	O	be	auxpass	7	SENT_100	[p8l227t718r421b762],
7	analyzed	VBN	O	analyze	_	0	SENT_100	[p8l458t694r819b783],
8	using	VBG	O	use	xcomp	7	SENT_100	[p8l853t698r1073b783],
9	the	DT	O	the	det	12	SENT_100	[p8l1107t694r1231b762],
10	Kruskal-Wallis	NN	O	kruskal-walli	nn	12	SENT_100	[p8l1267t694r1864b762],
11	1-way	JJ	O	1-way	amod	12	SENT_100	[p8l1907t705r2146b783],
12	ANOVA	NN	ORGANIZATION	anova	dobj	8	SENT_100	[p8l9t800r341b864],
13	on	IN	O	on	_	0	SENT_100	[p8l388t820r486b864],
14	ranks	NNS	O	rank	prep_on	12	SENT_100	[p8l530t796r771b875],
15	,	,	O	,	_	0	SENT_100	[p8l530t796r771b875],
16	and	CC	O	and	_	0	SENT_100	[p8l822t796r970b864],
17	multiple	JJ	O	multiple	amod	20	SENT_100	[p8l1015t796r1361b886],
18	post	NN	O	post	amod	20	SENT_100	[p8l1408t806r1579b886],
19	hoc	FW	O	hoc	dep	18	SENT_100	[p8l1622t796r1765b864],
20	comparisons	NNS	O	comparison	nsubjpass	22	SENT_100	[p8l1814t820r2144b886, p8l10t901r216b966],
21	were	VBD	O	be	auxpass	22	SENT_100	[p8l247t922r441b966],
22	performed	VBN	O	perform	conj_and	7	SENT_100	[p8l472t898r894b987],
23	using	VBG	O	use	xcomp	22	SENT_100	[p8l923t901r1141b987],
24	Dunn	NNP	PERSON	Dunn	poss	26	SENT_100	[p8l1171t902r1452b966],
25	’s	POS	O	’s	_	0	SENT_100	[p8l1171t902r1452b966],
26	test	NN	O	test	dobj	23	SENT_100	[p8l1483t908r1643b966],
27	.	.	O	.	_	0	SENT_100	[p8l1483t908r1643b966],

1	Simple	JJ	O	simple	amod	5	SENT_101	[p8l1681t898r1965b987],
2	and	CC	O	and	_	0	SENT_101	[p8l1997t898r2146b966],
3	multiple	JJ	O	multiple	conj_and	1	SENT_101	[p8l9t1001r356b1090],
4	regression	NN	O	regression	nn	5	SENT_101	[p8l390t1004r803b1090],
5	analyses	NNS	O	analysis	nsubjpass	7	SENT_101	[p8l838t1001r1177b1090],
6	were	VBD	O	be	auxpass	7	SENT_101	[p8l1212t1025r1405b1069],
7	performed	VBN	O	perform	_	0	SENT_101	[p8l1441t1001r1863b1090],
8	to	TO	O	to	aux	9	SENT_101	[p8l1896t1011r1969b1069],
9	test	VB	O	test	xcomp	7	SENT_101	[p8l2005t1011r2146b1069],
10	for	IN	O	for	_	0	SENT_101	[p8l11t1103r120b1171],
11	associations	NNS	O	association	prep_for	9	SENT_101	[p8l201t1106r688b1171],
12	between	IN	O	between	_	0	SENT_101	[p8l767t1102r1108b1171],
13	independent	JJ	O	independent	amod	14	SENT_101	[p8l1188t1102r1704b1192],
14	Variables	NNP	O	Variables	prep_between	11	SENT_101	[p8l1782t1102r2143b1171],
15	(	CD	NUMBER	(	num	14	SENT_101	[p8l14t1204r431b1294],
16	including	VBG	O	include	_	0	SENT_101	[p8l14t1204r431b1294],
17	CYP3A5	NN	O	cyp3a5	nn	18	SENT_101	[p8l471t1208r809b1272],
18	genotype	NN	O	genotype	prep_including	9	SENT_101	[p8l841t1214r1208b1294],
19	and	CC	O	and	_	0	SENT_101	[p8l1246t1204r1394b1272],
20	age	NN	O	age	nn	21	SENT_101	[p8l1430t1204r1584b1294],
21	)	NN	O	)	conj_and	18	SENT_101	[p8l1430t1204r1584b1294],
22	and	CC	O	and	_	0	SENT_101	[p8l1624t1204r1772b1272],
23	pharmacokinetic	JJ	O	pharmacokinetic	amod	24	SENT_101	[p8l1808t1204r2144b1294, p8l11t1306r379b1374],
24	parameters	NNS	O	parameter	conj_and	18	SENT_101	[p8l416t1316r860b1396],
25	(	RB	O	(	advmod	26	SENT_101	[p8l901t1306r1115b1387],
26	used	VBN	O	use	partmod	24	SENT_101	[p8l901t1306r1115b1387],
27	as	IN	O	as	mark	30	SENT_101	[p8l1150t1330r1227b1374],
28	dependent	JJ	O	dependent	amod	29	SENT_101	[p8l1266t1306r1696b1396],
29	variables	NNS	O	variable	nsubj	30	SENT_101	[p8l1727t1306r2139b1387],
30	)	VBP	O	)	advcl	26	SENT_101	[p8l1727t1306r2139b1387],
31	.	.	O	.	_	0	SENT_101	[p8l1727t1306r2139b1387],

1	Statistical	JJ	O	statistical	amod	2	SENT_102	[p8l13t1408r420b1476],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_102	[p8l465t1408r811b1497],
3	were	VBD	O	be	auxpass	4	SENT_102	[p8l855t1432r1051b1476],
4	performed	VBN	O	perform	_	0	SENT_102	[p8l1096t1408r1525b1498],
5	using	VBG	O	use	xcomp	4	SENT_102	[p8l1568t1412r1790b1497],
6	the	DT	O	the	det	11	SENT_102	[p8l1833t1408r1959b1476],
7	statistical	JJ	O	statistical	amod	11	SENT_102	[p8l2005t1418r2144b1476, p8l9t1510r292b1578],
8	software	NN	O	software	nn	11	SENT_102	[p8l341t1510r691b1578],
9	package	NN	O	package	nn	11	SENT_102	[p8l738t1510r1068b1599],
10	SAS	NNP	O	SAS	nn	11	SENT_102	[p8l1118t1513r1290b1578],
11	Version	NNP	O	Version	dobj	5	SENT_102	[p8l1337t1513r1645b1578],
12	9.1.3	CD	NUMBER	9.1.3	number	13	SENT_102	[p8l1694t1520r1886b1578],
13	(	CD	NUMBER	(	dep	11	SENT_102	[p8l1942t1510r2142b1591],
14	SAS	NNP	ORGANIZATION	SAS	nn	20	SENT_102	[p8l1942t1510r2142b1591],
15	Institute	NNP	ORGANIZATION	Institute	nn	20	SENT_102	[p8l10t1616r368b1692],
16	,	,	O	,	_	0	SENT_102	[p8l10t1616r368b1692],
17	Cary	NNP	PERSON	Cary	appos	20	SENT_102	[p8l404t1616r602b1702],
18	,	,	O	,	_	0	SENT_102	[p8l404t1616r602b1702],
19	NC	NNP	O	NC	appos	20	SENT_102	[p8l636t1613r810b1694],
20	)	NNP	O	)	dep	13	SENT_102	[p8l636t1613r810b1694],
21	.	.	O	.	_	0	SENT_102	[p8l636t1613r810b1694],

1	RESULTS	NNS	O	result	_	0	SENT_103	[p8l10t1843r407b1907],

1	The	DT	O	the	det	4	SENT_104	[p8l10t2049r164b2117],
2	plasma	NN	O	plasma	nn	4	SENT_104	[p8l197t2049r491b2139],
3	concentration-time	JJ	O	concentration-time	amod	4	SENT_104	[p8l523t2053r1310b2117],
4	profiles	NNS	O	profile	npadvmod	8	SENT_104	[p8l1343t2049r1655b2139],
5	for	IN	O	for	_	0	SENT_104	[p8l1690t2049r1801b2117],
6	simvastatin	NN	O	simvastatin	prep_for	8	SENT_104	[p8l1834t2053r2144b2117, p8l9t2154r192b2219],
7	were	VBD	O	be	auxpass	8	SENT_104	[p8l224t2175r416b2219],
8	compared	VBN	O	compare	_	0	SENT_104	[p8l453t2151r850b2240],
9	between	IN	O	between	_	0	SENT_104	[p8l881t2151r1218b2219],
10	the	DT	O	the	det	13	SENT_104	[p8l1251t2151r1374b2219],
11	CYP3A5	NN	O	cyp3a5	nn	13	SENT_104	[p8l1415t2154r1749b2219],
12	genotype	NN	O	genotype	nn	13	SENT_104	[p8l1781t2161r2144b2240],
13	groups	NNS	O	group	prep_between	8	SENT_104	[p8l9t2278r278b2343],
14	after	IN	O	after	_	0	SENT_104	[p8l312t2254r489b2322],
15	administration	NN	O	administration	prep_after	8	SENT_104	[p8l519t2254r1111b2322],
16	of	IN	O	of	_	0	SENT_104	[p8l1144t2254r1223b2322],
17	a	DT	O	a	det	19	SENT_104	[p8l1248t2278r1288b2322],
18	single	JJ	O	single	amod	19	SENT_104	[p8l1319t2254r1552b2343],
19	dose	NN	O	dose	prep_of	15	SENT_104	[p8l1586t2254r1765b2322],
20	of	IN	O	of	_	0	SENT_104	[p8l1799t2254r1878b2322],
21	20	CD	NUMBER	20	num	23	SENT_104	[p8l1905t2263r1993b2322],
22	mg	NN	O	mg	nn	23	SENT_104	[p8l2025t2278r2145b2343],
23	simvastatin	NN	O	simvastatin	prep_of	19	SENT_104	[p8l12t2359r496b2424],
24	(	CD	NUMBER	(	num	27	SENT_104	[p8l537t2356r831b2445],
25	Figure	NN	O	figure	nn	27	SENT_104	[p8l537t2356r831b2445],
26	1	CD	NUMBER	1	num	27	SENT_104	[p8l874t2356r967b2436],
27	)	NN	O	)	nsubjpass	8	SENT_104	[p8l874t2356r967b2436],
28	.	.	O	.	_	0	SENT_104	[p8l874t2356r967b2436],

1	The	DT	O	the	det	3	SENT_105	[p8l1010t2355r1167b2424],
2	CYP3A5	NN	O	cyp3a5	nn	3	SENT_105	[p8l1210t2355r1792b2424],
3	*	NN	O	*	_	0	SENT_105	[p8l1210t2355r1792b2424],
4	3	CD	NUMBER	3	dep	3	SENT_105	[p8l1210t2355r1792b2424],
5	/	:	O	/	punct	3	SENT_105	[p8l1210t2355r1792b2424],
6	*	CD	NUMBER	*	number	7	SENT_105	[p8l1210t2355r1792b2424],
7	3	CD	NUMBER	3	num	8	SENT_105	[p8l1210t2355r1792b2424],
8	carriers	NNS	O	carrier	nsubj	9	SENT_105	[p8l1830t2359r2143b2424],
9	showed	VBD	O	show	dep	34	SENT_105	[p8l12t2457r313b2525],
10	higher	JJR	O	higher	amod	13	SENT_105	[p8l337t2457r587b2547],
11	mean	JJ	O	mean	amod	13	SENT_105	[p8l610t2481r824b2525],
12	plasma	NN	O	plasma	nn	13	SENT_105	[p8l849t2457r1128b2547],
13	concentrations	NNS	O	concentration	dobj	9	SENT_105	[p8l1154t2461r1723b2525],
14	of	IN	O	of	_	0	SENT_105	[p8l1753t2457r1831b2525],
15	simvastatin	NN	O	simvastatin	prep_of	13	SENT_105	[p8l1851t2461r2144b2525, p8l9t2562r186b2626],
16	than	IN	O	than	mark	17	SENT_105	[p8l207t2558r380b2626],
17	did	VBD	O	do	advcl	9	SENT_105	[p8l405t2558r532b2626],
18	the	DT	O	the	det	20	SENT_105	[p8l553t2558r673b2626],
19	CYP3A5	NN	O	cyp3a5	nn	20	SENT_105	[p8l701t2562r1028b2626],
20	*	NN	O	*	dep	17	SENT_105	[p8l1041t2562r1110b2625],
21	1	CD	NUMBER	1	dep	20	SENT_105	[p8l1041t2562r1110b2625],
22	/	:	O	/	punct	20	SENT_105	[p8l1123t2558r1160b2626],
23	*	CD	NUMBER	*	num	25	SENT_105	[p8l1166t2562r1243b2626],
24	3	CD	NUMBER	3	num	25	SENT_105	[p8l1166t2562r1243b2626],
25	carriers	NNS	O	carrier	dep	20	SENT_105	[p8l1266t2562r1572b2636],
26	;	:	O	;	_	0	SENT_105	[p8l1266t2562r1572b2636],
27	CYP3A5	NN	O	cyp3a5	nn	28	SENT_105	[p8l1603t2562r1931b2626],
28	*	NN	O	*	dep	25	SENT_105	[p8l1943t2562r2012b2625],
29	1	CD	NUMBER	1	dep	28	SENT_105	[p8l1943t2562r2012b2625],
30	/	:	O	/	punct	20	SENT_105	[p8l2024t2558r2062b2626],
31	*	CD	NUMBER	*	num	32	SENT_105	[p8l2068t2562r2137b2625],
32	1	CD	NUMBER	1	dep	20	SENT_105	[p8l2068t2562r2137b2625],
33	carriers	NNS	O	carrier	dep	32	SENT_105	[p8l11t2664r310b2728],
34	had	VBD	O	have	dep	3	SENT_105	[p8l339t2660r489b2728],
35	the	DT	O	the	det	37	SENT_105	[p8l516t2660r640b2728],
36	lowest	JJS	O	lowest	amod	37	SENT_105	[p8l669t2660r933b2728],
37	levels	NNS	O	level	dobj	34	SENT_105	[p8l960t2660r1190b2728],
38	(	CD	NUMBER	(	num	41	SENT_105	[p8l1224t2660r1506b2749],
39	Figure	NN	O	figure	nn	41	SENT_105	[p8l1224t2660r1506b2749],
40	2	CD	NUMBER	2	num	41	SENT_105	[p8l1539t2660r1629b2741],
41	)	NN	O	)	nsubj	34	SENT_105	[p8l1539t2660r1629b2741],
42	.	.	O	.	_	0	SENT_105	[p8l1539t2660r1629b2741],

1	The	DT	O	the	det	2	SENT_106	[p8l1663t2660r1815b2728],
2	AUC	NN	O	auc	nsubj	6	SENT_106	[p8l1844t2664r2037b2728],
3	in	IN	O	in	_	0	SENT_106	[p8l2066t2664r2146b2728],
4	the	DT	O	the	det	5	SENT_106	[p8l9t2762r130b2830],
5	CYP3A5	NN	O	cyp3a5	prep_in	2	SENT_106	[p8l162t2762r701b2830],
6	*	NN	O	*	_	0	SENT_106	[p8l162t2762r701b2830],
7	1	CD	NUMBER	1	dobj	6	SENT_106	[p8l162t2762r701b2830],
8	/	:	O	/	punct	11	SENT_106	[p8l162t2762r701b2830],
9	*	CD	NUMBER	*	number	10	SENT_106	[p8l162t2762r701b2830],
10	1	CD	NUMBER	1	num	11	SENT_106	[p8l162t2762r701b2830],
11	carriers	NNS	O	carrier	dep	7	SENT_106	[p8l736t2765r1024b2830],
12	(	VBP	O	(	rcmod	11	SENT_106	[p8l1056t2762r1242b2843],
13	4.94	CD	NUMBER	4.94	dobj	12	SENT_106	[p8l1056t2762r1242b2843],
14	i	LS	O	i	dep	13	SENT_106	[p8l1269t2771r1317b2829],
15	-	:	O	-	_	0	SENT_106	[p8l1269t2771r1317b2829],
16	2.25	CD	NUMBER	2.25	num	18	SENT_106	[p8l1344t2772r1501b2830],
17	ng	NN	O	ng	nn	18	SENT_106	[p8l1530t2786r1624b2851],
18	o	NN	O	o	dep	13	SENT_106	[p8l1660t2782r1691b2814],
19	h/mL	NN	O	h/ml	nn	20	SENT_106	[p8l1726t2762r1964b2843],
20	)	NN	O	)	nsubj	23	SENT_106	[p8l1726t2762r1964b2843],
21	was	VBD	O	be	cop	23	SENT_106	[p8l1993t2786r2143b2830],
22	significantly	RB	O	significantly	advmod	23	SENT_106	[p8l12t2865r516b2954],
23	lower	JJR	O	lower	rcmod	18	SENT_106	[p8l566t2865r795b2933],
24	than	IN	O	than	_	0	SENT_106	[p8l843t2865r1023b2933],
25	that	DT	O	that	prep_than	11	SENT_106	[p8l1072t2865r1229b2933],
26	of	IN	O	of	_	0	SENT_106	[p8l1280t2865r1360b2933],
27	the	DT	O	the	det	29	SENT_106	[p8l1402t2865r1526b2933],
28	CYP3A5	NN	O	cyp3a5	nn	29	SENT_106	[p8l1583t2868r1921b2933],
29	*	NN	O	*	prep_of	25	SENT_106	[p8l1936t2868r2007b2932],
30	1	CD	NUMBER	1	dep	29	SENT_106	[p8l1936t2868r2007b2932],
31	/	:	O	/	punct	11	SENT_106	[p8l2021t2865r2058b2933],
32	*	CD	NUMBER	*	number	33	SENT_106	[p8l2066t2868r2145b2933],
33	3	CD	NUMBER	3	dep	34	SENT_106	[p8l2066t2868r2145b2933],
34	(	NN	O	(	amod	7	SENT_106	[p8l14t2967r255b3047],
35	11.54	CD	NUMBER	11.54	dep	40	SENT_106	[p8l14t2967r255b3047],
36	i	FW	O	i	dep	35	SENT_106	[p8l287t2975r335b3034],
37	6.44	CD	NUMBER	6.44	num	38	SENT_106	[p8l366t2976r530b3035],
38	ng	NN	O	ng	dep	40	SENT_106	[p8l563t2991r658b3056],
39	o	NN	O	o	nn	40	SENT_106	[p8l696t2987r727b3018],
40	h/mL	NN	O	h/ml	dep	51	SENT_106	[p8l765t2966r1010b3047],
41	)	NN	O	)	dep	40	SENT_106	[p8l765t2966r1010b3047],
42	and	CC	O	and	_	0	SENT_106	[p8l1046t2966r1194b3035],
43	CYP3A5	NN	O	cyp3a5	conj_and	41	SENT_106	[p8l1229t2966r1791b3035],
44	*	CD	NUMBER	*	number	45	SENT_106	[p8l1229t2966r1791b3035],
45	3	CD	NUMBER	3	amod	41	SENT_106	[p8l1229t2966r1791b3035],
46	/	:	O	/	punct	48	SENT_106	[p8l1229t2966r1791b3035],
47	*	CD	NUMBER	*	number	48	SENT_106	[p8l1229t2966r1791b3035],
48	3	CD	NUMBER	3	dep	45	SENT_106	[p8l1229t2966r1791b3035],
49	(	NN	O	(	prep	48	SENT_106	[p8l1826t2967r2065b3047],
50	16.35	CD	NUMBER	16.35	dep	49	SENT_106	[p8l1826t2967r2065b3047],
51	i	FW	O	i	dep	58	SENT_106	[p8l2099t2975r2147b3034],
52	6.37	CD	NUMBER	6.37	num	55	SENT_106	[p8l12t3078r172b3136],
53	ng	NN	O	ng	nn	55	SENT_106	[p8l202t3092r296b3158],
54	o	NN	O	o	nn	55	SENT_106	[p8l331t3089r362b3120],
55	h/mL	NN	O	h/ml	dep	51	SENT_106	[p8l397t3068r636b3149],
56	)	CD	NUMBER	)	num	57	SENT_106	[p8l397t3068r636b3149],
57	carriers	NNS	O	carrier	nsubj	58	SENT_106	[p8l670t3072r958b3136],
58	(	VBP	O	(	ccomp	34	SENT_106	[p8l993t3068r1073b3149],
59	P	NN	O	p	dep	58	SENT_106	[p8l993t3068r1073b3149],
60	=	JJ	O	=	amod	62	SENT_106	[p8l1097t3101r1143b3124],
61	.013	CD	NUMBER	.013	tmod	60	SENT_106	[p8l1178t3068r1384b3149],
62	)	NN	O	)	dobj	59	SENT_106	[p8l1178t3068r1384b3149],
63	.	.	O	.	_	0	SENT_106	[p8l1178t3068r1384b3149],

1	The	DT	O	the	det	3	SENT_107	[p8l1418t3068r1567b3136],
2	oral	JJ	O	oral	amod	3	SENT_107	[p8l1599t3068r1746b3136],
3	clearance	NN	O	clearance	_	0	SENT_107	[p8l1776t3068r2144b3136],
4	of	IN	O	of	_	0	SENT_107	[p8l12t3169r92b3237],
5	simvastatin	NN	O	simvastatin	prep_of	3	SENT_107	[p8l130t3173r589b3237],
6	in	IN	O	in	dep	3	SENT_107	[p8l631t3173r710b3236],
7	the	DT	O	the	det	9	SENT_107	[p8l751t3169r874b3237],
8	CYP3A5	NN	O	cyp3a5	nn	9	SENT_107	[p8l922t3173r1257b3237],
9	*	NN	O	*	pobj	6	SENT_107	[p8l1271t3169r1393b3237],
10	1	CD	NUMBER	1	dep	9	SENT_107	[p8l1271t3169r1393b3237],
11	/	:	O	/	punct	10	SENT_107	[p8l1271t3169r1393b3237],
12	*	CD	NUMBER	*	number	13	SENT_107	[p8l1400t3173r1471b3236],
13	1	CD	NUMBER	1	num	14	SENT_107	[p8l1400t3173r1471b3236],
14	carriers	NNS	O	carrier	nsubj	15	SENT_107	[p8l1523t3173r1817b3237],
15	(	VBP	O	(	dep	10	SENT_107	[p8l1866t3169r2056b3249],
16	4.80	CD	NUMBER	4.80	dobj	15	SENT_107	[p8l1866t3169r2056b3249],
17	i	FW	O	i	dep	9	SENT_107	[p8l2099t3178r2147b3236],
18	2.35	CD	NUMBER	2.35	num	20	SENT_107	[p8l13t3281r176b3339],
19	L/h	NN	O	l/h	nn	20	SENT_107	[p8l220t3271r386b3352],
20	)	NN	O	)	nsubj	22	SENT_107	[p8l220t3271r386b3352],
21	was	VBD	O	be	cop	22	SENT_107	[p8l428t3295r582b3339],
22	2.3	CD	NUMBER	2.3	rcmod	17	SENT_107	[p8l626t3281r772b3339],
23	-	:	O	-	_	0	SENT_107	[p8l626t3281r772b3339],
24	and	CC	O	and	_	0	SENT_107	[p8l813t3271r962b3339],
25	3.2-fold	RB	O	3.2-fold	advmod	26	SENT_107	[p8l1004t3271r1316b3339],
26	higher	JJR	O	higher	amod	50	SENT_107	[p8l1353t3271r1615b3360],
27	than	IN	O	than	prep	26	SENT_107	[p8l1652t3271r1833b3339],
28	for	IN	O	for	pcomp	27	SENT_107	[p8l1872t3271r1983b3339],
29	the	DT	O	the	det	31	SENT_107	[p8l2019t3271r2144b3339],
30	CP3A5	NN	O	cp3a5	nn	31	SENT_107	[p8l15t3372r512b3439],
31	*	NN	O	*	dep	28	SENT_107	[p8l15t3372r512b3439],
32	1	CD	NUMBER	1	dep	31	SENT_107	[p8l15t3372r512b3439],
33	/	:	O	/	punct	31	SENT_107	[p8l15t3372r512b3439],
34	*	CD	NUMBER	*	dep	38	SENT_107	[p8l15t3372r512b3439],
35	3	CD	NUMBER	3	dep	34	SENT_107	[p8l15t3372r512b3439],
36	(	NN	O	(	dep	38	SENT_107	[p8l544t3372r733b3452],
37	2.13	CD	NUMBER	2.13	num	36	SENT_107	[p8l544t3372r733b3452],
38	i	FW	O	i	dep	49	SENT_107	[p8l762t3380r811b3439],
39	1.08	CD	NUMBER	1.08	num	41	SENT_107	[p8l840t3382r1002b3439],
40	L/h	NN	O	l/h	nn	41	SENT_107	[p8l1032t3372r1196b3452],
41	)	NN	O	)	dep	38	SENT_107	[p8l1032t3372r1196b3452],
42	and	CC	O	and	_	0	SENT_107	[p8l1228t3372r1376b3439],
43	C'YP	NN	O	c'yp	nn	44	SENT_107	[p8l1407t3372r1969b3439],
44	3A5	NN	O	3a5	dep	49	SENT_107	[p8l1407t3372r1969b3439],
45	*	CD	NUMBER	*	number	46	SENT_107	[p8l1407t3372r1969b3439],
46	3	CD	NUMBER	3	dep	44	SENT_107	[p8l1407t3372r1969b3439],
47	/	:	O	/	punct	49	SENT_107	[p8l1407t3372r1969b3439],
48	*	CD	NUMBER	*	num	49	SENT_107	[p8l1407t3372r1969b3439],
49	3	CD	NUMBER	3	dep	31	SENT_107	[p8l1407t3372r1969b3439],
50	carriers	NNS	O	carrier	conj_and	9	SENT_107	[p8l1998t3396r2144b3439, p9l9t21r184b86],

1	(	NN	O	(	_	0	SENT_108	[p9l216t18r399b99],
2	1.35	CD	NUMBER	1.35	num	1	SENT_108	[p9l216t18r399b99],
3	i	FW	O	i	dep	1	SENT_108	[p9l427t26r475b85],
4	0.61	CD	NUMBER	0.61	num	5	SENT_108	[p9l500t27r657b86],
5	L/h	NN	O	l/h	dep	3	SENT_108	[p9l687t18r843b96],
6	;	:	O	;	_	0	SENT_108	[p9l687t18r843b96],
7	P	NN	O	p	dep	3	SENT_108	[p9l870t22r927b85],
8	=	JJ	O	=	amod	7	SENT_108	[p9l948t50r993b74],
9	.011	CD	NUMBER	.011	tmod	8	SENT_108	[p9l1024t27r1204b96],
10	;	:	O	;	_	0	SENT_108	[p9l1024t27r1204b96],
11	Table	NNP	O	Table	nn	12	SENT_108	[p9l1233t18r1441b86],
12	II	NNP	O	II	dep	3	SENT_108	[p9l1466t22r1520b85],
13	and	CC	O	and	_	0	SENT_108	[p9l1546t18r1691b86],
14	Figure	NNP	O	Figure	nn	16	SENT_108	[p9l1715t21r1965b107],
15	2C	NN	O	2c	nn	16	SENT_108	[p9l1994t18r2139b98],
16	)	NN	O	)	dep	3	SENT_108	[p9l1994t18r2139b98],
17	.	.	O	.	_	0	SENT_108	[p9l1994t18r2139b98],

1	Regression	NN	O	regression	nn	2	SENT_109	[p9l116t123r544b209],
2	analysis	NN	O	analysis	nsubj	3	SENT_109	[p9l587t119r904b209],
3	revealed	VBD	O	reveal	_	0	SENT_109	[p9l946t119r1283b188],
4	that	IN	O	that	complm	16	SENT_109	[p9l1323t120r1476b188],
5	the	DT	O	the	det	6	SENT_109	[p9l1515t119r1637b188],
6	presence	NN	O	presence	nsubj	16	SENT_109	[p9l1680t144r2028b209],
7	of	IN	O	of	_	0	SENT_109	[p9l2073t120r2152b188],
8	the	DT	O	the	det	12	SENT_109	[p9l9t221r131b289],
9	CYP3A5	NN	O	cyp3a5	nn	12	SENT_109	[p9l163t225r495b289],
10	*	NN	O	*	nn	12	SENT_109	[p9l509t225r587b289],
11	3	CD	NUMBER	3	num	12	SENT_109	[p9l509t225r587b289],
12	allele	NN	O	allele	prep_of	6	SENT_109	[p9l613t221r824b289],
13	is	VBZ	O	be	cop	16	SENT_109	[p9l852t225r912b289],
14	a	DT	O	a	det	16	SENT_109	[p9l942t245r982b289],
15	significant	JJ	O	significant	amod	16	SENT_109	[p9l1007t221r1423b311],
16	predictor	NN	O	predictor	ccomp	3	SENT_109	[p9l1447t221r1812b311],
17	of	IN	O	of	_	0	SENT_109	[p9l1838t221r1918b289],
18	pharmacokinetic	JJ	O	pharmacokinetic	amod	19	SENT_109	[p9l1936t221r2144b311, p9l9t323r494b391],
19	variability	NN	O	variability	prep_of	16	SENT_109	[p9l530t323r939b412],
20	(	CD	NUMBER	(	num	23	SENT_109	[p9l978t323r1212b404],
21	Table	NNP	O	Table	nn	23	SENT_109	[p9l978t323r1212b404],
22	III	NNP	O	III	nn	23	SENT_109	[p9l1249t323r1379b404],
23	)	NN	O	)	dep	19	SENT_109	[p9l1249t323r1379b404],
24	.	.	O	.	_	0	SENT_109	[p9l1249t323r1379b404],

1	Moreover	RB	O	moreover	advmod	12	SENT_110	[p9l1419t328r1815b402],
2	,	,	O	,	_	0	SENT_110	[p9l1419t328r1815b402],
3	30	CD	PERCENT	30	num	4	SENT_110	[p9l1858t323r2028b397],
4	%	NN	PERCENT	%	nsubjpass	12	SENT_110	[p9l1858t323r2028b397],
5	of	IN	O	of	_	0	SENT_110	[p9l2074t323r2153b391],
6	the	DT	O	the	det	7	SENT_110	[p9l9t425r131b493],
7	variance	NN	O	variance	prep_of	4	SENT_110	[p9l160t429r495b493],
8	in	IN	O	in	_	0	SENT_110	[p9l526t429r605b493],
9	the	DT	O	the	det	10	SENT_110	[p9l632t425r754b493],
10	AUC	NN	O	auc	prep_in	7	SENT_110	[p9l784t429r975b493],
11	is	VBZ	O	be	auxpass	12	SENT_110	[p9l1006t429r1067b493],
12	explained	VBN	O	explain	_	0	SENT_110	[p9l1100t425r1492b515],
13	by	IN	O	by	_	0	SENT_110	[p9l1518t425r1615b514],
14	the	DT	O	the	det	15	SENT_110	[p9l1643t425r1765b493],
15	presence	NN	O	presence	agent	12	SENT_110	[p9l1795t449r2144b515],
16	of	IN	O	of	_	0	SENT_110	[p9l12t527r93b595],
17	the	DT	O	the	det	21	SENT_110	[p9l124t527r249b595],
18	CYP3A5	NN	O	cyp3a5	nn	21	SENT_110	[p9l295t530r730b595],
19	*	NN	O	*	nn	21	SENT_110	[p9l295t530r730b595],
20	3	CD	NUMBER	3	num	21	SENT_110	[p9l295t530r730b595],
21	allele	NN	O	allele	prep_of	15	SENT_110	[p9l771t527r989b595],
22	(	CD	NUMBER	(	num	23	SENT_110	[p9l1035t527r1117b608],
23	P	NN	O	p	dep	21	SENT_110	[p9l1035t527r1117b608],
24	=	JJ	O	=	amod	26	SENT_110	[p9l1152t559r1198b583],
25	.0084	CD	NUMBER	.0084	tmod	24	SENT_110	[p9l1244t527r1510b608],
26	)	NN	O	)	dep	23	SENT_110	[p9l1244t527r1510b608],
27	.	.	O	.	_	0	SENT_110	[p9l1244t527r1510b608],

1	Similarly	RB	O	similarly	advmod	5	SENT_111	[p9l1558t527r1951b616],
2	,	,	O	,	_	0	SENT_111	[p9l1558t527r1951b616],
3	this	DT	O	this	det	4	SENT_111	[p9l1994t527r2143b595],
4	allele	NN	O	allele	nsubj	5	SENT_111	[p9l11t630r234b698],
5	explains	VBZ	O	explain	_	0	SENT_111	[p9l273t630r622b719],
6	45	CD	PERCENT	45	num	7	SENT_111	[p9l660t630r839b703],
7	%	NN	PERCENT	%	dobj	5	SENT_111	[p9l660t630r839b703],
8	of	IN	O	of	_	0	SENT_111	[p9l886t630r967b698],
9	the	DT	O	the	det	10	SENT_111	[p9l995t630r1122b698],
10	variance	NN	O	variance	prep_of	7	SENT_111	[p9l1158t633r1511b698],
11	in	IN	O	in	_	0	SENT_111	[p9l1549t633r1630b697],
12	the	DT	O	the	det	13	SENT_111	[p9l1665t630r1792b698],
13	CL/F	NN	O	cl/f	prep_in	10	SENT_111	[p9l1830t630r2032b698],
14	of	IN	O	of	_	0	SENT_111	[p9l2071t630r2153b698],
15	simvastatin	NN	O	simvastatin	prep_of	13	SENT_111	[p9l12t735r491b800],
16	in	IN	O	in	_	0	SENT_111	[p9l534t735r615b799],
17	this	DT	O	this	det	18	SENT_111	[p9l657t732r809b800],
18	population	NN	O	population	prep_in	15	SENT_111	[p9l855t731r1335b821],
19	.	.	O	.	_	0	SENT_111	[p9l855t731r1335b821],

1	Among	IN	O	among	_	0	SENT_112	[p9l1383t736r1682b821],
2	covariates	NNS	O	covariate	prep_among	13	SENT_112	[p9l1727t735r2143b800],
3	including	VBG	O	include	_	0	SENT_112	[p9l10t833r393b923],
4	age	NN	O	age	nn	7	SENT_112	[p9l422t857r546b923],
5	and	CC	O	and	_	0	SENT_112	[p9l576t833r722b901],
6	body	NN	O	body	nn	7	SENT_112	[p9l745t833r945b923],
7	weight	NN	O	weight	prep_including	2	SENT_112	[p9l970t833r1260b923],
8	,	,	O	,	_	0	SENT_112	[p9l970t833r1260b923],
9	adjusting	VBG	O	adjust	csubj	13	SENT_112	[p9l1291t833r1654b923],
10	only	RB	O	only	advmod	9	SENT_112	[p9l1683t833r1857b923],
11	for	IN	O	for	_	0	SENT_112	[p9l1884t833r1992b901],
12	age	NN	O	age	prep_for	9	SENT_112	[p9l2019t857r2144b923],
13	improved	VBD	O	improve	_	0	SENT_112	[p9l10t935r395b1025],
14	statistical	JJ	O	statistical	amod	15	SENT_112	[p9l454t935r828b1003],
15	significance	NN	O	significance	dobj	13	SENT_112	[p9l887t935r1359b1024],
16	in	IN	O	in	_	0	SENT_112	[p9l1418t939r1496b1003],
17	the	DT	O	the	det	18	SENT_112	[p9l1553t935r1674b1003],
18	prediction	NN	O	prediction	prep_in	13	SENT_112	[p9l1733t935r2146b1025],
19	with	IN	O	with	_	0	SENT_112	[p9l9t1037r187b1105],
20	the	DT	O	the	det	24	SENT_112	[p9l209t1037r328b1105],
21	CYP3A5	NN	O	cyp3a5	nn	24	SENT_112	[p9l358t1041r683b1105],
22	*	NN	O	*	nn	24	SENT_112	[p9l696t1041r772b1105],
23	3	CD	NUMBER	3	num	24	SENT_112	[p9l696t1041r772b1105],
24	allele	NN	O	allele	prep_with	13	SENT_112	[p9l797t1037r1001b1105],
25	in	IN	O	in	_	0	SENT_112	[p9l1026t1041r1104b1105],
26	the	DT	O	the	det	27	SENT_112	[p9l1126t1037r1245b1105],
27	variability	NN	O	variability	prep_in	24	SENT_112	[p9l1269t1037r1662b1126],
28	of	IN	O	of	_	0	SENT_112	[p9l1688t1037r1765b1105],
29	AUC	NN	O	auc	nn	31	SENT_112	[p9l1781t1041r1969b1105],
30	(	CD	NUMBER	(	num	31	SENT_112	[p9l1999t1037r2077b1118],
31	P	NN	O	p	prep_of	27	SENT_112	[p9l1999t1037r2077b1118],
32	=	JJ	O	=	advmod	24	SENT_112	[p9l2097t1069r2143b1093],
33	.0075	CD	NUMBER	.0075	num	34	SENT_112	[p9l14t1139r249b1219],
34	)	NN	O	)	dep	32	SENT_112	[p9l14t1139r249b1219],
35	but	CC	O	but	_	0	SENT_112	[p9l280t1139r411b1207],
36	not	RB	O	not	neg	24	SENT_112	[p9l439t1149r568b1207],
37	of	IN	O	of	_	0	SENT_112	[p9l599t1139r678b1207],
38	Cmax	NN	O	cmax	prep_of	24	SENT_112	[p9l701t1142r859b1230],
39	and	CC	O	and	_	0	SENT_112	[p9l888t1139r1034b1207],
40	CL/F	NN	O	cl/f	prep_of	24	SENT_112	[p9l1065t1139r1259b1207],
41	(	CD	NUMBER	(	num	44	SENT_112	[p9l1294t1139r1528b1220],
42	Table	NNP	MISC	Table	nn	44	SENT_112	[p9l1294t1139r1528b1220],
43	III	NNP	MISC	III	nn	44	SENT_112	[p9l1559t1139r1689b1219],
44	)	NN	O	)	dep	24	SENT_112	[p9l1559t1139r1689b1219],
45	.	.	O	.	_	0	SENT_112	[p9l1559t1139r1689b1219],

1	Even	RB	O	even	advmod	12	SENT_113	[p9l116t1246r316b1310],
2	though	IN	O	though	dep	12	SENT_113	[p9l344t1242r628b1331],
3	the	DT	O	the	det	4	SENT_113	[p9l655t1242r779b1310],
4	differences	NNS	O	difference	nsubj	12	SENT_113	[p9l812t1242r1253b1310],
5	in	IN	O	in	_	0	SENT_113	[p9l1284t1245r1364b1309],
6	the	DT	O	the	det	7	SENT_113	[p9l1391t1242r1516b1310],
7	Cmax	NN	MISC	cmax	prep_in	4	SENT_113	[p9l1546t1245r1707b1333],
8	of	IN	O	of	_	0	SENT_113	[p9l1736t1242r1816b1310],
9	simvastatin	NN	O	simvastatin	prep_of	7	SENT_113	[p9l1839t1245r2144b1310, p9l9t1347r194b1412],
10	did	VBD	O	do	aux	12	SENT_113	[p9l273t1343r404b1412],
11	not	RB	O	not	neg	12	SENT_113	[p9l480t1354r611b1412],
12	show	VB	O	show	_	0	SENT_113	[p9l688t1343r900b1412],
13	any	DT	O	any	det	15	SENT_113	[p9l977t1368r1121b1433],
14	statistical	JJ	O	statistical	amod	15	SENT_113	[p9l1199t1343r1582b1412],
15	significance	NN	O	significance	dobj	12	SENT_113	[p9l1661t1344r2144b1433],
16	between	IN	O	between	dep	22	SENT_113	[p9l7t1445r347b1513],
17	genotype	NN	O	genotype	nn	18	SENT_113	[p9l412t1455r779b1535],
18	groups	NNS	O	group	pobj	16	SENT_113	[p9l845t1469r1140b1535],
19	,	,	O	,	_	0	SENT_113	[p9l845t1469r1140b1535],
20	CYP3A5	NN	O	cyp3a5	nn	21	SENT_113	[p9l1215t1449r1552b1513],
21	*	NN	O	*	appos	18	SENT_113	[p9l1567t1445r1768b1513],
22	1	CD	NUMBER	1	dep	12	SENT_113	[p9l1567t1445r1768b1513],
23	/	:	O	/	punct	22	SENT_113	[p9l1567t1445r1768b1513],
24	*	CD	NUMBER	*	number	25	SENT_113	[p9l1567t1445r1768b1513],
25	1	CD	NUMBER	1	num	26	SENT_113	[p9l1567t1445r1768b1513],
26	carriers	NNS	O	carrier	dobj	12	SENT_113	[p9l1844t1449r2143b1513],

1	KIM	NNP	O	KIM	nn	3	SENT_114	[p9l976t1836r1058b1865],
2	ET	NNP	O	ET	nn	3	SENT_114	[p9l1067t1836r1124b1865],
3	AL	NNP	O	AL	_	0	SENT_114	[p9l1133t1836r1188b1865],

1	Table	NNP	O	Table	nn	4	SENT_115	[p9l189t1959r293b1991],
2	II	NNP	O	II	nn	4	SENT_115	[p9l307t1961r338b1991],
3	Pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_115	[p9l386t1959r705b1991],
4	Profiles	NNS	O	profile	_	0	SENT_115	[p9l720t1959r864b1991],
5	of	IN	O	of	_	0	SENT_115	[p9l880t1959r918b1991],
6	Simvastatin	NNP	O	Simvastatin	prep_of	4	SENT_115	[p9l931t1961r1154b1991],
7	According	VBG	O	accord	_	0	SENT_115	[p9l1168t1959r1366b2001],
8	to	TO	O	to	prepc_according_to	4	SENT_115	[p9l1380t1964r1415b1991],
9	the	DT	O	the	det	11	SENT_115	[p9l1430t1959r1488b1991],
10	CYP3A5	NNP	O	CYP3A5	nn	11	SENT_115	[p9l1506t1961r1663b1991],
11	Genotype	NNP	O	Genotype	pobj	4	SENT_115	[p9l1678t1961r1858b2001],
12	After	IN	O	after	prep	11	SENT_115	[p9l1872t1959r1969b1991],

1	Administration	NN	O	administration	_	0	SENT_116	[p9l368t2011r661b2043],
2	of	IN	O	of	_	0	SENT_116	[p9l676t2011r714b2043],
3	a	DT	O	a	det	5	SENT_116	[p9l726t2022r745b2043],
4	Single	JJ	O	single	amod	5	SENT_116	[p9l760t2011r877b2053],
5	Dose	NN	O	dose	prep_of	1	SENT_116	[p9l891t2013r982b2043],
6	of	IN	O	of	_	0	SENT_116	[p9l998t2011r1036b2043],
7	20	CD	NUMBER	20	num	9	SENT_116	[p9l1049t2016r1090b2043],
8	mg	NN	O	mg	nn	9	SENT_116	[p9l1106t2022r1162b2053],
9	Simvastatin	NN	O	simvastatin	prep_of	1	SENT_116	[p9l1178t2013r1402b2043],
10	in	IN	O	in	_	0	SENT_116	[p9l1416t2013r1454b2043],
11	Healthy	JJ	O	healthy	amod	12	SENT_116	[p9l1468t2011r1617b2053],
12	Subjects	NNS	O	subject	prep_in	9	SENT_116	[p9l1633t2011r1788b2053],

1	Parameter	NN	O	parameter	dep	105	SENT_117	[p9l39t2100r200b2124],
2	CYP3A5	NN	O	cyp3a5	dep	105	SENT_117	[p9l594t2099r723b2124],
3	*	NN	O	*	dep	105	SENT_117	[p9l727t2098r771b2124],
4	1	CD	NUMBER	1	dep	105	SENT_117	[p9l727t2098r771b2124],
5	/	:	O	/	dep	105	SENT_117	[p9l727t2098r771b2124],
6	*	CD	NUMBER	*	dep	105	SENT_117	[p9l773t2099r804b2124],
7	1	CD	NUMBER	1	dep	105	SENT_117	[p9l773t2099r804b2124],
8	CYP3A5	NN	O	cyp3a5	dep	105	SENT_117	[p9l1061t2099r1190b2124],
9	*	NN	O	*	dep	105	SENT_117	[p9l1194t2098r1239b2124],
10	1	CD	NUMBER	1	dep	105	SENT_117	[p9l1194t2098r1239b2124],
11	/	:	O	/	dep	105	SENT_117	[p9l1194t2098r1239b2124],
12	*	CD	NUMBER	*	dep	105	SENT_117	[p9l1241t2099r1273b2124],
13	3	CD	NUMBER	3	dep	105	SENT_117	[p9l1241t2099r1273b2124],
14	CYP3A5	NN	O	cyp3a5	dep	105	SENT_117	[p9l1529t2099r1658b2124],
15	*	CD	NUMBER	*	dep	105	SENT_117	[p9l1662t2098r1706b2124],
16	3	CD	NUMBER	3	dep	105	SENT_117	[p9l1662t2098r1706b2124],
17	/	:	O	/	dep	105	SENT_117	[p9l1662t2098r1706b2124],
18	*	CD	NUMBER	*	dep	105	SENT_117	[p9l1708t2099r1741b2124],
19	3	CD	NUMBER	3	dep	105	SENT_117	[p9l1708t2099r1741b2124],
20	P	NN	O	p	dep	105	SENT_117	[p9l1996t2100r2019b2124],
21	Value	NN	O	value	dep	105	SENT_117	[p9l2029t2098r2116b2124],
22	cm	NN	O	cm	dep	105	SENT_117	[p9l40t2173r237b2212],
23	,	,	O	,	_	0	SENT_117	[p9l40t2173r237b2212],
24	ng/mL	NN	O	ng/ml	dep	105	SENT_117	[p9l40t2173r237b2212],
25	1.85	CD	NUMBER	1.85	dep	105	SENT_117	[p9l607t2177r674b2202],
26	1	CD	NUMBER	1	dep	105	SENT_117	[p9l689t2177r709b2202],
27	0.84	CD	NUMBER	0.84	dep	105	SENT_117	[p9l722t2177r792b2202],
28	2.59	CD	NUMBER	2.59	dep	105	SENT_117	[p9l1084t2177r1153b2202],
29	1	CD	NUMBER	1	dep	105	SENT_117	[p9l1167t2177r1187b2202],
30	1.25	CD	NUMBER	1.25	dep	105	SENT_117	[p9l1201t2177r1268b2202],
31	3.29	CD	NUMBER	3.29	dep	105	SENT_117	[p9l1552t2177r1621b2202],
32	1	CD	NUMBER	1	dep	105	SENT_117	[p9l1634t2177r1654b2202],
33	1.23	CD	NUMBER	1.23	dep	105	SENT_117	[p9l1669t2177r1736b2202],
34	.130	CD	NUMBER	.130	dep	105	SENT_117	[p9l2012t2177r2081b2202],
35	tm	NN	O	tm	dep	105	SENT_117	[p9l40t2237r135b2276],
36	,	,	O	,	_	0	SENT_117	[p9l40t2237r135b2276],
37	h	NN	O	h	dep	105	SENT_117	[p9l40t2237r135b2276],
38	1.25	CD	NUMBER	1.25	dep	105	SENT_117	[p9l607t2241r674b2266],
39	1	CD	NUMBER	1	dep	105	SENT_117	[p9l689t2241r709b2266],
40	0.29	CD	NUMBER	0.29	dep	105	SENT_117	[p9l722t2241r792b2266],
41	1.67	CD	NUMBER	1.67	dep	105	SENT_117	[p9l1085t2241r1153b2266],
42	1	CD	NUMBER	1	dep	105	SENT_117	[p9l1167t2241r1187b2266],
43	1.08	CD	NUMBER	1.08	dep	105	SENT_117	[p9l1201t2241r1269b2266],
44	1.87	CD	NUMBER	1.87	dep	105	SENT_117	[p9l1552t2241r1620b2266],
45	1	CD	NUMBER	1	dep	105	SENT_117	[p9l1634t2241r1654b2266],
46	1.11	CD	NUMBER	1.11	dep	105	SENT_117	[p9l1669t2242r1736b2266],
47	.596	CD	NUMBER	.596	dep	105	SENT_117	[p9l2012t2241r2080b2266],
48	Half-1ife	JJ	O	half-1ife	dep	105	SENT_117	[p9l40t2296r225b2329],
49	,	,	O	,	_	0	SENT_117	[p9l40t2296r225b2329],
50	h	NN	O	h	dep	105	SENT_117	[p9l40t2296r225b2329],
51	2.46	CD	NUMBER	2.46	dep	105	SENT_117	[p9l606t2300r675b2325],
52	1	CD	NUMBER	1	dep	105	SENT_117	[p9l688t2300r709b2324],
53	0.69	CD	NUMBER	0.69	dep	105	SENT_117	[p9l722t2300r792b2325],
54	2.71	CD	NUMBER	2.71	dep	105	SENT_117	[p9l1084t2300r1152b2325],
55	1	CD	NUMBER	1	dep	105	SENT_117	[p9l1166t2300r1187b2324],
56	0.62	CD	NUMBER	0.62	dep	105	SENT_117	[p9l1200t2300r1269b2325],
57	3.75	CD	NUMBER	3.75	dep	105	SENT_117	[p9l1552t2300r1620b2325],
58	1	CD	NUMBER	1	dep	105	SENT_117	[p9l1634t2300r1654b2324],
59	1.80	CD	NUMBER	1.80	dep	105	SENT_117	[p9l1669t2300r1737b2325],
60	.161	CD	NUMBER	.161	dep	105	SENT_117	[p9l2012t2300r2079b2325],
61	AUC1aSt,ng-h	NN	O	auc1ast,ng-h	dep	105	SENT_117	[p9l40t2337r338b2376],
62	/	:	O	/	dep	105	SENT_117	[p9l40t2337r338b2376],
63	mL	NN	O	ml	dep	105	SENT_117	[p9l40t2337r338b2376],
64	4.65	CD	NUMBER	4.65	dep	105	SENT_117	[p9l605t2341r674b2366],
65	1	CD	NUMBER	1	dep	105	SENT_117	[p9l689t2341r709b2366],
66	2.06	CD	NUMBER	2.06	dep	105	SENT_117	[p9l723t2341r792b2366],
67	10.82	CD	NUMBER	10.82	dep	105	SENT_117	[p9l1064t2341r1152b2366],
68	1	CD	NUMBER	1	dep	105	SENT_117	[p9l1167t2341r1187b2366],
69	6.11	CD	NUMBER	6.11	dep	105	SENT_117	[p9l1200t2341r1268b2366],
70	14.34	CD	NUMBER	14.34	dep	105	SENT_117	[p9l1531t2341r1620b2366],
71	1	CD	NUMBER	1	dep	105	SENT_117	[p9l1634t2341r1654b2366],
72	5.29	CD	NUMBER	5.29	dep	105	SENT_117	[p9l1668t2341r1737b2366],
73	.019	CD	NUMBER	.019	dep	105	SENT_117	[p9l2012t2339r2099b2366],
74	*	CD	NUMBER	*	dep	105	SENT_117	[p9l2012t2339r2099b2366],
75	AUG	NN	DATE	aug	dep	105	SENT_117	[p9l40t2380r147b2415],
76	”	NN	O	”	dep	105	SENT_117	[p9l40t2380r147b2415],
77	,	,	O	,	_	0	SENT_117	[p9l40t2380r147b2415],
78	ng	NN	O	ng	dep	105	SENT_117	[p9l161t2379r317b2417],
79	°	CD	NUMBER	°	dep	105	SENT_117	[p9l161t2379r317b2417],
80	h/mL	NN	O	h/ml	dep	105	SENT_117	[p9l161t2379r317b2417],
81	4.94	CD	NUMBER	4.94	dep	105	SENT_117	[p9l605t2383r675b2408],
82	1	CD	NUMBER	1	dep	105	SENT_117	[p9l689t2383r709b2408],
83	2.25	CD	NUMBER	2.25	dep	105	SENT_117	[p9l723t2383r791b2408],
84	11.54	CD	NUMBER	11.54	dep	105	SENT_117	[p9l1064t2383r1153b2408],
85	1	CD	NUMBER	1	dep	105	SENT_117	[p9l1167t2383r1187b2408],
86	6.44	CD	NUMBER	6.44	dep	105	SENT_117	[p9l1200t2383r1270b2408],
87	16.35	CD	NUMBER	16.35	dep	105	SENT_117	[p9l1531t2383r1619b2408],
88	1	CD	NUMBER	1	dep	105	SENT_117	[p9l1634t2383r1654b2408],
89	6.37	CD	NUMBER	6.37	dep	105	SENT_117	[p9l1668t2383r1737b2408],
90	.013	CD	NUMBER	.013	dep	105	SENT_117	[p9l2012t2381r2099b2408],
91	*	NN	O	*	dep	105	SENT_117	[p9l2012t2381r2099b2408],
92	CL/F	NN	O	cl/f	dep	105	SENT_117	[p9l40t2420r129b2453],
93	,	,	O	,	_	0	SENT_117	[p9l40t2420r129b2453],
94	L/h	NN	O	l/h	dep	105	SENT_117	[p9l143t2420r202b2449],
95	4.80	CD	NUMBER	4.80	dep	105	SENT_117	[p9l605t2424r675b2449],
96	1	CD	NUMBER	1	dep	105	SENT_117	[p9l689t2424r709b2448],
97	2.35	CD	NUMBER	2.35	dep	105	SENT_117	[p9l723t2424r791b2449],
98	2.13	CD	NUMBER	2.13	dep	105	SENT_117	[p9l1084t2424r1152b2449],
99	1	CD	NUMBER	1	dep	105	SENT_117	[p9l1166t2424r1187b2448],
100	1.08	CD	NUMBER	1.08	dep	105	SENT_117	[p9l1201t2424r1269b2449],
101	1.35	CD	NUMBER	1.35	dep	105	SENT_117	[p9l1552t2424r1620b2449],
102	1	CD	NUMBER	1	dep	105	SENT_117	[p9l1634t2424r1654b2448],
103	0.61	CD	NUMBER	0.61	dep	105	SENT_117	[p9l1668t2424r1736b2449],
104	.011	CD	NUMBER	.011	dep	105	SENT_117	[p9l2012t2419r2094b2449],
105	*	NN	O	*	_	0	SENT_117	[p9l2012t2419r2094b2449],

1	Data	NNS	O	datum	nsubjpass	3	SENT_118	[p9l89t2497r149b2518],
2	are	VBP	O	be	auxpass	3	SENT_118	[p9l159t2504r198b2518],
3	shown	VBN	O	show	_	0	SENT_118	[p9l210t2496r297b2518],
4	as	IN	O	as	_	0	SENT_118	[p9l308t2504r333b2518],
5	mean	JJ	O	mean	amod	6	SENT_118	[p9l344t2504r416b2518],
6	i	FW	O	i	prep_as	3	SENT_118	[p9l426t2499r442b2518],
7	standard	JJ	O	standard	amod	8	SENT_118	[p9l453t2496r567b2518],
8	deviation	NN	O	deviation	dobj	3	SENT_118	[p9l579t2496r709b2518],
9	.	.	O	.	_	0	SENT_118	[p9l579t2496r709b2518],

1	Cm	NN	O	cm	nn	2	SENT_119	[p9l722t2497r774b2526],
2	“	NN	O	“	_	0	SENT_119	[p9l722t2497r774b2526],
3	=	JJ	O	=	amod	6	SENT_119	[p9l785t2506r800b2514],
4	peak	NN	O	peak	nn	6	SENT_119	[p9l812t2496r874b2525],
5	plasma	NN	O	plasma	nn	6	SENT_119	[p9l884t2496r979b2525],
6	concentration	NN	O	concentration	dep	2	SENT_119	[p9l990t2497r1180b2522],
7	;	:	O	;	_	0	SENT_119	[p9l990t2497r1180b2522],
8	tmax	NN	O	tmax	nn	10	SENT_119	[p9l1191t2499r1234b2526],
9	=	JJ	O	=	amod	10	SENT_119	[p9l1245t2506r1260b2514],
10	time	NN	O	time	dep	2	SENT_119	[p9l1271t2497r1330b2518],
11	to	TO	O	to	_	0	SENT_119	[p9l1341t2499r1365b2518],
12	Cum	NN	O	cum	prep_to	10	SENT_119	[p9l1376t2497r1435b2526],
13	;	:	O	;	_	0	SENT_119	[p9l1376t2497r1435b2526],
14	AUCIES	NNP	LOCATION	AUCIES	dep	2	SENT_119	[p9l1447t2497r1539b2526],
15	,	,	O	,	_	0	SENT_119	[p9l1447t2497r1539b2526],
16	=	JJ	O	=	amod	17	SENT_119	[p9l1550t2506r1565b2514],
17	area	NN	O	area	appos	14	SENT_119	[p9l1577t2504r1631b2518],
18	under	IN	O	under	_	0	SENT_119	[p9l1641t2496r1719b2518],
19	the	DT	O	the	det	21	SENT_119	[p9l1729t2496r1770b2518],
20	time-concentration	JJ	O	time-concentration	amod	21	SENT_119	[p9l1781t2497r2034b2518],
21	curve	NN	O	curve	prep_under	17	SENT_119	[p9l2045t2504r2118b2518],
22	from	IN	O	from	_	0	SENT_119	[p9l90t2532r152b2555],
23	o	NN	O	o	prep_from	21	SENT_119	[p9l163t2535r176b2555],
24	to	TO	O	to	_	0	SENT_119	[p9l187t2535r211b2555],
25	12	CD	DURATION	12	num	26	SENT_119	[p9l223t2535r251b2555],
26	hours	NNS	NUMBER	hour	prep_to	23	SENT_119	[p9l263t2532r345b2558],
27	;	:	O	;	_	0	SENT_119	[p9l263t2532r345b2558],
28	AUCN	NN	O	aucn	nn	30	SENT_119	[p9l356t2533r433b2560],
29	=	JJ	O	=	amod	30	SENT_119	[p9l443t2543r458b2551],
30	area	NN	O	area	dep	2	SENT_119	[p9l470t2540r523b2555],
31	under	IN	O	under	_	0	SENT_119	[p9l533t2532r612b2555],
32	the	DT	O	the	det	36	SENT_119	[p9l621t2532r662b2555],
33	time	NN	O	time	nn	36	SENT_119	[p9l672t2533r926b2555],
34	—	JJ	O	—	amod	36	SENT_119	[p9l672t2533r926b2555],
35	concentration	NN	O	concentration	nn	36	SENT_119	[p9l672t2533r926b2555],
36	curve	NN	O	curve	prep_under	30	SENT_119	[p9l936t2540r1009b2555],
37	from	IN	O	from	_	0	SENT_119	[p9l1020t2532r1081b2555],
38	o	NN	O	o	prep_from	2	SENT_119	[p9l1092t2535r1106b2555],
39	to	TO	O	to	aux	40	SENT_119	[p9l1116t2535r1141b2555],
40	infi	VB	O	infi	infmod	38	SENT_119	[p9l1152t2532r1197b2555],
41	‘	NN	O	‘	dobj	40	SENT_119	[p9l1218t2533r1222b2537],
42	;	:	O	;	_	0	SENT_119	[p9l1253t2540r1257b2558],
43	CL/F	NN	O	cl/f	dep	2	SENT_119	[p9l1269t2532r1334b2555],
44	=	JJ	O	=	amod	46	SENT_119	[p9l1345t2543r1360b2551],
45	oral	JJ	O	oral	amod	46	SENT_119	[p9l1372t2532r1421b2555],
46	clearance	NN	O	clearance	dep	43	SENT_119	[p9l1432t2532r1563b2555],
47	.	.	O	.	_	0	SENT_119	[p9l1432t2532r1563b2555],

1	*	NN	O	*	nn	2	SENT_120	[p9l94t2569r123b2591],
2	P	NN	O	p	_	0	SENT_120	[p9l94t2569r123b2591],
3	<	VBG	O	<	partmod	2	SENT_120	[p9l132t2575r148b2591],
4	.05	CD	NUMBER	.05	dobj	3	SENT_120	[p9l160t2571r196b2591],
5	by	IN	O	by	_	0	SENT_120	[p9l207t2568r239b2598],
6	ANOVA	NN	ORGANIZATION	anova	agent	3	SENT_120	[p9l249t2569r357b2591],
7	with	IN	O	with	_	0	SENT_120	[p9l367t2568r428b2591],
8	post	NN	O	post	prepc_with	3	SENT_120	[p9l438t2572r494b2598],
9	hoc	FW	O	hoc	nn	11	SENT_120	[p9l504t2568r550b2591],
10	Bonferroni	FW	PERSON	bonferroni	nn	11	SENT_120	[p9l561t2568r704b2591],
11	correction	NN	O	correction	dobj	8	SENT_120	[p9l715t2569r849b2591],
12	between	IN	O	between	prep	11	SENT_120	[p9l858t2568r970b2591],
13	CYP3A5	NN	O	cyp3a5	nn	14	SENT_120	[p9l982t2568r1163b2591],
14	*	NN	O	*	dep	12	SENT_120	[p9l982t2568r1163b2591],
15	1	CD	NUMBER	1	dep	14	SENT_120	[p9l982t2568r1163b2591],
16	/	:	O	/	punct	14	SENT_120	[p9l982t2568r1163b2591],
17	*	CD	NUMBER	*	number	18	SENT_120	[p9l982t2568r1163b2591],
18	1	CD	NUMBER	1	num	20	SENT_120	[p9l982t2568r1163b2591],
19	an	DT	O	a	det	20	SENT_120	[p9l1176t2576r1207b2591],
20	*	NN	O	*	dep	14	SENT_120	[p9l1239t2568r1308b2591],
21	3	CD	NUMBER	3	dep	20	SENT_120	[p9l1239t2568r1308b2591],
22	/	:	O	/	punct	14	SENT_120	[p9l1239t2568r1308b2591],
23	*	CD	NUMBER	*	num	24	SENT_120	[p9l1239t2568r1308b2591],
24	3	CD	NUMBER	3	dep	14	SENT_120	[p9l1239t2568r1308b2591],
25	genot	NN	O	genot	nn	26	SENT_120	[p9l1318t2572r1390b2598],
26	groups	NNS	O	group	dep	24	SENT_120	[p9l1448t2576r1544b2598],
27	.	.	O	.	_	0	SENT_120	[p9l1448t2576r1544b2598],

1	*	NN	O	*	nn	2	SENT_121	[p9l90t2604r118b2627],
2	P	NN	O	p	_	0	SENT_121	[p9l90t2604r118b2627],
3	<	VBG	O	<	partmod	2	SENT_121	[p9l127t2612r142b2627],
4	.05	CD	NUMBER	.05	dobj	3	SENT_121	[p9l154t2608r190b2627],
5	by	IN	O	by	_	0	SENT_121	[p9l201t2605r234b2634],
6	Kruskal-Wallis	NN	PERSON	kruskal-walli	nn	8	SENT_121	[p9l244t2605r439b2627],
7	1-way	JJ	O	1-way	amod	8	SENT_121	[p9l452t2608r530b2634],
8	ANOVA	NN	ORGANIZATION	anova	agent	3	SENT_121	[p9l540t2606r649b2627],
9	with	IN	O	with	_	0	SENT_121	[p9l658t2605r719b2627],
10	post	NN	O	post	prep_with	8	SENT_121	[p9l729t2608r785b2634],
11	hoc	FW	O	hoc	dep	15	SENT_121	[p9l794t2605r841b2627],
12	Dunn	NNP	PERSON	Dunn	poss	14	SENT_121	[p9l852t2606r944b2627],
13	’s	POS	O	’s	_	0	SENT_121	[p9l852t2606r944b2627],
14	test	NN	O	test	npadvmod	15	SENT_121	[p9l955t2608r1001b2627],
15	between	IN	O	between	advmod	3	SENT_121	[p9l1010t2605r1122b2627],
16	CYP3A5	NN	O	cyp3a5	nn	17	SENT_121	[p9l1133t2606r1244b2627],
17	*	NN	O	*	dep	3	SENT_121	[p9l1249t2605r1289b2627],
18	1	CD	NUMBER	1	dep	17	SENT_121	[p9l1249t2605r1289b2627],
19	/	:	O	/	punct	17	SENT_121	[p9l1249t2605r1289b2627],
20	*	CD	NUMBER	*	dep	17	SENT_121	[p9l1292t2606r1315b2627],
21	1	CD	NUMBER	1	number	25	SENT_121	[p9l1292t2606r1315b2627],
22	and	CC	O	and	_	0	SENT_121	[p9l1328t2605r1377b2627],
23	*	CD	NUMBER	*	num	27	SENT_121	[p9l1391t2606r1401b2616],
24	*	CD	NUMBER	*	number	25	SENT_121	[p9l1434t2606r1460b2627],
25	3	CD	NUMBER	3	num	27	SENT_121	[p9l1434t2606r1460b2627],
26	genotype	NN	O	genotype	nn	27	SENT_121	[p9l1470t2608r1590b2634],
27	groups	NNS	O	group	dep	20	SENT_121	[p9l1600t2613r1696b2634],
28	.	.	O	.	_	0	SENT_121	[p9l1600t2613r1696b2634],

1	E	NN	O	e	_	0	SENT_122	[p10l301t164r356b215],
2	“	CD	NUMBER	“	prep	1	SENT_122	[p10l301t164r356b215],
3	77	CD	NUMBER	77	dep	2	SENT_122	[p10l360t164r416b215],
4	'	''	O	'	_	0	SENT_122	[p10l360t164r416b215],
5	-	:	O	-	_	0	SENT_122	[p10l360t164r416b215],
6	"	``	O	"	punct	8	SENT_122	[p10l360t164r416b215],
7	‘	CD	NUMBER	‘	num	8	SENT_122	[p10l360t164r416b215],
8	um	NN	O	um	dep	1	SENT_122	[p10l360t347r395b398],

1	Wwp	NN	O	wwp	nsubj	5	SENT_123	[p10l1351t423r1457b479],
2	+	CC	O	+	_	0	SENT_123	[p10l1351t423r1457b479],
3	cvFaA5	NN	O	cvfaa5	conj_+	1	SENT_123	[p10l1474t428r1815b475],
4	'	''	O	'	_	0	SENT_123	[p10l1474t428r1815b475],
5	1x	JJ	O	1x	_	0	SENT_123	[p10l1474t428r1815b475],
6	"	``	O	"	punct	7	SENT_123	[p10l1474t428r1815b475],
7	1	CD	NUMBER	1	dobj	5	SENT_123	[p10l1474t428r1815b475],
8	=	JJ	O	=	amod	7	SENT_123	[p10l1351t503r1454b559],
9	&	CC	O	&	_	0	SENT_123	[p10l1351t503r1454b559],
10	=	JJ	O	=	amod	15	SENT_123	[p10l1351t503r1454b559],
11	I3	NN	O	i3	nn	15	SENT_123	[p10l1474t508r1823b555],
12	*	NN	O	*	nn	15	SENT_123	[p10l1474t508r1823b555],
13	r	NN	O	r	nn	15	SENT_123	[p10l1474t508r1823b555],
14	"	''	O	"	punct	15	SENT_123	[p10l1474t508r1823b555],
15	F3A5	NN	O	f3a5	conj_and	7	SENT_123	[p10l1474t508r1823b555],
16	*	CD	NUMBER	*	num	17	SENT_123	[p10l1474t508r1823b555],
17	tf	NN	O	tf	dep	15	SENT_123	[p10l1474t508r1823b555],
18	'	''	O	'	_	0	SENT_123	[p10l1474t508r1823b555],
19	3	LS	NUMBER	3	dep	23	SENT_123	[p10l1474t508r1823b555],
20	-	:	O	-	_	0	SENT_123	[p10l1351t584r1453b636],
21	I	PRP	O	I	dep	23	SENT_123	[p10l1351t584r1453b636],
22	-	:	O	-	_	0	SENT_123	[p10l1351t584r1453b636],
23	cves	NNS	O	cve	rcmod	7	SENT_123	[p10l1474t588r1823b635],
24	.	.	O	.	_	0	SENT_123	[p10l1474t588r1823b635],

1	A5	NN	O	a5	_	0	SENT_124	[p10l1474t588r1823b635],
2	*	CD	NUMBER	*	number	3	SENT_124	[p10l1474t588r1823b635],
3	3	CD	NUMBER	3	dep	1	SENT_124	[p10l1474t588r1823b635],
4	~	NN	O	~	dep	3	SENT_124	[p10l1474t588r1823b635],
5	"	''	O	"	punct	4	SENT_124	[p10l1474t588r1823b635],
6	a	DT	O	a	dep	1	SENT_124	[p10l1474t588r1823b635],

1	P4	NN	O	p4	nn	2	SENT_125	[p10l301t529r356b580],
2	‘	NN	O	‘	_	0	SENT_125	[p10l301t529r356b580],
3	in	IN	O	in	dep	2	SENT_125	[p10l360t529r395b581],

1	E	NN	O	e	_	0	SENT_126	[p10l83t546r135b598],
2	§	CD	NUMBER	§	num	4	SENT_126	[p10l84t627r135b759],
3	o	NN	O	o	nn	4	SENT_126	[p10l96t752r135b800],
4	p	NN	O	p	dep	1	SENT_126	[p10l96t752r135b800],
5	+	CC	O	+	_	0	SENT_126	[p10l96t752r135b800],
6	E	NN	O	e	dep	1	SENT_126	[p10l83t801r135b874],
7	an	DT	O	a	dep	6	SENT_126	[p10l83t878r135b921],

1	Gun	NN	O	gun	_	0	SENT_127	[p10l164t635r216b1092],
2	.	.	O	.	_	0	SENT_127	[p10l164t635r216b1092],

1	cenﬂ	NN	O	cenﬂ	_	0	SENT_128	[p10l164t635r216b1092],
2	'	''	O	'	_	0	SENT_128	[p10l164t635r216b1092],
3	.	.	O	.	_	0	SENT_128	[p10l164t635r216b1092],

1	atiun	NN	O	atiun	_	0	SENT_129	[p10l164t635r216b1092],
2	{	CD	NUMBER	{	num	4	SENT_129	[p10l164t368r229b614],
3	ngtrntL	NN	O	ngtrntl	nn	4	SENT_129	[p10l164t368r229b614],
4	)	NN	O	)	dep	1	SENT_129	[p10l164t368r229b614],
5	!	.	O	!	_	0	SENT_129	[p10l164t368r229b614],

1	Figure	NNP	O	Figure	_	0	SENT_130	[p10l8t1695r214b1763],
2	1	CD	NUMBER	1	dep	1	SENT_130	[p10l241t1700r288b1746],
3	.	.	O	.	_	0	SENT_130	[p10l241t1700r288b1746],

1	Mean	NN	O	mean	nn	4	SENT_131	[p10l372t1696r551b1746],
2	plasma	NN	O	plasma	nn	4	SENT_131	[p10l573t1692r812b1763],
3	simvastatin	NN	O	simvastatin	nn	4	SENT_131	[p10l837t1695r1209b1746],
4	concentrations	NNS	O	concentration	_	0	SENT_131	[p10l1236t1695r1716b1746],
5	after	IN	O	after	_	0	SENT_131	[p10l1740t1692r1890b1763],
6	administration	NN	O	administration	prep_after	4	SENT_131	[p10l1910t1692r2141b1746, p10l8t1773r278b1824],
7	of	IN	O	of	_	0	SENT_131	[p10l319t1770r388b1841],
8	a	DT	O	a	det	12	SENT_131	[p10l415t1789r449b1824],
9	single	JJ	O	single	amod	12	SENT_131	[p10l487t1770r675b1841],
10	20	CD	NUMBER	20	number	11	SENT_131	[p10l712t1778r913b1841],
11	—	CD	NUMBER	—	num	12	SENT_131	[p10l712t1778r913b1841],
12	mg	NN	O	mg	prep_of	4	SENT_131	[p10l712t1778r913b1841],
13	oral	JJ	O	oral	amod	14	SENT_131	[p10l948t1770r1074b1824],
14	dose	NN	O	dose	dep	12	SENT_131	[p10l1112t1770r1256b1824],
15	of	IN	O	of	_	0	SENT_131	[p10l1294t1770r1363b1841],
16	simvastatin	NN	O	simvastatin	prep_of	14	SENT_131	[p10l1390t1773r1761b1824],
17	in	IN	O	in	_	0	SENT_131	[p10l1799t1773r1860b1823],
18	healthy	JJ	O	healthy	amod	19	SENT_131	[p10l1898t1770r2147b1841],
19	subjects	NNS	O	subject	prep_in	4	SENT_131	[p10l10t1848r267b1919],
20	according	VBG	O	accord	_	0	SENT_131	[p10l299t1848r620b1919],
21	to	TO	O	to	prepc_according_to	4	SENT_131	[p10l649t1855r706b1902],
22	CYP3A5	NN	O	cyp3a5	nn	23	SENT_131	[p10l736t1851r1005b1902],
23	genotypes	NNS	O	genotype	pobj	4	SENT_131	[p10l1038t1856r1377b1919],
24	.	.	O	.	_	0	SENT_131	[p10l1038t1856r1377b1919],

1	Data	NNS	O	datum	nsubjpass	3	SENT_132	[p10l1410t1852r1561b1902],
2	are	VBP	O	be	auxpass	3	SENT_132	[p10l1595t1867r1693b1902],
3	expressed	VBN	O	express	_	0	SENT_132	[p10l1725t1848r2045b1919],
4	as	IN	O	as	_	0	SENT_132	[p10l2075t1867r2142b1902],
5	means	NNS	O	means	prep_as	3	SENT_132	[p10l8t1945r220b1980],
6	1	CD	NUMBER	1	number	7	SENT_132	[p10l242t1933r286b1979],
7	“	CD	NUMBER	“	num	9	SENT_132	[p10l242t1933r286b1979],
8	standard	JJ	O	standard	amod	9	SENT_132	[p10l306t1926r596b1980],
9	deviations	NNS	O	deviation	dep	5	SENT_132	[p10l621t1926r969b1980],
10	.	.	O	.	_	0	SENT_132	[p10l621t1926r969b1980],

1	showed	VBD	O	show	_	0	SENT_133	[p10l22t2140r332b2208],
2	40	CD	PERCENT	40	num	3	SENT_133	[p10l374t2140r549b2214],
3	%	NN	PERCENT	%	npadvmod	7	SENT_133	[p10l374t2140r549b2214],
4	and	CC	O	and	_	0	SENT_133	[p10l602t2140r749b2208],
5	78	CD	PERCENT	78	num	6	SENT_133	[p10l798t2140r967b2214],
6	%	NN	PERCENT	%	conj_and	3	SENT_133	[p10l798t2140r967b2214],
7	lower	JJR	O	lower	amod	9	SENT_133	[p10l1019t2140r1247b2208],
8	Cmax	NN	MISC	cmax	nn	9	SENT_133	[p10l1290t2144r1449b2232],
9	values	NNS	O	value	dobj	1	SENT_133	[p10l1489t2140r1745b2208],
10	than	IN	O	than	dep	11	SENT_133	[p10l1790t2140r1969b2208],
11	did	VBD	O	do	advcl	1	SENT_133	[p10l2015t2140r2146b2208],
12	CYP3A5	NNP	O	CYP3A5	iobj	11	SENT_133	[p10l25t2242r585b2310],
13	*	CD	NUMBER	*	number	14	SENT_133	[p10l25t2242r585b2310],
14	1	CD	NUMBER	1	amod	12	SENT_133	[p10l25t2242r585b2310],
15	/	:	O	/	punct	22	SENT_133	[p10l25t2242r585b2310],
16	*	CD	NUMBER	*	number	17	SENT_133	[p10l25t2242r585b2310],
17	3	CD	NUMBER	3	num	18	SENT_133	[p10l25t2242r585b2310],
18	carriers	NNS	O	carrier	dep	22	SENT_133	[p10l642t2245r939b2310],
19	and	CC	O	and	_	0	SENT_133	[p10l998t2242r1145b2310],
20	CYP3/l5	NN	O	cyp3/l5	conj_and	18	SENT_133	[p10l1205t2242r1765b2310],
21	*	CD	NUMBER	*	num	22	SENT_133	[p10l1205t2242r1765b2310],
22	3	CD	NUMBER	3	dep	14	SENT_133	[p10l1205t2242r1765b2310],
23	/	:	O	/	punct	22	SENT_133	[p10l1205t2242r1765b2310],
24	*	CD	NUMBER	*	number	25	SENT_133	[p10l1205t2242r1765b2310],
25	3	CD	NUMBER	3	num	26	SENT_133	[p10l1205t2242r1765b2310],
26	carriers	NNS	O	carrier	dobj	11	SENT_133	[p10l1822t2245r2142b2320],
27	,	,	O	,	_	0	SENT_133	[p10l1822t2245r2142b2320],
28	respectively	RB	O	respectively	advmod	31	SENT_133	[p10l19t2343r510b2431],
29	(	CD	NUMBER	(	num	30	SENT_133	[p10l555t2343r636b2423],
30	P	NN	O	p	dep	31	SENT_133	[p10l555t2343r636b2423],
31	=	JJ	O	=	amod	26	SENT_133	[p10l673t2375r719b2398],
32	.130	CD	NUMBER	.130	num	33	SENT_133	[p10l766t2343r979b2423],
33	)	NN	O	)	nsubj	11	SENT_133	[p10l766t2343r979b2423],
34	.	.	O	.	_	0	SENT_133	[p10l766t2343r979b2423],

1	The	DT	O	the	det	3	SENT_134	[p10l1026t2343r1178b2410],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_134	[p10l1221t2343r1900b2431],
3	parameters	NNS	O	parameter	nsubjpass	11	SENT_134	[p10l1943t2367r2144b2431, p10l20t2454r285b2512],
4	of	IN	O	of	_	0	SENT_134	[p10l338t2445r418b2512],
5	simvastatin	NN	O	simvastatin	prep_of	3	SENT_134	[p10l462t2448r924b2512],
6	according	VBG	O	accord	_	0	SENT_134	[p10l974t2445r1367b2533],
7	to	TO	O	to	prepc_according_to	11	SENT_134	[p10l1416t2454r1489b2512],
8	CYP3A5	NN	O	cyp3a5	nn	9	SENT_134	[p10l1545t2448r1881b2512],
9	genotypes	NNS	O	genotype	pobj	11	SENT_134	[p10l1928t2468r2144b2533, p10l19t2556r230b2634],
10	are	VBP	O	be	auxpass	11	SENT_134	[p10l266t2569r382b2613],
11	summarized	VBN	O	summarize	_	0	SENT_134	[p10l417t2545r913b2613],
12	in	IN	O	in	_	0	SENT_134	[p10l945t2549r1024b2612],
13	Table	NNP	O	Table	nn	14	SENT_134	[p10l1056t2546r1268b2613],
14	II	NNP	O	II	prep_in	11	SENT_134	[p10l1301t2550r1375b2613],
15	.	.	O	.	_	0	SENT_134	[p10l1301t2550r1375b2613],

1	DISCUSSION	NN	O	discussion	_	0	SENT_135	[p10l19t2761r579b2825],

1	Our	PRP$	O	we	poss	2	SENT_136	[p10l22t2969r174b3033],
2	aim	NN	O	aim	nsubj	6	SENT_136	[p10l214t2969r362b3032],
3	in	IN	O	in	_	0	SENT_136	[p10l402t2969r481b3032],
4	this	DT	O	this	det	5	SENT_136	[p10l519t2965r666b3033],
5	study	NN	O	study	prep_in	2	SENT_136	[p10l710t2965r931b3054],
6	was	VBD	O	be	_	0	SENT_136	[p10l968t2989r1120b3033],
7	to	TO	O	to	aux	8	SENT_136	[p10l1161t2975r1235b3033],
8	evaluate	VB	O	evaluate	xcomp	6	SENT_136	[p10l1278t2965r1610b3033],
9	the	DT	O	the	det	10	SENT_136	[p10l1650t2965r1774b3033],
10	effect	NN	O	effect	dobj	8	SENT_136	[p10l1816t2965r2033b3033],
11	of	IN	O	of	_	0	SENT_136	[p10l2073t2965r2153b3033],
12	the	DT	O	the	det	16	SENT_136	[p10l19t3066r142b3133],
13	CYP3A5	NN	O	cyp3a5	nn	16	SENT_136	[p10l179t3070r515b3133],
14	*	NN	O	*	nn	16	SENT_136	[p10l531t3070r609b3133],
15	3	CD	NUMBER	3	num	16	SENT_136	[p10l531t3070r609b3133],
16	genotype	NN	O	genotype	prep_of	10	SENT_136	[p10l639t3076r1004b3155],
17	on	IN	O	on	_	0	SENT_136	[p10l1038t3090r1136b3133],
18	the	DT	O	the	det	19	SENT_136	[p10l1165t3066r1288b3133],
19	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	8	SENT_136	[p10l1320t3066r2038b3155],
20	of	IN	O	of	_	0	SENT_136	[p10l2073t3066r2153b3133],
21	simvastatin	NN	O	simvastatin	prep_of	19	SENT_136	[p10l22t3170r484b3234],
22	in	IN	O	in	_	0	SENT_136	[p10l512t3170r591b3234],
23	humans	NNS	O	human	prep_in	8	SENT_136	[p10l617t3167r958b3234],
24	.	.	O	.	_	0	SENT_136	[p10l617t3167r958b3234],

1	We	PRP	O	we	nsubj	2	SENT_137	[p10l990t3171r1114b3234],
2	observed	VBD	O	observe	_	0	SENT_137	[p10l1144t3167r1504b3234],
3	that	IN	O	that	complm	10	SENT_137	[p10l1530t3167r1685b3234],
4	C	NN	O	c	nn	5	SENT_137	[p10l1716t3170r1774b3234],
5	YP3A5	NN	O	yp3a5	nsubjpass	10	SENT_137	[p10l1780t3171r2052b3234],
6	*	CD	NUMBER	*	num	7	SENT_137	[p10l2067t3170r2146b3234],
7	3	CD	NUMBER	3	dep	5	SENT_137	[p10l2067t3170r2146b3234],
8	was	VBD	O	be	auxpass	10	SENT_137	[p10l19t3292r171b3335],
9	significantly	RB	O	significantly	advmod	10	SENT_137	[p10l206t3268r708b3356],
10	correlated	VBN	O	correlate	ccomp	2	SENT_137	[p10l740t3268r1143b3335],
11	with	IN	O	with	_	0	SENT_137	[p10l1173t3268r1357b3335],
12	the	DT	O	the	det	14	SENT_137	[p10l1387t3268r1510b3335],
13	systemic	JJ	O	systemic	amod	14	SENT_137	[p10l1544t3271r1890b3356],
14	exposure	NN	O	exposure	prep_with	10	SENT_137	[p10l1925t3292r2145b3356, p10l22t3393r187b3437],
15	of	IN	O	of	_	0	SENT_137	[p10l227t3370r307b3437],
16	simvastatin	NN	O	simvastatin	prep_of	14	SENT_137	[p10l338t3373r820b3437],
17	.	.	O	.	_	0	SENT_137	[p10l338t3373r820b3437],

1	These	DT	O	these	det	2	SENT_138	[p10l862t3370r1098b3437],
2	findings	NNS	O	finding	nsubj	3	SENT_138	[p10l1137t3370r1464b3458],
3	suggest	VBP	O	suggest	_	0	SENT_138	[p10l1505t3380r1796b3458],
4	that	IN	O	that	complm	12	SENT_138	[p10l1831t3370r1986b3437],
5	the	DT	O	the	det	8	SENT_138	[p10l2021t3370r2145b3437],
6	polymorphic	JJ	O	polymorphic	amod	8	SENT_138	[p10l20t3470r541b3559],
7	CYP3A5	NN	O	cyp3a5	nn	8	SENT_138	[p10l579t3474r915b3538],
8	gene	NN	O	gene	nsubj	12	SENT_138	[p10l943t3494r1125b3559],
9	is	VBZ	O	be	cop	12	SENT_138	[p10l1158t3474r1220b3538],
10	an	DT	O	a	det	12	SENT_138	[p10l1254t3494r1347b3538],
11	important	JJ	O	important	amod	12	SENT_138	[p10l1379t3474r1779b3559],
12	factor	NN	O	factor	ccomp	3	SENT_138	[p10l1809t3471r2037b3538],
13	in	IN	O	in	_	0	SENT_138	[p10l2067t3474r2146b3537],
14	interindividual	JJ	O	interindividual	amod	15	SENT_138	[p10l21t3571r636b3639],
15	variation	NN	O	variation	prep_in	12	SENT_138	[p10l676t3575r1038b3639],
16	in	IN	O	in	_	0	SENT_138	[p10l1079t3575r1158b3638],
17	the	DT	O	the	det	18	SENT_138	[p10l1197t3571r1321b3639],
18	disposition	NN	O	disposition	prep_in	15	SENT_138	[p10l1366t3571r1817b3660],
19	of	IN	O	of	_	0	SENT_138	[p10l1859t3571r1939b3639],
20	simvastatin	NN	O	simvastatin	prep_of	18	SENT_138	[p10l1975t3575r2144b3639, p10l19t3676r336b3739],
21	in	IN	O	in	_	0	SENT_138	[p10l368t3676r447b3739],
22	humans	NNS	O	human	prep_in	20	SENT_138	[p10l478t3672r819b3739],
23	.	.	O	.	_	0	SENT_138	[p10l478t3672r819b3739],

1	Simvastatin	NNP	O	Simvastatin	nsubjpass	10	SENT_139	[p11l129t27r627b102],
2	,	,	O	,	_	0	SENT_139	[p11l129t27r627b102],
3	an	DT	O	a	det	6	SENT_139	[p11l666t48r760b92],
4	HMG-CoA	NN	O	hmg-coa	nn	6	SENT_139	[p11l795t27r1215b92],
5	reductase	NN	O	reductase	nn	6	SENT_139	[p11l1249t24r1634b92],
6	inhibitor	NN	O	inhibitor	appos	1	SENT_139	[p11l1671t24r2042b102],
7	,	,	O	,	_	0	SENT_139	[p11l1671t24r2042b102],
8	is	VBZ	O	be	auxpass	10	SENT_139	[p11l2082t27r2144b92],
9	mainly	RB	O	mainly	advmod	10	SENT_139	[p11l20t125r302b213],
10	metabolized	VBN	O	metabolize	_	0	SENT_139	[p11l356t125r850b192],
11	by	IN	O	by	_	0	SENT_139	[p11l901t125r1000b213],
12	CYP3A4/5	NN	O	cyp3a4/5	agent	10	SENT_139	[p11l1054t124r1635b192],
13	.1148	CD	NUMBER	.1148	num	12	SENT_139	[p11l1054t124r1635b192],
14	Because	IN	O	because	mark	15	SENT_139	[p11l1691t129r2015b192],
15	of	IN	O	of	dep	12	SENT_139	[p11l2073t125r2153b192],

1	90	CD	NUMBER	90	num	2	SENT_140	[p11l10t325r103b390],
2	o	NN	O	o	tmod	16	SENT_140	[p11l161t350r191b380],
3	I	PRP	O	I	nsubj	4	SENT_140	[p11l247t332r277b404],
4	Clin	VBP	O	clin	rcmod	2	SENT_140	[p11l304t328r456b389],
5	Pharmacol	NNP	O	Pharmacol	dobj	4	SENT_140	[p11l482t328r884b389],
6	2007	CD	DATE	2007	num	5	SENT_140	[p11l913t337r1420b400],
7	;	:	O	;	_	0	SENT_140	[p11l913t337r1420b400],
8	47:87	CD	NUMBER	47:87	dep	5	SENT_140	[p11l913t337r1420b400],
9	-93	CD	NUMBER	-93	num	13	SENT_140	[p11l913t337r1420b400],
10	extensive	JJ	O	extensive	amod	11	SENT_140	[p11l9t428r381b492],
11	CYP3A4/5-catalyzed	JJ	O	cyp3a4/5-catalyzed	amod	13	SENT_140	[p11l413t424r1240b514],
12	first-pass	JJ	O	first-pass	amod	13	SENT_140	[p11l1272t424r1627b514],
13	metabolism	NN	O	metabolism	dep	8	SENT_140	[p11l1660t424r2143b503],
14	,	,	O	,	_	0	SENT_140	[p11l1660t424r2143b503],
15	simvastatin	NN	O	simvastatin	nsubj	16	SENT_140	[p11l9t530r475b594],
16	has	VBZ	O	have	_	0	SENT_140	[p11l518t526r651b594],
17	a	DT	O	a	det	19	SENT_140	[p11l700t550r740b594],
18	low	JJ	O	low	amod	19	SENT_140	[p11l784t526r934b594],
19	mean	NN	O	mean	dobj	16	SENT_140	[p11l977t550r1197b594],
20	oral	JJ	O	oral	amod	21	SENT_140	[p11l1244t526r1395b594],
21	bioavailability	NN	O	bioavailability	nsubj	34	SENT_140	[p11l1438t526r2028b615],
22	of	IN	O	of	prep	21	SENT_140	[p11l2074t526r2154b594],
23	about	IN	O	about	pcomp	22	SENT_140	[p11l9t627r232b695],
24	50/o	JJ	O	50/o	amod	27	SENT_140	[p11l284t626r573b700],
25	.11	CD	NUMBER	.11	number	26	SENT_140	[p11l284t626r573b700],
26	’19	CD	NUMBER	’19	num	27	SENT_140	[p11l284t626r573b700],
27	CYP3A5	NN	O	cyp3a5	pobj	23	SENT_140	[p11l623t630r961b695],
28	is	VBZ	O	be	cop	34	SENT_140	[p11l1016t630r1078b695],
29	a	DT	O	a	det	34	SENT_140	[p11l1130t651r1170b695],
30	hepatic	JJ	O	hepatic	amod	34	SENT_140	[p11l1218t627r1514b716],
31	and	CC	O	and	_	0	SENT_140	[p11l1567t627r1716b695],
32	intestinal	JJ	O	intestinal	amod	34	SENT_140	[p11l1765t627r2146b695],
33	drug-metabolizing	JJ	O	drug-metabolizing	amod	34	SENT_140	[p11l10t731r752b820],
34	enzyme	NN	O	enzyme	rcmod	19	SENT_140	[p11l790t755r1101b820],
35	that	WDT	O	that	nsubj	38	SENT_140	[p11l1138t731r1294b799],
36	is	VBZ	O	be	cop	38	SENT_140	[p11l1331t734r1393b799],
37	closely	RB	O	closely	advmod	38	SENT_140	[p11l1433t731r1716b820],
38	related	JJ	O	related	rcmod	34	SENT_140	[p11l1751t731r2030b799],
39	in	IN	O	in	_	0	SENT_140	[p11l2067t734r2147b798],
40	structure	NN	O	structure	prep_in	38	SENT_140	[p11l9t842r364b899],
41	and	CC	O	and	_	0	SENT_140	[p11l394t832r541b899],
42	function	NN	O	function	prep_in	38	SENT_140	[p11l568t832r907b899],
43	to	TO	O	to	_	0	SENT_140	[p11l932t841r1005b899],
44	CYP3A4	NN	O	cyp3a4	prep_to	38	SENT_140	[p11l1035t832r1457b899],
45	.	.	O	.	_	0	SENT_140	[p11l1035t832r1457b899],

1	”	NN	O	”	npadvmod	8	SENT_141	[p11l1035t832r1457b899],
2	Unlike	IN	O	unlike	_	0	SENT_141	[p11l1484t832r1754b899],
3	CYP3A4	NN	O	cyp3a4	prep_unlike	8	SENT_141	[p11l1783t835r2143b910],
4	,	,	O	,	_	0	SENT_141	[p11l1783t835r2143b910],
5	CYP3A5	NN	O	cyp3a5	nsubjpass	8	SENT_141	[p11l8t937r345b1002],
6	is	VBZ	O	be	auxpass	8	SENT_141	[p11l392t937r454b1002],
7	polymorphically	RB	O	polymorphically	advmod	8	SENT_141	[p11l498t933r1179b1023],
8	expressed	VBN	O	express	_	0	SENT_141	[p11l1221t934r1641b1023],
9	.	.	O	.	_	0	SENT_141	[p11l1221t934r1641b1023],

1	Among	IN	O	among	_	0	SENT_142	[p11l1687t938r1981b1023],
2	the	DT	O	the	det	4	SENT_142	[p11l2021t934r2146b1002],
3	CYP3A5	NN	O	cyp3a5	nn	4	SENT_142	[p11l12t1039r350b1103],
4	polymorphisms	NNS	O	polymorphism	prep_among	13	SENT_142	[p11l406t1035r1068b1125],
5	,	,	O	,	_	0	SENT_142	[p11l406t1035r1068b1125],
6	the	DT	O	the	det	10	SENT_142	[p11l1128t1035r1252b1103],
7	CYP3A5	NN	O	cyp3a5	nn	10	SENT_142	[p11l1316t1039r1748b1103],
8	*	NN	O	*	nn	10	SENT_142	[p11l1316t1039r1748b1103],
9	3	CD	NUMBER	3	num	10	SENT_142	[p11l1316t1039r1748b1103],
10	allele	NN	O	allele	nsubj	13	SENT_142	[p11l1807t1035r2023b1103],
11	is	VBZ	O	be	cop	13	SENT_142	[p11l2082t1039r2144b1103],
12	very	RB	O	very	advmod	13	SENT_142	[p11l6t1161r182b1226],
13	common	JJ	O	common	_	0	SENT_142	[p11l228t1161r599b1205],
14	.	.	O	.	_	0	SENT_142	[p11l228t1161r599b1205],

1	It	PRP	O	it	nsubj	2	SENT_143	[p11l649t1142r706b1205],
2	has	VBZ	O	have	_	0	SENT_143	[p11l749t1137r881b1205],
3	a	DT	O	a	det	9	SENT_143	[p11l930t1161r970b1205],
4	single	JJ	O	single	amod	9	SENT_143	[p11l1016t1137r1251b1226],
5	nucleotide	NN	O	nucleotide	nn	9	SENT_143	[p11l1296t1137r1728b1205],
6	polymorphism	NN	O	polymorphism	nn	9	SENT_143	[p11l1774t1137r2146b1227, p11l7t1239r269b1328],
7	(	NN	O	(	nn	9	SENT_143	[p11l312t1239r705b1320],
8	A6986G	NN	O	a6986g	nn	9	SENT_143	[p11l312t1239r705b1320],
9	)	NN	O	)	dobj	2	SENT_143	[p11l312t1239r705b1320],
10	in	IN	O	in	_	0	SENT_143	[p11l750t1242r831b1306],
11	intron	NN	O	intron	prep_in	9	SENT_143	[p11l871t1242r1129b1307],
12	3	CD	NUMBER	3	num	11	SENT_143	[p11l1172t1249r1208b1307],
13	that	WDT	O	that	nsubj	23	SENT_143	[p11l1252t1239r1414b1307],
14	leads	VBZ	O	lead	rcmod	9	SENT_143	[p11l1453t1239r1667b1307],
15	to	TO	O	to	_	0	SENT_143	[p11l1708t1249r1783b1307],
16	alternative	JJ	O	alternative	amod	17	SENT_143	[p11l1826t1239r2146b1307, p11l7t1345r158b1410],
17	splicing	NN	O	splicing	prep_to	14	SENT_143	[p11l194t1342r515b1431],
18	and	CC	O	and	_	0	SENT_143	[p11l547t1342r696b1410],
19	protein	NN	O	protein	nn	20	SENT_143	[p11l726t1345r1020b1431],
20	truncation	NN	O	truncation	prep_to	14	SENT_143	[p11l1050t1345r1473b1410],
21	and	CC	O	and	_	0	SENT_143	[p11l1504t1342r1653b1410],
22	thus	RB	O	thus	advmod	23	SENT_143	[p11l1683t1342r1855b1410],
23	affects	VBZ	O	affect	conj_and	14	SENT_143	[p11l1890t1342r2145b1410],
24	CYP3A5	NN	O	cyp3a5	nn	25	SENT_143	[p11l8t1447r340b1512],
25	expression	NN	O	expression	dobj	23	SENT_143	[p11l376t1443r882b1533],
26	.	.	O	.	_	0	SENT_143	[p11l376t1443r882b1533],

1	”	NN	O	”	_	0	SENT_144	[p11l376t1443r882b1533],
2	The	DT	O	the	det	5	SENT_144	[p11l913t1444r1064b1512],
3	resultant	JJ	O	resultant	amod	4	SENT_144	[p11l1092t1444r1444b1512],
4	functional	JJ	O	functional	amod	5	SENT_144	[p11l1472t1444r1879b1512],
5	defect	NN	O	defect	nsubj	8	SENT_144	[p11l1911t1444r2148b1512],
6	in	IN	O	in	_	0	SENT_144	[p11l8t1549r88b1613],
7	CYP3A5	NN	O	cyp3a5	prep_in	5	SENT_144	[p11l118t1549r455b1614],
8	affects	VBZ	O	affect	rcmod	1	SENT_144	[p11l491t1546r747b1614],
9	the	DT	O	the	det	10	SENT_144	[p11l778t1546r902b1614],
10	disposition	NN	O	disposition	dobj	8	SENT_144	[p11l936t1546r1391b1635],
11	of	IN	O	of	_	0	SENT_144	[p11l1422t1546r1503b1614],
12	various	JJ	O	various	amod	14	SENT_144	[p11l1524t1549r1821b1614],
13	CYP3A	NN	O	cyp3a	nn	14	SENT_144	[p11l1854t1549r2147b1614],
14	substrates	NNS	O	substrate	prep_of	10	SENT_144	[p11l9t1647r718b1716],
15	.16	CD	NUMBER	.16	number	16	SENT_144	[p11l9t1647r718b1716],
16	’	CD	NUMBER	’	num	17	SENT_144	[p11l9t1647r718b1716],
17	17	CD	NUMBER	17	dep	1	SENT_144	[p11l9t1647r718b1716],
18	’	NN	O	’	nsubj	26	SENT_144	[p11l9t1647r718b1716],
19	2	CD	NUMBER	2	num	18	SENT_144	[p11l9t1647r718b1716],
20	°	CD	NUMBER	°	number	21	SENT_144	[p11l9t1647r718b1716],
21	'22	CD	NUMBER	'22	num	18	SENT_144	[p11l9t1647r718b1716],
22	Because	IN	O	because	_	0	SENT_144	[p11l753t1652r1080b1716],
23	simvastatin	NN	O	simvastatin	prep_because	18	SENT_144	[p11l1116t1651r1581b1716],
24	is	VBZ	O	be	cop	26	SENT_144	[p11l1614t1651r1676b1716],
25	a	DT	O	a	det	26	SENT_144	[p11l1712t1672r1752b1716],
26	substrate	NN	O	substrate	rcmod	17	SENT_144	[p11l1786t1647r2146b1716],
27	of	IN	O	of	_	0	SENT_144	[p11l9t1750r90b1818],
28	CYP3A4/5	NN	O	cyp3a4/5	prep_of	26	SENT_144	[p11l127t1750r710b1829],
29	,10	CD	NUMBER	,10	number	30	SENT_144	[p11l127t1750r710b1829],
30	“	CD	NUMBER	“	num	28	SENT_144	[p11l127t1750r710b1829],
31	we	PRP	O	we	nsubj	32	SENT_144	[p11l756t1774r870b1818],
32	hypothesized	VBD	O	hypothesize	rcmod	26	SENT_144	[p11l915t1750r1462b1840],
33	that	IN	O	that	complm	53	SENT_144	[p11l1505t1750r1662b1818],
34	if	IN	O	if	mark	36	SENT_144	[p11l1705t1750r1767b1818],
35	CYP3A5	NN	O	cyp3a5	nsubj	36	SENT_144	[p11l1804t1754r2142b1818],
36	plays	VBZ	O	play	advcl	53	SENT_144	[p11l7t1852r219b1941],
37	an	DT	O	a	det	39	SENT_144	[p11l251t1876r345b1920],
38	important	JJ	O	important	amod	39	SENT_144	[p11l374t1855r777b1941],
39	role	NN	O	role	dobj	36	SENT_144	[p11l803t1852r957b1920],
40	in	IN	O	in	_	0	SENT_144	[p11l988t1855r1068b1919],
41	the	DT	O	the	det	42	SENT_144	[p11l1095t1852r1219b1920],
42	disposition	NN	O	disposition	prep_in	39	SENT_144	[p11l1252t1852r1706b1941],
43	of	IN	O	of	_	0	SENT_144	[p11l1737t1852r1817b1920],
44	simvastatin	NN	O	simvastatin	prep_of	42	SENT_144	[p11l1841t1855r2145b1920, p11l7t1958r213b2033],
45	,	,	O	,	_	0	SENT_144	[p11l1841t1855r2145b1920, p11l7t1958r213b2033],
46	the	DT	O	the	det	50	SENT_144	[p11l273t1955r397b2023],
47	CYP3/l5	NN	O	cyp3/l5	nn	50	SENT_144	[p11l461t1958r888b2023],
48	*	NN	O	*	nn	50	SENT_144	[p11l461t1958r888b2023],
49	3	CD	NUMBER	3	num	50	SENT_144	[p11l461t1958r888b2023],
50	genotype	NN	O	genotype	nsubjpass	53	SENT_144	[p11l950t1965r1317b2044],
51	will	MD	O	will	aux	53	SENT_144	[p11l1375t1955r1534b2022],
52	be	VB	O	be	auxpass	53	SENT_144	[p11l1589t1955r1680b2023],
53	correlated	VBN	O	correlate	ccomp	32	SENT_144	[p11l1741t1955r2147b2023],
54	with	IN	O	with	_	0	SENT_144	[p11l6t2056r192b2125],
55	the	DT	O	the	det	57	SENT_144	[p11l225t2056r349b2125],
56	plasma	NN	O	plasma	nn	57	SENT_144	[p11l386t2056r675b2146],
57	levels	NNS	O	level	prep_with	53	SENT_144	[p11l709t2056r940b2125],
58	of	IN	O	of	_	0	SENT_144	[p11l979t2057r1060b2125],
59	simvastatin	NN	O	simvastatin	prep_of	57	SENT_144	[p11l1089t2060r1554b2125],
60	and	CC	O	and	_	0	SENT_144	[p11l1590t2057r1738b2125],
61	thus	RB	O	thus	advmod	53	SENT_144	[p11l1772t2056r1945b2125],
62	be	VB	O	be	cop	64	SENT_144	[p11l1979t2056r2071b2125],
63	a	DT	O	a	det	64	SENT_144	[p11l2108t2081r2148b2125],
64	factor	NN	O	factor	ccomp	32	SENT_144	[p11l8t2159r237b2227],
65	to	TO	O	to	aux	66	SENT_144	[p11l279t2169r353b2227],
66	cause	VB	O	cause	infmod	64	SENT_144	[p11l401t2182r622b2227],
67	an	DT	O	a	det	69	SENT_144	[p11l669t2182r763b2227],
68	interindividual	JJ	O	interindividual	amod	69	SENT_144	[p11l807t2158r1426b2227],
69	variability	NN	O	variability	dobj	66	SENT_144	[p11l1470t2158r1889b2248],
70	of	IN	O	of	_	0	SENT_144	[p11l1935t2159r2015b2227],
71	its	PRP$	O	its	poss	72	SENT_144	[p11l2053t2162r2145b2227],
72	disposition	NN	O	disposition	prep_of	69	SENT_144	[p11l10t2261r483b2351],
73	.	.	O	.	_	0	SENT_144	[p11l10t2261r483b2351],

1	In	IN	O	in	dep	26	SENT_145	[p11l114t2368r195b2431],
2	this	DT	O	this	det	3	SENT_145	[p11l225t2363r373b2431],
3	study	NN	O	study	pobj	1	SENT_145	[p11l409t2363r645b2452],
4	,	,	O	,	_	0	SENT_145	[p11l409t2363r645b2452],
5	the	DT	O	the	det	6	SENT_145	[p11l679t2363r803b2431],
6	values	NNS	O	value	appos	3	SENT_145	[p11l834t2363r1092b2431],
7	of	IN	O	of	_	0	SENT_145	[p11l1128t2363r1208b2431],
8	CL/F	NN	O	cl/f	prep_of	6	SENT_145	[p11l1233t2363r1430b2431],
9	of	IN	O	of	_	0	SENT_145	[p11l1465t2363r1545b2431],
10	simvastatin	NN	O	simvastatin	prep_of	8	SENT_145	[p11l1571t2367r2036b2431],
11	in	IN	O	in	_	0	SENT_145	[p11l2068t2367r2147b2431],
12	C	NN	O	c	nn	13	SENT_145	[p11l12t2467r71b2532],
13	YP3/l5	NN	O	yp3/l5	prep_in	10	SENT_145	[p11l75t2468r346b2532],
14	*	CD	NUMBER	*	number	15	SENT_145	[p11l360t2464r481b2532],
15	3	CD	NUMBER	3	num	13	SENT_145	[p11l360t2464r481b2532],
16	/	:	O	/	punct	26	SENT_145	[p11l360t2464r481b2532],
17	*	CD	NUMBER	*	number	18	SENT_145	[p11l487t2467r566b2532],
18	3	CD	NUMBER	3	num	19	SENT_145	[p11l487t2467r566b2532],
19	carriers	NNS	O	carrier	nsubj	26	SENT_145	[p11l593t2467r885b2532],
20	were	VBD	O	be	cop	26	SENT_145	[p11l913t2488r1103b2532],
21	56	CD	PERCENT	56	num	22	SENT_145	[p11l1134t2464r1304b2537],
22	%	NN	PERCENT	%	npadvmod	26	SENT_145	[p11l1134t2464r1304b2537],
23	and	CC	O	and	_	0	SENT_145	[p11l1340t2464r1486b2532],
24	72	CD	PERCENT	72	num	25	SENT_145	[p11l1517t2464r1686b2537],
25	%	NN	PERCENT	%	npadvmod	26	SENT_145	[p11l1517t2464r1686b2537],
26	lower	JJR	O	lower	_	0	SENT_145	[p11l1721t2464r1946b2532],
27	than	IN	O	than	_	0	SENT_145	[p11l1970t2464r2147b2532],
28	those	DT	O	those	prep_than	26	SENT_145	[p11l7t2568r220b2635],
29	in	IN	O	in	_	0	SENT_145	[p11l268t2571r348b2635],
30	CYP3/l5	NN	O	cyp3/l5	nn	31	SENT_145	[p11l399t2568r962b2636],
31	*	NN	O	*	prep_in	28	SENT_145	[p11l399t2568r962b2636],
32	1	CD	NUMBER	1	num	31	SENT_145	[p11l399t2568r962b2636],
33	/	:	O	/	punct	35	SENT_145	[p11l399t2568r962b2636],
34	*	CD	NUMBER	*	num	35	SENT_145	[p11l399t2568r962b2636],
35	3	CD	NUMBER	3	dep	28	SENT_145	[p11l399t2568r962b2636],
36	and	CC	O	and	_	0	SENT_145	[p11l1010t2568r1158b2635],
37	CYP3A5	CD	NUMBER	cyp3a5	num	38	SENT_145	[p11l1209t2568r1764b2636],
38	*	NN	O	*	dep	28	SENT_145	[p11l1209t2568r1764b2636],
39	1	CD	NUMBER	1	dep	35	SENT_145	[p11l1209t2568r1764b2636],
40	/	:	O	/	punct	35	SENT_145	[p11l1209t2568r1764b2636],
41	*	CD	NUMBER	*	number	42	SENT_145	[p11l1209t2568r1764b2636],
42	1	CD	NUMBER	1	num	43	SENT_145	[p11l1209t2568r1764b2636],
43	carriers	NNS	O	carrier	dep	28	SENT_145	[p11l1820t2571r2143b2646],
44	,	,	O	,	_	0	SENT_145	[p11l1820t2571r2143b2646],
45	respectively	RB	O	respectively	advmod	26	SENT_145	[p11l6t2669r512b2759],
46	.	.	O	.	_	0	SENT_145	[p11l6t2669r512b2759],

1	However	RB	O	however	advmod	9	SENT_146	[p11l559t2674r939b2748],
2	,	,	O	,	_	0	SENT_146	[p11l559t2674r939b2748],
3	the	DT	O	the	det	5	SENT_146	[p11l983t2669r1107b2738],
4	AUC	NN	O	auc	nn	5	SENT_146	[p11l1150t2673r1344b2738],
5	values	NNS	O	value	nsubj	9	SENT_146	[p11l1385t2669r1643b2738],
6	for	IN	O	for	_	0	SENT_146	[p11l1688t2670r1798b2738],
7	simvastatin	NN	O	simvastatin	prep_for	5	SENT_146	[p11l1841t2673r2146b2738, p11l7t2775r184b2840],
8	were	VBD	O	be	cop	9	SENT_146	[p11l206t2796r394b2840],
9	2.3	CD	NUMBER	2.3	_	0	SENT_146	[p11l423t2781r562b2840],
10	-	:	O	-	_	0	SENT_146	[p11l423t2781r562b2840],
11	and	CC	O	and	_	0	SENT_146	[p11l588t2771r733b2840],
12	3.2-fold	RB	O	3.2-fold	advmod	13	SENT_146	[p11l760t2772r1056b2840],
13	higher	JJR	O	higher	conj_and	9	SENT_146	[p11l1079t2771r1329b2861],
14	in	IN	O	in	prep	13	SENT_146	[p11l1353t2775r1431b2839],
15	the	DT	O	the	det	17	SENT_146	[p11l1453t2772r1573b2840],
16	CYP3A5	NN	O	cyp3a5	nn	17	SENT_146	[p11l1604t2775r1931b2840],
17	*	NN	O	*	dep	14	SENT_146	[p11l1945t2772r2147b2840],
18	1	CD	NUMBER	1	dep	17	SENT_146	[p11l1945t2772r2147b2840],
19	/	:	O	/	punct	17	SENT_146	[p11l1945t2772r2147b2840],
20	*	CD	NUMBER	*	number	21	SENT_146	[p11l1945t2772r2147b2840],
21	3	CD	NUMBER	3	dep	17	SENT_146	[p11l1945t2772r2147b2840],
22	and	CC	O	and	_	0	SENT_146	[p11l9t2873r156b2942],
23	CYP3A5	CD	NUMBER	cyp3a5	number	24	SENT_146	[p11l188t2877r523b2942],
24	*	CD	NUMBER	*	conj_and	21	SENT_146	[p11l538t2873r746b2942],
25	3	CD	NUMBER	3	dep	21	SENT_146	[p11l538t2873r746b2942],
26	/	:	O	/	punct	17	SENT_146	[p11l538t2873r746b2942],
27	*	CD	NUMBER	*	num	29	SENT_146	[p11l538t2873r746b2942],
28	3	CD	NUMBER	3	num	29	SENT_146	[p11l538t2873r746b2942],
29	carriers	NNS	O	carrier	npadvmod	30	SENT_146	[p11l774t2877r1069b2942],
30	than	IN	O	than	advmod	31	SENT_146	[p11l1098t2873r1276b2942],
31	in	IN	O	in	dep	34	SENT_146	[p11l1304t2877r1383b2941],
32	CYP3A5	NN	O	cyp3a5	nn	33	SENT_146	[p11l1414t2877r1750b2942],
33	*	NN	O	*	pobj	31	SENT_146	[p11l1764t2873r1964b2942],
34	1	CD	NUMBER	1	dep	17	SENT_146	[p11l1764t2873r1964b2942],
35	/	:	O	/	punct	34	SENT_146	[p11l1764t2873r1964b2942],
36	*	CD	NUMBER	*	number	37	SENT_146	[p11l1764t2873r1964b2942],
37	1	CD	NUMBER	1	num	38	SENT_146	[p11l1764t2873r1964b2942],
38	carriers	NNS	O	carrier	dep	13	SENT_146	[p11l2001t2898r2145b2942, p11l6t2980r206b3055],
39	,	,	O	,	_	0	SENT_146	[p11l2001t2898r2145b2942, p11l6t2980r206b3055],

1	respectively	RB	O	respectively	_	0	SENT_147	[p11l254t2976r760b3066],
2	.	.	O	.	_	0	SENT_147	[p11l254t2976r760b3066],

1	These	DT	O	these	det	2	SENT_148	[p11l813t2976r1050b3044],
2	findings	NNS	O	finding	nsubj	4	SENT_148	[p11l1099t2976r1429b3065],
3	strongly	RB	O	strongly	advmod	4	SENT_148	[p11l1480t2976r1807b3065],
4	suggest	VBP	O	suggest	_	0	SENT_148	[p11l1856t2986r2148b3065],
5	that	IN	O	that	complm	14	SENT_148	[p11l7t3078r163b3146],
6	the	DT	O	the	det	10	SENT_148	[p11l201t3078r325b3146],
7	CYP3A5	NN	O	cyp3a5	nn	10	SENT_148	[p11l371t3081r804b3146],
8	*	NN	O	*	nn	10	SENT_148	[p11l371t3081r804b3146],
9	3	CD	NUMBER	3	num	10	SENT_148	[p11l371t3081r804b3146],
10	genotype	NN	O	genotype	nsubj	14	SENT_148	[p11l843t3088r1210b3167],
11	is	VBZ	O	be	cop	14	SENT_148	[p11l1251t3081r1314b3146],
12	a	DT	O	a	det	14	SENT_148	[p11l1357t3102r1397b3146],
13	substantial	JJ	O	substantial	amod	14	SENT_148	[p11l1438t3078r1877b3146],
14	factor	NN	O	factor	ccomp	4	SENT_148	[p11l1919t3078r2148b3146],
15	in	IN	O	in	_	0	SENT_148	[p11l8t3184r88b3248],
16	increasing	VBG	O	increase	prepc_in	14	SENT_148	[p11l131t3184r547b3270],
17	the	DT	O	the	det	19	SENT_148	[p11l589t3181r713b3249],
18	systemic	JJ	O	systemic	amod	19	SENT_148	[p11l759t3184r1108b3270],
19	exposure	NN	O	exposure	dobj	16	SENT_148	[p11l1154t3205r1519b3270],
20	of	IN	O	of	_	0	SENT_148	[p11l1564t3181r1645b3249],
21	simvastatin	NN	O	simvastatin	prep_of	19	SENT_148	[p11l1682t3184r2147b3249],
22	in	IN	O	in	_	0	SENT_148	[p11l8t3286r88b3350],
23	humans	NNS	O	human	prep_in	16	SENT_148	[p11l115t3282r436b3351],
24	and	CC	O	and	_	0	SENT_148	[p11l468t3283r616b3351],
25	is	VBZ	O	be	cop	27	SENT_148	[p11l645t3286r707b3351],
26	a	DT	O	a	det	27	SENT_148	[p11l738t3307r779b3351],
27	cause	NN	O	cause	conj_and	14	SENT_148	[p11l807t3307r1028b3351],
28	of	IN	O	of	_	0	SENT_148	[p11l1059t3283r1140b3351],
29	interindividual	JJ	O	interindividual	amod	30	SENT_148	[p11l1161t3282r1780b3351],
30	variability	NN	O	variability	prep_of	27	SENT_148	[p11l1808t3282r2146b3351, p12l8t28r113b114],

1	in	IN	O	in	_	0	SENT_149	[p12l165t28r245b92],
2	simvastatin	NN	O	simvastatin	nn	3	SENT_149	[p12l299t28r764b93],
3	kinetics	NNS	O	kinetics	pobj	1	SENT_149	[p12l816t24r1132b93],
4	in	IN	O	in	_	0	SENT_149	[p12l1187t28r1267b92],
5	humans	NNS	O	human	prep_in	3	SENT_149	[p12l1319t24r1661b93],
6	.	.	O	.	_	0	SENT_149	[p12l1319t24r1661b93],

1	Consistent	JJ	O	consistent	nsubj	10	SENT_150	[p12l1720t28r2148b93],
2	with	IN	O	with	_	0	SENT_150	[p12l6t126r192b194],
3	this	DT	O	this	det	4	SENT_150	[p12l223t126r371b194],
4	result	NN	O	result	prep_with	1	SENT_150	[p12l404t126r656b205],
5	,	,	O	,	_	0	SENT_150	[p12l404t126r656b205],
6	many	JJ	O	many	amod	8	SENT_150	[p12l691t150r916b216],
7	other	JJ	O	other	amod	8	SENT_150	[p12l950t126r1158b194],
8	studies	NNS	O	study	appos	4	SENT_150	[p12l1191t126r1475b194],
9	have	VBP	O	have	aux	10	SENT_150	[p12l1509t126r1698b194],
10	revealed	VBN	O	reveal	_	0	SENT_150	[p12l1730t126r2074b194],
11	a	DT	O	a	det	13	SENT_150	[p12l2108t150r2148b194],
12	significant	JJ	O	significant	amod	13	SENT_150	[p12l9t228r436b317],
13	role	NN	O	role	dobj	10	SENT_150	[p12l478t228r632b296],
14	for	IN	O	for	_	0	SENT_150	[p12l679t228r789b296],
15	the	DT	O	the	det	19	SENT_150	[p12l832t228r956b296],
16	CYP3A5	NN	O	cyp3a5	nn	19	SENT_150	[p12l1008t232r1346b296],
17	*	NN	O	*	nn	19	SENT_150	[p12l1361t232r1440b296],
18	3	CD	NUMBER	3	num	19	SENT_150	[p12l1361t232r1440b296],
19	genotype	NN	O	genotype	prep_for	13	SENT_150	[p12l1484t238r1851b318],
20	in	IN	O	in	_	0	SENT_150	[p12l1898t232r1977b296],
21	the	DT	O	the	det	22	SENT_150	[p12l2021t228r2146b296],
22	disposition	NN	O	disposition	prep_in	10	SENT_150	[p12l10t329r465b418],
23	of	IN	O	of	_	0	SENT_150	[p12l498t329r578b397],
24	various	JJ	O	various	amod	26	SENT_150	[p12l602t332r899b397],
25	CYP3A	NN	O	cyp3a	nn	26	SENT_150	[p12l933t332r1226b397],
26	substrates	NNS	O	substrate	prep_of	22	SENT_150	[p12l1260t328r1894b397],
27	.	.	O	.	_	0	SENT_150	[p12l1260t328r1894b397],

1	”’	NN	O	”’	_	0	SENT_151	[p12l1260t328r1894b397],
2	2	CD	NUMBER	2	number	3	SENT_151	[p12l1260t328r1894b397],
3	°	CD	NUMBER	°	dep	1	SENT_151	[p12l1260t328r1894b397],
4	'23	CD	NUMBER	'23	dep	3	SENT_151	[p12l1260t328r1894b397],

1	Numerous	JJ	O	numerous	amod	3	SENT_152	[p12l114t437r548b501],
2	drug	NN	O	drug	nn	3	SENT_152	[p12l617t433r804b522],
3	interactions	NNS	O	interaction	nsubjpass	18	SENT_152	[p12l867t436r1368b501],
4	between	IN	O	between	_	0	SENT_152	[p12l1429t433r1783b501],
5	CYP3A	NN	O	cyp3a	nn	6	SENT_152	[p12l1846t436r2147b501],
6	inhibitors	NNS	O	inhibitor	prep_between	3	SENT_152	[p12l8t535r416b603],
7	and	CC	O	and	_	0	SENT_152	[p12l464t535r616b603],
8	simvastatin24	NN	O	simvastatin24	prep_between	3	SENT_152	[p12l662t534r1279b603],
9	’25	CD	NUMBER	’25	num	8	SENT_152	[p12l662t534r1279b603],
10	leading	VBG	O	lead	partmod	8	SENT_152	[p12l1326t534r1632b624],
11	to	TO	O	to	_	0	SENT_152	[p12l1676t544r1751b603],
12	elevated	JJ	O	elevated	amod	15	SENT_152	[p12l1800t535r2147b603],
13	plasma	NN	O	plasma	nn	15	SENT_152	[p12l7t636r285b726],
14	simvastatin	NN	O	simvastatin	nn	15	SENT_152	[p12l306t640r746b705],
15	levels	NNS	O	level	prep_to	10	SENT_152	[p12l767t636r986b705],
16	have	VBP	O	have	aux	18	SENT_152	[p12l1008t637r1189b705],
17	been	VBN	O	be	auxpass	18	SENT_152	[p12l1207t637r1393b705],
18	reported	VBN	O	report	_	0	SENT_152	[p12l1412t637r1755b726],
19	.	.	O	.	_	0	SENT_152	[p12l1412t637r1755b726],

1	Although	IN	O	although	mark	5	SENT_153	[p12l1781t637r2148b726],
2	we	PRP	O	we	nsubj	5	SENT_153	[p12l6t762r121b806],
3	could	MD	O	could	aux	5	SENT_153	[p12l166t738r393b806],
4	not	RB	O	not	neg	5	SENT_153	[p12l435t749r566b806],
5	find	VB	O	find	advcl	22	SENT_153	[p12l608t738r772b806],
6	any	DT	O	any	det	8	SENT_153	[p12l815t762r959b828],
7	previous	JJ	O	previous	amod	8	SENT_153	[p12l1001t742r1351b828],
8	data	NNS	O	datum	dobj	5	SENT_153	[p12l1399t738r1566b806],
9	assessing	VBG	O	assess	partmod	8	SENT_153	[p12l1609t742r1980b828],
10	the	DT	O	the	det	12	SENT_153	[p12l2021t738r2146b806],
11	genetic	JJ	O	genetic	amod	12	SENT_153	[p12l7t844r293b929],
12	inﬂuences	NNS	O	inﬂuences	dobj	9	SENT_153	[p12l335t840r754b908],
13	on	IN	O	on	_	0	SENT_153	[p12l797t864r895b908],
14	the	DT	O	the	det	15	SENT_153	[p12l932t840r1056b908],
15	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	9	SENT_153	[p12l1096t840r1819b930],
16	of	IN	O	of	_	0	SENT_153	[p12l1861t840r1942b908],
17	simvastatin	NN	O	simvastatin	prep_of	15	SENT_153	[p12l1975t844r2146b908, p12l6t945r347b1021],
18	,	,	O	,	_	0	SENT_153	[p12l1975t844r2146b908, p12l6t945r347b1021],
19	Kivisto	NNP	PERSON	Kivisto	nn	21	SENT_153	[p12l395t945r680b1010],
20	et	NNP	O	et	nn	21	SENT_153	[p12l728t952r798b1010],
21	al	NNP	O	al	nsubj	22	SENT_153	[p12l842t942r910b1010],
22	reported	VBD	O	report	_	0	SENT_153	[p12l954t942r1298b1031],
23	that	IN	O	that	_	0	SENT_153	[p12l1341t942r1497b1010],
24	the	DT	O	the	det	26	SENT_153	[p12l1540t942r1664b1010],
25	CYP3A5	NN	O	cyp3a5	nn	26	SENT_153	[p12l1714t945r2147b1010],
26	*	NN	O	*	prep_that	22	SENT_153	[p12l1714t945r2147b1010],
27	3	CD	NUMBER	3	dep	26	SENT_153	[p12l1714t945r2147b1010],

1	EFFECT	NN	O	effect	_	0	SENT_154	[p12l555t1106r713b1136],
2	OF	IN	O	of	_	0	SENT_154	[p12l726t1106r783b1136],
3	CYP3A5	NN	O	cyp3a5	prep_of	1	SENT_154	[p12l796t1106r998b1136],
4	*	CD	NUMBER	*	number	5	SENT_154	[p12l796t1106r998b1136],
5	3	CD	NUMBER	3	dep	1	SENT_154	[p12l796t1106r998b1136],
6	ON	IN	O	on	_	0	SENT_154	[p12l1015t1106r1081b1136],
7	THE	DT	O	the	det	8	SENT_154	[p12l1094t1106r1177b1136],
8	PK	NN	O	pk	prep_on	5	SENT_154	[p12l1188t1106r1245b1136],
9	OF	IN	O	of	_	0	SENT_154	[p12l1257t1106r1314b1136],
10	SIMVASTATIN	NNP	O	SIMVASTATIN	prep_of	8	SENT_154	[p12l1326t1106r1614b1136],
11	"	''	O	"	punct	10	SENT_154	[p12l96t1632r133b1642],

1	*	NN	O	*	nn	4	SENT_155	[p12l96t1632r133b1642],
2	3	CD	NUMBER	3	num	4	SENT_155	[p12l780t1630r817b1662],
3	E	NN	O	e	nn	4	SENT_155	[p12l96t1644r126b1712],
4	E	NN	O	e	_	0	SENT_155	[p12l780t1666r810b1708],
5	5	CD	NUMBER	5	dep	4	SENT_155	[p12l1462t1672r1499b1738],
6	ca	MD	O	can	rcmod	5	SENT_155	[p12l104t1714r133b1735],
7	-	:	O	-	_	0	SENT_155	[p12l780t1710r809b1736],
8	:	:	O	:	_	0	SENT_155	[p12l780t1710r809b1736],
9	5	CD	NUMBER	5	num	10	SENT_155	[p12l96t1738r134b1798],
10	E	NN	O	e	dep	4	SENT_155	[p12l780t1740r817b1796],
11	at	IN	O	at	prep	10	SENT_155	[p12l1463t1762r1493b1795],
12	.	.	O	.	_	0	SENT_155	[p12l1463t1762r1493b1795],

1	(	NN	O	(	nn	7	SENT_156	[p12l116t1802r135b1816],
2	B	NN	O	b	nn	7	SENT_156	[p12l116t1802r135b1816],
3	_	NN	O	_	nn	7	SENT_156	[p12l1463t1796r1491b1816],
4	l	NN	O	l	nn	7	SENT_156	[p12l1463t1796r1491b1816],
5	E	NN	O	e	nn	7	SENT_156	[p12l116t1818r134b1842],
6	g	NN	O	g	nn	7	SENT_156	[p12l780t1808r809b1860],
7	o	NN	O	o	_	0	SENT_156	[p12l1462t1820r1492b1844],
8	°	CD	NUMBER	°	number	9	SENT_156	[p12l96t1846r126b1870],
9	4	CD	NUMBER	4	dep	7	SENT_156	[p12l780t1862r809b1888],
10	:	:	O	:	_	0	SENT_156	[p12l780t1862r809b1888],

1	*	NN	O	*	_	0	SENT_157	[p12l248t2128r318b2155],
2	1	CD	NUMBER	1	num	1	SENT_157	[p12l248t2128r318b2155],
3	/	:	O	/	punct	7	SENT_157	[p12l248t2128r318b2155],
4	‘	CD	NUMBER	‘	number	5	SENT_157	[p12l248t2128r318b2155],
5	1	CD	NUMBER	1	num	7	SENT_157	[p12l248t2128r318b2155],
6	*	NN	O	*	nn	7	SENT_157	[p12l410t2128r483b2155],
7	1I	NN	O	1us	dep	1	SENT_157	[p12l410t2128r483b2155],
8	*	CD	NUMBER	*	number	9	SENT_157	[p12l410t2128r483b2155],
9	3	CD	NUMBER	3	num	14	SENT_157	[p12l410t2128r483b2155],
10	*	NN	O	*	nn	14	SENT_157	[p12l574t2128r645b2155],
11	3I	NN	O	3us	nn	14	SENT_157	[p12l574t2128r645b2155],
12	*	CD	NUMBER	*	number	13	SENT_157	[p12l574t2128r645b2155],
13	3	CD	NUMBER	3	num	14	SENT_157	[p12l574t2128r645b2155],
14	*	NN	O	*	dep	7	SENT_157	[p12l950t2132r1017b2158],
15	1I	NN	O	1us	nn	16	SENT_157	[p12l950t2132r1017b2158],
16	*	NN	O	*	dep	7	SENT_157	[p12l950t2132r1017b2158],
17	1	CD	NUMBER	1	number	18	SENT_157	[p12l950t2132r1017b2158],
18	*	CD	NUMBER	*	num	19	SENT_157	[p12l1107t2132r1178b2158],
19	1I	NN	O	1us	dep	16	SENT_157	[p12l1107t2132r1178b2158],
20	*	CD	NUMBER	*	number	21	SENT_157	[p12l1107t2132r1178b2158],
21	3	CD	NUMBER	3	num	19	SENT_157	[p12l1107t2132r1178b2158],
22	*	NN	O	*	dep	7	SENT_157	[p12l1264t2132r1335b2158],
23	3	CD	NUMBER	3	num	22	SENT_157	[p12l1264t2132r1335b2158],
24	:	:	O	:	_	0	SENT_157	[p12l1264t2132r1335b2158],
25	-	:	O	-	_	0	SENT_157	[p12l1264t2132r1335b2158],
26	*	NN	O	*	nn	29	SENT_157	[p12l1264t2132r1335b2158],
27	3	CD	NUMBER	3	num	29	SENT_157	[p12l1264t2132r1335b2158],
28	*	NN	O	*	nn	29	SENT_157	[p12l1632t2132r1699b2158],
29	1I	NN	O	1us	dep	1	SENT_157	[p12l1632t2132r1699b2158],
30	*	NN	O	*	dep	29	SENT_157	[p12l1632t2132r1699b2158],
31	1	CD	NUMBER	1	number	32	SENT_157	[p12l1632t2132r1699b2158],
32	*	CD	NUMBER	*	num	33	SENT_157	[p12l1790t2132r1861b2158],
33	1I	NN	O	1us	dep	30	SENT_157	[p12l1790t2132r1861b2158],
34	*	CD	NUMBER	*	number	35	SENT_157	[p12l1790t2132r1861b2158],
35	3	CD	NUMBER	3	num	40	SENT_157	[p12l1790t2132r1861b2158],
36	*	NN	O	*	nn	40	SENT_157	[p12l1947t2132r2018b2158],
37	3I	NN	O	3us	nn	40	SENT_157	[p12l1947t2132r2018b2158],
38	*	CD	NUMBER	*	number	39	SENT_157	[p12l1947t2132r2018b2158],
39	3	CD	NUMBER	3	num	40	SENT_157	[p12l1947t2132r2018b2158],
40	CYP3A5	NN	O	cyp3a5	dep	1	SENT_157	[p12l282t2192r431b2222],
41	Genotype	NN	O	genotype	nn	45	SENT_157	[p12l441t2192r611b2229],
42	CYP3A5	NN	O	cyp3a5	nn	45	SENT_157	[p12l982t2194r1125b2223],
43	Genotype	NN	O	genotype	nn	45	SENT_157	[p12l1136t2194r1301b2230],
44	CYP3A5	NN	O	cyp3a5	nn	45	SENT_157	[p12l1664t2194r1807b2223],
45	Genotype	NN	O	genotype	dep	40	SENT_157	[p12l1818t2194r1983b2231],

1	Figure	NN	O	figure	_	0	SENT_158	[p12l39t2330r136b2362],
2	2	CD	NUMBER	2	dep	1	SENT_158	[p12l146t2332r170b2354],
3	.	.	O	.	_	0	SENT_158	[p12l146t2332r170b2354],

1	Comparisons	NNS	O	comparison	_	0	SENT_159	[p12l212t2330r411b2362],
2	of	IN	O	of	_	0	SENT_159	[p12l422t2329r455b2362],
3	Cmax	NN	O	cmax	prep_of	1	SENT_159	[p12l461t2330r522b2363],
4	(	CD	NUMBER	(	num	3	SENT_159	[p12l532t2329r585b2359],
5	A	DT	O	a	det	6	SENT_159	[p12l532t2329r585b2359],
6	)	NN	O	)	dep	3	SENT_159	[p12l532t2329r585b2359],
7	,	,	O	,	_	0	SENT_159	[p12l532t2329r585b2359],
8	AUC	NN	O	auc	nn	11	SENT_159	[p12l596t2330r672b2354],
9	{	NN	O	{	nn	11	SENT_159	[p12l681t2329r729b2359],
10	B	NN	O	b	nn	11	SENT_159	[p12l681t2329r729b2359],
11	}	NN	O	}	conj_and	3	SENT_159	[p12l681t2329r729b2359],
12	,	,	O	,	_	0	SENT_159	[p12l681t2329r729b2359],
13	and	CC	O	and	_	0	SENT_159	[p12l742t2329r801b2354],
14	oral	JJ	O	oral	amod	18	SENT_159	[p12l811t2329r870b2354],
15	Clearance	NN	O	clearance	nn	18	SENT_159	[p12l880t2329r1026b2354],
16	(	NN	O	(	nn	18	SENT_159	[p12l1037t2329r1080b2359],
17	C	NN	O	c	nn	18	SENT_159	[p12l1037t2329r1080b2359],
18	)	NN	O	)	conj_and	3	SENT_159	[p12l1037t2329r1080b2359],
19	for	IN	O	for	_	0	SENT_159	[p12l1086t2329r1133b2362],
20	simvastatin	NN	O	simvastatin	prep_for	18	SENT_159	[p12l1142t2330r1316b2354],
21	according	VBG	O	accord	_	0	SENT_159	[p12l1328t2329r1479b2362],
22	to	TO	O	to	prepc_according_to	20	SENT_159	[p12l1489t2332r1516b2354],
23	CYP3A5	NNP	O	CYP3A5	nn	24	SENT_159	[p12l1526t2330r1653b2354],
24	genotype	NN	O	genotype	pobj	20	SENT_159	[p12l1664t2332r1802b2362],
25	after	IN	O	after	_	0	SENT_159	[p12l1813t2329r1883b2362],
26	administration	NN	O	administration	prep_after	1	SENT_159	[p12l1892t2329r2117b2354],
27	of	IN	O	of	_	0	SENT_159	[p12l41t2366r73b2400],
28	a	DT	O	a	det	32	SENT_159	[p12l81t2375r96b2392],
29	single	JJ	O	single	amod	32	SENT_159	[p12l109t2366r197b2400],
30	20-mg	NN	O	20-mg	nn	32	SENT_159	[p12l209t2369r303b2400],
31	oral	JJ	O	oral	amod	32	SENT_159	[p12l314t2366r373b2392],
32	dose	NN	O	dose	prep_of	1	SENT_159	[p12l385t2366r453b2392],
33	of	IN	O	of	_	0	SENT_159	[p12l465t2366r498b2400],
34	simvastatin	NN	O	simvastatin	prep_of	1	SENT_159	[p12l504t2367r679b2392],
35	in	IN	O	in	_	0	SENT_159	[p12l691t2367r720b2392],
36	healthy	JJ	O	healthy	amod	37	SENT_159	[p12l732t2366r849b2400],
37	subjects	NNS	O	subject	prep_in	1	SENT_159	[p12l858t2366r985b2400],
38	.	.	O	.	_	0	SENT_159	[p12l858t2366r985b2400],

1	Bars	NNS	O	bar	nsubj	2	SENT_160	[p12l998t2367r1066b2392],
2	indicate	VBP	O	indicate	_	0	SENT_160	[p12l1076t2366r1200b2392],
3	mean	JJ	O	mean	amod	4	SENT_160	[p12l1211t2375r1295b2392],
4	Values	NNS	O	value	dobj	2	SENT_160	[p12l1308t2366r1404b2392],
5	of	IN	O	of	_	0	SENT_160	[p12l1417t2366r1449b2400],
6	respective	JJ	O	respective	amod	7	SENT_160	[p12l1455t2367r1608b2400],
7	data	NNS	O	datum	prep_of	4	SENT_160	[p12l1621t2366r1694b2392],
8	.	.	O	.	_	0	SENT_160	[p12l1621t2366r1694b2392],

1	Table	NNP	O	Table	nn	2	SENT_161	[p12l141t2475r245b2507],
2	III	NNP	O	III	_	0	SENT_161	[p12l259t2477r307b2507],
3	Simple	NN	O	simple	dep	2	SENT_161	[p12l356t2475r489b2517],
4	and	CC	O	and	_	0	SENT_161	[p12l504t2475r574b2507],
5	Multiple	JJ	O	multiple	amod	7	SENT_161	[p12l588t2475r752b2517],
6	Regression	NN	O	regression	nn	7	SENT_161	[p12l767t2477r972b2517],
7	Coefficients	NNS	O	coefficient	conj_and	2	SENT_161	[p12l987t2475r1210b2507],
8	as	IN	O	as	_	0	SENT_161	[p12l1226t2487r1262b2507],
9	Well	NNP	O	Well	prep_as	7	SENT_161	[p12l1277t2475r1363b2507],
10	as	IN	O	as	dep	2	SENT_161	[p12l1379t2487r1415b2507],
11	Corresponding	VBG	O	correspond	pcomp	10	SENT_161	[p12l1431t2475r1711b2517],
12	1	CD	NUMBER	1	dobj	11	SENT_161	[p12l1725t2475r1758b2507],
13	'	''	O	'	_	0	SENT_161	[p12l1725t2475r1758b2507],
14	2	CD	NUMBER	2	num	15	SENT_161	[p12l1725t2475r1758b2507],
15	Values	NNS	O	value	dobj	11	SENT_161	[p12l1767t2475r1891b2507],
16	of	IN	O	of	_	0	SENT_161	[p12l1908t2475r1946b2507],
17	the	DT	O	the	prep_of	15	SENT_161	[p12l1957t2475r2015b2507],

1	Study	NNP	O	Study	nn	3	SENT_162	[p12l276t2524r387b2566],
2	Dependent	NNP	O	Dependent	nn	3	SENT_162	[p12l401t2524r608b2566],
3	Variables	NNP	O	Variables	nsubj	4	SENT_162	[p12l622t2524r794b2556],
4	Regressed	VBD	O	regress	_	0	SENT_162	[p12l810t2524r998b2566],
5	on	IN	O	on	_	0	SENT_162	[p12l1013t2535r1059b2556],
6	the	DT	O	the	det	7	SENT_162	[p12l1073t2524r1131b2556],
7	Presence	NN	O	presence	prep_on	4	SENT_162	[p12l1146t2526r1313b2556],
8	or	CC	O	or	_	0	SENT_162	[p12l1329t2535r1366b2556],
9	Absence	NN	O	absence	prep_on	4	SENT_162	[p12l1380t2524r1540b2556],
10	of	IN	O	of	_	0	SENT_162	[p12l1556t2524r1594b2556],
11	the	DT	O	the	det	13	SENT_162	[p12l1605t2524r1663b2556],
12	CYP3A5	NN	O	cyp3a5	nn	13	SENT_162	[p12l1680t2526r1882b2556],
13	*	NN	O	*	prep_of	7	SENT_162	[p12l1680t2526r1882b2556],
14	3	CD	NUMBER	3	dep	13	SENT_162	[p12l1680t2526r1882b2556],

1	Allele	NN	O	allele	_	0	SENT_163	[p12l665t2574r779b2606],
2	With	IN	O	with	prep	1	SENT_163	[p12l794t2574r886b2606],
3	and	CC	O	and	_	0	SENT_163	[p12l901t2574r970b2606],
4	Without	IN	O	without	prep	1	SENT_163	[p12l984t2574r1139b2606],
5	Adjusting	VBG	O	adjust	pcomp	4	SENT_163	[p12l1153t2574r1339b2616],
6	for	IN	O	for	_	0	SENT_163	[p12l1354t2574r1405b2606],
7	Age	NN	O	age	prep_for	5	SENT_163	[p12l1419t2576r1491b2616],

1	Dependent	JJ	O	dependent	amod	2	SENT_164	[p12l39t2660r205b2694],
2	Variables	NNS	O	variable	dep	13	SENT_164	[p12l216t2660r360b2686],
3	ra	NN	O	ra	dep	2	SENT_164	[p12l671t2669r698b2695],
4	1	CD	NUMBER	1	num	3	SENT_164	[p12l1035t2660r1073b2695],
5	'	''	O	'	_	0	SENT_164	[p12l1035t2660r1073b2695],
6	2	CD	NUMBER	2	dep	3	SENT_164	[p12l1035t2660r1073b2695],
7	“	CD	NUMBER	“	dep	13	SENT_164	[p12l1035t2660r1073b2695],
8	(	NN	O	(	nn	13	SENT_164	[p12l1081t2660r1113b2691],
9	P	NN	O	p	nn	13	SENT_164	[p12l1081t2660r1113b2691],
10	Value	NN	O	value	nn	13	SENT_164	[p12l1123t2660r1221b2691],
11	)	CD	NUMBER	)	num	13	SENT_164	[p12l1123t2660r1221b2691],
12	rb	NN	O	rb	nn	13	SENT_164	[p12l1558t2669r1586b2695],
13	rzb	NN	O	rzb	_	0	SENT_164	[p12l1910t2660r1952b2695],
14	(	CD	NUMBER	(	num	17	SENT_164	[p12l1960t2660r1992b2691],
15	P	NN	O	p	nn	17	SENT_164	[p12l1960t2660r1992b2691],
16	Value	NN	O	value	nn	17	SENT_164	[p12l2003t2660r2100b2691],
17	)	NN	O	)	dep	13	SENT_164	[p12l2003t2660r2100b2691],

1	Cmax	NN	O	cmax	dep	12	SENT_165	[p12l40t2757r107b2795],
2	0.416	CD	NUMBER	0.416	num	1	SENT_165	[p12l640t2760r730b2785],
3	0.173	CD	NUMBER	0.173	num	4	SENT_165	[p12l1008t2760r1097b2785],
4	(	NN	O	(	dep	1	SENT_165	[p12l1115t2756r1228b2790],
5	.0540	CD	NUMBER	.0540	number	6	SENT_165	[p12l1115t2756r1228b2790],
6	)	CD	NUMBER	)	num	8	SENT_165	[p12l1115t2756r1228b2790],
7	0.447	CD	NUMBER	0.447	number	8	SENT_165	[p12l1528t2760r1618b2785],
8	0.200	CD	NUMBER	0.200	dep	4	SENT_165	[p12l1896t2760r1986b2785],
9	(	NN	O	(	dep	12	SENT_165	[p12l2002t2756r2116b2790],
10	.1199	CD	NUMBER	.1199	num	9	SENT_165	[p12l2002t2756r2116b2790],
11	)	CD	NUMBER	)	num	12	SENT_165	[p12l2002t2756r2116b2790],
12	AUC	NN	O	auc	dep	20	SENT_165	[p12l39t2801r121b2828],
13	0.547	CD	NUMBER	0.547	number	14	SENT_165	[p12l640t2803r730b2828],
14	0.300	CD	NUMBER	0.300	num	15	SENT_165	[p12l1008t2803r1099b2828],
15	(	NN	O	(	dep	12	SENT_165	[p12l1115t2799r1228b2833],
16	.0084	CD	NUMBER	.0084	number	17	SENT_165	[p12l1115t2799r1228b2833],
17	)	CD	NUMBER	)	num	19	SENT_165	[p12l1115t2799r1228b2833],
18	0.634	CD	NUMBER	0.634	number	19	SENT_165	[p12l1528t2803r1618b2828],
19	0.402	CD	NUMBER	0.402	dep	15	SENT_165	[p12l1896t2803r1985b2828],
20	(	NN	O	(	dep	23	SENT_165	[p12l2002t2799r2116b2833],
21	.0075	CD	NUMBER	.0075	num	20	SENT_165	[p12l2002t2799r2116b2833],
22	)	CD	NUMBER	)	num	23	SENT_165	[p12l2002t2799r2116b2833],
23	CL/F	NN	O	cl/f	dep	26	SENT_165	[p12l40t2842r123b2871],
24	0.670	CD	NUMBER	0.670	num	26	SENT_165	[p12l640t2846r730b2871],
25	0.449	CD	NUMBER	0.449	num	26	SENT_165	[p12l1008t2846r1098b2871],
26	(	NN	O	(	dep	33	SENT_165	[p12l1115t2842r1228b2876],
27	.0007	CD	NUMBER	.0007	number	28	SENT_165	[p12l1115t2842r1228b2876],
28	)	CD	NUMBER	)	dep	26	SENT_165	[p12l1115t2842r1228b2876],
29	0.688	CD	NUMBER	0.688	num	31	SENT_165	[p12l1528t2846r1618b2871],
30	0.474	CD	NUMBER	0.474	num	31	SENT_165	[p12l1896t2846r1986b2871],
31	(	NN	O	(	dep	28	SENT_165	[p12l2002t2842r2116b2876],
32	.0022	CD	NUMBER	.0022	num	33	SENT_165	[p12l2002t2842r2116b2876],
33	)	NN	O	)	_	0	SENT_165	[p12l2002t2842r2116b2876],

1	r	NN	O	r	_	0	SENT_166	[p12l89t2931r102b2945],
2	=	JJ	O	=	amod	4	SENT_166	[p12l111t2933r126b2942],
3	regression	NN	O	regression	nn	4	SENT_166	[p12l136t2924r270b2952],
4	coefficient	NN	O	coefficient	dep	1	SENT_166	[p12l281t2923r425b2949],
5	;	:	O	;	_	0	SENT_166	[p12l281t2923r425b2949],
6	12	CD	NUMBER	12	num	9	SENT_166	[p12l436t2923r456b2945],
7	=	JJ	O	=	amod	9	SENT_166	[p12l467t2934r483b2942],
8	percentage	NN	O	percentage	nn	9	SENT_166	[p12l493t2926r634b2952],
9	variability	NN	O	variability	dep	1	SENT_166	[p12l645t2923r780b2952],
10	of	IN	O	of	_	0	SENT_166	[p12l791t2923r817b2945],
11	the	DT	O	the	det	19	SENT_166	[p12l825t2923r865b2945],
12	dependent	JJ	O	dependent	amod	19	SENT_166	[p12l877t2923r1016b2952],
13	variables	NNS	O	variable	nsubj	14	SENT_166	[p12l1026t2923r1143b2945],
14	explained	VBN	O	explain	ccomp	12	SENT_166	[p12l1154t2923r1284b2952],
15	by	IN	O	by	_	0	SENT_166	[p12l1293t2923r1326b2952],
16	CYP3A5	NN	O	cyp3a5	prep_by	14	SENT_166	[p12l1338t2924r1478b2945],
17	*	CD	NUMBER	*	number	18	SENT_166	[p12l1338t2924r1478b2945],
18	3	CD	NUMBER	3	num	19	SENT_166	[p12l1338t2924r1478b2945],
19	allele	NN	O	allele	prep_of	9	SENT_166	[p12l1488t2923r1566b2949],
20	;	:	O	;	_	0	SENT_166	[p12l1488t2923r1566b2949],
21	rm	NN	O	rm	dep	19	SENT_166	[p12l1577t2931r1597b2953],
22	=	JJ	O	=	amod	25	SENT_166	[p12l1608t2933r1623b2942],
23	bivariate	JJ	O	bivariate	amod	25	SENT_166	[p12l1633t2923r1748b2945],
24	regression	NN	O	regression	nn	25	SENT_166	[p12l1758t2924r1892b2952],
25	coefﬁcients	NNS	O	coefﬁcients	dep	21	SENT_166	[p12l1902t2923r2059b2949],
26	;	:	O	;	_	0	SENT_166	[p12l1902t2923r2059b2949],
27	rb	NN	O	rb	dep	1	SENT_166	[p12l2071t2931r2091b2953],
28	=	JJ	O	=	amod	27	SENT_166	[p12l2102t2933r2117b2942],
29	adjusted	VBN	O	adjust	partmod	27	SENT_166	[p12l102t2966r342b3029],
30	for	IN	O	for	_	0	SENT_166	[p12l364t2967r442b3014],
31	age	NN	O	age	prep_for	29	SENT_166	[p12l464t2983r568b3029],
32	.	.	O	.	_	0	SENT_166	[p12l464t2983r568b3029],

1	genotype	NN	O	genotype	nsubj	2	SENT_167	[p13l6t97r374b176],
2	affects	VBZ	O	affect	_	0	SENT_167	[p13l410t87r666b155],
3	lipid-lowering	JJ	O	lipid-lowering	amod	4	SENT_167	[p13l702t87r1289b176],
4	responses	NNS	O	response	dobj	2	SENT_167	[p13l1322t111r1719b176],
5	to	TO	O	to	_	0	SENT_167	[p13l1754t97r1827b155],
6	statins	NNS	O	statin	prep_to	4	SENT_167	[p13l1865t90r2149b166],
7	,	,	O	,	_	0	SENT_167	[p13l1865t90r2149b166],
8	including	VBG	O	include	dep	2	SENT_167	[p13l7t188r400b278],
9	simvastatin	NN	O	simvastatin	pobj	8	SENT_167	[p13l450t192r937b267],
10	,	,	O	,	_	0	SENT_167	[p13l450t192r937b267],
11	in	IN	O	in	_	0	SENT_167	[p13l988t192r1068b256],
12	patients	NNS	O	patient	prep_in	2	SENT_167	[p13l1115t188r1523b278],
13	.	.	O	.	_	0	SENT_167	[p13l1115t188r1523b278],

1	”	NN	O	”	nsubj	8	SENT_168	[p13l1115t188r1523b278],
2	Therefore	RB	O	therefore	advmod	8	SENT_168	[p13l1572t189r1987b267],
3	,	,	O	,	_	0	SENT_168	[p13l1572t189r1987b267],
4	we	PRP	O	we	nsubj	5	SENT_168	[p13l2036t213r2151b257],
5	could	MD	O	could	parataxis	8	SENT_168	[p13l8t290r236b358],
6	a	DT	O	a	det	7	SENT_168	[p13l267t314r307b358],
7	priori	FW	O	priori	nsubj	8	SENT_168	[p13l335t294r564b380],
8	postulate	VBP	O	postulate	_	0	SENT_168	[p13l594t290r966b380],
9	that	IN	O	that	complm	24	SENT_168	[p13l996t290r1153b358],
10	the	DT	O	the	det	12	SENT_168	[p13l1181t290r1305b358],
11	decreased	VBN	O	decrease	amod	12	SENT_168	[p13l1339t290r1739b358],
12	clearance	NN	O	clearance	nsubj	24	SENT_168	[p13l1770t290r2151b358],
13	of	IN	O	of	_	0	SENT_168	[p13l9t392r89b460],
14	simvastatin	NN	O	simvastatin	prep_of	12	SENT_168	[p13l132t396r598b460],
15	due	JJ	O	due	_	0	SENT_168	[p13l648t392r794b460],
16	to	TO	O	to	_	0	SENT_168	[p13l842t402r916b460],
17	the	DT	O	the	det	22	SENT_168	[p13l965t392r1089b460],
18	polymorphic	JJ	O	polymorphic	amod	22	SENT_168	[p13l1138t392r1664b482],
19	CYP3A5	NN	O	cyp3a5	nn	22	SENT_168	[p13l1719t396r2058b460],
20	*	NN	O	*	nn	22	SENT_168	[p13l2073t396r2152b460],
21	3	CD	NUMBER	3	num	22	SENT_168	[p13l2073t396r2152b460],
22	gene	NN	O	gene	prep_due_to	14	SENT_168	[p13l6t518r190b583],
23	should	MD	O	should	aux	24	SENT_168	[p13l227t494r505b562],
24	elevate	VB	O	elevate	ccomp	8	SENT_168	[p13l539t494r821b562],
25	simvastatin	NN	O	simvastatin	nn	26	SENT_168	[p13l858t498r1324b562],
26	levels	NNS	O	level	dobj	24	SENT_168	[p13l1358t494r1590b562],
27	in	IN	O	in	_	0	SENT_168	[p13l1626t498r1706b562],
28	the	DT	O	the	det	29	SENT_168	[p13l1739t494r1863b562],
29	blood	NN	O	blood	prep_in	26	SENT_168	[p13l1895t494r2149b573],
30	,	,	O	,	_	0	SENT_168	[p13l1895t494r2149b573],
31	thereby	RB	O	thereby	advmod	32	SENT_168	[p13l6t596r323b685],
32	eliciting	VBG	O	elicit	partmod	24	SENT_168	[p13l371t596r719b685],
33	higher	JJR	O	higher	amod	35	SENT_168	[p13l764t596r1035b685],
34	hypolipidemic	JJ	O	hypolipidemic	amod	35	SENT_168	[p13l1080t596r1705b685],
35	effects	NNS	O	effect	dobj	32	SENT_168	[p13l1755t596r2022b664],
36	in	IN	O	in	_	0	SENT_168	[p13l2071t599r2153b663],
37	CYP3A5	NN	O	cyp3a5	prep_in	32	SENT_168	[p13l12t702r446b766],
38	*	CD	NUMBER	*	number	39	SENT_168	[p13l12t702r446b766],
39	3	CD	NUMBER	3	num	40	SENT_168	[p13l12t702r446b766],
40	carriers	NNS	O	carrier	dep	32	SENT_168	[p13l481t702r803b766],
41	.	.	O	.	_	0	SENT_168	[p13l481t702r803b766],

1	However	RB	O	however	advmod	30	SENT_169	[p13l842t703r1223b777],
2	,	,	O	,	_	0	SENT_169	[p13l842t703r1223b777],
3	there	EX	O	there	expl	4	SENT_169	[p13l1260t699r1464b766],
4	is	VBZ	O	be	parataxis	30	SENT_169	[p13l1501t702r1563b766],
5	also	RB	O	also	advmod	4	SENT_169	[p13l1601t699r1757b766],
6	a	DT	O	a	det	8	SENT_169	[p13l1795t722r1835b766],
7	contradictory	JJ	O	contradictory	amod	8	SENT_169	[p13l1870t709r2151b766, p13l10t800r297b890],
8	report	NN	O	report	nsubj	4	SENT_169	[p13l329t811r576b890],
9	that	IN	O	that	complm	15	SENT_169	[p13l608t801r765b869],
10	the	DT	O	the	det	14	SENT_169	[p13l797t800r921b869],
11	CYP3A5	NN	O	cyp3a5	nn	14	SENT_169	[p13l963t804r1302b869],
12	*	NN	O	*	nn	14	SENT_169	[p13l1316t804r1396b869],
13	3	CD	NUMBER	3	num	14	SENT_169	[p13l1316t804r1396b869],
14	gene	NN	O	gene	nsubj	15	SENT_169	[p13l1429t824r1614b890],
15	has	VBZ	O	have	ccomp	4	SENT_169	[p13l1649t801r1782b869],
16	no	DT	O	no	det	17	SENT_169	[p13l1818t824r1917b869],
17	association	NN	O	association	dobj	15	SENT_169	[p13l1954t824r2151b869, p13l8t906r286b970],
18	with	IN	O	with	_	0	SENT_169	[p13l318t902r504b970],
19	the	DT	O	the	det	20	SENT_169	[p13l536t902r660b970],
20	efficacy	NN	O	efficacy	prep_with	17	SENT_169	[p13l696t902r1009b992],
21	and	CC	O	and	_	0	SENT_169	[p13l1042t902r1192b970],
22	safety	NN	O	safety	conj_and	20	SENT_169	[p13l1226t902r1460b992],
23	of	IN	O	of	_	0	SENT_169	[p13l1494t902r1574b970],
24	simvastatin	NN	O	simvastatin	prep_of	20	SENT_169	[p13l1602t902r2152b970],
25	.27	CD	NUMBER	.27	num	24	SENT_169	[p13l1602t902r2152b970],
26	However	RB	O	however	advmod	15	SENT_169	[p13l6t1009r384b1083],
27	,	,	O	,	_	0	SENT_169	[p13l6t1009r384b1083],
28	the	DT	O	the	det	29	SENT_169	[p13l413t1004r537b1072],
29	authors	NNS	O	author	nsubj	30	SENT_169	[p13l567t1004r864b1072],
30	described	VBD	O	describe	_	0	SENT_169	[p13l897t1004r1284b1072],
31	that	IN	O	that	complm	65	SENT_169	[p13l1310t1004r1485b1083],
32	,	,	O	,	_	0	SENT_169	[p13l1310t1004r1485b1083],
33	similar	JJ	O	similar	nsubj	65	SENT_169	[p13l1518t1004r1798b1072],
34	to	TO	O	to	_	0	SENT_169	[p13l1824t1014r1897b1072],
35	a	DT	O	a	det	37	SENT_169	[p13l1928t1028r1968b1072],
36	previous	JJ	O	previous	amod	37	SENT_169	[p13l1994t1028r2151b1094, p13l6t1110r223b1174],
37	finding	NN	O	finding	prep_to	33	SENT_169	[p13l279t1106r654b1195],
38	,	,	O	,	_	0	SENT_169	[p13l279t1106r654b1195],
39	”	IN	O	”	_	0	SENT_169	[p13l279t1106r654b1195],
40	the	DT	O	the	det	44	SENT_169	[p13l707t1106r832b1174],
41	mean	NN	O	mean	nn	44	SENT_169	[p13l885t1130r1105b1174],
42	low-density	JJ	O	low-density	amod	44	SENT_169	[p13l1159t1106r1642b1195],
43	lipoprotein	NN	O	lipoprotein	nn	44	SENT_169	[p13l1695t1106r2153b1196],
44	concentration	NN	O	concentration	nsubj	47	SENT_169	[p13l8t1211r570b1276],
45	in	IN	O	in	_	0	SENT_169	[p13l607t1211r687b1275],
46	subjects	NNS	O	subject	prep_in	44	SENT_169	[p13l724t1208r1044b1297],
47	possessing	VBG	O	possess	prepc_”	65	SENT_169	[p13l1083t1211r1516b1297],
48	the	DT	O	the	det	50	SENT_169	[p13l1552t1208r1676b1276],
49	CYP3/l5	NN	O	cyp3/l5	nn	50	SENT_169	[p13l1719t1211r2145b1276],
50	*	NN	O	*	dobj	47	SENT_169	[p13l1719t1211r2145b1276],
51	1	CD	NUMBER	1	num	52	SENT_169	[p13l1719t1211r2145b1276],
52	allele	NN	O	allele	nsubj	65	SENT_169	[p13l8t1311r235b1379],
53	was	VBD	O	be	cop	65	SENT_169	[p13l276t1335r434b1379],
54	24	CD	PERCENT	24	num	55	SENT_169	[p13l480t1311r657b1384],
55	%	NN	PERCENT	%	npadvmod	56	SENT_169	[p13l480t1311r657b1384],
56	higher	JJR	O	higher	amod	65	SENT_169	[p13l706t1311r977b1400],
57	than	IN	O	than	mark	64	SENT_169	[p13l1015t1311r1203b1379],
58	in	IN	O	in	dep	59	SENT_169	[p13l1244t1314r1325b1378],
59	CYP3/l5	NN	O	cyp3/l5	dep	61	SENT_169	[p13l1371t1311r1956b1379],
60	*	CD	NUMBER	*	num	59	SENT_169	[p13l1371t1311r1956b1379],
61	3	CD	NUMBER	3	dep	64	SENT_169	[p13l1371t1311r1956b1379],
62	/	:	O	/	punct	64	SENT_169	[p13l1371t1311r1956b1379],
63	*	CD	NUMBER	*	num	64	SENT_169	[p13l1371t1311r1956b1379],
64	3	CD	NUMBER	3	dep	56	SENT_169	[p13l1371t1311r1956b1379],
65	carriers	NNS	O	carrier	ccomp	30	SENT_169	[p13l1998t1335r2151b1379, p13l6t1416r218b1491],
66	,	,	O	,	_	0	SENT_169	[p13l1998t1335r2151b1379, p13l6t1416r218b1491],
67	albeit	IN	O	albeit	advmod	65	SENT_169	[p13l257t1412r491b1481],
68	without	IN	O	without	_	0	SENT_169	[p13l524t1412r857b1481],
69	statistical	JJ	O	statistical	amod	70	SENT_169	[p13l893t1412r1298b1481],
70	significance	NN	O	significance	prep_without	67	SENT_169	[p13l1336t1413r1865b1502],
71	.	.	O	.	_	0	SENT_169	[p13l1336t1413r1865b1502],

1	These	DT	O	these	det	2	SENT_170	[p13l1905t1412r2151b1481],
2	authors	NNS	O	author	nsubj	4	SENT_170	[p13l8t1514r308b1582],
3	also	RB	O	also	advmod	4	SENT_170	[p13l369t1514r525b1582],
4	suggested	VBD	O	suggest	_	0	SENT_170	[p13l586t1514r978b1604],
5	that	IN	O	that	complm	8	SENT_170	[p13l1034t1514r1191b1582],
6	their	PRP$	O	they	dep	8	SENT_170	[p13l1245t1514r1437b1582],
7	relatively	RB	O	relatively	advmod	8	SENT_170	[p13l1491t1514r1877b1604],
8	small	JJ	O	small	dep	4	SENT_170	[p13l1935t1514r2152b1582],

1	PHARMACOGENOMICS	NN	O	pharmacogenomic	nn	3	SENT_171	[p13l11t1765r852b1826],
2	sample	NN	O	sample	nn	3	SENT_171	[p13l9t1860r294b1949],
3	size	NN	O	size	nsubj	6	SENT_171	[p13l336t1863r487b1928],
4	might	MD	O	might	aux	6	SENT_171	[p13l526t1860r762b1949],
5	have	VB	O	have	aux	6	SENT_171	[p13l798t1860r987b1928],
6	caused	VBN	O	cause	_	0	SENT_171	[p13l1028t1860r1306b1928],
7	results	NNS	O	result	dobj	6	SENT_171	[p13l1342t1860r1610b1928],
8	that	WDT	O	that	nsubj	9	SENT_171	[p13l1650t1860r1807b1928],
9	conﬂict	VBP	O	conﬂict	rcmod	7	SENT_171	[p13l1845t1860r2154b1928],
10	with	IN	O	with	_	0	SENT_171	[p13l6t1962r192b2030],
11	previous	JJ	O	previous	amod	12	SENT_171	[p13l242t1965r594b2051],
12	findings	NNS	O	finding	prep_with	9	SENT_171	[p13l648t1962r1001b2051],
13	.	.	O	.	_	0	SENT_171	[p13l648t1962r1001b2051],

1	In	IN	O	in	_	0	SENT_172	[p13l1056t1966r1137b2029],
2	addition	NN	O	addition	prep_in	23	SENT_172	[p13l1189t1962r1553b2040],
3	,	,	O	,	_	0	SENT_172	[p13l1189t1962r1553b2040],
4	because	IN	O	because	mark	8	SENT_172	[p13l1604t1962r1925b2030],
5	they	PRP	O	they	nsubj	8	SENT_172	[p13l1977t1962r2153b2051],
6	could	MD	O	could	aux	8	SENT_172	[p13l8t2063r236b2131],
7	not	RB	O	not	neg	8	SENT_172	[p13l262t2074r393b2131],
8	recruit	VB	O	recruit	advcl	23	SENT_172	[p13l417t2067r689b2131],
9	any	DT	O	any	det	11	SENT_172	[p13l715t2087r860b2153],
10	CYP3A5	NN	O	cyp3a5	nn	11	SENT_172	[p13l891t2067r1229b2131],
11	*	NN	O	*	dobj	8	SENT_172	[p13l1244t2063r1447b2131],
12	1	CD	NUMBER	1	num	11	SENT_172	[p13l1244t2063r1447b2131],
13	/	:	O	/	punct	14	SENT_172	[p13l1244t2063r1447b2131],
14	*	CD	NUMBER	*	dep	8	SENT_172	[p13l1244t2063r1447b2131],
15	1	CD	NUMBER	1	num	16	SENT_172	[p13l1244t2063r1447b2131],
16	carriers	NNS	O	carrier	dep	14	SENT_172	[p13l1483t2067r1807b2142],
17	,	,	O	,	_	0	SENT_172	[p13l1483t2067r1807b2142],
18	it	PRP	O	it	nsubj	23	SENT_172	[p13l1837t2067r1893b2131],
19	might	MD	O	might	aux	23	SENT_172	[p13l1917t2063r2154b2153],
20	not	RB	O	not	neg	23	SENT_172	[p13l6t2175r138b2233],
21	have	VB	O	have	aux	23	SENT_172	[p13l168t2165r357b2233],
22	been	VBN	O	be	cop	23	SENT_172	[p13l387t2165r580b2233],
23	possible	JJ	O	possible	_	0	SENT_172	[p13l612t2165r944b2255],
24	to	TO	O	to	aux	25	SENT_172	[p13l977t2176r1050b2233],
25	observe	VB	O	observe	xcomp	23	SENT_172	[p13l1086t2165r1392b2233],
26	an	DT	O	a	det	28	SENT_172	[p13l1427t2189r1521b2233],
27	obvious	JJ	O	obvious	amod	28	SENT_172	[p13l1554t2165r1869b2233],
28	difference	NN	O	difference	dobj	25	SENT_172	[p13l1906t2165r2151b2233, p13l8t2291r190b2335],
29	between	IN	O	between	_	0	SENT_172	[p13l225t2267r567b2335],
30	CYP3A5	NN	O	cyp3a5	nn	32	SENT_172	[p13l604t2271r942b2335],
31	genotype	NN	O	genotype	nn	32	SENT_172	[p13l983t2277r1351b2357],
32	groups	NNS	O	group	prep_between	28	SENT_172	[p13l1388t2291r1682b2357],
33	.	.	O	.	_	0	SENT_172	[p13l1388t2291r1682b2357],

1	Consistent	JJ	O	consistent	nsubj	53	SENT_173	[p13l1725t2271r2154b2335],
2	with	IN	O	with	_	0	SENT_173	[p13l6t2369r192b2437],
3	this	DT	O	this	prep_with	1	SENT_173	[p13l230t2369r402b2448],
4	,	,	O	,	_	0	SENT_173	[p13l230t2369r402b2448],
5	in	IN	O	in	_	0	SENT_173	[p13l446t2372r525b2436],
6	our	PRP$	O	we	poss	7	SENT_173	[p13l567t2393r701b2437],
7	study	NN	O	study	prep_in	53	SENT_173	[p13l741t2369r979b2458],
8	,	,	O	,	_	0	SENT_173	[p13l741t2369r979b2458],
9	despite	IN	O	despite	_	0	SENT_173	[p13l1025t2369r1314b2458],
10	a	DT	O	a	det	12	SENT_173	[p13l1356t2393r1397b2437],
11	significant	JJ	O	significant	amod	12	SENT_173	[p13l1437t2369r1865b2458],
12	difference	NN	O	difference	prep_despite	53	SENT_173	[p13l1906t2369r2151b2437, p13l8t2496r194b2540],
13	in	IN	O	in	_	0	SENT_173	[p13l242t2475r323b2539],
14	CL/F	NN	O	cl/f	prep_in	12	SENT_173	[p13l368t2472r571b2540],
15	between	IN	O	between	_	0	SENT_173	[p13l614t2472r965b2540],
16	CYP3/l5	NN	O	cyp3/l5	nn	17	SENT_173	[p13l1015t2472r1587b2540],
17	*	NN	O	*	prep_between	14	SENT_173	[p13l1015t2472r1587b2540],
18	1	CD	NUMBER	1	num	17	SENT_173	[p13l1015t2472r1587b2540],
19	/	:	O	/	punct	22	SENT_173	[p13l1015t2472r1587b2540],
20	*	CD	NUMBER	*	number	21	SENT_173	[p13l1015t2472r1587b2540],
21	1	CD	NUMBER	1	num	22	SENT_173	[p13l1015t2472r1587b2540],
22	carriers	NNS	O	carrier	dep	14	SENT_173	[p13l1641t2475r1952b2540],
23	and	CC	O	and	_	0	SENT_173	[p13l2001t2472r2153b2540],
24	CYP3A5	NN	O	cyp3a5	dep	14	SENT_173	[p13l12t2578r338b2643],
25	*	CD	NUMBER	*	number	26	SENT_173	[p13l351t2575r552b2643],
26	3	CD	NUMBER	3	dep	24	SENT_173	[p13l351t2575r552b2643],
27	/	:	O	/	punct	30	SENT_173	[p13l351t2575r552b2643],
28	*	CD	NUMBER	*	number	29	SENT_173	[p13l351t2575r552b2643],
29	3	CD	NUMBER	3	num	30	SENT_173	[p13l351t2575r552b2643],
30	carriers	NNS	O	carrier	dep	26	SENT_173	[p13l577t2578r881b2653],
31	,	,	O	,	_	0	SENT_173	[p13l577t2578r881b2653],
32	the	DT	O	the	det	34	SENT_173	[p13l907t2574r1026b2643],
33	potential	JJ	O	potential	amod	34	SENT_173	[p13l1052t2575r1394b2664],
34	difference	NN	O	difference	appos	30	SENT_173	[p13l1422t2575r1804b2643],
35	between	IN	O	between	_	0	SENT_173	[p13l1825t2575r2153b2643],
36	CYP3/l5	NN	O	cyp3/l5	nn	37	SENT_173	[p13l12t2676r596b2745],
37	*	NN	O	*	prep_between	30	SENT_173	[p13l12t2676r596b2745],
38	1	CD	NUMBER	1	num	37	SENT_173	[p13l12t2676r596b2745],
39	/	:	O	/	punct	30	SENT_173	[p13l12t2676r596b2745],
40	*	CD	NUMBER	*	number	41	SENT_173	[p13l12t2676r596b2745],
41	3	CD	NUMBER	3	num	42	SENT_173	[p13l12t2676r596b2745],
42	carriers	NNS	O	carrier	dep	24	SENT_173	[p13l642t2680r956b2745],
43	and	CC	O	and	_	0	SENT_173	[p13l1004t2676r1157b2745],
44	CYP3/l5	NN	O	cyp3/l5	conj_and	22	SENT_173	[p13l1206t2676r1791b2745],
45	*	CD	NUMBER	*	number	46	SENT_173	[p13l1206t2676r1791b2745],
46	3	CD	NUMBER	3	dep	44	SENT_173	[p13l1206t2676r1791b2745],
47	/	:	O	/	punct	22	SENT_173	[p13l1206t2676r1791b2745],
48	*	CD	NUMBER	*	number	49	SENT_173	[p13l1206t2676r1791b2745],
49	3	CD	NUMBER	3	num	50	SENT_173	[p13l1206t2676r1791b2745],
50	carriers	NNS	O	carrier	nsubj	53	SENT_173	[p13l1836t2680r2150b2745],
51	did	VBD	O	do	aux	53	SENT_173	[p13l10t2779r142b2847],
52	not	RB	O	not	neg	53	SENT_173	[p13l173t2789r305b2847],
53	reach	VB	O	reach	_	0	SENT_173	[p13l334t2779r555b2847],
54	statistical	JJ	O	statistical	amod	55	SENT_173	[p13l588t2779r974b2847],
55	significance	NN	O	significance	dobj	53	SENT_173	[p13l1009t2779r1514b2869],
56	.	.	O	.	_	0	SENT_173	[p13l1009t2779r1514b2869],

1	In	IN	O	in	_	0	SENT_174	[p13l114t2886r195b2949],
2	this	DT	O	this	det	3	SENT_174	[p13l221t2881r369b2949],
3	study	NN	O	study	prep_in	13	SENT_174	[p13l400t2881r638b2970],
4	,	,	O	,	_	0	SENT_174	[p13l400t2881r638b2970],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_174	[p13l669t2881r1353b2971],
6	parameters	NNS	O	parameter	nsubj	13	SENT_174	[p13l1383t2891r1829b2971],
7	including	VBG	O	include	_	0	SENT_174	[p13l1859t2881r2151b2949, p13l7t2986r132b3072],
8	AUC	NN	O	auc	prep_including	6	SENT_174	[p13l180t2986r374b3051],
9	and	CC	O	and	_	0	SENT_174	[p13l426t2983r575b3051],
10	CL/F	NN	O	cl/f	prep_including	6	SENT_174	[p13l625t2983r823b3051],
11	were	VBD	O	be	cop	13	SENT_174	[p13l871t3007r1066b3051],
12	varied	JJ	O	varied	amod	13	SENT_174	[p13l1115t2983r1372b3051],
13	gene-dose	NN	O	gene-dose	_	0	SENT_174	[p13l1420t2983r1823b3072],
14	dependently	RB	O	dependently	advmod	13	SENT_174	[p13l1876t2983r2151b3072, p13l10t3086r267b3175],
15	according	VBG	O	accord	_	0	SENT_174	[p13l314t3086r711b3175],
16	to	TO	O	to	prepc_according_to	13	SENT_174	[p13l758t3096r832b3154],
17	CYP3A5	NNP	O	CYP3A5	nn	18	SENT_174	[p13l886t3089r1225b3154],
18	genotype	NN	O	genotype	pobj	13	SENT_174	[p13l1270t3096r1659b3175],
19	.	.	O	.	_	0	SENT_174	[p13l1270t3096r1659b3175],

1	Given	VBN	O	give	_	0	SENT_175	[p13l1712t3089r1951b3154],
2	that	IN	O	that	complm	19	SENT_175	[p13l1997t3086r2154b3154],
3	the	DT	O	the	det	4	SENT_175	[p13l6t3188r130b3256],
4	prevalence	NN	O	prevalence	nsubj	19	SENT_175	[p13l160t3188r602b3277],
5	of	IN	O	of	_	0	SENT_175	[p13l634t3188r715b3256],
6	CYP3A5	NN	O	cyp3a5	prep_of	4	SENT_175	[p13l740t3191r1079b3256],
7	*	CD	NUMBER	*	number	8	SENT_175	[p13l1095t3188r1305b3256],
8	3	CD	NUMBER	3	amod	6	SENT_175	[p13l1095t3188r1305b3256],
9	/	:	O	/	punct	11	SENT_175	[p13l1095t3188r1305b3256],
10	*	CD	NUMBER	*	number	11	SENT_175	[p13l1095t3188r1305b3256],
11	3	CD	NUMBER	3	dep	8	SENT_175	[p13l1095t3188r1305b3256],
12	in	IN	O	in	_	0	SENT_175	[p13l1334t3191r1414b3255],
13	the	DT	O	the	det	15	SENT_175	[p13l1441t3188r1566b3256],
14	Korean	JJ	MISC	korean	amod	15	SENT_175	[p13l1596t3192r1885b3256],
15	population	NN	O	population	prep_in	11	SENT_175	[p13l1913t3212r2151b3277, p13l7t3289r242b3357],
16	is	VBZ	O	be	cop	19	SENT_175	[p13l275t3293r337b3357],
17	approximately	RB	O	approximately	quantmod	19	SENT_175	[p13l375t3289r967b3379],
18	60	CD	NUMBER	60	number	19	SENT_175	[p13l1002t3289r1268b3368],
19	°	CD	NUMBER	°	ccomp	1	SENT_175	[p13l1002t3289r1268b3368],
20	/	:	O	/	punct	21	SENT_175	[p13l1002t3289r1268b3368],
21	o	NN	O	o	dep	19	SENT_175	[p13l1002t3289r1268b3368],
22	,28	CD	NUMBER	,28	num	21	SENT_175	[p13l1002t3289r1268b3368],
23	a	DT	O	a	det	25	SENT_175	[p13l1304t3313r1344b3357],
24	significant	JJ	O	significant	amod	25	SENT_175	[p13l1379t3289r1806b3379],
25	fraction	NN	O	fraction	dep	21	SENT_175	[p13l1839t3289r2153b3357],

1	KIM	NNP	O	KIM	nn	3	SENT_176	[p13l974t3681r1056b3710],
2	ET	NNP	O	ET	nn	3	SENT_176	[p13l1065t3681r1122b3710],
3	AL	NNP	O	AL	_	0	SENT_176	[p13l1131t3681r1187b3710],

1	of	IN	O	of	amod	3	SENT_177	[p14l19t114r99b182],
2	the	DT	O	the	det	3	SENT_177	[p14l130t114r253b182],
3	population	NN	O	population	nsubj	7	SENT_177	[p14l294t114r739b203],
4	may	MD	O	may	aux	7	SENT_177	[p14l777t138r947b203],
5	be	VB	O	be	cop	7	SENT_177	[p14l982t114r1073b182],
6	more	RBR	O	more	advmod	7	SENT_177	[p14l1113t138r1315b182],
7	exposed	VBN	O	expose	_	0	SENT_177	[p14l1357t114r1687b203],
8	to	TO	O	to	_	0	SENT_177	[p14l1725t124r1798b182],
9	simvastatin	NN	O	simvastatin	prep_to	7	SENT_177	[p14l1841t117r2145b182, p14l16t220r200b285],
10	with	IN	O	with	_	0	SENT_177	[p14l245t217r429b285],
11	this	DT	O	this	det	13	SENT_177	[p14l473t217r620b285],
12	susceptible	JJ	O	susceptible	amod	13	SENT_177	[p14l670t217r1121b306],
13	genotype	NN	O	genotype	prep_with	7	SENT_177	[p14l1167t227r1553b306],
14	.	.	O	.	_	0	SENT_177	[p14l1167t227r1553b306],

1	In	IN	O	in	_	0	SENT_178	[p14l1604t221r1684b284],
2	this	DT	O	this	det	3	SENT_178	[p14l1728t217r1875b285],
3	situation	NN	O	situation	prep_in	9	SENT_178	[p14l1925t220r2144b285, p14l16t322r197b397],
4	,	,	O	,	_	0	SENT_178	[p14l1925t220r2144b285, p14l16t322r197b397],
5	therapeutic	JJ	O	therapeutic	amod	6	SENT_178	[p14l255t318r713b408],
6	effect	NN	O	effect	nsubjpass	9	SENT_178	[p14l773t319r990b387],
7	might	MD	O	might	aux	9	SENT_178	[p14l1045t318r1279b408],
8	be	VB	O	be	auxpass	9	SENT_178	[p14l1331t318r1422b387],
9	elevated	VBN	O	elevate	_	0	SENT_178	[p14l1481t318r1816b387],
10	by	IN	O	by	_	0	SENT_178	[p14l1868t318r1967b408],
11	the	DT	O	the	det	13	SENT_178	[p14l2021t318r2145b387],
12	increased	VBN	O	increase	amod	13	SENT_178	[p14l18t420r391b488],
13	exposure	NN	O	exposure	agent	9	SENT_178	[p14l415t444r768b510],
14	of	IN	O	of	_	0	SENT_178	[p14l793t420r872b488],
15	simvastatin	NN	O	simvastatin	prep_of	13	SENT_178	[p14l889t424r1357b499],
16	,	,	O	,	_	0	SENT_178	[p14l889t424r1357b499],
17	whereas	IN	O	whereas	mark	31	SENT_178	[p14l1382t420r1703b488],
18	the	DT	O	the	det	19	SENT_178	[p14l1726t420r1847b488],
19	chance	NN	O	chance	nsubjpass	31	SENT_178	[p14l1873t420r2145b488],
20	of	IN	O	of	_	0	SENT_178	[p14l19t522r99b590],
21	development	NN	O	development	prep_of	19	SENT_178	[p14l135t522r662b612],
22	of	IN	O	of	_	0	SENT_178	[p14l703t522r783b590],
23	side	JJ	O	side	amod	24	SENT_178	[p14l818t522r978b590],
24	effects	NNS	O	effect	prep_of	21	SENT_178	[p14l1021t522r1274b590],
25	related	VBN	O	relate	partmod	24	SENT_178	[p14l1316t522r1594b590],
26	to	TO	O	to	_	0	SENT_178	[p14l1633t532r1707b590],
27	drug	NN	O	drug	nn	28	SENT_178	[p14l1752t522r1932b611],
28	concentrations	NNS	O	concentration	prep_to	25	SENT_178	[p14l1974t546r2145b590, p14l19t627r465b690],
29	would	MD	O	would	aux	31	SENT_178	[p14l497t623r756b690],
30	be	VB	O	be	auxpass	31	SENT_178	[p14l784t623r875b690],
31	increased	VBN	O	increase	advcl	9	SENT_178	[p14l908t622r1377b690],
32	.	.	O	.	_	0	SENT_178	[p14l908t622r1377b690],

1	“	NN	O	“	_	0	SENT_179	[p14l908t622r1377b690],

1	Conversely	RB	O	conversely	advmod	31	SENT_180	[p14l124t725r588b814],
2	,	,	O	,	_	0	SENT_180	[p14l124t725r588b814],
3	despite	IN	O	despite	_	0	SENT_180	[p14l631t725r919b814],
4	the	DT	O	the	det	5	SENT_180	[p14l956t725r1080b793],
5	differences	NNS	O	difference	prep_despite	31	SENT_180	[p14l1121t725r1560b793],
6	in	IN	O	in	_	0	SENT_180	[p14l1600t728r1679b792],
7	pharmacokinetic	JJ	O	pharmacokinetic	amod	8	SENT_180	[p14l1716t725r2145b814, p14l16t828r283b896],
8	parameters	NNS	O	parameter	prep_in	5	SENT_180	[p14l310t838r761b917],
9	,	,	O	,	_	0	SENT_180	[p14l310t838r761b917],
10	including	VBG	O	include	_	0	SENT_180	[p14l790t828r1168b917],
11	CL	NN	O	cl	prep_including	5	SENT_180	[p14l1193t828r1332b896],
12	/	:	O	/	punct	13	SENT_180	[p14l1193t828r1332b896],
13	F	NN	O	f	dep	11	SENT_180	[p14l1336t832r1385b895],
14	and	CC	O	and	_	0	SENT_180	[p14l1411t828r1556b896],
15	AUC	NN	O	auc	dep	11	SENT_180	[p14l1580t831r1791b906],
16	,	,	O	,	_	0	SENT_180	[p14l1580t831r1791b906],
17	between	IN	O	between	_	0	SENT_180	[p14l1815t828r2146b896],
18	CYP3A5	NN	O	cyp3a5	nn	19	SENT_180	[p14l22t933r358b998],
19	genotypes	NNS	O	genotype	prep_between	13	SENT_180	[p14l382t940r810b1019],
20	,	,	O	,	_	0	SENT_180	[p14l382t940r810b1019],
21	other	JJ	O	other	amod	22	SENT_180	[p14l842t929r1048b998],
22	parameters	NNS	O	parameter	nsubj	31	SENT_180	[p14l1074t940r1540b1019],
23	,	,	O	,	_	0	SENT_180	[p14l1074t940r1540b1019],
24	including	VBG	O	include	_	0	SENT_180	[p14l1571t929r1960b1019],
25	Cmax	NNP	PERSON	Cmax	prep_including	22	SENT_180	[p14l1988t933r2147b1021],
26	and	CC	O	and	_	0	SENT_180	[p14l18t1031r166b1099],
27	half-life	NN	O	half-life	prep_including	22	SENT_180	[p14l215t1031r553b1110],
28	,	,	O	,	_	0	SENT_180	[p14l215t1031r553b1110],
29	did	VBD	O	do	aux	31	SENT_180	[p14l609t1031r740b1099],
30	not	RB	O	not	neg	31	SENT_180	[p14l789t1042r919b1099],
31	show	VB	O	show	_	0	SENT_180	[p14l970t1031r1182b1099],
32	any	DT	O	any	det	34	SENT_180	[p14l1232t1055r1375b1121],
33	significant	JJ	O	significant	amod	34	SENT_180	[p14l1426t1031r1850b1121],
34	differences	NNS	O	difference	dobj	31	SENT_180	[p14l1901t1031r2144b1099, p14l19t1157r238b1201],
35	between	IN	O	between	_	0	SENT_180	[p14l269t1133r609b1201],
36	genotype	NN	O	genotype	nn	37	SENT_180	[p14l640t1143r1006b1223],
37	groups	NNS	O	group	prep_between	34	SENT_180	[p14l1038t1157r1333b1223],
38	,	,	O	,	_	0	SENT_180	[p14l1038t1157r1333b1223],
39	although	IN	O	although	mark	41	SENT_180	[p14l1370t1133r1725b1222],
40	there	EX	O	there	expl	41	SENT_180	[p14l1756t1133r1958b1201],
41	was	VBD	O	be	advcl	31	SENT_180	[p14l1991t1157r2144b1201],
42	a	DT	O	a	det	43	SENT_180	[p14l18t1259r58b1303],
43	trend	NN	O	trend	nsubj	41	SENT_180	[p14l83t1235r297b1303],
44	toward	IN	O	toward	_	0	SENT_180	[p14l323t1235r605b1303],
45	being	VBG	O	be	auxpass	46	SENT_180	[p14l629t1235r850b1324],
46	influenced	VBN	O	influence	prepc_toward	43	SENT_180	[p14l877t1235r1312b1303],
47	by	IN	O	by	_	0	SENT_180	[p14l1335t1235r1433b1324],
48	the	DT	O	the	det	49	SENT_180	[p14l1458t1235r1582b1303],
49	genotypes	NNS	O	genotype	agent	46	SENT_180	[p14l1609t1245r2034b1325],
50	.	.	O	.	_	0	SENT_180	[p14l1609t1245r2034b1325],

1	In	IN	O	in	_	0	SENT_181	[p14l2066t1240r2146b1303],
2	this	DT	O	this	det	3	SENT_181	[p14l16t1337r163b1405],
3	study	NN	O	study	pobj	1	SENT_181	[p14l197t1337r433b1426],
4	,	,	O	,	_	0	SENT_181	[p14l197t1337r433b1426],
5	the	DT	O	the	det	6	SENT_181	[p14l465t1337r589b1405],
6	number	NN	O	number	appos	3	SENT_181	[p14l619t1337r932b1405],
7	of	IN	O	of	_	0	SENT_181	[p14l963t1337r1043b1405],
8	CYP3A5	NN	O	cyp3a5	nn	9	SENT_181	[p14l1071t1340r1407b1405],
9	*	NN	O	*	prep_of	6	SENT_181	[p14l1422t1340r1493b1404],
10	1	CD	NUMBER	1	num	9	SENT_181	[p14l1422t1340r1493b1404],
11	/	:	O	/	punct	16	SENT_181	[p14l1507t1337r1544b1405],
12	*	CD	NUMBER	*	number	13	SENT_181	[p14l1552t1340r1623b1404],
13	1	CD	NUMBER	1	num	14	SENT_181	[p14l1552t1340r1623b1404],
14	carriers	NNS	O	carrier	nsubj	16	SENT_181	[p14l1662t1340r1960b1405],
15	was	VBD	O	be	cop	16	SENT_181	[p14l1991t1361r2144b1405],
16	smaller	JJR	O	smaller	dep	6	SENT_181	[p14l19t1440r315b1508],
17	than	IN	O	than	prep	16	SENT_181	[p14l340t1440r519b1508],
18	in	IN	O	in	pcomp	17	SENT_181	[p14l546t1443r625b1507],
19	the	DT	O	the	det	22	SENT_181	[p14l651t1440r774b1508],
20	other	JJ	O	other	amod	22	SENT_181	[p14l804t1440r1011b1508],
21	genotype	NN	O	genotype	nn	22	SENT_181	[p14l1036t1450r1401b1529],
22	groups	NNS	O	group	pobj	18	SENT_181	[p14l1429t1464r1699b1529],
23	because	IN	O	because	_	0	SENT_181	[p14l1725t1440r2043b1508],
24	of	IN	O	of	_	0	SENT_181	[p14l2073t1440r2153b1508],
25	difficulty	NN	O	difficulty	prep_because_of	16	SENT_181	[p14l20t1542r389b1631],
26	of	IN	O	of	_	0	SENT_181	[p14l417t1542r497b1610],
27	recruitment	NN	O	recruitment	prep_of	25	SENT_181	[p14l515t1545r987b1610],
28	because	IN	O	because	_	0	SENT_181	[p14l1009t1542r1325b1610],
29	of	IN	O	of	_	0	SENT_181	[p14l1355t1542r1434b1610],
30	its	PRP$	O	its	poss	32	SENT_181	[p14l1455t1545r1545b1610],
31	low	JJ	O	low	amod	32	SENT_181	[p14l1575t1541r1723b1610],
32	frequency	NN	O	frequency	prep_of	37	SENT_181	[p14l1750t1542r2147b1631],
33	in	IN	O	in	_	0	SENT_181	[p14l18t1647r97b1711],
34	Korean	JJ	LOCATION	korean	amod	35	SENT_181	[p14l140t1648r427b1711],
35	populations	NNS	O	population	prep_in	32	SENT_181	[p14l470t1643r1111b1733],
36	.17	CD	NUMBER	.17	number	37	SENT_181	[p14l470t1643r1111b1733],
37	’28	CD	NUMBER	’28	prep_because	16	SENT_181	[p14l470t1643r1111b1733],
38	However	RB	O	however	advmod	37	SENT_181	[p14l1155t1648r1533b1722],
39	,	,	O	,	_	0	SENT_181	[p14l1155t1648r1533b1722],
40	given	VBN	O	give	partmod	6	SENT_181	[p14l1578t1647r1797b1733],
41	the	DT	O	the	det	44	SENT_181	[p14l1839t1643r1963b1711],
42	significant	JJ	O	significant	amod	44	SENT_181	[p14l2009t1647r2145b1733, p14l16t1745r330b1813],
43	intestinal	JJ	O	intestinal	amod	44	SENT_181	[p14l372t1745r751b1813],
44	expression	NN	O	expression	nn	63	SENT_181	[p14l796t1749r1229b1835],
45	of	IN	O	of	_	0	SENT_181	[p14l1273t1745r1353b1813],
46	CYP3A529	NN	O	cyp3a529	prep_of	44	SENT_181	[p14l1394t1745r1787b1813],
47	and	CC	O	and	_	0	SENT_181	[p14l1832t1745r1979b1813],
48	the	DT	O	the	det	50	SENT_181	[p14l2021t1745r2145b1813],
49	low	JJ	O	low	amod	50	SENT_181	[p14l18t1846r163b1914],
50	bioavailability	NN	O	bioavailability	conj_and	44	SENT_181	[p14l182t1846r741b1935],
51	of	IN	O	of	_	0	SENT_181	[p14l766t1846r844b1914],
52	simvastatin	NN	O	simvastatin	prep_of	50	SENT_181	[p14l862t1845r1383b1925],
53	,	,	O	,	_	0	SENT_181	[p14l862t1845r1383b1925],
54	”	CD	NUMBER	”	num	56	SENT_181	[p14l862t1845r1383b1925],
55	significant	JJ	O	significant	amod	56	SENT_181	[p14l1409t1846r1814b1935],
56	changes	NNS	O	change	appos	52	SENT_181	[p14l1838t1846r2144b1935],
57	in	IN	O	in	_	0	SENT_181	[p14l18t1952r97b2016],
58	AUC	NN	O	auc	prep_in	56	SENT_181	[p14l146t1952r338b2017],
59	and	CC	O	and	_	0	SENT_181	[p14l390t1949r538b2017],
60	CL/F	NN	O	cl/f	prep_in	56	SENT_181	[p14l588t1949r785b2017],
61	but	CC	O	but	_	0	SENT_181	[p14l832t1949r965b2017],
62	insignificant	JJ	O	insignificant	conj_but	44	SENT_181	[p14l1014t1949r1523b2038],
63	differences	NNS	O	difference	iobj	40	SENT_181	[p14l1575t1949r2014b2017],
64	in	IN	O	in	_	0	SENT_181	[p14l2067t1952r2146b2016],
65	elimination	NN	O	elimination	nn	66	SENT_181	[p14l19t2051r506b2118],
66	rate	NN	O	rate	prep_in	63	SENT_181	[p14l565t2060r719b2118],
67	constant	JJ	O	constant	dobj	40	SENT_181	[p14l781t2061r1136b2118],
68	and	CC	O	and	_	0	SENT_181	[p14l1195t2051r1347b2118],
69	half-life	NN	O	half-life	conj_and	67	SENT_181	[p14l1405t2051r1737b2118],
70	between	IN	O	between	prep	40	SENT_181	[p14l1794t2051r2146b2118],

1	CYP3A5	NN	O	cyp3a5	nn	3	SENT_182	[p14l22t2156r358b2221],
2	genotype	NN	O	genotype	nn	3	SENT_182	[p14l391t2162r756b2242],
3	groups	NNS	O	group	nsubj	4	SENT_182	[p14l792t2177r1063b2242],
4	suggest	VBP	O	suggest	_	0	SENT_182	[p14l1102t2163r1393b2242],
5	that	IN	O	that	complm	10	SENT_182	[p14l1426t2152r1582b2221],
6	the	DT	O	the	det	9	SENT_182	[p14l1615t2152r1738b2221],
7	polymorphic	JJ	O	polymorphic	amod	9	SENT_182	[p14l1775t2152r2145b2242, p14l17t2254r193b2344],
8	CYP3A5	NN	O	cyp3a5	nn	9	SENT_182	[p14l245t2258r581b2322],
9	genotype	NN	O	genotype	nsubj	10	SENT_182	[p14l622t2264r988b2344],
10	affects	VBZ	O	affect	ccomp	4	SENT_182	[p14l1035t2254r1288b2322],
11	more	RBR	O	more	advmod	12	SENT_182	[p14l1334t2278r1536b2322],
12	largely	RB	O	largely	advmod	10	SENT_182	[p14l1582t2254r1855b2344],
13	in	IN	O	in	_	0	SENT_182	[p14l1899t2258r1978b2322],
14	the	DT	O	the	det	16	SENT_182	[p14l2021t2254r2145b2322],
15	absorption	NN	O	absorption	nn	16	SENT_182	[p14l18t2356r448b2446],
16	phase	NN	O	phase	prep_in	12	SENT_182	[p14l477t2356r708b2446],
17	of	IN	O	of	_	0	SENT_182	[p14l742t2356r822b2424],
18	simvastatin	NN	O	simvastatin	prep_of	16	SENT_182	[p14l846t2360r1309b2424],
19	than	IN	O	than	prep	10	SENT_182	[p14l1338t2356r1517b2424],
20	in	IN	O	in	pcomp	19	SENT_182	[p14l1547t2360r1626b2424],
21	the	DT	O	the	det	23	SENT_182	[p14l1655t2356r1779b2424],
22	elimination	NN	O	elimination	nn	23	SENT_182	[p14l1812t2356r2145b2424, p14l16t2462r176b2526],
23	phase	NN	O	phase	pobj	20	SENT_182	[p14l208t2458r462b2548],
24	,	,	O	,	_	0	SENT_182	[p14l208t2458r462b2548],
25	indicating	VBG	O	indicate	xcomp	10	SENT_182	[p14l499t2458r909b2547],
26	that	IN	O	that	complm	29	SENT_182	[p14l941t2458r1096b2526],
27	the	DT	O	the	det	28	SENT_182	[p14l1127t2458r1251b2526],
28	effect	NN	O	effect	nsubj	29	SENT_182	[p14l1287t2458r1504b2526],
29	is	VBZ	O	be	ccomp	25	SENT_182	[p14l1536t2462r1598b2526],
30	primarily	RB	O	primarily	advmod	29	SENT_182	[p14l1633t2458r2014b2548],
31	on	IN	O	on	_	0	SENT_182	[p14l2048t2482r2146b2526],
32	intestinal	JJ	O	intestinal	amod	33	SENT_182	[p14l18t2559r397b2626],
33	metabolism	NN	O	metabolism	prep_on	29	SENT_182	[p14l428t2559r899b2626],
34	rather	RB	O	rather	prep	29	SENT_182	[p14l929t2559r1169b2626],
35	liver	NN	O	liver	nn	36	SENT_182	[p14l1200t2559r1383b2626],
36	metabolism	NN	O	metabolism	pobj	34	SENT_182	[p14l1413t2559r1903b2626],
37	.	.	O	.	_	0	SENT_182	[p14l1413t2559r1903b2626],

1	Simvastatin	NNP	O	Simvastatin	nsubj	5	SENT_183	[p14l126t2665r603b2730],
2	is	VBZ	O	be	cop	5	SENT_183	[p14l649t2665r711b2730],
3	a	DT	O	a	det	5	SENT_183	[p14l760t2686r800b2730],
4	prodrug	NN	O	prodrug	nn	5	SENT_183	[p14l845t2661r1299b2751],
5	“’	NN	O	“’	_	0	SENT_183	[p14l845t2661r1299b2751],
6	19	CD	NUMBER	19	dep	5	SENT_183	[p14l845t2661r1299b2751],
7	that	WDT	O	that	nsubjpass	9	SENT_183	[p14l1344t2662r1500b2730],
8	is	VBZ	O	be	auxpass	9	SENT_183	[p14l1545t2665r1607b2730],
9	activated	VBN	O	activate	rcmod	5	SENT_183	[p14l1656t2662r2021b2730],
10	in	IN	O	in	_	0	SENT_183	[p14l2067t2665r2146b2729],
11	the	DT	O	the	det	12	SENT_183	[p14l16t2763r140b2832],
12	liver	NN	O	liver	prep_in	9	SENT_183	[p14l186t2763r369b2832],
13	to	TO	O	to	aux	14	SENT_183	[p14l411t2774r485b2832],
14	generate	VB	O	generate	xcomp	9	SENT_183	[p14l530t2774r866b2853],
15	simvastatin	NN	O	simvastatin	nn	16	SENT_183	[p14l913t2767r1376b2832],
16	acid	NN	O	acid	dobj	14	SENT_183	[p14l1421t2763r1607b2832],
17	.	.	O	.	_	0	SENT_183	[p14l1421t2763r1607b2832],

1	Considering	VBG	O	consider	dep	17	SENT_184	[p14l1657t2763r2146b2853],
2	that	IN	O	that	complm	8	SENT_184	[p14l16t2865r172b2933],
3	the	DT	O	the	det	4	SENT_184	[p14l220t2865r343b2933],
4	latter	JJ	O	latter	nsubj	8	SENT_184	[p14l396t2865r604b2933],
5	is	VBZ	O	be	cop	8	SENT_184	[p14l654t2869r716b2933],
6	an	DT	O	a	det	8	SENT_184	[p14l770t2889r863b2933],
7	active	JJ	O	active	amod	8	SENT_184	[p14l914t2869r1149b2933],
8	metabolite	NN	O	metabolite	pcomp	1	SENT_184	[p14l1200t2865r1625b2933],
9	structurally	RB	O	structurally	advmod	10	SENT_184	[p14l1678t2865r2147b2955],
10	similar	JJ	O	similar	amod	8	SENT_184	[p14l19t2967r300b3035],
11	to	TO	O	to	_	0	SENT_184	[p14l336t2977r410b3035],
12	HMG-CoA	NN	O	hmg-coa	prep_to	10	SENT_184	[p14l450t2971r892b3046],
13	,	,	O	,	_	0	SENT_184	[p14l450t2971r892b3046],
14	it	PRP	O	it	nsubj	17	SENT_184	[p14l934t2971r990b3035],
15	should	MD	O	should	aux	17	SENT_184	[p14l1029t2967r1304b3035],
16	be	VB	O	be	cop	17	SENT_184	[p14l1339t2967r1430b3035],
17	helpful	JJ	O	helpful	_	0	SENT_184	[p14l1469t2967r1761b3057],
18	to	TO	O	to	aux	19	SENT_184	[p14l1799t2977r1873b3035],
19	determine	VB	O	determine	xcomp	17	SENT_184	[p14l1916t2967r2144b3035, p14l16t3073r217b3137],
20	the	DT	O	the	det	22	SENT_184	[p14l244t3069r367b3137],
21	plasma	NN	O	plasma	nn	22	SENT_184	[p14l395t3069r680b3159],
22	levels	NNS	O	level	dobj	19	SENT_184	[p14l707t3069r934b3137],
23	of	IN	O	of	_	0	SENT_184	[p14l965t3069r1045b3137],
24	simvastatin	NN	O	simvastatin	nn	25	SENT_184	[p14l1066t3073r1524b3137],
25	acid	NN	O	acid	prep_of	22	SENT_184	[p14l1552t3069r1736b3137],
26	.	.	O	.	_	0	SENT_184	[p14l1552t3069r1736b3137],

1	However	RB	O	however	advmod	13	SENT_185	[p14l1768t3074r2142b3148],
2	,	,	O	,	_	0	SENT_185	[p14l1768t3074r2142b3148],
3	as	IN	O	as	mark	8	SENT_185	[p14l18t3195r94b3239],
4	this	DT	O	this	det	5	SENT_185	[p14l136t3171r283b3239],
5	compound	NN	O	compound	nsubj	8	SENT_185	[p14l326t3171r760b3260],
6	is	VBZ	O	be	cop	8	SENT_185	[p14l800t3174r862b3239],
7	commercially	RB	O	commercially	advmod	8	SENT_185	[p14l906t3171r1459b3260],
8	unavailable	JJ	O	unavailable	advcl	13	SENT_185	[p14l1497t3171r1989b3250],
9	,	,	O	,	_	0	SENT_185	[p14l1497t3171r1989b3250],
10	we	PRP	O	we	nsubj	13	SENT_185	[p14l2030t3195r2145b3239],
11	could	MD	O	could	aux	13	SENT_185	[p14l19t3274r253b3342],
12	not	RB	O	not	neg	13	SENT_185	[p14l298t3284r433b3342],
13	determine	VB	O	determine	_	0	SENT_185	[p14l480t3274r902b3342],
14	its	PRP$	O	its	poss	16	SENT_185	[p14l950t3277r1045b3342],
15	plasma	NN	O	plasma	nn	16	SENT_185	[p14l1094t3274r1392b3363],
16	levels	NNS	O	level	dobj	13	SENT_185	[p14l1437t3274r1700b3342],
17	.	.	O	.	_	0	SENT_185	[p14l1437t3274r1700b3342],

1	However	RB	O	however	advmod	6	SENT_186	[p14l1751t3278r2142b3352],
2	,	,	O	,	_	0	SENT_186	[p14l1751t3278r2142b3352],
3	CYP3A4	NN	O	cyp3a4	nsubj	6	SENT_186	[p14l18t3375r392b3444],
4	/	:	O	/	punct	5	SENT_186	[p14l18t3375r392b3444],
5	5	CD	NUMBER	5	dep	3	SENT_186	[p14l401t3386r437b3444],
6	mediates	VBZ	O	mediate	_	0	SENT_186	[p14l481t3375r840b3444],
7	only	RB	O	only	advmod	10	SENT_186	[p14l883t3375r1060b3465],
8	the	DT	O	the	det	10	SENT_186	[p14l1098t3375r1221b3444],
9	oxidative	JJ	O	oxidative	amod	10	SENT_186	[p14l1263t3376r1636b3444],
10	biotransformation	NN	O	biotransformation	dobj	6	SENT_186	[p14l1673t3376r2145b3444, p14l16t3480r299b3544],
11	of	IN	O	of	_	0	SENT_186	[p14l331t3476r411b3544],
12	simvastatin	NN	O	simvastatin	prep_of	10	SENT_186	[p14l435t3480r898b3544],
13	but	CC	O	but	_	0	SENT_186	[p14l924t3476r1058b3544],
14	not	RB	O	not	conj_but	10	SENT_186	[p14l1086t3486r1217b3544],
15	of	IN	O	of	amod	10	SENT_186	[p14l1247t3476r1327b3544],
16	simvastatin	NN	O	simvastatin	nn	17	SENT_186	[p14l1352t3480r1815b3544],
17	acid	NN	O	acid	dep	10	SENT_186	[p14l1846t3476r2145b3544],
18	“’	CD	NUMBER	“’	number	19	SENT_186	[p14l1846t3476r2145b3544],
19	18	CD	NUMBER	18	dep	17	SENT_186	[p14l1846t3476r2145b3544],

1	to	TO	O	to	nsubj	3	SENT_187	[p15l16t34r89b92],
2	the	DT	O	the	det	3	SENT_187	[p15l125t24r249b92],
3	3	CD	NUMBER	3	_	0	SENT_187	[p15l288t24r987b113],
4	’	NN	O	’	rcmod	3	SENT_187	[p15l288t24r987b113],
5	,5	CD	NUMBER	,5	dep	4	SENT_187	[p15l288t24r987b113],
6	’	SYM	O	’	dep	4	SENT_187	[p15l288t24r987b113],
7	-	:	O	-	_	0	SENT_187	[p15l288t24r987b113],
8	dihydrodiol	NN	O	dihydrodiol	dep	3	SENT_187	[p15l288t24r987b113],
9	,	,	O	,	_	0	SENT_187	[p15l288t24r987b113],
10	3	CD	NUMBER	3	appos	8	SENT_187	[p15l1029t24r1477b113],
11	’	SYM	O	’	dep	3	SENT_187	[p15l1029t24r1477b113],
12	-	:	O	-	_	0	SENT_187	[p15l1029t24r1477b113],
13	hydroxy	NN	O	hydroxy	dep	19	SENT_187	[p15l1029t24r1477b113],
14	,	,	O	,	_	0	SENT_187	[p15l1029t24r1477b113],
15	and	CC	O	and	_	0	SENT_187	[p15l1516t24r1664b92],
16	6	CD	NUMBER	6	num	17	SENT_187	[p15l1701t24r2144b92, p15l16t126r233b215],
17	’	NN	O	’	conj_and	13	SENT_187	[p15l1701t24r2144b92, p15l16t126r233b215],
18	exomethylene	NN	O	exomethylene	nn	19	SENT_187	[p15l1701t24r2144b92, p15l16t126r233b215],
19	metabolites	NNS	O	metabolite	parataxis	3	SENT_187	[p15l267t126r752b194],
20	.	.	O	.	_	0	SENT_187	[p15l267t126r752b194],

1	Therefore	RB	O	therefore	advmod	19	SENT_188	[p15l791t126r1203b205],
2	,	,	O	,	_	0	SENT_188	[p15l791t126r1203b205],
3	similar	JJ	O	similar	amod	17	SENT_188	[p15l1241t126r1522b194],
4	to	TO	O	to	_	0	SENT_188	[p15l1554t136r1627b194],
5	the	DT	O	the	det	6	SENT_188	[p15l1662t126r1785b194],
6	effect	NN	O	effect	prep_to	3	SENT_188	[p15l1822t126r2039b194],
7	of	IN	O	of	_	0	SENT_188	[p15l2073t126r2153b194],
8	CYP3A	NN	O	cyp3a	nn	9	SENT_188	[p15l18t230r307b295],
9	inhibitors	NNS	O	inhibitor	prep_of	6	SENT_188	[p15l336t226r881b306],
10	,24	CD	NUMBER	,24	number	11	SENT_188	[p15l336t226r881b306],
11	’25	CD	NUMBER	’25	num	14	SENT_188	[p15l336t226r881b306],
12	the	DT	O	the	det	14	SENT_188	[p15l911t227r1033b295],
13	C	NN	O	c	nn	14	SENT_188	[p15l1069t230r1126b295],
14	YP3A5	NN	O	yp3a5	dep	9	SENT_188	[p15l1131t231r1402b295],
15	*	CD	NUMBER	*	number	16	SENT_188	[p15l1417t230r1495b295],
16	3	CD	NUMBER	3	num	14	SENT_188	[p15l1417t230r1495b295],
17	genotype	NN	O	genotype	nsubj	19	SENT_188	[p15l1523t237r1885b316],
18	might	MD	O	might	aux	19	SENT_188	[p15l1915t227r2147b316],
19	elevate	VB	O	elevate	_	0	SENT_188	[p15l19t331r297b399],
20	the	DT	O	the	det	22	SENT_188	[p15l329t331r452b399],
21	plasma	NN	O	plasma	nn	22	SENT_188	[p15l484t331r772b420],
22	levels	NNS	O	level	dobj	19	SENT_188	[p15l802t331r1032b399],
23	of	IN	O	of	_	0	SENT_188	[p15l1067t331r1146b399],
24	simvastatin	NN	O	simvastatin	nn	25	SENT_188	[p15l1172t334r1635b399],
25	acid	NN	O	acid	prep_of	22	SENT_188	[p15l1666t331r1833b399],
26	consistent	JJ	O	consistent	dep	19	SENT_188	[p15l1866t334r2145b399, p15l16t443r172b501],
27	with	IN	O	with	_	0	SENT_188	[p15l198t432r383b501],
28	the	DT	O	the	det	29	SENT_188	[p15l410t432r533b501],
29	elevation	NN	O	elevation	prep_with	19	SENT_188	[p15l565t432r934b501],
30	of	IN	O	of	_	0	SENT_188	[p15l965t433r1044b501],
31	simvastatin	NN	O	simvastatin	nn	32	SENT_188	[p15l1067t436r1530b501],
32	levels	NNS	O	level	prep_of	29	SENT_188	[p15l1559t432r1812b511],
33	,	,	O	,	_	0	SENT_188	[p15l1559t432r1812b511],
34	thereby	RB	O	thereby	advmod	35	SENT_188	[p15l1843t432r2147b522],
35	modulating	VBG	O	modulate	partmod	19	SENT_188	[p15l16t534r482b624],
36	the	DT	O	the	det	38	SENT_188	[p15l513t534r636b602],
37	hypolipidemic	JJ	O	hypolipidemic	amod	38	SENT_188	[p15l669t534r1266b624],
38	effect	NN	O	effect	dobj	35	SENT_188	[p15l1302t534r1519b602],
39	of	IN	O	of	_	0	SENT_188	[p15l1552t534r1632b602],
40	simvastatin	NN	O	simvastatin	prep_of	38	SENT_188	[p15l1659t538r2140b602],
41	.	.	O	.	_	0	SENT_188	[p15l1659t538r2140b602],

1	However	RB	O	however	advmod	6	SENT_189	[p15l16t640r394b713],
2	,	,	O	,	_	0	SENT_189	[p15l16t640r394b713],
3	further	JJ	O	further	amod	4	SENT_189	[p15l433t635r710b703],
4	evaluations	NNS	O	evaluation	nsubjpass	6	SENT_189	[p15l745t635r1205b703],
5	are	VBP	O	be	auxpass	6	SENT_189	[p15l1243t659r1359b703],
6	needed	VBN	O	need	_	0	SENT_189	[p15l1394t635r1687b703],
7	to	TO	O	to	aux	8	SENT_189	[p15l1720t645r1793b703],
8	confirm	VB	O	confirm	xcomp	6	SENT_189	[p15l1831t635r2146b703],
9	whether	IN	O	whether	complm	14	SENT_189	[p15l16t737r349b805],
10	the	DT	O	the	det	13	SENT_189	[p15l384t737r507b805],
11	polymorphic	JJ	O	polymorphic	amod	13	SENT_189	[p15l545t737r1067b827],
12	CYP3A5	NN	O	cyp3a5	nn	13	SENT_189	[p15l1111t741r1447b805],
13	genotype	NN	O	genotype	nsubj	14	SENT_189	[p15l1481t747r1846b827],
14	modulates	VBZ	O	modulate	ccomp	8	SENT_189	[p15l1883t737r2145b805, p15l18t839r198b907],
15	the	DT	O	the	det	17	SENT_189	[p15l228t839r352b907],
16	plasma	NN	O	plasma	nn	17	SENT_189	[p15l382t839r671b928],
17	levels	NNS	O	level	dobj	14	SENT_189	[p15l699t839r929b907],
18	of	IN	O	of	_	0	SENT_189	[p15l962t839r1042b907],
19	simvastatin	NN	O	simvastatin	nn	20	SENT_189	[p15l1066t842r1529b907],
20	acid	NN	O	acid	prep_of	17	SENT_189	[p15l1559t839r1726b907],
21	as	RB	O	as	_	0	SENT_189	[p15l1756t863r1832b907],
22	well	RB	O	well	_	0	SENT_189	[p15l1863t839r2036b907],
23	as	IN	O	as	_	0	SENT_189	[p15l2067t863r2144b907],
24	simvastatin	NN	O	simvastatin	dobj	14	SENT_189	[p15l19t944r501b1008],
25	.	.	O	.	_	0	SENT_189	[p15l19t944r501b1008],

1	In	IN	O	in	_	0	SENT_190	[p15l123t1047r204b1110],
2	conclusion	NN	O	conclusion	prep_in	11	SENT_190	[p15l232t1042r696b1121],
3	,	,	O	,	_	0	SENT_190	[p15l232t1042r696b1121],
4	the	DT	O	the	det	6	SENT_190	[p15l726t1042r849b1111],
5	C	NN	O	c	nn	6	SENT_190	[p15l883t1046r940b1111],
6	YPBA5	NN	O	ypba5	nsubjpass	11	SENT_190	[p15l946t1047r1219b1111],
7	*	CD	NUMBER	*	num	9	SENT_190	[p15l1234t1046r1313b1111],
8	3	CD	NUMBER	3	num	9	SENT_190	[p15l1234t1046r1313b1111],
9	genotype	NN	O	genotype	dep	6	SENT_190	[p15l1339t1052r1704b1132],
10	was	VBD	O	be	auxpass	11	SENT_190	[p15l1731t1067r1884b1111],
11	correlated	VBN	O	correlate	_	0	SENT_190	[p15l1915t1067r2144b1111, p15l18t1144r223b1212],
12	with	IN	O	with	_	0	SENT_190	[p15l267t1144r458b1212],
13	the	DT	O	the	det	15	SENT_190	[p15l503t1144r630b1212],
14	systemic	JJ	O	systemic	amod	15	SENT_190	[p15l679t1148r1040b1234],
15	exposure	NN	O	exposure	prep_with	11	SENT_190	[p15l1089t1168r1466b1234],
16	of	IN	O	of	_	0	SENT_190	[p15l1515t1144r1597b1212],
17	simvastatin	NN	O	simvastatin	prep_of	15	SENT_190	[p15l1637t1148r2140b1212],
18	.	.	O	.	_	0	SENT_190	[p15l1637t1148r2140b1212],

1	These	DT	O	these	det	2	SENT_191	[p15l17t1246r249b1314],
2	findings	NNS	O	finding	nsubj	3	SENT_191	[p15l279t1246r600b1335],
3	suggest	VBP	O	suggest	_	0	SENT_191	[p15l632t1256r917b1335],
4	that	IN	O	that	complm	9	SENT_191	[p15l941t1246r1094b1314],
5	the	DT	O	the	det	8	SENT_191	[p15l1119t1246r1241b1314],
6	polymorphic	JJ	O	polymorphic	amod	8	SENT_191	[p15l1270t1246r1782b1336],
7	CYP3A5	NN	O	cyp3a5	nn	8	SENT_191	[p15l1816t1250r2148b1314],
8	gene	NN	O	gene	nsubj	9	SENT_191	[p15l16t1372r199b1437],
9	affects	VBZ	O	affect	ccomp	3	SENT_191	[p15l238t1348r492b1416],
10	the	DT	O	the	det	11	SENT_191	[p15l531t1348r654b1416],
11	disposition	NN	O	disposition	dobj	9	SENT_191	[p15l695t1348r1147b1438],
12	of	IN	O	of	_	0	SENT_191	[p15l1186t1348r1266b1416],
13	simvastatin	NN	O	simvastatin	prep_of	11	SENT_191	[p15l1297t1352r1760b1416],
14	and	CC	O	and	_	0	SENT_191	[p15l1798t1348r1946b1416],
15	provides	VBZ	O	provide	ccomp	3	SENT_191	[p15l1982t1372r2145b1438, p15l16t1450r228b1518],
16	a	DT	O	a	det	18	SENT_191	[p15l260t1474r300b1518],
17	plausible	JJ	O	plausible	amod	18	SENT_191	[p15l328t1450r698b1539],
18	explanation	NN	O	explanation	dobj	15	SENT_191	[p15l730t1450r1208b1539],
19	for	IN	O	for	_	0	SENT_191	[p15l1238t1450r1347b1518],
20	the	DT	O	the	det	22	SENT_191	[p15l1374t1450r1498b1518],
21	interindividual	JJ	O	interindividual	amod	22	SENT_191	[p15l1529t1450r2145b1518],
22	variability	NN	O	variability	prep_for	15	SENT_191	[p15l16t1553r433b1642],
23	of	IN	O	of	_	0	SENT_191	[p15l466t1553r546b1621],
24	simvastatin	NN	O	simvastatin	nn	25	SENT_191	[p15l572t1556r1034b1621],
25	disposition	NN	O	disposition	prep_of	22	SENT_191	[p15l1068t1553r1540b1642],
26	.	.	O	.	_	0	SENT_191	[p15l1068t1553r1540b1642],

1	We	PRP	O	we	nsubj	2	SENT_192	[p15l87t1806r186b1857],
2	thank	VBP	O	thank	_	0	SENT_192	[p15l213t1803r398b1857],
3	Dr	NNP	O	Dr	nn	9	SENT_192	[p15l422t1806r499b1856],
4	Chi-Yun	NNP	PERSON	Chi-Yun	nn	9	SENT_192	[p15l525t1802r794b1857],
5	Lim	NNP	PERSON	Lim	nn	9	SENT_192	[p15l821t1805r948b1856],
6	(	NNP	O	(	nn	9	SENT_192	[p15l978t1803r1091b1867],
7	LG	NNP	ORGANIZATION	LG	nn	9	SENT_192	[p15l978t1803r1091b1867],
8	Life	NNP	ORGANIZATION	Life	nn	9	SENT_192	[p15l1116t1803r1238b1857],
9	Sciences	NNPS	ORGANIZATION	Sciences	dobj	2	SENT_192	[p15l1269t1805r1564b1865],
10	,	,	O	,	_	0	SENT_192	[p15l1269t1805r1564b1865],
11	Seoul	NNP	LOCATION	Seoul	appos	9	SENT_192	[p15l1596t1802r1793b1865],
12	,	,	O	,	_	0	SENT_192	[p15l1596t1802r1793b1865],
13	Korea	NNP	LOCATION	Korea	nn	14	SENT_192	[p15l1822t1803r2029b1867],
14	]	NNP	O	]	appos	11	SENT_192	[p15l1822t1803r2029b1867],
15	for	IN	O	for	_	0	SENT_192	[p15l2060t1803r2147b1857],
16	helping	VBG	O	help	prepc_for	2	SENT_192	[p15l16t1890r262b1961],
17	with	IN	O	with	_	0	SENT_192	[p15l286t1890r434b1944],
18	the	DT	O	the	det	20	SENT_192	[p15l458t1890r557b1944],
19	statistical	JJ	O	statistical	amod	20	SENT_192	[p15l585t1890r891b1944],
20	analysis	NN	O	analysis	prep_with	16	SENT_192	[p15l918t1890r1193b1961],
21	.	.	O	.	_	0	SENT_192	[p15l918t1890r1193b1961],

1	92	CD	NUMBER	92	num	2	SENT_193	[p15l7t2121r99b2186],
2	o	NN	O	o	_	0	SENT_193	[p15l158t2146r188b2176],
3	I	PRP	O	I	nsubj	4	SENT_193	[p15l244t2128r274b2200],
4	Clin	VBP	O	clin	rcmod	2	SENT_193	[p15l301t2124r454b2185],
5	Pharmacol	NNP	O	Pharmacol	dobj	4	SENT_193	[p15l480t2124r882b2185],
6	2007	CD	DATE	2007	num	5	SENT_193	[p15l911t2133r1418b2196],
7	;	:	O	;	_	0	SENT_193	[p15l911t2133r1418b2196],
8	47:87	CD	NUMBER	47:87	num	9	SENT_193	[p15l911t2133r1418b2196],
9	-93	CD	NUMBER	-93	dep	5	SENT_193	[p15l911t2133r1418b2196],

1	Financial	NNP	O	Financial	nn	2	SENT_194	[p15l80t2225r385b2280],
2	disclosure	NN	O	disclosure	_	0	SENT_194	[p15l413t2225r761b2280],
3	:	:	O	:	_	0	SENT_194	[p15l413t2225r761b2280],
4	None	NN	O	none	nsubj	5	SENT_194	[p15l789t2228r960b2280],
5	declared	VBD	O	declare	dep	2	SENT_194	[p15l989t2225r1280b2280],
6	.	.	O	.	_	0	SENT_194	[p15l989t2225r1280b2280],

1	REFERENCES	NNS	O	reference	_	0	SENT_195	[p15l8t2441r588b2505],

1	1	LS	NUMBER	1	_	0	SENT_196	[p15l10t2657r61b2703],
2	.	.	O	.	_	0	SENT_196	[p15l10t2657r61b2703],

1	Evans	NNP	PERSON	Evans	nn	2	SENT_197	[p15l97t2652r288b2703],
2	WE	NNP	O	WE	_	0	SENT_197	[p15l322t2652r452b2712],
3	,	,	O	,	_	0	SENT_197	[p15l322t2652r452b2712],
4	Relling	NNP	O	Relling	nn	5	SENT_197	[p15l488t2649r720b2720],
5	MV	NNP	O	MV	appos	2	SENT_197	[p15l754t2652r877b2703],
6	.	.	O	.	_	0	SENT_197	[p15l754t2652r877b2703],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_198	[p15l915t2649r1564b2720],
2	:	:	O	:	_	0	SENT_198	[p15l915t2649r1564b2720],
3	translating	VBG	O	translate	dep	1	SENT_198	[p15l1601t2648r1947b2720],
4	functional	JJ	O	functional	amod	5	SENT_198	[p15l1982t2649r2147b2703, p15l7t2735r200b2790],
5	genomics	NNS	O	genomic	dobj	3	SENT_198	[p15l235t2738r548b2807],
6	into	IN	O	into	_	0	SENT_198	[p15l585t2738r714b2790],
7	rational	JJ	O	rational	amod	8	SENT_198	[p15l749t2735r1008b2790],
8	therapeutics	NNS	O	therapeutics	prep_into	3	SENT_198	[p15l1042t2735r1474b2807],
9	.	.	O	.	_	0	SENT_198	[p15l1042t2735r1474b2807],

1	Science	NN	O	science	_	0	SENT_199	[p15l1515t2738r1786b2790],
2	.	.	O	.	_	0	SENT_199	[p15l1515t2738r1786b2790],

1	1999	CD	DATE	1999	_	0	SENT_200	[p15l1828t2743r2145b2798],
2	;	:	O	;	_	0	SENT_200	[p15l1828t2743r2145b2798],
3	286	CD	NUMBER	286	num	5	SENT_200	[p15l1828t2743r2145b2798],
4	:	:	O	:	_	0	SENT_200	[p15l1828t2743r2145b2798],
5	487-491	CD	NUMBER	487-491	dep	1	SENT_200	[p15l8t2829r282b2876],
6	.	.	O	.	_	0	SENT_200	[p15l8t2829r282b2876],

1	2	LS	NUMBER	2	_	0	SENT_201	[p15l9t2923r61b2970],
2	.	.	O	.	_	0	SENT_201	[p15l9t2923r61b2970],

1	Guengerich	NNP	PERSON	Guengerich	_	0	SENT_202	[p15l93t2916r466b2987],
2	FP	NN	O	fp	dep	1	SENT_202	[p15l494t2919r584b2970],
3	.	.	O	.	_	0	SENT_202	[p15l494t2919r584b2970],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_203	[p15l617t2916r1008b2987],
2	P-450	NN	O	p-450	nn	3	SENT_203	[p15l1037t2919r1219b2970],
3	3A4	NN	O	3a4	_	0	SENT_203	[p15l1251t2919r1396b2970],
4	:	:	O	:	_	0	SENT_203	[p15l1251t2919r1396b2970],
5	regulation	NN	O	regulation	dep	3	SENT_203	[p15l1427t2916r1758b2987],
6	and	CC	O	and	_	0	SENT_203	[p15l1786t2916r1905b2970],
7	role	NN	O	role	dep	3	SENT_203	[p15l1932t2916r2055b2970],
8	in	IN	O	in	_	0	SENT_203	[p15l2085t2919r2149b2970],
9	drug	NN	O	drug	nn	10	SENT_203	[p15l10t3002r155b3074],
10	metabolism	NN	O	metabolism	prep_in	5	SENT_203	[p15l180t3002r574b3057],
11	.	.	O	.	_	0	SENT_203	[p15l180t3002r574b3057],

1	Annu	NNP	PERSON	Annu	nn	2	SENT_204	[p15l602t3006r783b3056],
2	Rev	NN	PERSON	rev	_	0	SENT_204	[p15l810t3006r934b3057],
3	Pharmacol	NNP	PERSON	Pharmacol	nn	4	SENT_204	[p15l951t3002r1309b3057],
4	Toxicol	NNP	PERSON	Toxicol	dep	2	SENT_204	[p15l1337t3002r1584b3057],
5	.	.	O	.	_	0	SENT_204	[p15l1337t3002r1584b3057],

1	1999	CD	DATE	1999	_	0	SENT_205	[p15l1617t3010r2046b3065],
2	;	:	O	;	_	0	SENT_205	[p15l1617t3010r2046b3065],
3	39:1	CD	NUMBER	39:1	number	4	SENT_205	[p15l1617t3010r2046b3065],
4	-17	CD	NUMBER	-17	dep	1	SENT_205	[p15l1617t3010r2046b3065],
5	.	.	O	.	_	0	SENT_205	[p15l1617t3010r2046b3065],

1	3	LS	NUMBER	3	_	0	SENT_206	[p15l9t3104r61b3151],
2	.	.	O	.	_	0	SENT_206	[p15l9t3104r61b3151],

1	Kinirons	NNPS	O	Kinirons	nn	2	SENT_207	[p15l88t3099r368b3151],
2	MT	NNP	O	MT	_	0	SENT_207	[p15l394t3100r516b3160],
3	,	,	O	,	_	0	SENT_207	[p15l394t3100r516b3160],
4	O’Shea	NN	O	o’shea	nn	5	SENT_207	[p15l544t3096r775b3151],
5	D	NN	O	d	appos	2	SENT_207	[p15l797t3100r863b3160],
6	,	,	O	,	_	0	SENT_207	[p15l797t3100r863b3160],
7	Downing	NNP	O	Downing	nn	8	SENT_207	[p15l889t3099r1184b3168],
8	TE	NNP	O	TE	appos	2	SENT_207	[p15l1208t3100r1313b3160],
9	,	,	O	,	_	0	SENT_207	[p15l1208t3100r1313b3160],
10	et	FW	O	et	nn	11	SENT_207	[p15l1341t3105r1396b3151],
11	al.	FW	O	al.	appos	2	SENT_207	[p15l1421t3096r1491b3151],
12	.	.	O	.	_	0	SENT_207	[p15l1421t3096r1491b3151],

1	Absence	NN	O	absence	_	0	SENT_208	[p15l1519t3096r1793b3151],
2	of	IN	O	of	_	0	SENT_208	[p15l1819t3097r1884b3151],
3	correlations	NNS	O	correlation	prep_of	1	SENT_208	[p15l1903t3097r2147b3151, p15l7t3186r166b3237],
4	among	IN	O	among	_	0	SENT_208	[p15l196t3202r410b3254],
5	three	CD	NUMBER	three	prep_among	3	SENT_208	[p15l437t3183r600b3237],
6	putative	JJ	O	putative	amod	5	SENT_208	[p15l629t3186r894b3255],
7	in	FW	O	in	prep	1	SENT_208	[p15l923t3185r987b3237],
8	vivo	FW	O	vivo	nn	9	SENT_208	[p15l1013t3185r1152b3237],
9	probes	NNS	O	probe	pobj	7	SENT_208	[p15l1182t3183r1395b3255],
10	of	IN	O	of	_	0	SENT_208	[p15l1426t3183r1491b3237],
11	human	JJ	O	human	amod	14	SENT_208	[p15l1512t3183r1739b3237],
12	cytochrome	NN	O	cytochrome	nn	14	SENT_208	[p15l1768t3183r2148b3254],
13	P4503A	NN	O	p4503a	nn	14	SENT_208	[p15l7t3273r263b3324],
14	activity	NN	O	activity	prep_of	1	SENT_208	[p15l304t3272r546b3341],
15	in	IN	O	in	_	0	SENT_208	[p15l586t3272r650b3323],
16	young	JJ	O	young	amod	18	SENT_208	[p15l689t3288r889b3341],
17	healthy	JJ	O	healthy	amod	18	SENT_208	[p15l929t3269r1172b3341],
18	men	NNS	O	man	prep_in	14	SENT_208	[p15l1211t3288r1367b3324],
19	.	.	O	.	_	0	SENT_208	[p15l1211t3288r1367b3324],

1	Clin	NNP	O	Clin	nn	3	SENT_209	[p15l1415t3269r1543b3324],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_209	[p15l1583t3269r1940b3324],
3	Ther	NNP	O	Ther	_	0	SENT_209	[p15l1983t3269r2144b3324],
4	.	.	O	.	_	0	SENT_209	[p15l1983t3269r2144b3324],

1	1993	CD	DATE	1993	_	0	SENT_210	[p15l12t3364r560b3419],
2	;	:	O	;	_	0	SENT_210	[p15l12t3364r560b3419],
3	54:621	CD	NUMBER	54:621	number	4	SENT_210	[p15l12t3364r560b3419],
4	-629	CD	NUMBER	-629	dep	1	SENT_210	[p15l12t3364r560b3419],
5	.	.	O	.	_	0	SENT_210	[p15l12t3364r560b3419],

1	4	LS	NUMBER	4	_	0	SENT_211	[p15l8t3458r61b3505],
2	.	.	O	.	_	0	SENT_211	[p15l8t3458r61b3505],

1	Wilkinson	NNP	PERSON	Wilkinson	_	0	SENT_212	[p15l88t3450r425b3505],
2	GR	NN	O	gr	dep	1	SENT_212	[p15l451t3453r561b3505],
3	.	.	O	.	_	0	SENT_212	[p15l451t3453r561b3505],

1	Cytochrome	NN	O	cytochrome	_	0	SENT_213	[p15l592t3450r984b3522],
2	P4503A	NN	O	p4503a	nn	4	SENT_213	[p15l1009t3454r1265b3505],
3	(	CD	NUMBER	(	num	4	SENT_213	[p15l1294t3450r1569b3515],
4	CYPBA	NNP	O	CYPBA	dep	1	SENT_213	[p15l1294t3450r1569b3515],
5	)	CD	NUMBER	)	num	6	SENT_213	[p15l1294t3450r1569b3515],
6	metabolism	NN	O	metabolism	dep	4	SENT_213	[p15l1597t3450r1992b3505],
7	:	:	O	:	_	0	SENT_213	[p15l1597t3450r1992b3505],
8	prediction	NN	O	prediction	dep	4	SENT_213	[p15l2021t3469r2147b3522, p15l10t3536r239b3591],
9	of	IN	O	of	prep	8	SENT_213	[p15l263t3536r327b3591],
10	in	FW	O	in	nn	11	SENT_213	[p15l344t3539r408b3590],
11	vivo	FW	O	vivo	dep	12	SENT_213	[p15l429t3539r568b3591],
12	activity	NN	O	activity	dep	13	SENT_213	[p15l593t3539r835b3608],
13	in	IN	O	in	dep	9	SENT_213	[p15l858t3539r922b3590],
14	humans	NNS	O	human	pobj	13	SENT_213	[p15l943t3536r1217b3591],
15	.	.	O	.	_	0	SENT_213	[p15l943t3536r1217b3591],
16	]	SYM	O	]	dep	8	SENT_213	[p15l1239t3536r2144b3608],

1	Pharmaco1	NN	O	pharmaco1	_	0	SENT_214	[p15l1239t3536r2144b3608],
2	<	JJR	O	<	dep	1	SENT_214	[p15l1239t3536r2144b3608],
3	1	CD	NUMBER	1	rcmod	2	SENT_214	[p15l1239t3536r2144b3608],
4	'	''	O	'	_	0	SENT_214	[p15l1239t3536r2144b3608],
5	netB1	NN	O	netb1	dep	3	SENT_214	[p15l1239t3536r2144b3608],
6	'	''	O	'	_	0	SENT_214	[p15l1239t3536r2144b3608],
7	opharm	NN	O	opharm	dep	3	SENT_214	[p15l1239t3536r2144b3608],
8	.	.	O	.	_	0	SENT_214	[p15l1239t3536r2144b3608],

1	1996	CD	DATE	1996	_	0	SENT_215	[p15l11t3631r560b3686],
2	;	:	O	;	_	0	SENT_215	[p15l11t3631r560b3686],
3	24:475	CD	NUMBER	24:475	number	4	SENT_215	[p15l11t3631r560b3686],
4	-490	CD	NUMBER	-490	dep	1	SENT_215	[p15l11t3631r560b3686],
5	.	.	O	.	_	0	SENT_215	[p15l11t3631r560b3686],

1	5	CD	NUMBER	5	_	0	SENT_216	[p16l10t30r61b77],
2	.	.	O	.	_	0	SENT_216	[p16l10t30r61b77],

1	Wolbold	JJ	O	wolbold	amod	2	SENT_217	[p16l85t22r359b77],
2	R	NN	O	r	_	0	SENT_217	[p16l381t26r442b85],
3	,	,	O	,	_	0	SENT_217	[p16l381t26r442b85],
4	Klein	NNP	PERSON	Klein	nn	5	SENT_217	[p16l468t22r641b77],
5	K	NNP	PERSON	K	appos	2	SENT_217	[p16l664t26r729b85],
6	,	,	O	,	_	0	SENT_217	[p16l664t26r729b85],
7	Burk	NNP	PERSON	Burk	nn	8	SENT_217	[p16l754t22r910b77],
8	O	NNP	O	O	appos	2	SENT_217	[p16l932t25r1000b85],
9	,	,	O	,	_	0	SENT_217	[p16l932t25r1000b85],
10	et	FW	O	et	nn	11	SENT_217	[p16l1026t30r1081b77],
11	al.	FW	O	al.	appos	2	SENT_217	[p16l1104t22r1174b77],
12	.	.	O	.	_	0	SENT_217	[p16l1104t22r1174b77],

1	Sex	NN	O	sex	nsubj	5	SENT_218	[p16l1203t25r1317b77],
2	is	VBZ	O	be	cop	5	SENT_218	[p16l1339t25r1389b77],
3	a	DT	O	a	det	5	SENT_218	[p16l1414t41r1446b77],
4	major	JJ	O	major	amod	5	SENT_218	[p16l1468t25r1650b94],
5	determinant	NN	O	determinant	_	0	SENT_218	[p16l1675t22r2066b77],
6	of	IN	O	of	_	0	SENT_218	[p16l2090t22r2154b77],
7	CYP3A4	NN	O	cyp3a4	nn	8	SENT_218	[p16l8t111r278b163],
8	expression	NN	O	expression	prep_of	5	SENT_218	[p16l304t111r649b180],
9	in	IN	O	in	_	0	SENT_218	[p16l672t111r736b162],
10	human	JJ	O	human	amod	11	SENT_218	[p16l757t108r983b163],
11	liver	NN	O	liver	prep_in	8	SENT_218	[p16l1006t108r1163b163],
12	.	.	O	.	_	0	SENT_218	[p16l1006t108r1163b163],

1	Hepatology	NNP	O	Hepatology	_	0	SENT_219	[p16l1188t108r1571b180],
2	.	.	O	.	_	0	SENT_219	[p16l1188t108r1571b180],

1	2003	CD	DATE	2003	_	0	SENT_220	[p16l1601t116r2144b171],
2	;	:	O	;	_	0	SENT_220	[p16l1601t116r2144b171],
3	38:978	CD	NUMBER	38:978	number	4	SENT_220	[p16l1601t116r2144b171],
4	-988	CD	NUMBER	-988	dep	1	SENT_220	[p16l1601t116r2144b171],
5	.	.	O	.	_	0	SENT_220	[p16l1601t116r2144b171],

1	6	CD	NUMBER	6	_	0	SENT_221	[p16l9t210r61b257],
2	.	.	O	.	_	0	SENT_221	[p16l9t210r61b257],

1	Ozdemir	NNP	PERSON	Ozdemir	nn	2	SENT_222	[p16l88t203r370b257],
2	V	NNP	PERSON	V	_	0	SENT_222	[p16l392t206r450b266],
3	,	,	O	,	_	0	SENT_222	[p16l392t206r450b266],
4	Kalowa	NNP	PERSON	Kalowa	nn	5	SENT_222	[p16l476t203r719b257],
5	W	NNP	PERSON	W	appos	2	SENT_222	[p16l740t206r820b266],
6	,	,	O	,	_	0	SENT_222	[p16l740t206r820b266],
7	Tang	NNP	PERSON	Tang	nn	8	SENT_222	[p16l846t206r999b274],
8	BK	NNP	PERSON	BK	appos	2	SENT_222	[p16l1022t206r1135b266],
9	,	,	O	,	_	0	SENT_222	[p16l1022t206r1135b266],
10	et	FW	O	et	nn	11	SENT_222	[p16l1162t211r1217b257],
11	al.	FW	O	al.	appos	2	SENT_222	[p16l1241t203r1311b257],
12	.	.	O	.	_	0	SENT_222	[p16l1241t203r1311b257],

1	Evaluation	NN	O	evaluation	_	0	SENT_223	[p16l1337t203r1689b257],
2	of	IN	O	of	_	0	SENT_223	[p16l1713t203r1778b257],
3	the	DT	O	the	det	5	SENT_223	[p16l1794t203r1893b257],
4	genetic	JJ	O	genetic	amod	5	SENT_223	[p16l1917t206r2147b274],
5	component	NN	O	component	prep_of	1	SENT_223	[p16l9t297r375b361],
6	of	IN	O	of	_	0	SENT_223	[p16l415t289r480b344],
7	variability	NN	O	variability	prep_of	5	SENT_223	[p16l513t289r849b361],
8	in	IN	O	in	_	0	SENT_223	[p16l889t292r953b343],
9	CYP3A4	NN	O	cyp3a4	nn	10	SENT_223	[p16l993t292r1265b344],
10	activity	NN	O	activity	prep_in	7	SENT_223	[p16l1308t292r1566b361],
11	:	:	O	:	_	0	SENT_223	[p16l1308t292r1566b361],
12	a	DT	O	a	det	15	SENT_223	[p16l1611t308r1643b344],
13	repeated	VBN	O	repeat	amod	15	SENT_223	[p16l1681t289r1961b361],
14	drug	NN	O	drug	nn	15	SENT_223	[p16l2003t289r2148b361],
15	administration	NN	O	administration	dep	1	SENT_223	[p16l9t374r489b429],
16	method	NN	O	method	dep	15	SENT_223	[p16l513t374r776b429],
17	.	.	O	.	_	0	SENT_223	[p16l513t374r776b429],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_224	[p16l804t374r1416b446],
2	.	.	O	.	_	0	SENT_224	[p16l804t374r1416b446],

1	2000	CD	DATE	2000	_	0	SENT_225	[p16l1448t382r1998b438],
2	;	:	O	;	_	0	SENT_225	[p16l1448t382r1998b438],
3	10:373	CD	NUMBER	10:373	number	4	SENT_225	[p16l1448t382r1998b438],
4	-388	CD	NUMBER	-388	dep	1	SENT_225	[p16l1448t382r1998b438],
5	.	.	O	.	_	0	SENT_225	[p16l1448t382r1998b438],

1	7	CD	NUMBER	7	_	0	SENT_226	[p16l11t478r61b525],
2	.	.	O	.	_	0	SENT_226	[p16l11t478r61b525],

1	Randomised	JJ	O	randomised	amod	2	SENT_227	[p16l87t470r494b525],
2	trial	NN	O	trial	_	0	SENT_227	[p16l517t470r649b525],
3	of	IN	O	of	_	0	SENT_227	[p16l675t470r739b525],
4	cholesterol	NN	O	cholesterol	nn	5	SENT_227	[p16l759t470r1115b525],
5	lowering	NN	O	lowering	prep_of	2	SENT_227	[p16l1140t470r1426b542],
6	in	IN	O	in	_	0	SENT_227	[p16l1451t473r1514b524],
7	4444	CD	DATE	4444	num	8	SENT_227	[p16l1539t478r1692b524],
8	patients	NNS	O	patient	prep_in	5	SENT_227	[p16l1718t473r1975b542],
9	with	IN	O	with	_	0	SENT_227	[p16l2000t470r2149b525],
10	coronary	JJ	O	coronary	amod	12	SENT_227	[p16l9t575r295b628],
11	heart	NN	O	heart	nn	12	SENT_227	[p16l333t556r497b611],
12	disease	NN	O	disease	prep_with	8	SENT_227	[p16l537t556r786b611],
13	:	:	O	:	_	0	SENT_227	[p16l537t556r786b611],
14	the	DT	O	the	det	21	SENT_227	[p16l827t556r927b611],
15	Scandinavian	JJ	O	scandinavian	amod	21	SENT_227	[p16l968t556r1412b611],
16	Simvastatin	NNP	O	Simvastatin	nn	21	SENT_227	[p16l1452t559r1836b611],
17	Survival	NNP	O	Survival	nn	21	SENT_227	[p16l1876t556r2148b611],
18	Study	NNP	O	Study	nn	21	SENT_227	[p16l10t641r200b713],
19	(	CD	NUMBER	(	num	21	SENT_227	[p16l228t641r367b706],
20	4S	NN	O	4	nn	21	SENT_227	[p16l228t641r367b706],
21	)	NN	O	)	dep	2	SENT_227	[p16l228t641r367b706],
22	.	.	O	.	_	0	SENT_227	[p16l228t641r367b706],

1	Lancet	NNP	O	Lancet	_	0	SENT_228	[p16l395t645r627b696],
2	.	.	O	.	_	0	SENT_228	[p16l395t645r627b696],

1	1994	CD	DATE	1994	_	0	SENT_229	[p16l661t649r1328b705],
2	;	:	O	;	_	0	SENT_229	[p16l661t649r1328b705],
3	344:1383	CD	DURATION	344:1383	number	4	SENT_229	[p16l661t649r1328b705],
4	-1389	CD	DURATION	-1389	dep	1	SENT_229	[p16l661t649r1328b705],
5	.	.	O	.	_	0	SENT_229	[p16l661t649r1328b705],

1	8	CD	NUMBER	8	_	0	SENT_230	[p16l9t745r61b792],
2	.	.	O	.	_	0	SENT_230	[p16l9t745r61b792],

1	Plosker	NNP	O	Plosker	nn	2	SENT_231	[p16l88t737r328b792],
2	GL	NNP	O	GL	_	0	SENT_231	[p16l352t740r461b800],
3	,	,	O	,	_	0	SENT_231	[p16l352t740r461b800],
4	McTavish	NNP	PERSON	McTavish	nn	6	SENT_231	[p16l487t737r804b792],
5	D.	NNP	O	D.	nn	6	SENT_231	[p16l827t740r891b792],
6	Simvastatin	NNP	O	Simvastatin	appos	2	SENT_231	[p16l922t740r1322b792],
7	:	:	O	:	_	0	SENT_231	[p16l922t740r1322b792],
8	a	DT	O	a	det	9	SENT_231	[p16l1351t756r1383b792],
9	reappraisal	NN	O	reappraisal	dep	2	SENT_231	[p16l1405t737r1767b809],
10	of	IN	O	of	_	0	SENT_231	[p16l1794t737r1858b792],
11	its	PRP$	O	its	poss	12	SENT_231	[p16l1877t740r1951b792],
12	pharmacology	NN	O	pharmacology	prep_of	9	SENT_231	[p16l1977t737r2147b809, p16l7t822r319b894],
13	and	CC	O	and	_	0	SENT_231	[p16l372t822r491b877],
14	therapeutic	JJ	O	therapeutic	amod	15	SENT_231	[p16l543t822r911b894],
15	efficacy	NN	O	efficacy	conj_and	12	SENT_231	[p16l967t822r1217b894],
16	in	IN	O	in	_	0	SENT_231	[p16l1269t825r1333b877],
17	hypercholesterolaemia	NN	O	hypercholesterolaemia	prep_in	12	SENT_231	[p16l1385t822r2144b894],
18	.	.	O	.	_	0	SENT_231	[p16l1385t822r2144b894],

1	Drugs	NNS	O	drug	_	0	SENT_232	[p16l7t912r211b980],
2	.	.	O	.	_	0	SENT_232	[p16l7t912r211b980],

1	1995	CD	DATE	1995	_	0	SENT_233	[p16l244t916r793b972],
2	;	:	O	;	_	0	SENT_233	[p16l244t916r793b972],
3	50:334	CD	NUMBER	50:334	number	4	SENT_233	[p16l244t916r793b972],
4	-363	CD	NUMBER	-363	dep	1	SENT_233	[p16l244t916r793b972],
5	.	.	O	.	_	0	SENT_233	[p16l244t916r793b972],

1	9	CD	NUMBER	9	_	0	SENT_234	[p16l9t1012r61b1059],
2	.	.	O	.	_	0	SENT_234	[p16l9t1012r61b1059],

1	Kjekshus	NNP	O	Kjekshus	nn	2	SENT_235	[p16l90t1004r382b1076],
2	I	NNP	O	I	_	0	SENT_235	[p16l408t1008r448b1073],
3	,	,	O	,	_	0	SENT_235	[p16l408t1008r448b1073],
4	Pedersen	NNP	PERSON	Pedersen	nn	5	SENT_235	[p16l476t1004r771b1059],
5	TR	NN	O	tr	appos	2	SENT_235	[p16l797t1008r906b1067],
6	,	,	O	,	_	0	SENT_235	[p16l797t1008r906b1067],
7	Olsson	NNP	ORGANIZATION	Olsson	nn	8	SENT_235	[p16l936t1004r1158b1059],
8	AG	NNP	ORGANIZATION	AG	appos	2	SENT_235	[p16l1183t1007r1305b1067],
9	,	,	O	,	_	0	SENT_235	[p16l1183t1007r1305b1067],
10	Faergeman	NNP	PERSON	Faergeman	nn	11	SENT_235	[p16l1334t1008r1688b1076],
11	O	NNP	PERSON	O	appos	2	SENT_235	[p16l1714t1007r1783b1067],
12	,	,	O	,	_	0	SENT_235	[p16l1714t1007r1783b1067],
13	Pyorala	NNP	O	Pyorala	nn	15	SENT_235	[p16l1811t1004r2055b1076],
14	K.	NNP	O	K.	nn	15	SENT_235	[p16l2081t1008r2144b1059],
15	The	NNP	O	The	appos	2	SENT_235	[p16l8t1089r131b1144],
16	effects	NNS	O	effect	dep	15	SENT_235	[p16l171t1089r375b1144],
17	of	IN	O	of	prep	16	SENT_235	[p16l416t1089r481b1144],
18	simvastatin	NN	O	simvastatin	dep	24	SENT_235	[p16l514t1092r886b1144],
19	on	IN	O	on	_	0	SENT_235	[p16l926t1109r1004b1144],
20	the	DT	O	the	det	21	SENT_235	[p16l1041t1089r1141b1144],
21	incidence	NN	O	incidence	prep_on	18	SENT_235	[p16l1181t1089r1497b1144],
22	of	IN	O	of	_	0	SENT_235	[p16l1538t1089r1602b1144],
23	heart	NN	O	heart	prep_of	21	SENT_235	[p16l1634t1089r1798b1144],
24	failure	NN	O	failure	dep	17	SENT_235	[p16l1836t1089r2045b1144],
25	in	IN	O	in	_	0	SENT_235	[p16l2085t1092r2149b1144],
26	patients	NNS	O	patient	prep_in	24	SENT_235	[p16l8t1178r265b1247],
27	with	IN	O	with	_	0	SENT_235	[p16l290t1176r438b1230],
28	coronary	JJ	O	coronary	amod	30	SENT_235	[p16l463t1195r749b1247],
29	heart	NN	O	heart	nn	30	SENT_235	[p16l772t1176r937b1230],
30	disease	NN	O	disease	prep_with	26	SENT_235	[p16l963t1175r1211b1230],
31	.	.	O	.	_	0	SENT_235	[p16l963t1175r1211b1230],
32	]	SYM	O	]	dep	16	SENT_235	[p16l1234t1179r1268b1244],

1	Card	NN	O	card	_	0	SENT_236	[p16l1288t1175r1443b1230],
2	Fail	NN	O	fail	dep	1	SENT_236	[p16l1462t1175r1603b1230],
3	.	.	O	.	_	0	SENT_236	[p16l1462t1175r1603b1230],

1	1997	CD	DATE	1997	_	0	SENT_237	[p16l1635t1183r2144b1239],
2	;	:	O	;	_	0	SENT_237	[p16l1635t1183r2144b1239],
3	3:249	CD	NUMBER	3:249	number	4	SENT_237	[p16l1635t1183r2144b1239],
4	-254	CD	NUMBER	-254	dep	1	SENT_237	[p16l1635t1183r2144b1239],
5	.	.	O	.	_	0	SENT_237	[p16l1635t1183r2144b1239],

1	10	CD	NUMBER	10	_	0	SENT_238	[p16l10t1279r101b1326],
2	.	.	O	.	_	0	SENT_238	[p16l10t1279r101b1326],

1	Christians	NNS	MISC	christian	_	0	SENT_239	[p16l139t1271r467b1326],
2	U	NNP	O	U	nn	5	SENT_239	[p16l503t1275r572b1334],
3	,	,	O	,	_	0	SENT_239	[p16l503t1275r572b1334],
4	Jacobsen	NNP	PERSON	Jacobsen	appos	5	SENT_239	[p16l607t1271r892b1339],
5	W	NNP	O	W	dep	1	SENT_239	[p16l926t1275r1005b1334],
6	,	,	O	,	_	0	SENT_239	[p16l926t1275r1005b1334],
7	Floren	NNP	ORGANIZATION	Floren	nn	8	SENT_239	[p16l1043t1271r1254b1326],
8	LC	NNP	ORGANIZATION	LC	appos	5	SENT_239	[p16l1288t1274r1392b1326],
9	.	.	O	.	_	0	SENT_239	[p16l1288t1274r1392b1326],

1	Metabolism	NN	O	metabolism	nn	4	SENT_240	[p16l1430t1271r1812b1326],
2	and	CC	O	and	_	0	SENT_240	[p16l1847t1271r1967b1326],
3	drug	NN	O	drug	conj_and	1	SENT_240	[p16l2003t1271r2148b1343],
4	interactions	NNS	O	interaction	dep	10	SENT_240	[p16l8t1359r392b1411],
5	of	IN	O	of	_	0	SENT_240	[p16l436t1357r500b1411],
6	3-hydroxy-3-methylglutaryl	JJ	O	3-hydroxy-3-methylglutaryl	amod	7	SENT_240	[p16l538t1356r1440b1428],
7	coenzyme	NN	O	coenzyme	prep_of	4	SENT_240	[p16l1483t1376r1807b1428],
8	A	DT	O	a	det	9	SENT_240	[p16l1848t1360r1901b1411],
9	reductase	NN	O	reductase	dep	10	SENT_240	[p16l1941t1357r2147b1411, p16l7t1451r131b1497],
10	inhibitors	NNS	O	inhibitor	dep	17	SENT_240	[p16l162t1443r478b1497],
11	in	IN	O	in	_	0	SENT_240	[p16l510t1446r574b1497],
12	transplant	NN	O	transplant	nn	13	SENT_240	[p16l603t1443r934b1515],
13	patients	NNS	O	patient	prep_in	10	SENT_240	[p16l963t1446r1238b1515],
14	:	:	O	:	_	0	SENT_240	[p16l963t1446r1238b1515],
15	are	VBP	O	be	cop	17	SENT_240	[p16l1272t1462r1366b1497],
16	the	DT	O	the	det	17	SENT_240	[p16l1396t1443r1495b1497],
17	statins	NNS	O	statin	_	0	SENT_240	[p16l1528t1446r1735b1497],
18	mechanistically	RB	O	mechanistically	advmod	19	SENT_240	[p16l1767t1443r2147b1497, p16l9t1529r164b1601],
19	similar	JJ	O	similar	amod	17	SENT_240	[p16l190t1529r446b1584],
20	?	.	O	?	_	0	SENT_240	[p16l190t1529r446b1584],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_241	[p16l471t1529r828b1584],
2	Ther	NNP	O	Ther	_	0	SENT_241	[p16l856t1529r1017b1584],
3	.	.	O	.	_	0	SENT_241	[p16l856t1529r1017b1584],

1	1998	CD	DATE	1998	_	0	SENT_242	[p16l1050t1537r1480b1592],
2	;	:	O	;	_	0	SENT_242	[p16l1050t1537r1480b1592],
3	80:1	CD	NUMBER	80:1	number	4	SENT_242	[p16l1050t1537r1480b1592],
4	-34	CD	NUMBER	-34	dep	1	SENT_242	[p16l1050t1537r1480b1592],
5	.	.	O	.	_	0	SENT_242	[p16l1050t1537r1480b1592],

1	11	CD	NUMBER	11	_	0	SENT_243	[p16l10t1632r101b1678],
2	.	.	O	.	_	0	SENT_243	[p16l10t1632r101b1678],

1	Vickers	NNP	PERSON	Vickers	nn	2	SENT_244	[p16l144t1624r382b1678],
2	S	NNP	O	S	_	0	SENT_244	[p16l428t1626r483b1687],
3	,	,	O	,	_	0	SENT_244	[p16l428t1626r483b1687],
4	Duncan	NNP	PERSON	Duncan	nn	5	SENT_244	[p16l526t1627r778b1678],
5	CA	NNP	O	CA	appos	2	SENT_244	[p16l819t1626r936b1687],
6	,	,	O	,	_	0	SENT_244	[p16l819t1626r936b1687],
7	Chen	NNP	ORGANIZATION	Chen	nn	8	SENT_244	[p16l980t1624r1148b1678],
8	IW	NNP	ORGANIZATION	IW	appos	2	SENT_244	[p16l1188t1627r1291b1687],
9	,	,	O	,	_	0	SENT_244	[p16l1188t1627r1291b1687],
10	Rosegay	NNP	O	Rosegay	nn	11	SENT_244	[p16l1335t1627r1598b1695],
11	A	NNP	O	A	appos	2	SENT_244	[p16l1638t1627r1708b1687],
12	,	,	O	,	_	0	SENT_244	[p16l1638t1627r1708b1687],
13	Duggan	NNP	PERSON	Duggan	nn	14	SENT_244	[p16l1752t1627r1996b1695],
14	DE	NN	O	de	appos	2	SENT_244	[p16l2036t1627r2144b1678],
15	.	.	O	.	_	0	SENT_244	[p16l2036t1627r2144b1678],

1	Metabolic	JJ	MISC	metabolic	amod	3	SENT_245	[p16l8t1710r341b1764],
2	disposition	NN	O	disposition	nn	3	SENT_245	[p16l388t1710r768b1782],
3	studies	NNS	O	study	_	0	SENT_245	[p16l812t1710r1049b1764],
4	on	IN	O	on	_	0	SENT_245	[p16l1096t1729r1176b1764],
5	simvastatin	NN	O	simvastatin	prep_on	3	SENT_245	[p16l1221t1713r1628b1773],
6	,	,	O	,	_	0	SENT_245	[p16l1221t1713r1628b1773],
7	a	DT	O	a	det	9	SENT_245	[p16l1675t1729r1707b1764],
8	cholesterollowering	NN	O	cholesterollowering	nn	9	SENT_245	[p16l1751t1710r2147b1764, p16l8t1796r298b1868],
9	prodrug	NN	O	prodrug	appos	5	SENT_245	[p16l323t1796r597b1868],
10	.	.	O	.	_	0	SENT_245	[p16l323t1796r597b1868],

1	Drug	NN	O	drug	_	0	SENT_246	[p16l626t1800r787b1868],
2	Metab	NNP	O	Metab	nn	3	SENT_246	[p16l806t1796r1007b1851],
3	Dispos	NNP	O	Dispos	dep	1	SENT_246	[p16l1031t1799r1265b1868],
4	.	.	O	.	_	0	SENT_246	[p16l1031t1799r1265b1868],

1	1990	CD	DATE	1990	_	0	SENT_247	[p16l1298t1804r1847b1859],
2	;	:	O	;	_	0	SENT_247	[p16l1298t1804r1847b1859],
3	18:138	CD	NUMBER	18:138	number	4	SENT_247	[p16l1298t1804r1847b1859],
4	-145	CD	NUMBER	-145	dep	1	SENT_247	[p16l1298t1804r1847b1859],
5	.	.	O	.	_	0	SENT_247	[p16l1298t1804r1847b1859],

1	12	CD	NUMBER	12	_	0	SENT_248	[p16l10t1898r101b1945],
2	.	.	O	.	_	0	SENT_248	[p16l10t1898r101b1945],

1	Hustert	NNP	PERSON	Hustert	nn	2	SENT_249	[p16l126t1894r363b1945],
2	E	NNP	PERSON	E	_	0	SENT_249	[p16l383t1894r441b1954],
3	,	,	O	,	_	0	SENT_249	[p16l383t1894r441b1954],
4	Haberl	NNP	PERSON	Haberl	nn	5	SENT_249	[p16l465t1890r678b1945],
5	M	NNP	O	M	appos	2	SENT_249	[p16l699t1894r781b1954],
6	,	,	O	,	_	0	SENT_249	[p16l699t1894r781b1954],
7	Burk	NNP	PERSON	Burk	nn	8	SENT_249	[p16l805t1891r961b1945],
8	O	NNP	O	O	appos	2	SENT_249	[p16l982t1893r1050b1954],
9	,	,	O	,	_	0	SENT_249	[p16l982t1893r1050b1954],
10	et	FW	O	et	nn	11	SENT_249	[p16l1075t1899r1130b1945],
11	al.	FW	O	al.	appos	2	SENT_249	[p16l1152t1891r1222b1945],
12	.	.	O	.	_	0	SENT_249	[p16l1152t1891r1222b1945],

1	The	DT	O	the	det	3	SENT_250	[p16l1248t1890r1370b1945],
2	genetic	JJ	O	genetic	amod	3	SENT_250	[p16l1392t1893r1619b1962],
3	determinants	NNS	O	determinant	_	0	SENT_250	[p16l1645t1890r2065b1945],
4	of	IN	O	of	_	0	SENT_250	[p16l2090t1891r2154b1945],
5	the	DT	O	the	det	7	SENT_250	[p16l7t1977r106b2032],
6	CYP3A5	NN	O	cyp3a5	nn	7	SENT_250	[p16l132t1980r400b2032],
7	polymorphism	NN	O	polymorphism	prep_of	3	SENT_250	[p16l428t1977r920b2049],
8	.	.	O	.	_	0	SENT_250	[p16l428t1977r920b2049],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_251	[p16l948t1977r1553b2049],
2	.	.	O	.	_	0	SENT_251	[p16l948t1977r1553b2049],

1	2001	CD	DATE	2001	_	0	SENT_252	[p16l1584t1985r2127b2040],
2	;	:	O	;	_	0	SENT_252	[p16l1584t1985r2127b2040],
3	11:773	CD	NUMBER	11:773	number	4	SENT_252	[p16l1584t1985r2127b2040],
4	-779	CD	NUMBER	-779	dep	1	SENT_252	[p16l1584t1985r2127b2040],
5	.	.	O	.	_	0	SENT_252	[p16l1584t1985r2127b2040],

1	13	CD	NUMBER	13	_	0	SENT_253	[p16l10t2079r101b2126],
2	.	.	O	.	_	0	SENT_253	[p16l10t2079r101b2126],

1	Kuehl	NNP	PERSON	Kuehl	nn	2	SENT_254	[p16l134t2072r328b2126],
2	P	NN	O	p	_	0	SENT_254	[p16l358t2075r407b2135],
3	,	,	O	,	_	0	SENT_254	[p16l358t2075r407b2135],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_254	[p16l440t2071r642b2143],
5	J	NNP	PERSON	J	appos	2	SENT_254	[p16l669t2075r710b2140],
6	,	,	O	,	_	0	SENT_254	[p16l669t2075r710b2140],
7	Lin	NNP	O	Lin	nn	8	SENT_254	[p16l743t2074r851b2126],
8	Y	NN	O	y	appos	2	SENT_254	[p16l880t2075r939b2135],
9	,	,	O	,	_	0	SENT_254	[p16l880t2075r939b2135],
10	et	FW	O	et	nn	11	SENT_254	[p16l973t2080r1029b2126],
11	al.	FW	O	al.	appos	2	SENT_254	[p16l1058t2072r1129b2126],
12	.	.	O	.	_	0	SENT_254	[p16l1058t2072r1129b2126],

1	Sequence	NN	O	sequence	nn	2	SENT_255	[p16l1166t2074r1472b2143],
2	diversity	NN	O	diversity	_	0	SENT_255	[p16l1506t2071r1790b2143],
3	in	IN	O	in	_	0	SENT_255	[p16l1820t2074r1884b2126],
4	CYP3A	NN	O	cyp3a	nn	5	SENT_255	[p16l1914t2074r2149b2126],
5	promoters	NNS	O	promoter	prep_in	2	SENT_255	[p16l8t2166r336b2230],
6	and	CC	O	and	_	0	SENT_255	[p16l371t2158r490b2212],
7	characterization	NN	O	characterization	prep_in	2	SENT_255	[p16l524t2158r1047b2212],
8	of	IN	O	of	_	0	SENT_255	[p16l1080t2158r1145b2212],
9	the	DT	O	the	det	11	SENT_255	[p16l1170t2158r1270b2212],
10	genetic	JJ	O	genetic	amod	11	SENT_255	[p16l1303t2161r1532b2229],
11	basis	NN	O	basis	prep_of	2	SENT_255	[p16l1563t2158r1724b2212],
12	of	IN	O	of	_	0	SENT_255	[p16l1759t2158r1824b2212],
13	polymorphic	JJ	O	polymorphic	amod	15	SENT_255	[p16l1850t2158r2147b2230, p16l8t2244r150b2316],
14	CYP3A5	NN	O	cyp3a5	nn	15	SENT_255	[p16l177t2247r447b2299],
15	expression	NN	O	expression	prep_of	11	SENT_255	[p16l478t2247r842b2316],
16	.	.	O	.	_	0	SENT_255	[p16l478t2247r842b2316],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_256	[p16l871t2248r991b2299],
2	Genet	NNP	PERSON	Genet	_	0	SENT_256	[p16l1017t2247r1215b2299],
3	.	.	O	.	_	0	SENT_256	[p16l1017t2247r1215b2299],

1	2001	CD	DATE	2001	_	0	SENT_257	[p16l1247t2252r1797b2307],
2	;	:	O	;	_	0	SENT_257	[p16l1247t2252r1797b2307],
3	27:383	CD	NUMBER	27:383	number	4	SENT_257	[p16l1247t2252r1797b2307],
4	-391	CD	NUMBER	-391	dep	1	SENT_257	[p16l1247t2252r1797b2307],
5	.	.	O	.	_	0	SENT_257	[p16l1247t2252r1797b2307],

1	14	CD	NUMBER	14	_	0	SENT_258	[p16l10t2347r101b2393],
2	.	.	O	.	_	0	SENT_258	[p16l10t2347r101b2393],

1	Williams	NNP	ORGANIZATION	Williams	nn	2	SENT_259	[p16l136t2338r426b2393],
2	IA	NNP	ORGANIZATION	IA	_	0	SENT_259	[p16l458t2342r554b2407],
3	,	,	O	,	_	0	SENT_259	[p16l458t2342r554b2407],
4	Ring	NN	O	ring	nn	6	SENT_259	[p16l589t2341r737b2410],
5	B	NN	O	b	nn	6	SENT_259	[p16l769t2342r855b2407],
6	]	NN	O	]	appos	2	SENT_259	[p16l769t2342r855b2407],
7	,	,	O	,	_	0	SENT_259	[p16l769t2342r855b2407],
8	Cantrell	NNP	PERSON	Cantrell	nn	9	SENT_259	[p16l890t2339r1148b2393],
9	VE	NNP	O	VE	appos	2	SENT_259	[p16l1180t2342r1290b2402],
10	,	,	O	,	_	0	SENT_259	[p16l1180t2342r1290b2402],
11	et	FW	O	et	nn	12	SENT_259	[p16l1327t2347r1383b2393],
12	al.	FW	O	al.	appos	2	SENT_259	[p16l1415t2339r1486b2393],
13	.	.	O	.	_	0	SENT_259	[p16l1415t2339r1486b2393],

1	Comparative	JJ	O	comparative	amod	3	SENT_260	[p16l1524t2341r1936b2410],
2	metabolic	JJ	O	metabolic	amod	3	SENT_260	[p16l1969t2347r2147b2393, p16l6t2425r166b2479],
3	capabilities	NNS	O	capability	_	0	SENT_260	[p16l192t2425r563b2497],
4	of	IN	O	of	_	0	SENT_260	[p16l590t2425r655b2479],
5	CYP3A4	NN	O	cyp3a4	prep_of	3	SENT_260	[p16l673t2427r964b2488],
6	,	,	O	,	_	0	SENT_260	[p16l673t2427r964b2488],
7	CYP3A5	NN	O	cyp3a5	prep_of	3	SENT_260	[p16l991t2427r1282b2488],
8	,	,	O	,	_	0	SENT_260	[p16l991t2427r1282b2488],
9	and	CC	O	and	_	0	SENT_260	[p16l1309t2425r1429b2479],
10	CYP3A7	NN	O	cyp3a7	prep_of	3	SENT_260	[p16l1453t2427r1742b2479],
11	.	.	O	.	_	0	SENT_260	[p16l1453t2427r1742b2479],

1	Drug	NN	O	drug	_	0	SENT_261	[p16l1769t2428r1930b2496],
2	Metab	NNP	O	Metab	nn	3	SENT_261	[p16l1948t2425r2149b2479],
3	Dispos	NNP	O	Dispos	dep	1	SENT_261	[p16l7t2514r241b2583],
4	.	.	O	.	_	0	SENT_261	[p16l7t2514r241b2583],

1	2002	CD	DATE	2002	_	0	SENT_262	[p16l273t2519r823b2574],
2	;	:	O	;	_	0	SENT_262	[p16l273t2519r823b2574],
3	30:883	CD	NUMBER	30:883	number	4	SENT_262	[p16l273t2519r823b2574],
4	-891	CD	NUMBER	-891	dep	1	SENT_262	[p16l273t2519r823b2574],
5	.	.	O	.	_	0	SENT_262	[p16l273t2519r823b2574],

1	15	CD	NUMBER	15	_	0	SENT_263	[p16l10t2614r101b2660],
2	.	.	O	.	_	0	SENT_263	[p16l10t2614r101b2660],

1	Lin	NNP	PERSON	Lin	nn	2	SENT_264	[p16l148t2608r255b2660],
2	YS	NNP	O	YS	_	0	SENT_264	[p16l298t2608r408b2669],
3	,	,	O	,	_	0	SENT_264	[p16l298t2608r408b2669],
4	Dowling	NNP	ORGANIZATION	Dowling	nn	5	SENT_264	[p16l453t2606r728b2677],
5	AL	NNP	ORGANIZATION	AL	appos	2	SENT_264	[p16l771t2609r885b2669],
6	,	,	O	,	_	0	SENT_264	[p16l771t2609r885b2669],
7	Quigley	NNP	PERSON	Quigley	nn	8	SENT_264	[p16l932t2606r1186b2677],
8	SD	NN	O	sd	appos	2	SENT_264	[p16l1232t2608r1338b2669],
9	,	,	O	,	_	0	SENT_264	[p16l1232t2608r1338b2669],
10	et	FW	O	et	nn	11	SENT_264	[p16l1386t2614r1441b2660],
11	al.	FW	O	al.	appos	2	SENT_264	[p16l1485t2606r1556b2660],
12	.	.	O	.	_	0	SENT_264	[p16l1485t2606r1556b2660],

1	Co-regulation	NN	O	co-regulation	_	0	SENT_265	[p16l1604t2606r2045b2677],
2	of	IN	O	of	_	0	SENT_265	[p16l2090t2606r2154b2660],
3	CYP3A4	NN	O	cyp3a4	prep_of	1	SENT_265	[p16l8t2695r280b2747],
4	and	CC	O	and	_	0	SENT_265	[p16l311t2692r430b2747],
5	CYP3A5	NN	O	cyp3a5	prep_of	1	SENT_265	[p16l458t2695r728b2747],
6	and	CC	O	and	_	0	SENT_265	[p16l761t2692r880b2747],
7	contribution	NN	O	contribution	prep_of	1	SENT_265	[p16l909t2692r1313b2747],
8	to	TO	O	to	_	0	SENT_265	[p16l1340t2700r1399b2747],
9	hepatic	JJ	O	hepatic	amod	13	SENT_265	[p16l1428t2692r1665b2764],
10	and	CC	O	and	_	0	SENT_265	[p16l1696t2692r1815b2747],
11	intestinal	JJ	O	intestinal	amod	13	SENT_265	[p16l1843t2692r2148b2747],
12	midazolam	NN	O	midazolam	nn	13	SENT_265	[p16l7t2778r370b2833],
13	metabolism	NN	O	metabolism	prep_to	1	SENT_265	[p16l394t2778r788b2833],
14	.	.	O	.	_	0	SENT_265	[p16l394t2778r788b2833],

1	M01	NN	O	m01	_	0	SENT_266	[p16l816t2778r943b2833],
2	Pharmacol	NN	O	pharmacol	dep	1	SENT_266	[p16l964t2778r1333b2833],
3	.	.	O	.	_	0	SENT_266	[p16l964t2778r1333b2833],

1	2002	CD	DATE	2002	_	0	SENT_267	[p16l1366t2786r1915b2841],
2	;	:	O	;	_	0	SENT_267	[p16l1366t2786r1915b2841],
3	62:162	CD	NUMBER	62:162	number	4	SENT_267	[p16l1366t2786r1915b2841],
4	-172	CD	NUMBER	-172	dep	1	SENT_267	[p16l1366t2786r1915b2841],
5	.	.	O	.	_	0	SENT_267	[p16l1366t2786r1915b2841],

1	16	CD	NUMBER	16	_	0	SENT_268	[p16l10t2879r101b2926],
2	.	.	O	.	_	0	SENT_268	[p16l10t2879r101b2926],

1	Williams	NNP	ORGANIZATION	Williams	nn	2	SENT_269	[p16l125t2872r416b2926],
2	IA	NNP	ORGANIZATION	IA	_	0	SENT_269	[p16l437t2875r533b2940],
3	,	,	O	,	_	0	SENT_269	[p16l437t2875r533b2940],
4	Cook	NNP	O	Cook	nn	8	SENT_269	[p16l559t2872r723b2926],
5	I	PRP	O	I	dep	8	SENT_269	[p16l741t2875r781b2940],
6	,	,	O	,	_	0	SENT_269	[p16l741t2875r781b2940],
7	Hurst	NNP	PERSON	Hurst	dep	8	SENT_269	[p16l806t2875r986b2926],
8	SI	NNP	O	SI	appos	2	SENT_269	[p16l1010t2874r1087b2926],
9	.	.	O	.	_	0	SENT_269	[p16l1010t2874r1087b2926],

1	A	DT	O	a	det	4	SENT_270	[p16l1113t2875r1166b2926],
2	significant	JJ	O	significant	amod	4	SENT_270	[p16l1190t2872r1531b2943],
3	drug-metabolizing	JJ	O	drug-metabolizing	amod	4	SENT_270	[p16l1555t2872r2148b2943],
4	role	NN	O	role	_	0	SENT_270	[p16l7t2958r131b3013],
5	for	IN	O	for	_	0	SENT_270	[p16l158t2958r245b3013],
6	CYP3A5	NN	O	cyp3a5	prep_for	4	SENT_270	[p16l271t2961r575b3013],
7	?	.	O	?	_	0	SENT_270	[p16l271t2961r575b3013],

1	Drug	NN	O	drug	_	0	SENT_271	[p16l601t2962r762b3030],
2	Metab	NNP	O	Metab	nn	3	SENT_271	[p16l781t2958r982b3013],
3	Dispos	NNP	O	Dispos	dep	1	SENT_271	[p16l1005t2961r1239b3030],
4	.	.	O	.	_	0	SENT_271	[p16l1005t2961r1239b3030],

1	2003	CD	DATE	2003	_	0	SENT_272	[p16l1272t2966r1901b3021],
2	;	:	O	;	_	0	SENT_272	[p16l1272t2966r1901b3021],
3	31:1526	CD	DURATION	31:1526	number	4	SENT_272	[p16l1272t2966r1901b3021],
4	-1530	CD	DURATION	-1530	dep	1	SENT_272	[p16l1272t2966r1901b3021],
5	.	.	O	.	_	0	SENT_272	[p16l1272t2966r1901b3021],

1	17	CD	NUMBER	17	_	0	SENT_273	[p16l10t3061r101b3107],
2	.	.	O	.	_	0	SENT_273	[p16l10t3061r101b3107],

1	Park	NNP	O	Park	nn	2	SENT_274	[p16l126t3053r272b3107],
2	JY	NN	O	jy	_	0	SENT_274	[p16l289t3056r375b3121],
3	,	,	O	,	_	0	SENT_274	[p16l289t3056r375b3121],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_274	[p16l400t3055r536b3107],
5	KA	NN	O	ka	appos	2	SENT_274	[p16l558t3056r678b3116],
6	,	,	O	,	_	0	SENT_274	[p16l558t3056r678b3116],
7	Park	NNP	O	Park	nn	8	SENT_274	[p16l703t3052r849b3107],
8	PW	NNP	O	PW	appos	2	SENT_274	[p16l869t3056r992b3116],
9	,	,	O	,	_	0	SENT_274	[p16l869t3056r992b3116],
10	et	FW	O	et	nn	11	SENT_274	[p16l1018t3060r1074b3107],
11	al.	FW	O	al.	appos	2	SENT_274	[p16l1096t3052r1167b3107],
12	.	.	O	.	_	0	SENT_274	[p16l1096t3052r1167b3107],

1	Effect	NN	O	effect	_	0	SENT_275	[p16l1193t3053r1378b3107],
2	of	IN	O	of	_	0	SENT_275	[p16l1401t3053r1465b3107],
3	C	NN	O	c	nn	4	SENT_275	[p16l1486t3055r1532b3107],
4	YP3A5	NN	O	yp3a5	prep_of	1	SENT_275	[p16l1537t3056r1756b3107],
5	*	CD	NUMBER	*	number	6	SENT_275	[p16l1768t3055r1832b3107],
6	3	CD	NUMBER	3	num	7	SENT_275	[p16l1768t3055r1832b3107],
7	genotype	NN	O	genotype	dep	1	SENT_275	[p16l1853t3060r2148b3124],
8	on	IN	O	on	_	0	SENT_275	[p16l9t3158r88b3193],
9	the	DT	O	the	det	10	SENT_275	[p16l120t3139r220b3193],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	7	SENT_275	[p16l254t3139r832b3211],
11	and	CC	O	and	_	0	SENT_275	[p16l869t3139r987b3193],
12	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	10	SENT_275	[p16l1021t3139r1658b3211],
13	of	IN	O	of	_	0	SENT_275	[p16l1695t3139r1759b3193],
14	alprazolam	NN	O	alprazolam	prep_of	10	SENT_275	[p16l1787t3139r2149b3211],
15	in	IN	O	in	_	0	SENT_275	[p16l8t3228r72b3279],
16	healthy	JJ	O	healthy	amod	17	SENT_275	[p16l97t3225r341b3297],
17	subjects	NNS	O	subject	prep_in	14	SENT_275	[p16l366t3225r639b3297],
18	.	.	O	.	_	0	SENT_275	[p16l366t3225r639b3297],

1	Clin	NNP	O	Clin	nn	3	SENT_276	[p16l673t3225r800b3280],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_276	[p16l826t3225r1183b3280],
3	Ther	NNP	O	Ther	_	0	SENT_276	[p16l1211t3225r1372b3280],
4	.	.	O	.	_	0	SENT_276	[p16l1211t3225r1372b3280],

1	2006	CD	DATE	2006	_	0	SENT_277	[p16l1404t3233r1954b3288],
2	;	:	O	;	_	0	SENT_277	[p16l1404t3233r1954b3288],
3	79:590	CD	NUMBER	79:590	number	4	SENT_277	[p16l1404t3233r1954b3288],
4	-599	CD	NUMBER	-599	dep	1	SENT_277	[p16l1404t3233r1954b3288],
5	.	.	O	.	_	0	SENT_277	[p16l1404t3233r1954b3288],

1	18	CD	NUMBER	18	_	0	SENT_278	[p16l10t3327r101b3374],
2	.	.	O	.	_	0	SENT_278	[p16l10t3327r101b3374],

1	Prueksaritanont	JJ	O	prueksaritanont	amod	2	SENT_279	[p16l132t3320r650b3374],
2	T	NN	O	t	_	0	SENT_279	[p16l678t3323r732b3383],
3	,	,	O	,	_	0	SENT_279	[p16l678t3323r732b3383],
4	Gorham	NNP	ORGANIZATION	Gorham	nn	5	SENT_279	[p16l764t3320r1022b3374],
5	LM	NNP	ORGANIZATION	LM	appos	2	SENT_279	[p16l1051t3323r1176b3383],
6	,	,	O	,	_	0	SENT_279	[p16l1051t3323r1176b3383],
7	Ma	NNP	O	Ma	nn	8	SENT_279	[p16l1206t3323r1308b3374],
8	B	NNP	O	B	appos	2	SENT_279	[p16l1335t3323r1397b3382],
9	,	,	O	,	_	0	SENT_279	[p16l1335t3323r1397b3382],
10	et	FW	O	et	nn	11	SENT_279	[p16l1429t3328r1485b3374],
11	al.	FW	O	al.	appos	2	SENT_279	[p16l1514t3320r1584b3374],
12	.	.	O	.	_	0	SENT_279	[p16l1514t3320r1584b3374],

1	In	FW	O	in	nn	3	SENT_280	[p16l1617t3323r1681b3374],
2	vitro	FW	O	vitro	nn	3	SENT_280	[p16l1709t3323r1859b3374],
3	metabolism	NN	O	metabolism	_	0	SENT_280	[p16l1889t3320r2148b3374, p16l8t3406r148b3460],
4	of	IN	O	of	_	0	SENT_280	[p16l180t3406r244b3460],
5	simvastatin	NN	O	simvastatin	prep_of	3	SENT_280	[p16l271t3409r643b3460],
6	in	IN	O	in	_	0	SENT_280	[p16l674t3409r738b3460],
7	humans	NNS	O	human	prep_in	3	SENT_280	[p16l768t3406r1025b3460],
8	[	CD	NUMBER	[	num	9	SENT_280	[p16l1063t3406r1685b3468],
9	SBT	NN	O	sbt	dep	7	SENT_280	[p16l1063t3406r1685b3468],
10	]	CD	NUMBER	]	num	11	SENT_280	[p16l1063t3406r1685b3468],
11	identification	NN	O	identification	dep	9	SENT_280	[p16l1063t3406r1685b3468],
12	of	IN	O	of	_	0	SENT_280	[p16l1717t3406r1782b3460],
13	metabolizing	VBG	O	metabolize	prepc_of	3	SENT_280	[p16l1806t3406r2147b3460, p16l8t3494r108b3563],
14	enzymes	NNS	O	enzyme	dobj	13	SENT_280	[p16l134t3510r413b3563],
15	and	CC	O	and	_	0	SENT_280	[p16l441t3491r559b3546],
16	effect	NN	O	effect	dobj	13	SENT_280	[p16l585t3491r760b3546],
17	of	IN	O	of	_	0	SENT_280	[p16l785t3491r850b3546],
18	the	DT	O	the	det	19	SENT_280	[p16l868t3491r968b3546],
19	drug	NN	O	drug	prep_of	3	SENT_280	[p16l995t3491r1140b3563],
20	on	IN	O	on	_	0	SENT_280	[p16l1167t3510r1245b3546],
21	hepatic	JJ	O	hepatic	amod	22	SENT_280	[p16l1269t3491r1507b3563],
22	P450s	NNS	O	p450	prep_on	3	SENT_280	[p16l1533t3495r1740b3546],
23	.	.	O	.	_	0	SENT_280	[p16l1533t3495r1740b3546],

1	Drug	NN	O	drug	_	0	SENT_281	[p16l1768t3495r1929b3563],
2	Metab	NNP	O	Metab	nn	3	SENT_281	[p16l1948t3491r2149b3546],
3	Dispos	NNP	O	Dispos	dep	1	SENT_281	[p16l7t3581r241b3649],
4	.	.	O	.	_	0	SENT_281	[p16l7t3581r241b3649],

1	1997	CD	DATE	1997	_	0	SENT_282	[p16l274t3585r902b3641],
2	;	:	O	;	_	0	SENT_282	[p16l274t3585r902b3641],
3	25:1191	CD	DURATION	25:1191	number	4	SENT_282	[p16l274t3585r902b3641],
4	-1199	CD	DURATION	-1199	dep	1	SENT_282	[p16l274t3585r902b3641],
5	.	.	O	.	_	0	SENT_282	[p16l274t3585r902b3641],

1	EFFECT	NN	O	effect	_	0	SENT_283	[p16l552t3724r711b3754],
2	OF	IN	O	of	_	0	SENT_283	[p16l724t3724r781b3754],
3	CYP3A5	NN	O	cyp3a5	prep_of	1	SENT_283	[p16l794t3724r952b3754],
4	*	CD	NUMBER	*	number	5	SENT_283	[p16l959t3724r996b3754],
5	3	CD	NUMBER	3	dep	1	SENT_283	[p16l959t3724r996b3754],
6	ON	IN	O	on	_	0	SENT_283	[p16l1013t3724r1078b3754],
7	THE	DT	O	the	det	8	SENT_283	[p16l1091t3724r1175b3754],
8	PK	NN	O	pk	prep_on	5	SENT_283	[p16l1186t3724r1243b3754],
9	OF	IN	O	of	_	0	SENT_283	[p16l1255t3724r1312b3754],
10	SIMVASTATIN	NNP	O	SIMVASTATIN	prep_of	8	SENT_283	[p16l1324t3724r1612b3754],

1	19	CD	NUMBER	19	_	0	SENT_284	[p17l10t145r101b192],
2	.	.	O	.	_	0	SENT_284	[p17l10t145r101b192],

1	Vickers	NNP	PERSON	Vickers	nn	2	SENT_285	[p17l127t137r364b192],
2	S	NNP	O	S	_	0	SENT_285	[p17l392t140r447b200],
3	,	,	O	,	_	0	SENT_285	[p17l392t140r447b200],
4	Duncan	NNP	PERSON	Duncan	nn	5	SENT_285	[p17l472t141r724b192],
5	CA	NNP	O	CA	appos	2	SENT_285	[p17l748t140r864b200],
6	,	,	O	,	_	0	SENT_285	[p17l748t140r864b200],
7	Vyas	NNP	PERSON	Vyas	nn	8	SENT_285	[p17l889t141r1040b209],
8	KP	NNP	O	KP	appos	2	SENT_285	[p17l1065t140r1165b200],
9	,	,	O	,	_	0	SENT_285	[p17l1065t140r1165b200],
10	et	FW	O	et	nn	11	SENT_285	[p17l1192t145r1248b192],
11	al.	FW	O	al.	appos	2	SENT_285	[p17l1272t137r1342b192],
12	.	.	O	.	_	0	SENT_285	[p17l1272t137r1342b192],

1	In	FW	O	in	nn	2	SENT_286	[p17l1369t141r1434b191],
2	vitro	FW	O	vitro	dep	6	SENT_286	[p17l1456t140r1607b192],
3	and	CC	O	and	_	0	SENT_286	[p17l1633t137r1751b192],
4	in	FW	O	in	dep	6	SENT_286	[p17l1775t140r1839b191],
5	vivo	FW	O	vivo	pobj	4	SENT_286	[p17l1861t140r2000b192],
6	biotransformation	NN	O	biotransformation	_	0	SENT_286	[p17l2023t137r2148b192, p17l8t223r490b278],
7	of	IN	O	of	_	0	SENT_286	[p17l524t223r588b278],
8	simvastatin	NN	O	simvastatin	prep_of	6	SENT_286	[p17l617t226r1006b286],
9	,	,	O	,	_	0	SENT_286	[p17l617t226r1006b286],
10	an	DT	O	a	det	11	SENT_286	[p17l1043t242r1119b277],
11	inhibitor	NN	O	inhibitor	appos	6	SENT_286	[p17l1152t223r1439b278],
12	of	IN	O	of	_	0	SENT_286	[p17l1473t223r1537b278],
13	HMG	NN	O	hmg	nn	15	SENT_286	[p17l1564t226r1737b278],
14	CoA	NN	O	coa	nn	15	SENT_286	[p17l1769t226r1909b278],
15	reductase	NN	O	reductase	prep_of	11	SENT_286	[p17l1941t223r2148b278, p17l8t315r148b362],
16	.	.	O	.	_	0	SENT_286	[p17l1941t223r2148b278, p17l8t315r148b362],

1	Drug	NN	O	drug	_	0	SENT_287	[p17l176t311r337b379],
2	Metab	NNP	O	Metab	nn	3	SENT_287	[p17l356t307r558b362],
3	Dispos	NNP	O	Dispos	dep	1	SENT_287	[p17l581t311r815b379],
4	.	.	O	.	_	0	SENT_287	[p17l581t311r815b379],

1	1990	CD	DATE	1990	_	0	SENT_288	[p17l848t315r1397b371],
2	;	:	O	;	_	0	SENT_288	[p17l848t315r1397b371],
3	18:476	CD	NUMBER	18:476	number	4	SENT_288	[p17l848t315r1397b371],
4	-483	CD	NUMBER	-483	dep	1	SENT_288	[p17l848t315r1397b371],
5	.	.	O	.	_	0	SENT_288	[p17l848t315r1397b371],

1	20	CD	NUMBER	20	_	0	SENT_289	[p17l10t411r101b458],
2	.	.	O	.	_	0	SENT_289	[p17l10t411r101b458],

1	Dai	NNP	PERSON	Dai	nn	2	SENT_290	[p17l126t406r233b458],
2	Y	NN	PERSON	y	_	0	SENT_290	[p17l256t406r315b466],
3	,	,	O	,	_	0	SENT_290	[p17l256t406r315b466],
4	Hebert	NNP	PERSON	Hebert	nn	5	SENT_290	[p17l339t403r556b458],
5	MF	NN	O	mf	appos	2	SENT_290	[p17l577t407r694b466],
6	,	,	O	,	_	0	SENT_290	[p17l577t407r694b466],
7	Isoherranen	NN	O	isoherranen	nn	8	SENT_290	[p17l719t403r1105b458],
8	N	NN	O	n	appos	2	SENT_290	[p17l1126t407r1196b466],
9	,	,	O	,	_	0	SENT_290	[p17l1126t407r1196b466],
10	et	FW	O	et	nn	11	SENT_290	[p17l1222t411r1278b458],
11	al.	FW	O	al.	appos	2	SENT_290	[p17l1300t403r1371b458],
12	.	.	O	.	_	0	SENT_290	[p17l1300t403r1371b458],

1	Effect	NN	O	effect	_	0	SENT_291	[p17l1396t403r1581b458],
2	of	IN	O	of	_	0	SENT_291	[p17l1604t403r1669b458],
3	CYP3A5	NN	O	cyp3a5	nn	4	SENT_291	[p17l1685t406r1955b458],
4	polymorphism	NN	O	polymorphism	prep_of	1	SENT_291	[p17l1981t403r2148b475, p17l8t489r343b561],
5	on	IN	O	on	_	0	SENT_291	[p17l365t508r443b544],
6	tacrolimus	NN	O	tacrolimus	nn	8	SENT_291	[p17l463t489r808b544],
7	metabolic	JJ	O	metabolic	amod	8	SENT_291	[p17l830t489r1147b544],
8	clearance	NN	O	clearance	prep_on	1	SENT_291	[p17l1171t489r1475b544],
9	in	FW	O	in	nn	10	SENT_291	[p17l1497t492r1561b543],
10	vitro	FW	O	vitro	dep	8	SENT_291	[p17l1580t492r1748b544],
11	.	.	O	.	_	0	SENT_291	[p17l1580t492r1748b544],

1	Drug	NN	O	drug	_	0	SENT_292	[p17l1772t493r1933b561],
2	Metab	NNP	O	Metab	nn	3	SENT_292	[p17l1948t489r2150b544],
3	Dispos	NNP	O	Dispos	dep	1	SENT_292	[p17l7t578r241b646],
4	.	.	O	.	_	0	SENT_292	[p17l7t578r241b646],

1	2006	CD	DATE	2006	_	0	SENT_293	[p17l274t582r823b638],
2	;	:	O	;	_	0	SENT_293	[p17l274t582r823b638],
3	34:836	CD	NUMBER	34:836	number	4	SENT_293	[p17l274t582r823b638],
4	-847	CD	NUMBER	-847	dep	1	SENT_293	[p17l274t582r823b638],
5	.	.	O	.	_	0	SENT_293	[p17l274t582r823b638],

1	21	CD	NUMBER	21	_	0	SENT_294	[p17l10t677r101b724],
2	.	.	O	.	_	0	SENT_294	[p17l10t677r101b724],

1	Frohlich	NNP	PERSON	Frohlich	nn	2	SENT_295	[p17l139t669r418b724],
2	M	NNP	O	M	_	0	SENT_295	[p17l452t673r533b733],
3	,	,	O	,	_	0	SENT_295	[p17l452t673r533b733],
4	Hoffmann	NNP	PERSON	Hoffmann	nn	5	SENT_295	[p17l571t669r897b724],
5	MM	NN	O	mm	appos	2	SENT_295	[p17l931t673r1080b733],
6	,	,	O	,	_	0	SENT_295	[p17l931t673r1080b733],
7	Burhenne	NN	O	burhenne	nn	8	SENT_295	[p17l1118t669r1435b724],
8	I	NN	O	i	appos	5	SENT_295	[p17l1468t673r1508b738],
9	,	,	O	,	_	0	SENT_295	[p17l1468t673r1508b738],
10	Mikus	NNP	PERSON	Mikus	nn	11	SENT_295	[p17l1546t669r1747b724],
11	G	NNP	PERSON	G	appos	5	SENT_295	[p17l1784t672r1849b733],
12	,	,	O	,	_	0	SENT_295	[p17l1784t672r1849b733],
13	Weiss	NNP	PERSON	Weiss	nn	14	SENT_295	[p17l1886t672r2072b724],
14	I	NNP	O	I	appos	5	SENT_295	[p17l2106t673r2146b738],
15	,	,	O	,	_	0	SENT_295	[p17l2106t673r2146b738],
16	Haefeli	NNP	O	Haefeli	nn	17	SENT_295	[p17l8t756r239b810],
17	WE	NNP	O	WE	appos	5	SENT_295	[p17l281t759r409b810],
18	.	.	O	.	_	0	SENT_295	[p17l281t759r409b810],

1	Association	NNP	O	Association	_	0	SENT_296	[p17l455t758r838b810],
2	of	IN	O	of	_	0	SENT_296	[p17l881t756r946b810],
3	the	DT	O	the	det	7	SENT_296	[p17l982t755r1081b810],
4	CYP3A5	NN	O	cyp3a5	nn	7	SENT_296	[p17l1125t758r1395b810],
5	A6986G	NN	O	a6986g	nn	7	SENT_296	[p17l1441t758r1706b810],
6	(	CD	NUMBER	(	num	7	SENT_296	[p17l1751t756r2145b820],
7	CYP3A5	NN	O	cyp3a5	prep_of	1	SENT_296	[p17l1751t756r2145b820],
8	*	CD	NUMBER	*	number	9	SENT_296	[p17l1751t756r2145b820],
9	3	CD	NUMBER	3	num	11	SENT_296	[p17l1751t756r2145b820],
10	)	NN	O	)	nn	11	SENT_296	[p17l1751t756r2145b820],
11	polymorphism	NN	O	polymorphism	dep	1	SENT_296	[p17l8t841r490b913],
12	with	IN	O	with	_	0	SENT_296	[p17l546t841r695b896],
13	saquinavir	NN	O	saquinavir	nn	14	SENT_296	[p17l753t844r1095b913],
14	pharmacokinetics	NNS	O	pharmacokinetic	prep_with	11	SENT_296	[p17l1152t841r1747b913],
15	.	.	O	.	_	0	SENT_296	[p17l1152t841r1747b913],

1	Br	NN	O	br	_	0	SENT_297	[p17l1808t845r1885b895],
2	I	CD	NUMBER	i	num	1	SENT_297	[p17l1932t845r1967b909],
3	Clin	NNP	O	Clin	nn	4	SENT_297	[p17l2020t841r2148b896],
4	Pharmacol	NNP	O	Pharmacol	dep	1	SENT_297	[p17l7t927r377b982],
5	.	.	O	.	_	0	SENT_297	[p17l7t927r377b982],

1	2004	CD	DATE	2004	_	0	SENT_298	[p17l409t935r958b990],
2	;	:	O	;	_	0	SENT_298	[p17l409t935r958b990],
3	58:443	CD	NUMBER	58:443	number	4	SENT_298	[p17l409t935r958b990],
4	-444	CD	NUMBER	-444	dep	1	SENT_298	[p17l409t935r958b990],
5	.	.	O	.	_	0	SENT_298	[p17l409t935r958b990],

1	22	CD	NUMBER	22	_	0	SENT_299	[p17l10t1029r101b1075],
2	.	.	O	.	_	0	SENT_299	[p17l10t1029r101b1075],

1	Haufroid	JJ	O	haufroid	amod	2	SENT_300	[p17l132t1021r423b1076],
2	V	NN	O	v	_	0	SENT_300	[p17l450t1025r508b1084],
3	,	,	O	,	_	0	SENT_300	[p17l450t1025r508b1084],
4	Mourad	NNP	PERSON	Mourad	nn	5	SENT_300	[p17l538t1021r794b1076],
5	M	NNP	PERSON	M	appos	2	SENT_300	[p17l821t1025r902b1084],
6	,	,	O	,	_	0	SENT_300	[p17l821t1025r902b1084],
7	Van	NNP	PERSON	Van	nn	9	SENT_300	[p17l932t1025r1056b1075],
8	Kerckhove	NNP	PERSON	Kerckhove	nn	9	SENT_300	[p17l1084t1021r1429b1076],
9	V	NNP	O	V	appos	2	SENT_300	[p17l1456t1025r1515b1084],
10	,	,	O	,	_	0	SENT_300	[p17l1456t1025r1515b1084],
11	et	FW	O	et	nn	12	SENT_300	[p17l1547t1029r1603b1076],
12	al.	FW	O	al.	appos	2	SENT_300	[p17l1631t1021r1702b1075],
13	.	.	O	.	_	0	SENT_300	[p17l1631t1021r1702b1075],

1	The	DT	O	the	det	2	SENT_301	[p17l1734t1021r1856b1076],
2	effect	NN	O	effect	nsubj	8	SENT_301	[p17l1887t1021r2062b1076],
3	of	IN	O	of	_	0	SENT_301	[p17l2090t1021r2154b1076],
4	CYP3A5	NN	O	cyp3a5	prep_of	2	SENT_301	[p17l9t1108r279b1160],
5	and	CC	O	and	_	0	SENT_301	[p17l325t1105r445b1160],
6	MDR1	NN	O	mdr1	prep_of	2	SENT_301	[p17l486t1109r685b1160],
7	(	CD	NUMBER	(	num	8	SENT_301	[p17l735t1105r1010b1170],
8	ABCB1	NN	O	abcb1	_	0	SENT_301	[p17l735t1105r1010b1170],
9	)	CD	NUMBER	)	num	10	SENT_301	[p17l735t1105r1010b1170],
10	polymorphisms	NNS	O	polymorphism	dobj	8	SENT_301	[p17l1055t1105r1566b1177],
11	on	IN	O	on	_	0	SENT_301	[p17l1611t1124r1690b1160],
12	cyclosporine	NN	O	cyclosporine	nn	16	SENT_301	[p17l1733t1105r2148b1177],
13	and	CC	O	and	_	0	SENT_301	[p17l9t1192r128b1246],
14	tacrolimus	NN	O	tacrolimus	nn	16	SENT_301	[p17l152t1192r497b1246],
15	dose	NN	O	dose	nn	16	SENT_301	[p17l526t1192r670b1246],
16	requirements	NNS	O	requirement	prep_on	10	SENT_301	[p17l694t1194r1123b1263],
17	and	CC	O	and	_	0	SENT_301	[p17l1150t1192r1269b1246],
18	trough	NN	O	trough	nn	20	SENT_301	[p17l1293t1191r1505b1263],
19	blood	NN	O	blood	nn	20	SENT_301	[p17l1527t1191r1712b1246],
20	levels	NNS	O	level	prep_on	10	SENT_301	[p17l1737t1192r1922b1246],
21	in	IN	O	in	_	0	SENT_301	[p17l1949t1194r2013b1246],
22	stable	JJ	O	stable	amod	25	SENT_301	[p17l2039t1199r2148b1246, p17l6t1278r103b1332],
23	renal	JJ	O	renal	amod	25	SENT_301	[p17l124t1278r287b1332],
24	transplant	NN	O	transplant	nn	25	SENT_301	[p17l307t1278r639b1350],
25	patients	NNS	O	patient	prep_in	8	SENT_301	[p17l659t1281r932b1350],
26	.	.	O	.	_	0	SENT_301	[p17l659t1281r932b1350],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_302	[p17l956t1278r1567b1349],
2	.	.	O	.	_	0	SENT_302	[p17l956t1278r1567b1349],

1	2004	CD	DATE	2004	_	0	SENT_303	[p17l1594t1285r2144b1341],
2	;	:	O	;	_	0	SENT_303	[p17l1594t1285r2144b1341],
3	14:147	CD	NUMBER	14:147	number	4	SENT_303	[p17l1594t1285r2144b1341],
4	-154	CD	NUMBER	-154	dep	1	SENT_303	[p17l1594t1285r2144b1341],
5	.	.	O	.	_	0	SENT_303	[p17l1594t1285r2144b1341],

1	23	CD	NUMBER	23	_	0	SENT_304	[p17l10t1380r101b1427],
2	.	.	O	.	_	0	SENT_304	[p17l10t1380r101b1427],

1	Hesselink	NNP	ORGANIZATION	Hesselink	nn	2	SENT_305	[p17l126t1373r443b1427],
2	DA	NNP	ORGANIZATION	DA	_	0	SENT_305	[p17l461t1376r583b1435],
3	,	,	O	,	_	0	SENT_305	[p17l461t1376r583b1435],
4	van	NNP	PERSON	van	nn	6	SENT_305	[p17l606t1392r722b1427],
5	Schaik	NNP	PERSON	Schaik	nn	6	SENT_305	[p17l745t1373r961b1427],
6	RH	NNP	O	RH	appos	2	SENT_305	[p17l980t1376r1097b1435],
7	,	,	O	,	_	0	SENT_305	[p17l980t1376r1097b1435],
8	van	NNP	PERSON	van	nn	11	SENT_305	[p17l1120t1392r1236b1427],
9	der	NNP	PERSON	der	nn	11	SENT_305	[p17l1260t1373r1361b1427],
10	Heiden	NNP	PERSON	Heiden	nn	11	SENT_305	[p17l1381t1373r1615b1427],
11	IP	NNP	O	IP	appos	2	SENT_305	[p17l1635t1376r1707b1435],
12	,	,	O	,	_	0	SENT_305	[p17l1635t1376r1707b1435],
13	et	FW	O	et	nn	14	SENT_305	[p17l1732t1381r1788b1427],
14	al.	FW	O	al.	appos	2	SENT_305	[p17l1809t1373r1879b1427],
15	.	.	O	.	_	0	SENT_305	[p17l1809t1373r1879b1427],

1	Genetic	JJ	O	genetic	amod	2	SENT_306	[p17l1905t1375r2147b1427],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_306	[p17l8t1458r514b1530],
3	of	IN	O	of	_	0	SENT_306	[p17l549t1458r613b1513],
4	the	DT	O	the	det	5	SENT_306	[p17l637t1458r736b1513],
5	CYP3A4	NN	O	cyp3a4	prep_of	2	SENT_306	[p17l768t1461r1057b1521],
6	,	,	O	,	_	0	SENT_306	[p17l768t1461r1057b1521],
7	CYP3A5	NN	O	cyp3a5	prep_of	2	SENT_306	[p17l1092t1461r1380b1521],
8	,	,	O	,	_	0	SENT_306	[p17l1092t1461r1380b1521],
9	and	CC	O	and	_	0	SENT_306	[p17l1415t1458r1533b1513],
10	MDR-1	NN	O	mdr-1	nn	11	SENT_306	[p17l1563t1462r1785b1512],
11	genes	NNS	O	gene	conj_and	5	SENT_306	[p17l1820t1477r1996b1530],
12	and	CC	O	and	_	0	SENT_306	[p17l2030t1458r2149b1513],
13	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	5	SENT_306	[p17l8t1543r586b1615],
14	of	IN	O	of	_	0	SENT_306	[p17l619t1543r684b1598],
15	the	DT	O	the	det	18	SENT_306	[p17l706t1543r806b1598],
16	calcineurin	NN	O	calcineurin	nn	18	SENT_306	[p17l838t1543r1206b1598],
17	inhibitors	NNS	O	inhibitor	nn	18	SENT_306	[p17l1236t1543r1551b1598],
18	cyclosporine	NN	O	cyclosporine	prep_of	2	SENT_306	[p17l1584t1543r1999b1615],
19	and	CC	O	and	_	0	SENT_306	[p17l2030t1543r2149b1598],
20	tacrolimus	NN	O	tacrolimus	conj_and	18	SENT_306	[p17l8t1630r370b1684],
21	.	.	O	.	_	0	SENT_306	[p17l8t1630r370b1684],

1	Clin	NNP	O	Clin	nn	3	SENT_307	[p17l403t1629r531b1684],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_307	[p17l556t1629r913b1684],
3	Ther	NNP	O	Ther	_	0	SENT_307	[p17l941t1630r1102b1684],
4	.	.	O	.	_	0	SENT_307	[p17l941t1630r1102b1684],

1	2003	CD	DATE	2003	_	0	SENT_308	[p17l1134t1637r1684b1692],
2	;	:	O	;	_	0	SENT_308	[p17l1134t1637r1684b1692],
3	74:245	CD	NUMBER	74:245	number	4	SENT_308	[p17l1134t1637r1684b1692],
4	-254	CD	NUMBER	-254	dep	1	SENT_308	[p17l1134t1637r1684b1692],
5	.	.	O	.	_	0	SENT_308	[p17l1134t1637r1684b1692],

1	24	CD	NUMBER	24	_	0	SENT_309	[p17l10t1731r101b1778],
2	.	.	O	.	_	0	SENT_309	[p17l10t1731r101b1778],

1	Igel	NN	O	igel	nn	2	SENT_310	[p17l141t1723r256b1795],
2	M	NN	O	m	nsubj	19	SENT_310	[p17l293t1727r374b1787],
3	,	,	O	,	_	0	SENT_310	[p17l293t1727r374b1787],
4	Sudhop	NNP	PERSON	Sudhop	nn	5	SENT_310	[p17l416t1723r666b1795],
5	T	NN	PERSON	t	nsubj	19	SENT_310	[p17l705t1727r760b1787],
6	,	,	O	,	_	0	SENT_310	[p17l705t1727r760b1787],
7	von	NN	PERSON	von	nn	10	SENT_310	[p17l798t1742r919b1778],
8	Bergmann	NNP	PERSON	Bergmann	nn	10	SENT_310	[p17l955t1727r1286b1795],
9	K.	NNP	PERSON	K.	nn	10	SENT_310	[p17l1322t1727r1386b1778],
10	Metabolism	NNP	PERSON	Metabolism	conj_and	2	SENT_310	[p17l1426t1723r1809b1778],
11	and	CC	O	and	_	0	SENT_310	[p17l1846t1723r1965b1778],
12	drug	NN	O	drug	nn	13	SENT_310	[p17l2004t1723r2149b1795],
13	interactions	NNS	O	interaction	nsubj	19	SENT_310	[p17l9t1813r388b1864],
14	of	IN	O	of	_	0	SENT_310	[p17l415t1810r479b1864],
15	3-hydroxy-3-methylglutaryl	JJ	O	3-hydroxy-3-methylglutaryl	amod	18	SENT_310	[p17l500t1810r1392b1881],
16	coenzyme	NN	O	coenzyme	nn	18	SENT_310	[p17l1417t1829r1738b1881],
17	A-reductase	NN	MISC	a-reductase	nn	18	SENT_310	[p17l1763t1810r2148b1864],
18	inhibitors	NNS	O	inhibitor	prep_of	13	SENT_310	[p17l9t1896r324b1951],
19	(	VBP	O	(	_	0	SENT_310	[p17l355t1896r625b1961],
20	statins	NNS	O	statin	dobj	19	SENT_310	[p17l355t1896r625b1961],
21	)	CD	NUMBER	)	tmod	19	SENT_310	[p17l355t1896r625b1961],
22	.	.	O	.	_	0	SENT_310	[p17l355t1896r625b1961],

1	Eur	NNP	MISC	Eur	nn	4	SENT_311	[p17l653t1900r821b1964],
2	]	NNP	O	]	nn	4	SENT_311	[p17l653t1900r821b1964],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_311	[p17l842t1896r969b1951],
4	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_311	[p17l994t1896r1364b1951],
5	.	.	O	.	_	0	SENT_311	[p17l994t1896r1364b1951],

1	2001	CD	DATE	2001	_	0	SENT_312	[p17l1396t1904r1945b1960],
2	;	:	O	;	_	0	SENT_312	[p17l1396t1904r1945b1960],
3	57:357	CD	NUMBER	57:357	number	4	SENT_312	[p17l1396t1904r1945b1960],
4	-364	CD	NUMBER	-364	dep	1	SENT_312	[p17l1396t1904r1945b1960],
5	.	.	O	.	_	0	SENT_312	[p17l1396t1904r1945b1960],

1	PHARMACOGENOMICS	NN	O	pharmacogenomic	_	0	SENT_313	[p17l13t2125r852b2186],
2	25	CD	NUMBER	25	dep	1	SENT_313	[p17l10t2224r102b2271],
3	.	.	O	.	_	0	SENT_313	[p17l10t2224r102b2271],

1	Martin	NNP	PERSON	Martin	nn	2	SENT_314	[p17l129t2219r349b2271],
2	J	NNP	PERSON	J	_	0	SENT_314	[p17l372t2220r412b2284],
3	,	,	O	,	_	0	SENT_314	[p17l372t2220r412b2284],
4	Krum	NNP	PERSON	Krum	nn	9	SENT_314	[p17l441t2219r624b2271],
5	H.	NNP	O	H.	nn	9	SENT_314	[p17l649t2220r717b2271],
6	Cytochrome	NNP	O	Cytochrome	nn	9	SENT_314	[p17l748t2216r1140b2288],
7	P450	NN	O	p450	nn	9	SENT_314	[p17l1166t2220r1324b2271],
8	drug	NN	O	drug	nn	9	SENT_314	[p17l1354t2216r1500b2288],
9	interactions	NNS	O	interaction	appos	2	SENT_314	[p17l1526t2219r1909b2271],
10	within	IN	O	within	_	0	SENT_314	[p17l1936t2216r2152b2271],
11	the	DT	O	the	det	15	SENT_314	[p17l8t2302r107b2357],
12	HMG-CoA	NN	O	hmg-coa	nn	15	SENT_314	[p17l139t2305r478b2357],
13	reductase	NN	O	reductase	nn	15	SENT_314	[p17l507t2302r818b2357],
14	inhibitor	NN	O	inhibitor	nn	15	SENT_314	[p17l850t2302r1137b2357],
15	class	NN	O	class	prep_within	9	SENT_314	[p17l1168t2302r1339b2357],
16	:	:	O	:	_	0	SENT_314	[p17l1168t2302r1339b2357],
17	are	VBP	O	be	cop	20	SENT_314	[p17l1375t2321r1468b2357],
18	they	PRP	O	they	nsubj	20	SENT_314	[p17l1500t2302r1641b2374],
19	clinically	RB	O	clinically	advmod	20	SENT_314	[p17l1672t2302r1978b2374],
20	relevant	JJ	O	relevant	dep	15	SENT_314	[p17l2008t2302r2151b2357, p17l7t2390r178b2442],
21	?	.	O	?	_	0	SENT_314	[p17l2008t2302r2151b2357, p17l7t2390r178b2442],

1	Drug	NN	O	drug	_	0	SENT_315	[p17l204t2391r366b2459],
2	Saf	NN	O	saf	dep	1	SENT_315	[p17l389t2388r505b2459],
3	.	.	O	.	_	0	SENT_315	[p17l389t2388r505b2459],

1	2003	CD	DATE	2003	_	0	SENT_316	[p17l538t2395r1009b2451],
2	;	:	O	;	_	0	SENT_316	[p17l538t2395r1009b2451],
3	26:13	CD	NUMBER	26:13	number	4	SENT_316	[p17l538t2395r1009b2451],
4	-21	CD	NUMBER	-21	dep	1	SENT_316	[p17l538t2395r1009b2451],
5	.	.	O	.	_	0	SENT_316	[p17l538t2395r1009b2451],

1	26	CD	NUMBER	26	_	0	SENT_317	[p17l10t2491r101b2538],
2	.	.	O	.	_	0	SENT_317	[p17l10t2491r101b2538],

1	Kivisto	NNP	PERSON	Kivisto	nn	2	SENT_318	[p17l147t2486r376b2538],
2	KT	NNP	O	KT	_	0	SENT_318	[p17l420t2487r527b2547],
3	,	,	O	,	_	0	SENT_318	[p17l420t2487r527b2547],
4	Niemi	NNP	PERSON	Niemi	nn	5	SENT_318	[p17l571t2486r770b2538],
5	M	NNP	O	M	appos	2	SENT_318	[p17l812t2487r894b2547],
6	,	,	O	,	_	0	SENT_318	[p17l812t2487r894b2547],
7	Schaeffeler	NNP	O	Schaeffeler	nn	8	SENT_318	[p17l941t2483r1302b2538],
8	E	NNP	O	E	appos	2	SENT_318	[p17l1342t2487r1401b2547],
9	,	,	O	,	_	0	SENT_318	[p17l1342t2487r1401b2547],
10	et	FW	O	et	nn	11	SENT_318	[p17l1447t2491r1503b2538],
11	al.	FW	O	al.	appos	2	SENT_318	[p17l1545t2483r1616b2538],
12	.	.	O	.	_	0	SENT_318	[p17l1545t2483r1616b2538],

1	Lipid-lowering	JJ	O	lipid-lowering	amod	2	SENT_319	[p17l1663t2483r2152b2555],
2	response	NN	O	response	nsubjpass	6	SENT_319	[p17l7t2588r294b2640],
3	to	TO	O	to	_	0	SENT_319	[p17l326t2577r385b2623],
4	statins	NNS	O	statin	prep_to	2	SENT_319	[p17l419t2571r627b2623],
5	is	VBZ	O	be	auxpass	6	SENT_319	[p17l661t2571r711b2623],
6	affected	VBN	O	affect	_	0	SENT_319	[p17l745t2569r999b2623],
7	by	IN	O	by	_	0	SENT_319	[p17l1028t2568r1107b2640],
8	CYP3A5	NN	O	cyp3a5	nn	9	SENT_319	[p17l1138t2571r1408b2623],
9	polymorphism	NN	O	polymorphism	agent	6	SENT_319	[p17l1444t2568r1941b2640],
10	.	.	O	.	_	0	SENT_319	[p17l1444t2568r1941b2640],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_320	[p17l1976t2569r2153b2623, p17l8t2658r464b2727],
2	.	.	O	.	_	0	SENT_320	[p17l1976t2569r2153b2623, p17l8t2658r464b2727],

1	2004	CD	DATE	2004	_	0	SENT_321	[p17l497t2662r1047b2718],
2	;	:	O	;	_	0	SENT_321	[p17l497t2662r1047b2718],
3	14:523	CD	NUMBER	14:523	number	4	SENT_321	[p17l497t2662r1047b2718],
4	-525	CD	NUMBER	-525	dep	1	SENT_321	[p17l497t2662r1047b2718],
5	.	.	O	.	_	0	SENT_321	[p17l497t2662r1047b2718],

1	27	CD	NUMBER	27	_	0	SENT_322	[p17l10t2757r102b2804],
2	.	.	O	.	_	0	SENT_322	[p17l10t2757r102b2804],

1	Fiegenbaum	NNP	PERSON	Fiegenbaum	nn	2	SENT_323	[p17l136t2750r533b2821],
2	M	NN	O	m	_	0	SENT_323	[p17l564t2753r646b2813],
3	,	,	O	,	_	0	SENT_323	[p17l564t2753r646b2813],
4	da	NN	PERSON	da	nn	6	SENT_323	[p17l682t2750r757b2804],
5	Silveira	NNP	PERSON	Silveira	nn	6	SENT_323	[p17l789t2750r1039b2804],
6	FR	NN	O	fr	appos	2	SENT_323	[p17l1069t2753r1174b2813],
7	,	,	O	,	_	0	SENT_323	[p17l1069t2753r1174b2813],
8	Van	NNP	PERSON	Van	nn	10	SENT_323	[p17l1207t2753r1331b2804],
9	der	NNP	O	der	nn	10	SENT_323	[p17l1364t2750r1466b2804],
10	Sand	NNP	O	Sand	appos	2	SENT_323	[p17l1499t2750r1660b2804],
11	CR	NN	O	cr	dep	10	SENT_323	[p17l1691t2752r1800b2813],
12	,	,	O	,	_	0	SENT_323	[p17l1691t2752r1800b2813],
13	et	FW	O	et	nn	14	SENT_323	[p17l1835t2758r1891b2804],
14	al.	FW	O	al.	appos	2	SENT_323	[p17l1922t2750r1993b2804],
15	.	.	O	.	_	0	SENT_323	[p17l1922t2750r1993b2804],

1	The	DT	O	the	det	2	SENT_324	[p17l2028t2750r2151b2804],
2	role	NN	O	role	_	0	SENT_324	[p17l7t2836r131b2891],
3	of	IN	O	of	_	0	SENT_324	[p17l159t2836r224b2891],
4	common	JJ	O	common	amod	5	SENT_324	[p17l245t2855r527b2891],
5	variants	NNS	O	variant	prep_of	2	SENT_324	[p17l552t2839r810b2891],
6	of	IN	O	of	_	0	SENT_324	[p17l840t2836r904b2891],
7	ABCB1	NN	O	abcb1	nn	9	SENT_324	[p17l924t2839r1176b2899],
8	,	,	O	,	_	0	SENT_324	[p17l924t2839r1176b2899],
9	CYP3A4	NN	O	cyp3a4	prep_of	5	SENT_324	[p17l1206t2839r1497b2899],
10	,	,	O	,	_	0	SENT_324	[p17l1206t2839r1497b2899],
11	and	CC	O	and	_	0	SENT_324	[p17l1527t2836r1646b2891],
12	CYP3A5	NN	O	cyp3a5	nn	13	SENT_324	[p17l1672t2839r1943b2891],
13	genes	NNS	O	gene	prep_of	5	SENT_324	[p17l1972t2855r2150b2908],
14	in	IN	O	in	_	0	SENT_324	[p17l9t2924r73b2975],
15	lipid-lowering	JJ	O	lipid-lowering	amod	16	SENT_324	[p17l114t2921r583b2993],
16	efficacy	NN	O	efficacy	prep_in	2	SENT_324	[p17l625t2921r876b2993],
17	and	CC	O	and	_	0	SENT_324	[p17l917t2921r1036b2976],
18	safety	NN	O	safety	conj_and	16	SENT_324	[p17l1078t2921r1265b2993],
19	of	IN	O	of	_	0	SENT_324	[p17l1307t2921r1372b2976],
20	simvastatin	NN	O	simvastatin	nn	21	SENT_324	[p17l1408t2924r1781b2976],
21	treatment	NN	O	treatment	prep_of	2	SENT_324	[p17l1821t2929r2148b2976],
22	.	.	O	.	_	0	SENT_324	[p17l1821t2929r2148b2976],

1	Clin	NNP	O	Clin	nn	3	SENT_325	[p17l12t3008r140b3063],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_325	[p17l166t3008r523b3063],
3	Ther	NNP	O	Ther	_	0	SENT_325	[p17l551t3008r712b3063],
4	.	.	O	.	_	0	SENT_325	[p17l551t3008r712b3063],

1	2005	CD	DATE	2005	_	0	SENT_326	[p17l745t3016r1295b3071],
2	;	:	O	;	_	0	SENT_326	[p17l745t3016r1295b3071],
3	78:551	CD	NUMBER	78:551	number	4	SENT_326	[p17l745t3016r1295b3071],
4	-558	CD	NUMBER	-558	dep	1	SENT_326	[p17l745t3016r1295b3071],
5	.	.	O	.	_	0	SENT_326	[p17l745t3016r1295b3071],

1	28	CD	NUMBER	28	_	0	SENT_327	[p17l10t3110r102b3157],
2	.	.	O	.	_	0	SENT_327	[p17l10t3110r102b3157],

1	Yu	NNP	PERSON	Yu	nn	2	SENT_328	[p17l126t3106r214b3157],
2	KS	NN	PERSON	k	_	0	SENT_328	[p17l237t3105r345b3166],
3	,	,	O	,	_	0	SENT_328	[p17l237t3105r345b3166],
4	Cho	NNP	PERSON	Cho	nn	5	SENT_328	[p17l371t3102r497b3157],
5	IY	NNP	O	IY	appos	2	SENT_328	[p17l518t3106r603b3171],
6	,	,	O	,	_	0	SENT_328	[p17l518t3106r603b3171],
7	Iang	NNP	O	Iang	appos	2	SENT_328	[p17l625t3106r764b3174],
8	I	PRP	O	I	nsubj	9	SENT_328	[p17l785t3106r847b3171],
9	]	VBP	O	]	rcmod	7	SENT_328	[p17l785t3106r847b3171],
10	,	,	O	,	_	0	SENT_328	[p17l785t3106r847b3171],
11	et	FW	O	et	nn	12	SENT_328	[p17l873t3111r929b3157],
12	al.	FW	O	al.	appos	7	SENT_328	[p17l951t3102r1022b3157],
13	.	.	O	.	_	0	SENT_328	[p17l951t3102r1022b3157],

1	Effect	NN	O	effect	_	0	SENT_329	[p17l1047t3103r1233b3157],
2	of	IN	O	of	_	0	SENT_329	[p17l1255t3103r1320b3157],
3	the	DT	O	the	det	5	SENT_329	[p17l1335t3103r1435b3157],
4	CYP3A5	NN	O	cyp3a5	nn	5	SENT_329	[p17l1458t3105r1729b3157],
5	genotype	NN	O	genotype	prep_of	1	SENT_329	[p17l1755t3110r2049b3174],
6	on	IN	O	on	_	0	SENT_329	[p17l2074t3122r2152b3157],
7	the	DT	O	the	det	8	SENT_329	[p17l8t3189r107b3243],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_329	[p17l131t3189r711b3261],
9	of	IN	O	of	_	0	SENT_329	[p17l738t3189r802b3243],
10	intravenous	JJ	O	intravenous	amod	11	SENT_329	[p17l820t3192r1204b3243],
11	midazolam	NN	O	midazolam	prep_of	1	SENT_329	[p17l1229t3189r1592b3243],
12	during	IN	O	during	_	0	SENT_329	[p17l1617t3189r1830b3260],
13	inhibited	VBN	O	inhibit	amod	17	SENT_329	[p17l1854t3189r2152b3243],
14	and	CC	O	and	_	0	SENT_329	[p17l9t3275r132b3329],
15	induced	VBN	O	induce	conj_and	13	SENT_329	[p17l166t3275r442b3329],
16	metabolic	JJ	O	metabolic	amod	17	SENT_329	[p17l475t3275r805b3329],
17	states	NNS	O	state	prep_during	1	SENT_329	[p17l842t3283r1044b3329],
18	.	.	O	.	_	0	SENT_329	[p17l842t3283r1044b3329],

1	Clin	NNP	O	Clin	nn	3	SENT_330	[p17l1087t3275r1219b3329],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_330	[p17l1253t3275r1624b3329],
3	Ther	NNP	O	Ther	_	0	SENT_330	[p17l1660t3275r1828b3329],
4	.	.	O	.	_	0	SENT_330	[p17l1660t3275r1828b3329],

1	2004	CD	DATE	2004	_	0	SENT_331	[p17l1868t3283r2149b3338],
2	;	:	O	;	_	0	SENT_331	[p17l1868t3283r2149b3338],
3	76	CD	NUMBER	76	num	5	SENT_331	[p17l1868t3283r2149b3338],
4	:	:	O	:	_	0	SENT_331	[p17l1868t3283r2149b3338],
5	104-112	CD	NUMBER	104-112	dep	1	SENT_331	[p17l12t3368r283b3415],
6	.	.	O	.	_	0	SENT_331	[p17l12t3368r283b3415],

1	29	CD	NUMBER	29	_	0	SENT_332	[p17l10t3463r102b3510],
2	.	.	O	.	_	0	SENT_332	[p17l10t3463r102b3510],

1	Kivisto	NNP	PERSON	Kivisto	nn	2	SENT_333	[p17l142t3458r371b3510],
2	KT	NNP	O	KT	_	0	SENT_333	[p17l410t3459r517b3518],
3	,	,	O	,	_	0	SENT_333	[p17l410t3459r517b3518],
4	Bookjans	NNP	MISC	Bookjans	nn	5	SENT_333	[p17l556t3455r850b3527],
5	G	NNP	O	G	appos	2	SENT_333	[p17l889t3458r954b3518],
6	,	,	O	,	_	0	SENT_333	[p17l889t3458r954b3518],
7	Fromm	NNP	ORGANIZATION	Fromm	nn	8	SENT_333	[p17l994t3459r1229b3510],
8	MF	NN	ORGANIZATION	mf	appos	5	SENT_333	[p17l1266t3459r1383b3518],
9	,	,	O	,	_	0	SENT_333	[p17l1266t3459r1383b3518],
10	Griese	NNP	ORGANIZATION	Griese	nn	11	SENT_333	[p17l1424t3458r1625b3510],
11	EU	NNP	ORGANIZATION	EU	appos	5	SENT_333	[p17l1663t3459r1777b3518],
12	,	,	O	,	_	0	SENT_333	[p17l1663t3459r1777b3518],
13	Munzel	NNP	PERSON	Munzel	nn	14	SENT_333	[p17l1816t3455r2063b3510],
14	P	NN	PERSON	p	appos	5	SENT_333	[p17l2100t3459r2149b3518],
15	,	,	O	,	_	0	SENT_333	[p17l2100t3459r2149b3518],
16	Kroemer	NNP	PERSON	Kroemer	nn	17	SENT_333	[p17l9t3545r288b3596],
17	HK	NNP	O	HK	appos	5	SENT_333	[p17l324t3545r443b3596],
18	.	.	O	.	_	0	SENT_333	[p17l324t3545r443b3596],

1	Expression	NN	O	expression	_	0	SENT_334	[p17l483t3544r843b3613],
2	of	IN	O	of	_	0	SENT_334	[p17l881t3541r946b3596],
3	CYP3A4	NN	O	cyp3a4	prep_of	1	SENT_334	[p17l977t3544r1269b3605],
4	,	,	O	,	_	0	SENT_334	[p17l977t3544r1269b3605],
5	CYP3A5	NN	O	cyp3a5	prep_of	1	SENT_334	[p17l1308t3544r1579b3596],
6	and	CC	O	and	_	0	SENT_334	[p17l1620t3541r1740b3596],
7	CYP3A7	NN	O	cyp3a7	prep_of	1	SENT_334	[p17l1777t3544r2049b3596],
8	in	IN	O	in	_	0	SENT_334	[p17l2088t3544r2152b3595],
9	human	JJ	O	human	amod	11	SENT_334	[p17l8t3627r236b3681],
10	duodenal	JJ	O	duodenal	amod	11	SENT_334	[p17l263t3627r567b3681],
11	tissue	NN	O	tissue	prep_in	1	SENT_334	[p17l592t3630r795b3681],
12	.	.	O	.	_	0	SENT_334	[p17l592t3630r795b3681],

1	Br	NN	O	br	_	0	SENT_335	[p17l824t3630r950b3695],
2	]	CD	NUMBER	]	num	1	SENT_335	[p17l824t3630r950b3695],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_335	[p17l971t3627r1099b3681],
4	Pharmacol	NNP	PERSON	Pharmacol	dep	1	SENT_335	[p17l1124t3627r1494b3681],
5	.	.	O	.	_	0	SENT_335	[p17l1124t3627r1494b3681],

1	1996	CD	DATE	1996	_	0	SENT_336	[p17l1527t3634r2077b3690],
2	;	:	O	;	_	0	SENT_336	[p17l1527t3634r2077b3690],
3	42:387	CD	NUMBER	42:387	number	4	SENT_336	[p17l1527t3634r2077b3690],
4	-389	CD	NUMBER	-389	dep	1	SENT_336	[p17l1527t3634r2077b3690],
5	.	.	O	.	_	0	SENT_336	[p17l1527t3634r2077b3690],

1	30	CD	NUMBER	30	_	0	SENT_337	[p18l10t28r102b75],
2	.	.	O	.	_	0	SENT_337	[p18l10t28r102b75],

1	Mauro	NNP	PERSON	Mauro	nn	2	SENT_338	[p18l137t24r347b75],
2	VF	NNP	O	VF	_	0	SENT_338	[p18l381t24r481b75],
3	.	.	O	.	_	0	SENT_338	[p18l381t24r481b75],

1	Clinical	JJ	O	clinical	amod	2	SENT_339	[p18l519t20r773b75],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_339	[p18l807t21r1386b92],
3	and	CC	O	and	_	0	SENT_339	[p18l1422t21r1540b75],
4	practical	JJ	O	practical	amod	5	SENT_339	[p18l1573t21r1856b92],
5	applications	NNS	O	application	conj_and	2	SENT_339	[p18l1890t21r2151b92, p18l8t111r166b162],
6	of	IN	O	of	_	0	SENT_339	[p18l195t108r259b162],
7	simvastatin	NN	O	simvastatin	prep_of	5	SENT_339	[p18l280t111r668b162],
8	.	.	O	.	_	0	SENT_339	[p18l280t111r668b162],

1	CI1	NN	O	ci1	_	0	SENT_340	[p18l702t108r829b162],
2	'n	CC	O	'n	cc	3	SENT_340	[p18l702t108r829b162],
3	Pharmacokinet	NN	O	pharmacokinet	dep	1	SENT_340	[p18l855t108r1368b162],
4	.	.	O	.	_	0	SENT_340	[p18l855t108r1368b162],

1	1993	CD	DATE	1993	_	0	SENT_341	[p18l1401t115r1951b170],
2	;	:	O	;	_	0	SENT_341	[p18l1401t115r1951b170],
3	24:195	CD	NUMBER	24:195	number	4	SENT_341	[p18l1401t115r1951b170],
4	-202	CD	NUMBER	-202	dep	1	SENT_341	[p18l1401t115r1951b170],
5	.	.	O	.	_	0	SENT_341	[p18l1401t115r1951b170],

